,GeneID,GO_ID,gene-symbol,GO_term,gene-score
553,23394,GO:0000785,ADNP,chromatin,1.0
554,23394,GO:0000981,ADNP,"DNA-binding transcription factor activity, RNA polymerase II-specific",1.0
555,23394,GO:0003677,ADNP,DNA binding,1.0
556,23394,GO:0005507,ADNP,copper ion binding,1.0
557,23394,GO:0005515,ADNP,protein binding,1.0
558,23394,GO:0005615,ADNP,extracellular space,1.0
559,23394,GO:0005634,ADNP,nucleus,1.0
560,23394,GO:0005737,ADNP,cytoplasm,1.0
561,23394,GO:0006357,ADNP,regulation of transcription by RNA polymerase II,1.0
562,23394,GO:0007614,ADNP,short-term memory,1.0
563,23394,GO:0009743,ADNP,response to carbohydrate,1.0
564,23394,GO:0010035,ADNP,response to inorganic substance,1.0
565,23394,GO:0010468,ADNP,regulation of gene expression,1.0
566,23394,GO:0010629,ADNP,negative regulation of gene expression,1.0
567,23394,GO:0010835,ADNP,regulation of protein ADP-ribosylation,1.0
568,23394,GO:0019934,ADNP,cGMP-mediated signaling,1.0
569,23394,GO:0030424,ADNP,axon,1.0
570,23394,GO:0030425,ADNP,dendrite,1.0
571,23394,GO:0031668,ADNP,cellular response to extracellular stimulus,1.0
572,23394,GO:0032091,ADNP,negative regulation of protein binding,1.0
573,23394,GO:0032147,ADNP,activation of protein kinase activity,1.0
574,23394,GO:0033484,ADNP,nitric oxide homeostasis,1.0
575,23394,GO:0042277,ADNP,peptide binding,1.0
576,23394,GO:0043025,ADNP,neuronal cell body,1.0
577,23394,GO:0043524,ADNP,negative regulation of neuron apoptotic process,1.0
578,23394,GO:0044849,ADNP,estrous cycle,1.0
579,23394,GO:0045773,ADNP,positive regulation of axon extension,1.0
580,23394,GO:0048487,ADNP,beta-tubulin binding,1.0
581,23394,GO:0050731,ADNP,positive regulation of peptidyl-tyrosine phosphorylation,1.0
582,23394,GO:0050805,ADNP,negative regulation of synaptic transmission,1.0
583,23394,GO:0051965,ADNP,positive regulation of synapse assembly,1.0
584,23394,GO:0090575,ADNP,RNA polymerase II transcription regulator complex,1.0
598,158,GO:0001666,ADSL,response to hypoxia,1.0
599,158,GO:0004018,ADSL,"N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity",1.0
600,158,GO:0004018,ADSL,"N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity",1.0
601,158,GO:0005829,ADSL,cytosol,1.0
602,158,GO:0005829,ADSL,cytosol,1.0
603,158,GO:0005829,ADSL,cytosol,1.0
604,158,GO:0006164,ADSL,purine nucleotide biosynthetic process,1.0
605,158,GO:0006167,ADSL,AMP biosynthetic process,1.0
606,158,GO:0006189,ADSL,'de novo' IMP biosynthetic process,1.0
607,158,GO:0007584,ADSL,response to nutrient,1.0
608,158,GO:0009060,ADSL,aerobic respiration,1.0
609,158,GO:0009168,ADSL,purine ribonucleoside monophosphate biosynthetic process,1.0
610,158,GO:0014850,ADSL,response to muscle activity,1.0
611,158,GO:0032991,ADSL,protein-containing complex,1.0
612,158,GO:0042594,ADSL,response to starvation,1.0
613,158,GO:0042802,ADSL,identical protein binding,1.0
614,158,GO:0044208,ADSL,'de novo' AMP biosynthetic process,1.0
615,158,GO:0044208,ADSL,'de novo' AMP biosynthetic process,1.0
616,158,GO:0070626,ADSL,(S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate AMP-lyase (fumarate-forming) activity,1.0
617,2334,GO:0002151,AFF2,G-quadruplex RNA binding,1.0
618,2334,GO:0002151,AFF2,G-quadruplex RNA binding,1.0
619,2334,GO:0006397,AFF2,mRNA processing,1.0
620,2334,GO:0007420,AFF2,brain development,1.0
621,2334,GO:0007611,AFF2,learning or memory,1.0
622,2334,GO:0008380,AFF2,RNA splicing,1.0
623,2334,GO:0010468,AFF2,regulation of gene expression,1.0
624,2334,GO:0010468,AFF2,regulation of gene expression,1.0
625,2334,GO:0010629,AFF2,negative regulation of gene expression,1.0
626,2334,GO:0016607,AFF2,nuclear speck,1.0
627,2334,GO:0016607,AFF2,nuclear speck,1.0
628,2334,GO:0032783,AFF2,super elongation complex,1.0
629,2334,GO:0035063,AFF2,nuclear speck organization,1.0
630,2334,GO:0043484,AFF2,regulation of RNA splicing,1.0
631,2334,GO:0043484,AFF2,regulation of RNA splicing,1.0
890,27245,GO:0003677,AHDC1,DNA binding,1.0
891,27245,GO:0005515,AHDC1,protein binding,1.0
1003,7915,GO:0004777,ALDH5A1,succinate-semialdehyde dehydrogenase (NAD+) activity,1.0
1004,7915,GO:0004777,ALDH5A1,succinate-semialdehyde dehydrogenase (NAD+) activity,1.0
1005,7915,GO:0004777,ALDH5A1,succinate-semialdehyde dehydrogenase (NAD+) activity,1.0
1006,7915,GO:0004777,ALDH5A1,succinate-semialdehyde dehydrogenase (NAD+) activity,1.0
1007,7915,GO:0005739,ALDH5A1,mitochondrion,1.0
1008,7915,GO:0005739,ALDH5A1,mitochondrion,1.0
1009,7915,GO:0005739,ALDH5A1,mitochondrion,1.0
1010,7915,GO:0005759,ALDH5A1,mitochondrial matrix,1.0
1011,7915,GO:0006105,ALDH5A1,succinate metabolic process,1.0
1012,7915,GO:0006536,ALDH5A1,glutamate metabolic process,1.0
1013,7915,GO:0007417,ALDH5A1,central nervous system development,1.0
1014,7915,GO:0009450,ALDH5A1,gamma-aminobutyric acid catabolic process,1.0
1015,7915,GO:0009450,ALDH5A1,gamma-aminobutyric acid catabolic process,1.0
1016,7915,GO:0009450,ALDH5A1,gamma-aminobutyric acid catabolic process,1.0
1017,7915,GO:0009791,ALDH5A1,post-embryonic development,1.0
1018,7915,GO:0042135,ALDH5A1,neurotransmitter catabolic process,1.0
1019,7915,GO:0042802,ALDH5A1,identical protein binding,1.0
1020,7915,GO:0055114,ALDH5A1,oxidation-reduction process,1.0
1045,287,GO:0002027,ANK2,regulation of heart rate,1.0
1046,287,GO:0003283,ANK2,atrial septum development,1.0
1047,287,GO:0005515,ANK2,protein binding,1.0
1048,287,GO:0005739,ANK2,mitochondrion,1.0
1049,287,GO:0005764,ANK2,lysosome,1.0
1050,287,GO:0005769,ANK2,early endosome,1.0
1051,287,GO:0005829,ANK2,cytosol,1.0
1052,287,GO:0005856,ANK2,cytoskeleton,1.0
1053,287,GO:0005886,ANK2,plasma membrane,1.0
1054,287,GO:0005886,ANK2,plasma membrane,1.0
1055,287,GO:0005886,ANK2,plasma membrane,1.0
1056,287,GO:0005886,ANK2,plasma membrane,1.0
1057,287,GO:0006874,ANK2,cellular calcium ion homeostasis,1.0
1058,287,GO:0006888,ANK2,endoplasmic reticulum to Golgi vesicle-mediated transport,1.0
1059,287,GO:0006897,ANK2,endocytosis,1.0
1060,287,GO:0007010,ANK2,cytoskeleton organization,1.0
1061,287,GO:0008093,ANK2,cytoskeletal anchor activity,1.0
1062,287,GO:0010628,ANK2,positive regulation of gene expression,1.0
1063,287,GO:0010881,ANK2,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,1.0
1064,287,GO:0010881,ANK2,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,1.0
1065,287,GO:0010882,ANK2,regulation of cardiac muscle contraction by calcium ion signaling,1.0
1066,287,GO:0014704,ANK2,intercalated disc,1.0
1067,287,GO:0015031,ANK2,protein transport,1.0
1068,287,GO:0016323,ANK2,basolateral plasma membrane,1.0
1069,287,GO:0016324,ANK2,apical plasma membrane,1.0
1070,287,GO:0019899,ANK2,enzyme binding,1.0
1071,287,GO:0019901,ANK2,protein kinase binding,1.0
1072,287,GO:0030018,ANK2,Z disc,1.0
1073,287,GO:0030315,ANK2,T-tubule,1.0
1074,287,GO:0030507,ANK2,spectrin binding,1.0
1075,287,GO:0030507,ANK2,spectrin binding,1.0
1076,287,GO:0030674,ANK2,protein-macromolecule adaptor activity,1.0
1077,287,GO:0031430,ANK2,M band,1.0
1078,287,GO:0031647,ANK2,regulation of protein stability,1.0
1079,287,GO:0031672,ANK2,A band,1.0
1080,287,GO:0033292,ANK2,T-tubule organization,1.0
1081,287,GO:0033365,ANK2,protein localization to organelle,1.0
1082,287,GO:0034394,ANK2,protein localization to cell surface,1.0
1083,287,GO:0034613,ANK2,cellular protein localization,1.0
1084,287,GO:0036309,ANK2,protein localization to M-band,1.0
1085,287,GO:0036371,ANK2,protein localization to T-tubule,1.0
1086,287,GO:0042383,ANK2,sarcolemma,1.0
1087,287,GO:0043005,ANK2,neuron projection,1.0
1088,287,GO:0043034,ANK2,costamere,1.0
1089,287,GO:0043268,ANK2,positive regulation of potassium ion transport,1.0
1090,287,GO:0044325,ANK2,ion channel binding,1.0
1091,287,GO:0044325,ANK2,ion channel binding,1.0
1092,287,GO:0044325,ANK2,ion channel binding,1.0
1093,287,GO:0045211,ANK2,postsynaptic membrane,1.0
1094,287,GO:0050821,ANK2,protein stabilization,1.0
1095,287,GO:0051117,ANK2,ATPase binding,1.0
1096,287,GO:0051279,ANK2,regulation of release of sequestered calcium ion into cytosol,1.0
1097,287,GO:0051924,ANK2,regulation of calcium ion transport,1.0
1098,287,GO:0051928,ANK2,positive regulation of calcium ion transport,1.0
1099,287,GO:0055037,ANK2,recycling endosome,1.0
1100,287,GO:0055117,ANK2,regulation of cardiac muscle contraction,1.0
1101,287,GO:0060307,ANK2,regulation of ventricular cardiac muscle cell membrane repolarization,1.0
1102,287,GO:0070296,ANK2,sarcoplasmic reticulum calcium ion transport,1.0
1103,287,GO:0070972,ANK2,protein localization to endoplasmic reticulum,1.0
1104,287,GO:0072659,ANK2,protein localization to plasma membrane,1.0
1105,287,GO:0072659,ANK2,protein localization to plasma membrane,1.0
1106,287,GO:0072659,ANK2,protein localization to plasma membrane,1.0
1107,287,GO:0086004,ANK2,regulation of cardiac muscle cell contraction,1.0
1108,287,GO:0086005,ANK2,ventricular cardiac muscle cell action potential,1.0
1109,287,GO:0086014,ANK2,atrial cardiac muscle cell action potential,1.0
1110,287,GO:0086015,ANK2,SA node cell action potential,1.0
1111,287,GO:0086046,ANK2,membrane depolarization during SA node cell action potential,1.0
1112,287,GO:0086066,ANK2,atrial cardiac muscle cell to AV node cell communication,1.0
1113,287,GO:0086070,ANK2,SA node cell to atrial cardiac muscle cell communication,1.0
1114,287,GO:0086091,ANK2,regulation of heart rate by cardiac conduction,1.0
1115,287,GO:0086091,ANK2,regulation of heart rate by cardiac conduction,1.0
1116,287,GO:0098907,ANK2,regulation of SA node cell action potential,1.0
1117,287,GO:0098910,ANK2,regulation of atrial cardiac muscle cell action potential,1.0
1118,287,GO:0140031,ANK2,phosphorylation-dependent protein binding,1.0
1119,287,GO:1901018,ANK2,positive regulation of potassium ion transmembrane transporter activity,1.0
1120,287,GO:1901019,ANK2,regulation of calcium ion transmembrane transporter activity,1.0
1121,287,GO:1901021,ANK2,positive regulation of calcium ion transmembrane transporter activity,1.0
1122,287,GO:2001259,ANK2,positive regulation of cation channel activity,1.0
1123,288,GO:0000281,ANK3,mitotic cytokinesis,1.0
1124,288,GO:0005200,ANK3,structural constituent of cytoskeleton,1.0
1125,288,GO:0005515,ANK3,protein binding,1.0
1126,288,GO:0005764,ANK3,lysosome,1.0
1127,288,GO:0005783,ANK3,endoplasmic reticulum,1.0
1128,288,GO:0005794,ANK3,Golgi apparatus,1.0
1129,288,GO:0005829,ANK3,cytosol,1.0
1130,288,GO:0005886,ANK3,plasma membrane,1.0
1131,288,GO:0005886,ANK3,plasma membrane,1.0
1132,288,GO:0005886,ANK3,plasma membrane,1.0
1133,288,GO:0005923,ANK3,bicellular tight junction,1.0
1134,288,GO:0006888,ANK3,endoplasmic reticulum to Golgi vesicle-mediated transport,1.0
1135,288,GO:0007009,ANK3,plasma membrane organization,1.0
1136,288,GO:0007010,ANK3,cytoskeleton organization,1.0
1137,288,GO:0007165,ANK3,signal transduction,1.0
1138,288,GO:0007409,ANK3,axonogenesis,1.0
1139,288,GO:0007528,ANK3,neuromuscular junction development,1.0
1140,288,GO:0008092,ANK3,cytoskeletal protein binding,1.0
1141,288,GO:0008093,ANK3,cytoskeletal anchor activity,1.0
1142,288,GO:0009925,ANK3,basal plasma membrane,1.0
1143,288,GO:0009986,ANK3,cell surface,1.0
1144,288,GO:0010628,ANK3,positive regulation of gene expression,1.0
1145,288,GO:0010650,ANK3,positive regulation of cell communication by electrical coupling,1.0
1146,288,GO:0010765,ANK3,positive regulation of sodium ion transport,1.0
1147,288,GO:0010960,ANK3,magnesium ion homeostasis,1.0
1148,288,GO:0014704,ANK3,intercalated disc,1.0
1149,288,GO:0014731,ANK3,spectrin-associated cytoskeleton,1.0
1150,288,GO:0016323,ANK3,basolateral plasma membrane,1.0
1151,288,GO:0016328,ANK3,lateral plasma membrane,1.0
1152,288,GO:0016529,ANK3,sarcoplasmic reticulum,1.0
1153,288,GO:0019228,ANK3,neuronal action potential,1.0
1154,288,GO:0030018,ANK3,Z disc,1.0
1155,288,GO:0030315,ANK3,T-tubule,1.0
1156,288,GO:0030425,ANK3,dendrite,1.0
1157,288,GO:0030507,ANK3,spectrin binding,1.0
1158,288,GO:0030507,ANK3,spectrin binding,1.0
1159,288,GO:0030674,ANK3,protein-macromolecule adaptor activity,1.0
1160,288,GO:0031594,ANK3,neuromuscular junction,1.0
1161,288,GO:0033268,ANK3,node of Ranvier,1.0
1162,288,GO:0034112,ANK3,positive regulation of homotypic cell-cell adhesion,1.0
1163,288,GO:0042383,ANK3,sarcolemma,1.0
1164,288,GO:0043001,ANK3,Golgi to plasma membrane protein transport,1.0
1165,288,GO:0043005,ANK3,neuron projection,1.0
1166,288,GO:0043005,ANK3,neuron projection,1.0
1167,288,GO:0043034,ANK3,costamere,1.0
1168,288,GO:0043194,ANK3,axon initial segment,1.0
1169,288,GO:0043194,ANK3,axon initial segment,1.0
1170,288,GO:0043266,ANK3,regulation of potassium ion transport,1.0
1171,288,GO:0044325,ANK3,ion channel binding,1.0
1172,288,GO:0044325,ANK3,ion channel binding,1.0
1173,288,GO:0045184,ANK3,establishment of protein localization,1.0
1174,288,GO:0045211,ANK3,postsynaptic membrane,1.0
1175,288,GO:0045296,ANK3,cadherin binding,1.0
1176,288,GO:0045838,ANK3,positive regulation of membrane potential,1.0
1177,288,GO:0071286,ANK3,cellular response to magnesium ion,1.0
1178,288,GO:0071709,ANK3,membrane assembly,1.0
1179,288,GO:0071709,ANK3,membrane assembly,1.0
1180,288,GO:0072659,ANK3,protein localization to plasma membrane,1.0
1181,288,GO:0072659,ANK3,protein localization to plasma membrane,1.0
1182,288,GO:0072659,ANK3,protein localization to plasma membrane,1.0
1183,288,GO:0072659,ANK3,protein localization to plasma membrane,1.0
1184,288,GO:0072660,ANK3,maintenance of protein location in plasma membrane,1.0
1185,288,GO:0090314,ANK3,positive regulation of protein targeting to membrane,1.0
1186,288,GO:0099612,ANK3,protein localization to axon,1.0
1187,288,GO:1900827,ANK3,positive regulation of membrane depolarization during cardiac muscle cell action potential,1.0
1188,288,GO:1902260,ANK3,negative regulation of delayed rectifier potassium channel activity,1.0
1189,288,GO:2000651,ANK3,positive regulation of sodium ion transmembrane transporter activity,1.0
1190,288,GO:2001259,ANK3,positive regulation of cation channel activity,1.0
1195,29123,GO:0001701,ANKRD11,in utero embryonic development,1.0
1196,29123,GO:0001894,ANKRD11,tissue homeostasis,1.0
1197,29123,GO:0005634,ANKRD11,nucleus,1.0
1198,29123,GO:0005634,ANKRD11,nucleus,1.0
1199,29123,GO:0005654,ANKRD11,nucleoplasm,1.0
1200,29123,GO:0005829,ANKRD11,cytosol,1.0
1201,29123,GO:0005886,ANKRD11,plasma membrane,1.0
1202,29123,GO:0009653,ANKRD11,anatomical structure morphogenesis,1.0
1203,29123,GO:0035264,ANKRD11,multicellular organism growth,1.0
1204,29123,GO:0042475,ANKRD11,odontogenesis of dentin-containing tooth,1.0
1205,29123,GO:0048705,ANKRD11,skeletal system morphogenesis,1.0
1206,29123,GO:0060325,ANKRD11,face morphogenesis,1.0
1207,29123,GO:0060348,ANKRD11,bone development,1.0
1523,23229,GO:0005085,ARHGEF9,guanyl-nucleotide exchange factor activity,1.0
1524,23229,GO:0005515,ARHGEF9,protein binding,1.0
1525,23229,GO:0005829,ARHGEF9,cytosol,1.0
1526,23229,GO:0005829,ARHGEF9,cytosol,1.0
1527,23229,GO:0007186,ARHGEF9,G protein-coupled receptor signaling pathway,1.0
1528,23229,GO:0014069,ARHGEF9,postsynaptic density,1.0
1529,23229,GO:0043065,ARHGEF9,positive regulation of apoptotic process,1.0
1530,23229,GO:0051056,ARHGEF9,regulation of small GTPase mediated signal transduction,1.0
1531,57492,GO:0002931,ARID1B,response to ischemia,1.0
1532,57492,GO:0003677,ARID1B,DNA binding,1.0
1533,57492,GO:0003713,ARID1B,transcription coactivator activity,1.0
1534,57492,GO:0005515,ARID1B,protein binding,1.0
1535,57492,GO:0005654,ARID1B,nucleoplasm,1.0
1536,57492,GO:0005654,ARID1B,nucleoplasm,1.0
1537,57492,GO:0005829,ARID1B,cytosol,1.0
1538,57492,GO:0005886,ARID1B,plasma membrane,1.0
1539,57492,GO:0006357,ARID1B,regulation of transcription by RNA polymerase II,1.0
1540,57492,GO:0007270,ARID1B,neuron-neuron synaptic transmission,1.0
1541,57492,GO:0016514,ARID1B,SWI/SNF complex,1.0
1542,57492,GO:0016514,ARID1B,SWI/SNF complex,1.0
1543,57492,GO:0031491,ARID1B,nucleosome binding,1.0
1544,57492,GO:0035060,ARID1B,brahma complex,1.0
1545,57492,GO:0043044,ARID1B,ATP-dependent chromatin remodeling,1.0
1546,57492,GO:0045202,ARID1B,synapse,1.0
1547,57492,GO:0045893,ARID1B,"positive regulation of transcription, DNA-templated",1.0
1548,57492,GO:0048096,ARID1B,chromatin-mediated maintenance of transcription,1.0
1549,57492,GO:0060996,ARID1B,dendritic spine development,1.0
1550,57492,GO:0071565,ARID1B,nBAF complex,1.0
1551,57492,GO:0097026,ARID1B,dendritic cell dendrite assembly,1.0
1552,57492,GO:1904385,ARID1B,cellular response to angiotensin,1.0
1602,170302,GO:0000122,ARX,negative regulation of transcription by RNA polymerase II,1.0
1603,170302,GO:0000785,ARX,chromatin,1.0
1604,170302,GO:0000785,ARX,chromatin,1.0
1605,170302,GO:0000977,ARX,RNA polymerase II transcription regulatory region sequence-specific DNA binding,1.0
1606,170302,GO:0000978,ARX,RNA polymerase II cis-regulatory region sequence-specific DNA binding,1.0
1607,170302,GO:0000981,ARX,"DNA-binding transcription factor activity, RNA polymerase II-specific",1.0
1608,170302,GO:0000981,ARX,"DNA-binding transcription factor activity, RNA polymerase II-specific",1.0
1609,170302,GO:0000981,ARX,"DNA-binding transcription factor activity, RNA polymerase II-specific",1.0
1610,170302,GO:0001227,ARX,"DNA-binding transcription repressor activity, RNA polymerase II-specific",1.0
1611,170302,GO:0003682,ARX,chromatin binding,1.0
1612,170302,GO:0006357,ARX,regulation of transcription by RNA polymerase II,1.0
1613,170302,GO:0007411,ARX,axon guidance,1.0
1614,170302,GO:0010628,ARX,positive regulation of gene expression,1.0
1615,170302,GO:0021759,ARX,globus pallidus development,1.0
1616,170302,GO:0021800,ARX,cerebral cortex tangential migration,1.0
1617,170302,GO:0021831,ARX,embryonic olfactory bulb interneuron precursor migration,1.0
1618,170302,GO:0021846,ARX,cell proliferation in forebrain,1.0
1619,170302,GO:0021853,ARX,cerebral cortex GABAergic interneuron migration,1.0
1620,170302,GO:0042127,ARX,regulation of cell population proliferation,1.0
1621,170302,GO:0044241,ARX,lipid digestion,1.0
1622,170302,GO:0046622,ARX,positive regulation of organ growth,1.0
1623,170302,GO:0048484,ARX,enteric nervous system development,1.0
1624,170302,GO:0072148,ARX,epithelial cell fate commitment,1.0
1625,170302,GO:1990837,ARX,sequence-specific double-stranded DNA binding,1.0
1636,55870,GO:0001501,ASH1L,skeletal system development,1.0
1637,55870,GO:0002674,ASH1L,negative regulation of acute inflammatory response,1.0
1638,55870,GO:0003677,ASH1L,DNA binding,1.0
1639,55870,GO:0003682,ASH1L,chromatin binding,1.0
1640,55870,GO:0005634,ASH1L,nucleus,1.0
1641,55870,GO:0005654,ASH1L,nucleoplasm,1.0
1642,55870,GO:0005654,ASH1L,nucleoplasm,1.0
1643,55870,GO:0005694,ASH1L,chromosome,1.0
1644,55870,GO:0005794,ASH1L,Golgi apparatus,1.0
1645,55870,GO:0005923,ASH1L,bicellular tight junction,1.0
1646,55870,GO:0007338,ASH1L,single fertilization,1.0
1647,55870,GO:0009791,ASH1L,post-embryonic development,1.0
1648,55870,GO:0030317,ASH1L,flagellated sperm motility,1.0
1649,55870,GO:0032635,ASH1L,interleukin-6 production,1.0
1650,55870,GO:0042800,ASH1L,histone methyltransferase activity (H3-K4 specific),1.0
1651,55870,GO:0043124,ASH1L,negative regulation of I-kappaB kinase/NF-kappaB signaling,1.0
1652,55870,GO:0043409,ASH1L,negative regulation of MAPK cascade,1.0
1653,55870,GO:0045944,ASH1L,positive regulation of transcription by RNA polymerase II,1.0
1654,55870,GO:0046697,ASH1L,decidualization,1.0
1655,55870,GO:0046872,ASH1L,metal ion binding,1.0
1656,55870,GO:0046974,ASH1L,histone methyltransferase activity (H3-K9 specific),1.0
1657,55870,GO:0046975,ASH1L,histone methyltransferase activity (H3-K36 specific),1.0
1658,55870,GO:0051567,ASH1L,histone H3-K9 methylation,1.0
1659,55870,GO:0051568,ASH1L,histone H3-K4 methylation,1.0
1660,55870,GO:0061038,ASH1L,uterus morphogenesis,1.0
1661,55870,GO:0097676,ASH1L,histone H3-K36 dimethylation,1.0
1662,55870,GO:1903699,ASH1L,tarsal gland development,1.0
1663,55870,GO:1903709,ASH1L,uterine gland development,1.0
1855,1175,GO:0005515,AP2S1,protein binding,1.0
1856,1175,GO:0005829,AP2S1,cytosol,1.0
1857,1175,GO:0005886,AP2S1,plasma membrane,1.0
1858,1175,GO:0006886,AP2S1,intracellular protein transport,1.0
1859,1175,GO:0016192,AP2S1,vesicle-mediated transport,1.0
1860,1175,GO:0019886,AP2S1,antigen processing and presentation of exogenous peptide antigen via MHC class II,1.0
1861,1175,GO:0030100,AP2S1,regulation of endocytosis,1.0
1862,1175,GO:0030122,AP2S1,AP-2 adaptor complex,1.0
1863,1175,GO:0030666,AP2S1,endocytic vesicle membrane,1.0
1864,1175,GO:0030669,AP2S1,clathrin-coated endocytic vesicle membrane,1.0
1865,1175,GO:0032802,AP2S1,low-density lipoprotein particle receptor catabolic process,1.0
1866,1175,GO:0034383,AP2S1,low-density lipoprotein particle clearance,1.0
1867,1175,GO:0035615,AP2S1,clathrin adaptor activity,1.0
1868,1175,GO:0036020,AP2S1,endolysosome membrane,1.0
1869,1175,GO:0043231,AP2S1,intracellular membrane-bounded organelle,1.0
1870,1175,GO:0045334,AP2S1,clathrin-coated endocytic vesicle,1.0
1871,1175,GO:0048013,AP2S1,ephrin receptor signaling pathway,1.0
1872,1175,GO:0048268,AP2S1,clathrin coat assembly,1.0
1873,1175,GO:0050690,AP2S1,regulation of defense response to virus by virus,1.0
1874,1175,GO:0060071,AP2S1,"Wnt signaling pathway, planar cell polarity pathway",1.0
1875,1175,GO:0061024,AP2S1,membrane organization,1.0
1876,1175,GO:0072583,AP2S1,clathrin-dependent endocytosis,1.0
1877,80816,GO:0003677,ASXL3,DNA binding,1.0
1878,80816,GO:0003682,ASXL3,chromatin binding,1.0
1879,80816,GO:0006351,ASXL3,"transcription, DNA-templated",1.0
1880,80816,GO:0009887,ASXL3,animal organ morphogenesis,1.0
1881,80816,GO:0035517,ASXL3,PR-DUB complex,1.0
1882,80816,GO:0042975,ASXL3,peroxisome proliferator activated receptor binding,1.0
1883,80816,GO:0045944,ASXL3,positive regulation of transcription by RNA polymerase II,1.0
1884,80816,GO:0046872,ASXL3,metal ion binding,1.0
1885,80816,GO:0051055,ASXL3,negative regulation of lipid biosynthetic process,1.0
2188,546,GO:0000212,ATRX,meiotic spindle organization,1.0
2189,546,GO:0000779,ATRX,"condensed chromosome, centromeric region",1.0
2190,546,GO:0000781,ATRX,"chromosome, telomeric region",1.0
2191,546,GO:0000781,ATRX,"chromosome, telomeric region",1.0
2192,546,GO:0000792,ATRX,heterochromatin,1.0
2193,546,GO:0003677,ATRX,DNA binding,1.0
2194,546,GO:0003678,ATRX,DNA helicase activity,1.0
2195,546,GO:0003682,ATRX,chromatin binding,1.0
2196,546,GO:0005515,ATRX,protein binding,1.0
2197,546,GO:0005524,ATRX,ATP binding,1.0
2198,546,GO:0005634,ATRX,nucleus,1.0
2199,546,GO:0005654,ATRX,nucleoplasm,1.0
2200,546,GO:0005721,ATRX,pericentric heterochromatin,1.0
2201,546,GO:0005721,ATRX,pericentric heterochromatin,1.0
2202,546,GO:0006281,ATRX,DNA repair,1.0
2203,546,GO:0006306,ATRX,DNA methylation,1.0
2204,546,GO:0006334,ATRX,nucleosome assembly,1.0
2205,546,GO:0006336,ATRX,DNA replication-independent nucleosome assembly,1.0
2206,546,GO:0006338,ATRX,chromatin remodeling,1.0
2207,546,GO:0006355,ATRX,"regulation of transcription, DNA-templated",1.0
2208,546,GO:0007283,ATRX,spermatogenesis,1.0
2209,546,GO:0010571,ATRX,positive regulation of nuclear cell cycle DNA replication,1.0
2210,546,GO:0015616,ATRX,DNA translocase activity,1.0
2211,546,GO:0016604,ATRX,nuclear body,1.0
2212,546,GO:0016605,ATRX,PML body,1.0
2213,546,GO:0030330,ATRX,"DNA damage response, signal transduction by p53 class mediator",1.0
2214,546,GO:0030900,ATRX,forebrain development,1.0
2215,546,GO:0031297,ATRX,replication fork processing,1.0
2216,546,GO:0032206,ATRX,positive regulation of telomere maintenance,1.0
2217,546,GO:0032508,ATRX,DNA duplex unwinding,1.0
2218,546,GO:0035064,ATRX,methylated histone binding,1.0
2219,546,GO:0035128,ATRX,post-embryonic forelimb morphogenesis,1.0
2220,546,GO:0035264,ATRX,multicellular organism growth,1.0
2221,546,GO:0042393,ATRX,histone binding,1.0
2222,546,GO:0045944,ATRX,positive regulation of transcription by RNA polymerase II,1.0
2223,546,GO:0046872,ATRX,metal ion binding,1.0
2224,546,GO:0060009,ATRX,Sertoli cell development,1.0
2225,546,GO:0070087,ATRX,chromo shadow domain binding,1.0
2226,546,GO:0070192,ATRX,chromosome organization involved in meiotic cell cycle,1.0
2227,546,GO:0070198,ATRX,"protein localization to chromosome, telomeric region",1.0
2228,546,GO:0072520,ATRX,seminiferous tubule development,1.0
2229,546,GO:0072711,ATRX,cellular response to hydroxyurea,1.0
2230,546,GO:0099115,ATRX,"chromosome, subtelomeric region",1.0
2231,546,GO:1900112,ATRX,regulation of histone H3-K9 trimethylation,1.0
2232,546,GO:1901581,ATRX,negative regulation of telomeric RNA transcription from RNA pol II promoter,1.0
2233,546,GO:1901582,ATRX,positive regulation of telomeric RNA transcription from RNA pol II promoter,1.0
2234,546,GO:1904908,ATRX,"negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric",1.0
2235,26053,GO:0001764,AUTS2,neuron migration,1.0
2236,26053,GO:0003682,AUTS2,chromatin binding,1.0
2237,26053,GO:0005515,AUTS2,protein binding,1.0
2238,26053,GO:0005575,AUTS2,cellular_component,1.0
2239,26053,GO:0005634,AUTS2,nucleus,1.0
2240,26053,GO:0005737,AUTS2,cytoplasm,1.0
2241,26053,GO:0010592,AUTS2,positive regulation of lamellipodium assembly,1.0
2242,26053,GO:0015629,AUTS2,actin cytoskeleton,1.0
2243,26053,GO:0030426,AUTS2,growth cone,1.0
2244,26053,GO:0031532,AUTS2,actin cytoskeleton reorganization,1.0
2245,26053,GO:0035022,AUTS2,positive regulation of Rac protein signal transduction,1.0
2246,26053,GO:0045944,AUTS2,positive regulation of transcription by RNA polymerase II,1.0
2247,26053,GO:0048675,AUTS2,axon extension,1.0
2248,26053,GO:0051571,AUTS2,positive regulation of histone H3-K4 methylation,1.0
2249,26053,GO:0097484,AUTS2,dendrite extension,1.0
2250,26053,GO:2000620,AUTS2,positive regulation of histone H4-K16 acetylation,1.0
2318,29994,GO:0000785,BAZ2B,chromatin,1.0
2319,29994,GO:0003677,BAZ2B,DNA binding,1.0
2320,29994,GO:0005515,BAZ2B,protein binding,1.0
2321,29994,GO:0005634,BAZ2B,nucleus,1.0
2322,29994,GO:0006338,BAZ2B,chromatin remodeling,1.0
2323,29994,GO:0006357,BAZ2B,regulation of transcription by RNA polymerase II,1.0
2324,29994,GO:0046872,BAZ2B,metal ion binding,1.0
2401,10295,GO:0004674,BCKDK,protein serine/threonine kinase activity,1.0
2402,10295,GO:0004674,BCKDK,protein serine/threonine kinase activity,1.0
2403,10295,GO:0005515,BCKDK,protein binding,1.0
2404,10295,GO:0005524,BCKDK,ATP binding,1.0
2405,10295,GO:0005739,BCKDK,mitochondrion,1.0
2406,10295,GO:0005739,BCKDK,mitochondrion,1.0
2407,10295,GO:0005739,BCKDK,mitochondrion,1.0
2408,10295,GO:0005739,BCKDK,mitochondrion,1.0
2409,10295,GO:0005759,BCKDK,mitochondrial matrix,1.0
2410,10295,GO:0005947,BCKDK,mitochondrial alpha-ketoglutarate dehydrogenase complex,1.0
2411,10295,GO:0005947,BCKDK,mitochondrial alpha-ketoglutarate dehydrogenase complex,1.0
2412,10295,GO:0006468,BCKDK,protein phosphorylation,1.0
2413,10295,GO:0009063,BCKDK,cellular amino acid catabolic process,1.0
2414,10295,GO:0009083,BCKDK,branched-chain amino acid catabolic process,1.0
2415,10295,GO:0009083,BCKDK,branched-chain amino acid catabolic process,1.0
2416,10295,GO:0016301,BCKDK,kinase activity,1.0
2417,10295,GO:0016310,BCKDK,phosphorylation,1.0
2418,10295,GO:0016310,BCKDK,phosphorylation,1.0
2419,10295,GO:0042593,BCKDK,glucose homeostasis,1.0
2420,10295,GO:0047323,BCKDK,[3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)] kinase activity,1.0
2421,10295,GO:1904183,BCKDK,negative regulation of pyruvate dehydrogenase activity,1.0
2422,53335,GO:0000122,BCL11A,negative regulation of transcription by RNA polymerase II,1.0
2423,53335,GO:0000978,BCL11A,RNA polymerase II cis-regulatory region sequence-specific DNA binding,1.0
2424,53335,GO:0000978,BCL11A,RNA polymerase II cis-regulatory region sequence-specific DNA binding,1.0
2425,53335,GO:0001227,BCL11A,"DNA-binding transcription repressor activity, RNA polymerase II-specific",1.0
2426,53335,GO:0003700,BCL11A,DNA-binding transcription factor activity,1.0
2427,53335,GO:0005634,BCL11A,nucleus,1.0
2428,53335,GO:0005654,BCL11A,nucleoplasm,1.0
2429,53335,GO:0005737,BCL11A,cytoplasm,1.0
2430,53335,GO:0006357,BCL11A,regulation of transcription by RNA polymerase II,1.0
2431,53335,GO:0010628,BCL11A,positive regulation of gene expression,1.0
2432,53335,GO:0014069,BCL11A,postsynaptic density,1.0
2433,53335,GO:0016925,BCL11A,protein sumoylation,1.0
2434,53335,GO:0019901,BCL11A,protein kinase binding,1.0
2435,53335,GO:0046872,BCL11A,metal ion binding,1.0
2436,53335,GO:1903860,BCL11A,negative regulation of dendrite extension,1.0
2437,53335,GO:1904800,BCL11A,negative regulation of neuron remodeling,1.0
2438,53335,GO:1905232,BCL11A,cellular response to L-glutamate,1.0
2439,53335,GO:2000171,BCL11A,negative regulation of dendrite development,1.0
2440,53335,GO:2000173,BCL11A,negative regulation of branching morphogenesis of a nerve,1.0
2472,673,GO:0000165,BRAF,MAPK cascade,1.0
2473,673,GO:0000165,BRAF,MAPK cascade,1.0
2474,673,GO:0000186,BRAF,activation of MAPKK activity,1.0
2475,673,GO:0004672,BRAF,protein kinase activity,1.0
2476,673,GO:0004672,BRAF,protein kinase activity,1.0
2477,673,GO:0004672,BRAF,protein kinase activity,1.0
2478,673,GO:0004674,BRAF,protein serine/threonine kinase activity,1.0
2479,673,GO:0005509,BRAF,calcium ion binding,1.0
2480,673,GO:0005515,BRAF,protein binding,1.0
2481,673,GO:0005524,BRAF,ATP binding,1.0
2482,673,GO:0005634,BRAF,nucleus,1.0
2483,673,GO:0005829,BRAF,cytosol,1.0
2484,673,GO:0005829,BRAF,cytosol,1.0
2485,673,GO:0005886,BRAF,plasma membrane,1.0
2486,673,GO:0005886,BRAF,plasma membrane,1.0
2487,673,GO:0006468,BRAF,protein phosphorylation,1.0
2488,673,GO:0007173,BRAF,epidermal growth factor receptor signaling pathway,1.0
2489,673,GO:0009887,BRAF,animal organ morphogenesis,1.0
2490,673,GO:0010628,BRAF,positive regulation of gene expression,1.0
2491,673,GO:0010828,BRAF,positive regulation of glucose transmembrane transport,1.0
2492,673,GO:0031267,BRAF,small GTPase binding,1.0
2493,673,GO:0033138,BRAF,positive regulation of peptidyl-serine phosphorylation,1.0
2494,673,GO:0042802,BRAF,identical protein binding,1.0
2495,673,GO:0043066,BRAF,negative regulation of apoptotic process,1.0
2496,673,GO:0043231,BRAF,intracellular membrane-bounded organelle,1.0
2497,673,GO:0070374,BRAF,positive regulation of ERK1 and ERK2 cascade,1.0
2498,673,GO:0070413,BRAF,trehalose metabolism in response to stress,1.0
2499,673,GO:0071277,BRAF,cellular response to calcium ion,1.0
2500,673,GO:0090150,BRAF,establishment of protein localization to membrane,1.0
2501,673,GO:0097110,BRAF,scaffold protein binding,1.0
2502,673,GO:0106310,BRAF,protein serine kinase activity,1.0
2503,673,GO:0106311,BRAF,protein threonine kinase activity,1.0
2580,9024,GO:0000086,BRSK2,G2/M transition of mitotic cell cycle,1.0
2581,9024,GO:0000287,BRSK2,magnesium ion binding,1.0
2582,9024,GO:0004674,BRSK2,protein serine/threonine kinase activity,1.0
2583,9024,GO:0004674,BRSK2,protein serine/threonine kinase activity,1.0
2584,9024,GO:0004674,BRSK2,protein serine/threonine kinase activity,1.0
2585,9024,GO:0005524,BRSK2,ATP binding,1.0
2586,9024,GO:0005634,BRSK2,nucleus,1.0
2587,9024,GO:0005737,BRSK2,cytoplasm,1.0
2588,9024,GO:0005737,BRSK2,cytoplasm,1.0
2589,9024,GO:0005783,BRSK2,endoplasmic reticulum,1.0
2590,9024,GO:0005813,BRSK2,centrosome,1.0
2591,9024,GO:0005813,BRSK2,centrosome,1.0
2592,9024,GO:0006468,BRSK2,protein phosphorylation,1.0
2593,9024,GO:0006468,BRSK2,protein phosphorylation,1.0
2594,9024,GO:0006887,BRSK2,exocytosis,1.0
2595,9024,GO:0007409,BRSK2,axonogenesis,1.0
2596,9024,GO:0007409,BRSK2,axonogenesis,1.0
2597,9024,GO:0010975,BRSK2,regulation of neuron projection development,1.0
2598,9024,GO:0018105,BRSK2,peptidyl-serine phosphorylation,1.0
2599,9024,GO:0019901,BRSK2,protein kinase binding,1.0
2600,9024,GO:0030010,BRSK2,establishment of cell polarity,1.0
2601,9024,GO:0030010,BRSK2,establishment of cell polarity,1.0
2602,9024,GO:0030182,BRSK2,neuron differentiation,1.0
2603,9024,GO:0031532,BRSK2,actin cytoskeleton reorganization,1.0
2604,9024,GO:0035556,BRSK2,intracellular signal transduction,1.0
2605,9024,GO:0036503,BRSK2,ERAD pathway,1.0
2606,9024,GO:0042149,BRSK2,cellular response to glucose starvation,1.0
2607,9024,GO:0043462,BRSK2,regulation of ATPase activity,1.0
2608,9024,GO:0048156,BRSK2,tau protein binding,1.0
2609,9024,GO:0048471,BRSK2,perinuclear region of cytoplasm,1.0
2610,9024,GO:0050321,BRSK2,tau-protein kinase activity,1.0
2611,9024,GO:0050321,BRSK2,tau-protein kinase activity,1.0
2612,9024,GO:0050321,BRSK2,tau-protein kinase activity,1.0
2613,9024,GO:0050321,BRSK2,tau-protein kinase activity,1.0
2614,9024,GO:0050770,BRSK2,regulation of axonogenesis,1.0
2615,9024,GO:0051117,BRSK2,ATPase binding,1.0
2616,9024,GO:0051301,BRSK2,cell division,1.0
2617,9024,GO:0060590,BRSK2,ATPase regulator activity,1.0
2618,9024,GO:0061178,BRSK2,regulation of insulin secretion involved in cellular response to glucose stimulus,1.0
2619,9024,GO:0061178,BRSK2,regulation of insulin secretion involved in cellular response to glucose stimulus,1.0
2620,9024,GO:0070059,BRSK2,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,1.0
2621,9024,GO:0090176,BRSK2,microtubule cytoskeleton organization involved in establishment of planar polarity,1.0
2622,9024,GO:0106310,BRSK2,protein serine kinase activity,1.0
2623,9024,GO:0106311,BRSK2,protein threonine kinase activity,1.0
2624,9024,GO:0150034,BRSK2,distal axon,1.0
2625,9024,GO:1904152,BRSK2,"regulation of retrograde protein transport, ER to cytosol",1.0
2626,9024,GO:1904152,BRSK2,"regulation of retrograde protein transport, ER to cytosol",1.0
2627,9024,GO:2000807,BRSK2,regulation of synaptic vesicle clustering,1.0
2841,775,GO:0002520,CACNA1C,immune system development,1.0
2842,775,GO:0005245,CACNA1C,voltage-gated calcium channel activity,1.0
2843,775,GO:0005245,CACNA1C,voltage-gated calcium channel activity,1.0
2844,775,GO:0005245,CACNA1C,voltage-gated calcium channel activity,1.0
2845,775,GO:0005515,CACNA1C,protein binding,1.0
2846,775,GO:0005516,CACNA1C,calmodulin binding,1.0
2847,775,GO:0005737,CACNA1C,cytoplasm,1.0
2848,775,GO:0005886,CACNA1C,plasma membrane,1.0
2849,775,GO:0005886,CACNA1C,plasma membrane,1.0
2850,775,GO:0005887,CACNA1C,integral component of plasma membrane,1.0
2851,775,GO:0005891,CACNA1C,voltage-gated calcium channel complex,1.0
2852,775,GO:0006816,CACNA1C,calcium ion transport,1.0
2853,775,GO:0007204,CACNA1C,positive regulation of cytosolic calcium ion concentration,1.0
2854,775,GO:0007507,CACNA1C,heart development,1.0
2855,775,GO:0008331,CACNA1C,high voltage-gated calcium channel activity,1.0
2856,775,GO:0008331,CACNA1C,high voltage-gated calcium channel activity,1.0
2857,775,GO:0008331,CACNA1C,high voltage-gated calcium channel activity,1.0
2858,775,GO:0010881,CACNA1C,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,1.0
2859,775,GO:0010881,CACNA1C,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,1.0
2860,775,GO:0014069,CACNA1C,postsynaptic density,1.0
2861,775,GO:0016021,CACNA1C,integral component of membrane,1.0
2862,775,GO:0016032,CACNA1C,viral process,1.0
2863,775,GO:0030018,CACNA1C,Z disc,1.0
2864,775,GO:0030425,CACNA1C,dendrite,1.0
2865,775,GO:0035115,CACNA1C,embryonic forelimb morphogenesis,1.0
2866,775,GO:0035585,CACNA1C,calcium-mediated signaling using extracellular calcium source,1.0
2867,775,GO:0043010,CACNA1C,camera-type eye development,1.0
2868,775,GO:0043204,CACNA1C,perikaryon,1.0
2869,775,GO:0045762,CACNA1C,positive regulation of adenylate cyclase activity,1.0
2870,775,GO:0046872,CACNA1C,metal ion binding,1.0
2871,775,GO:0050796,CACNA1C,regulation of insulin secretion,1.0
2872,775,GO:0051393,CACNA1C,alpha-actinin binding,1.0
2873,775,GO:0060402,CACNA1C,calcium ion transport into cytosol,1.0
2874,775,GO:0060402,CACNA1C,calcium ion transport into cytosol,1.0
2875,775,GO:0061337,CACNA1C,cardiac conduction,1.0
2876,775,GO:0061337,CACNA1C,cardiac conduction,1.0
2877,775,GO:0061577,CACNA1C,calcium ion transmembrane transport via high voltage-gated calcium channel,1.0
2878,775,GO:0070509,CACNA1C,calcium ion import,1.0
2879,775,GO:0070588,CACNA1C,calcium ion transmembrane transport,1.0
2880,775,GO:0070588,CACNA1C,calcium ion transmembrane transport,1.0
2881,775,GO:0086002,CACNA1C,cardiac muscle cell action potential involved in contraction,1.0
2882,775,GO:0086007,CACNA1C,voltage-gated calcium channel activity involved in cardiac muscle cell action potential,1.0
2883,775,GO:0086007,CACNA1C,voltage-gated calcium channel activity involved in cardiac muscle cell action potential,1.0
2884,775,GO:0086012,CACNA1C,membrane depolarization during cardiac muscle cell action potential,1.0
2885,775,GO:0086045,CACNA1C,membrane depolarization during AV node cell action potential,1.0
2886,775,GO:0086056,CACNA1C,voltage-gated calcium channel activity involved in AV node cell action potential,1.0
2887,775,GO:0086064,CACNA1C,cell communication by electrical coupling involved in cardiac conduction,1.0
2888,775,GO:0086091,CACNA1C,regulation of heart rate by cardiac conduction,1.0
2889,775,GO:0098839,CACNA1C,postsynaptic density membrane,1.0
2890,775,GO:0098911,CACNA1C,regulation of ventricular cardiac muscle cell action potential,1.0
2891,775,GO:0098912,CACNA1C,membrane depolarization during atrial cardiac muscle cell action potential,1.0
2892,775,GO:1990454,CACNA1C,L-type voltage-gated calcium channel complex,1.0
2930,777,GO:0005245,CACNA1E,voltage-gated calcium channel activity,1.0
2931,777,GO:0005245,CACNA1E,voltage-gated calcium channel activity,1.0
2932,777,GO:0005509,CACNA1E,calcium ion binding,1.0
2933,777,GO:0005886,CACNA1E,plasma membrane,1.0
2934,777,GO:0005891,CACNA1E,voltage-gated calcium channel complex,1.0
2935,777,GO:0006816,CACNA1E,calcium ion transport,1.0
2936,777,GO:0007268,CACNA1E,chemical synaptic transmission,1.0
2937,777,GO:0022843,CACNA1E,voltage-gated cation channel activity,1.0
2938,777,GO:0034765,CACNA1E,regulation of ion transmembrane transport,1.0
2939,777,GO:0045202,CACNA1E,synapse,1.0
2940,777,GO:0050796,CACNA1E,regulation of insulin secretion,1.0
2941,777,GO:0051899,CACNA1E,membrane depolarization,1.0
2942,777,GO:0070509,CACNA1E,calcium ion import,1.0
2943,777,GO:0070588,CACNA1E,calcium ion transmembrane transport,1.0
3105,55799,GO:0005245,CACNA2D3,voltage-gated calcium channel activity,1.0
3106,55799,GO:0005886,CACNA2D3,plasma membrane,1.0
3107,55799,GO:0005891,CACNA2D3,voltage-gated calcium channel complex,1.0
3108,55799,GO:0034765,CACNA2D3,regulation of ion transmembrane transport,1.0
3109,55799,GO:0046872,CACNA2D3,metal ion binding,1.0
3110,55799,GO:0061337,CACNA2D3,cardiac conduction,1.0
3111,55799,GO:0070588,CACNA2D3,calcium ion transmembrane transport,1.0
3323,4076,GO:0000932,CAPRIN1,P-body,1.0
3324,4076,GO:0003723,CAPRIN1,RNA binding,1.0
3325,4076,GO:0003723,CAPRIN1,RNA binding,1.0
3326,4076,GO:0005515,CAPRIN1,protein binding,1.0
3327,4076,GO:0005737,CAPRIN1,cytoplasm,1.0
3328,4076,GO:0005829,CAPRIN1,cytosol,1.0
3329,4076,GO:0010494,CAPRIN1,cytoplasmic stress granule,1.0
3330,4076,GO:0016020,CAPRIN1,membrane,1.0
3331,4076,GO:0017148,CAPRIN1,negative regulation of translation,1.0
3332,4076,GO:0030027,CAPRIN1,lamellipodium,1.0
3333,4076,GO:0030425,CAPRIN1,dendrite,1.0
3334,4076,GO:0031252,CAPRIN1,cell leading edge,1.0
3335,4076,GO:0050775,CAPRIN1,positive regulation of dendrite morphogenesis,1.0
3336,4076,GO:0061003,CAPRIN1,positive regulation of dendritic spine morphogenesis,1.0
3374,8573,GO:0001953,CASK,negative regulation of cell-matrix adhesion,1.0
3375,8573,GO:0004385,CASK,guanylate kinase activity,1.0
3376,8573,GO:0004674,CASK,protein serine/threonine kinase activity,1.0
3377,8573,GO:0005515,CASK,protein binding,1.0
3378,8573,GO:0005516,CASK,calmodulin binding,1.0
3379,8573,GO:0005524,CASK,ATP binding,1.0
3380,8573,GO:0005604,CASK,basement membrane,1.0
3381,8573,GO:0005604,CASK,basement membrane,1.0
3382,8573,GO:0005652,CASK,nuclear lamina,1.0
3383,8573,GO:0005730,CASK,nucleolus,1.0
3384,8573,GO:0005737,CASK,cytoplasm,1.0
3385,8573,GO:0005829,CASK,cytosol,1.0
3386,8573,GO:0005886,CASK,plasma membrane,1.0
3387,8573,GO:0005911,CASK,cell-cell junction,1.0
3388,8573,GO:0005925,CASK,focal adhesion,1.0
3389,8573,GO:0006468,CASK,protein phosphorylation,1.0
3390,8573,GO:0007155,CASK,cell adhesion,1.0
3391,8573,GO:0007269,CASK,neurotransmitter secretion,1.0
3392,8573,GO:0010839,CASK,negative regulation of keratinocyte proliferation,1.0
3393,8573,GO:0010839,CASK,negative regulation of keratinocyte proliferation,1.0
3394,8573,GO:0015629,CASK,actin cytoskeleton,1.0
3395,8573,GO:0016323,CASK,basolateral plasma membrane,1.0
3396,8573,GO:0016363,CASK,nuclear matrix,1.0
3397,8573,GO:0031982,CASK,vesicle,1.0
3398,8573,GO:0042043,CASK,neurexin family protein binding,1.0
3399,8573,GO:0042734,CASK,presynaptic membrane,1.0
3400,8573,GO:0045944,CASK,positive regulation of transcription by RNA polymerase II,1.0
3401,8573,GO:0046037,CASK,GMP metabolic process,1.0
3402,8573,GO:0046710,CASK,GDP metabolic process,1.0
3403,8573,GO:0060170,CASK,ciliary membrane,1.0
3404,8573,GO:0061045,CASK,negative regulation of wound healing,1.0
3405,8573,GO:0070509,CASK,calcium ion import,1.0
3406,8573,GO:0090280,CASK,positive regulation of calcium ion import,1.0
3407,8573,GO:0090288,CASK,negative regulation of cellular response to growth factor stimulus,1.0
3408,8573,GO:0098685,CASK,Schaffer collateral - CA1 synapse,1.0
3409,8573,GO:0106310,CASK,protein serine kinase activity,1.0
3410,8573,GO:0106311,CASK,protein threonine kinase activity,1.0
3411,8573,GO:2000300,CASK,regulation of synaptic vesicle exocytosis,1.0
3412,54897,GO:0000785,CASZ1,chromatin,1.0
3413,54897,GO:0000977,CASZ1,RNA polymerase II transcription regulatory region sequence-specific DNA binding,1.0
3414,54897,GO:0001228,CASZ1,"DNA-binding transcription activator activity, RNA polymerase II-specific",1.0
3415,54897,GO:0005634,CASZ1,nucleus,1.0
3416,54897,GO:0005654,CASZ1,nucleoplasm,1.0
3417,54897,GO:0005829,CASZ1,cytosol,1.0
3418,54897,GO:0006355,CASZ1,"regulation of transcription, DNA-templated",1.0
3419,54897,GO:0043231,CASZ1,intracellular membrane-bounded organelle,1.0
3420,54897,GO:0045664,CASZ1,regulation of neuron differentiation,1.0
3421,54897,GO:0045893,CASZ1,"positive regulation of transcription, DNA-templated",1.0
3422,54897,GO:0045944,CASZ1,positive regulation of transcription by RNA polymerase II,1.0
3423,54897,GO:0046872,CASZ1,metal ion binding,1.0
3846,6792,GO:0001764,CDKL5,neuron migration,1.0
3847,6792,GO:0004672,CDKL5,protein kinase activity,1.0
3848,6792,GO:0004674,CDKL5,protein serine/threonine kinase activity,1.0
3849,6792,GO:0004693,CDKL5,cyclin-dependent protein serine/threonine kinase activity,1.0
3850,6792,GO:0005515,CDKL5,protein binding,1.0
3851,6792,GO:0005524,CDKL5,ATP binding,1.0
3852,6792,GO:0005634,CDKL5,nucleus,1.0
3853,6792,GO:0005634,CDKL5,nucleus,1.0
3854,6792,GO:0005813,CDKL5,centrosome,1.0
3855,6792,GO:0006468,CDKL5,protein phosphorylation,1.0
3856,6792,GO:0016301,CDKL5,kinase activity,1.0
3857,6792,GO:0031267,CDKL5,small GTPase binding,1.0
3858,6792,GO:0032587,CDKL5,ruffle membrane,1.0
3859,6792,GO:0032839,CDKL5,dendrite cytoplasm,1.0
3860,6792,GO:0032839,CDKL5,dendrite cytoplasm,1.0
3861,6792,GO:0036064,CDKL5,ciliary basal body,1.0
3862,6792,GO:0043547,CDKL5,positive regulation of GTPase activity,1.0
3863,6792,GO:0044294,CDKL5,dendritic growth cone,1.0
3864,6792,GO:0045773,CDKL5,positive regulation of axon extension,1.0
3865,6792,GO:0045773,CDKL5,positive regulation of axon extension,1.0
3866,6792,GO:0046777,CDKL5,protein autophosphorylation,1.0
3867,6792,GO:0048471,CDKL5,perinuclear region of cytoplasm,1.0
3868,6792,GO:0050773,CDKL5,regulation of dendrite development,1.0
3869,6792,GO:0050773,CDKL5,regulation of dendrite development,1.0
3870,6792,GO:0050775,CDKL5,positive regulation of dendrite morphogenesis,1.0
3871,6792,GO:0051726,CDKL5,regulation of cell cycle,1.0
3872,6792,GO:0060999,CDKL5,positive regulation of dendritic spine development,1.0
3873,6792,GO:0097542,CDKL5,ciliary tip,1.0
3874,6792,GO:0098978,CDKL5,glutamatergic synapse,1.0
3875,6792,GO:0098978,CDKL5,glutamatergic synapse,1.0
3876,6792,GO:0099175,CDKL5,regulation of postsynapse organization,1.0
3877,6792,GO:0099175,CDKL5,regulation of postsynapse organization,1.0
3878,6792,GO:1902017,CDKL5,regulation of cilium assembly,1.0
3914,56853,GO:0000380,CELF4,"alternative mRNA splicing, via spliceosome",1.0
3915,56853,GO:0000381,CELF4,"regulation of alternative mRNA splicing, via spliceosome",1.0
3916,56853,GO:0000381,CELF4,"regulation of alternative mRNA splicing, via spliceosome",1.0
3917,56853,GO:0000900,CELF4,"translation repressor activity, mRNA regulatory element binding",1.0
3918,56853,GO:0003723,CELF4,RNA binding,1.0
3919,56853,GO:0003729,CELF4,mRNA binding,1.0
3920,56853,GO:0005634,CELF4,nucleus,1.0
3921,56853,GO:0005634,CELF4,nucleus,1.0
3922,56853,GO:0005654,CELF4,nucleoplasm,1.0
3923,56853,GO:0005737,CELF4,cytoplasm,1.0
3924,56853,GO:0006376,CELF4,mRNA splice site selection,1.0
3925,56853,GO:0007281,CELF4,germ cell development,1.0
3926,56853,GO:0009792,CELF4,embryo development ending in birth or egg hatching,1.0
3927,56853,GO:0017148,CELF4,negative regulation of translation,1.0
3928,56853,GO:0036002,CELF4,pre-mRNA binding,1.0
3929,56853,GO:0042835,CELF4,BRE binding,1.0
3930,56853,GO:0048025,CELF4,"negative regulation of mRNA splicing, via spliceosome",1.0
3931,56853,GO:0048026,CELF4,"positive regulation of mRNA splicing, via spliceosome",1.0
3932,56853,GO:0090394,CELF4,negative regulation of excitatory postsynaptic potential,1.0
3933,56853,GO:1902866,CELF4,regulation of retina development in camera-type eye,1.0
3934,56853,GO:1990904,CELF4,ribonucleoprotein complex,1.0
4013,283489,GO:0000777,CHAMP1,condensed chromosome kinetochore,1.0
4014,283489,GO:0000777,CHAMP1,condensed chromosome kinetochore,1.0
4015,283489,GO:0000793,CHAMP1,condensed chromosome,1.0
4016,283489,GO:0005515,CHAMP1,protein binding,1.0
4017,283489,GO:0005634,CHAMP1,nucleus,1.0
4018,283489,GO:0005654,CHAMP1,nucleoplasm,1.0
4019,283489,GO:0005654,CHAMP1,nucleoplasm,1.0
4020,283489,GO:0005737,CHAMP1,cytoplasm,1.0
4021,283489,GO:0005819,CHAMP1,spindle,1.0
4022,283489,GO:0005819,CHAMP1,spindle,1.0
4023,283489,GO:0016604,CHAMP1,nuclear body,1.0
4024,283489,GO:0031134,CHAMP1,sister chromatid biorientation,1.0
4025,283489,GO:0031134,CHAMP1,sister chromatid biorientation,1.0
4026,283489,GO:0034501,CHAMP1,protein localization to kinetochore,1.0
4027,283489,GO:0034501,CHAMP1,protein localization to kinetochore,1.0
4028,283489,GO:0035372,CHAMP1,protein localization to microtubule,1.0
4029,283489,GO:0035372,CHAMP1,protein localization to microtubule,1.0
4030,283489,GO:0046872,CHAMP1,metal ion binding,1.0
4031,283489,GO:0051315,CHAMP1,attachment of mitotic spindle microtubules to kinetochore,1.0
4032,283489,GO:0051315,CHAMP1,attachment of mitotic spindle microtubules to kinetochore,1.0
4033,283489,GO:0090543,CHAMP1,Flemming body,1.0
4048,1106,GO:0000978,CHD2,RNA polymerase II cis-regulatory region sequence-specific DNA binding,1.0
4049,1106,GO:0003677,CHD2,DNA binding,1.0
4050,1106,GO:0003678,CHD2,DNA helicase activity,1.0
4051,1106,GO:0003723,CHD2,RNA binding,1.0
4052,1106,GO:0005515,CHD2,protein binding,1.0
4053,1106,GO:0005524,CHD2,ATP binding,1.0
4054,1106,GO:0005634,CHD2,nucleus,1.0
4055,1106,GO:0005654,CHD2,nucleoplasm,1.0
4056,1106,GO:0005730,CHD2,nucleolus,1.0
4057,1106,GO:0006325,CHD2,chromatin organization,1.0
4058,1106,GO:0006357,CHD2,regulation of transcription by RNA polymerase II,1.0
4059,1106,GO:0007517,CHD2,muscle organ development,1.0
4060,1106,GO:0032508,CHD2,DNA duplex unwinding,1.0
4061,1106,GO:0042393,CHD2,histone binding,1.0
4062,1106,GO:0043231,CHD2,intracellular membrane-bounded organelle,1.0
4063,1107,GO:0000122,CHD3,negative regulation of transcription by RNA polymerase II,1.0
4064,1107,GO:0000976,CHD3,transcription regulatory region sequence-specific DNA binding,1.0
4065,1107,GO:0003677,CHD3,DNA binding,1.0
4066,1107,GO:0003678,CHD3,DNA helicase activity,1.0
4067,1107,GO:0003723,CHD3,RNA binding,1.0
4068,1107,GO:0004386,CHD3,helicase activity,1.0
4069,1107,GO:0005515,CHD3,protein binding,1.0
4070,1107,GO:0005524,CHD3,ATP binding,1.0
4071,1107,GO:0005634,CHD3,nucleus,1.0
4072,1107,GO:0005634,CHD3,nucleus,1.0
4073,1107,GO:0005654,CHD3,nucleoplasm,1.0
4074,1107,GO:0005654,CHD3,nucleoplasm,1.0
4075,1107,GO:0005730,CHD3,nucleolus,1.0
4076,1107,GO:0005737,CHD3,cytoplasm,1.0
4077,1107,GO:0005813,CHD3,centrosome,1.0
4078,1107,GO:0006333,CHD3,chromatin assembly or disassembly,1.0
4079,1107,GO:0006355,CHD3,"regulation of transcription, DNA-templated",1.0
4080,1107,GO:0006357,CHD3,regulation of transcription by RNA polymerase II,1.0
4081,1107,GO:0007051,CHD3,spindle organization,1.0
4082,1107,GO:0007098,CHD3,centrosome cycle,1.0
4083,1107,GO:0008270,CHD3,zinc ion binding,1.0
4084,1107,GO:0016581,CHD3,NuRD complex,1.0
4085,1107,GO:0016581,CHD3,NuRD complex,1.0
4086,1107,GO:0016605,CHD3,PML body,1.0
4087,1107,GO:0016887,CHD3,ATPase activity,1.0
4088,1107,GO:0032508,CHD3,DNA duplex unwinding,1.0
4089,1107,GO:0034451,CHD3,centriolar satellite,1.0
4090,1107,GO:0036121,CHD3,double-stranded DNA helicase activity,1.0
4091,1107,GO:0043044,CHD3,ATP-dependent chromatin remodeling,1.0
4092,1107,GO:0070615,CHD3,nucleosome-dependent ATPase activity,1.0
4093,1107,GO:1901796,CHD3,regulation of signal transduction by p53 class mediator,1.0
4094,55636,GO:0000978,CHD7,RNA polymerase II cis-regulatory region sequence-specific DNA binding,1.0
4095,55636,GO:0001501,CHD7,skeletal system development,1.0
4096,55636,GO:0001701,CHD7,in utero embryonic development,1.0
4097,55636,GO:0001974,CHD7,blood vessel remodeling,1.0
4098,55636,GO:0003007,CHD7,heart morphogenesis,1.0
4099,55636,GO:0003222,CHD7,ventricular trabecula myocardium morphogenesis,1.0
4100,55636,GO:0003226,CHD7,right ventricular compact myocardium morphogenesis,1.0
4101,55636,GO:0003678,CHD7,DNA helicase activity,1.0
4102,55636,GO:0003682,CHD7,chromatin binding,1.0
4103,55636,GO:0005515,CHD7,protein binding,1.0
4104,55636,GO:0005524,CHD7,ATP binding,1.0
4105,55636,GO:0005634,CHD7,nucleus,1.0
4106,55636,GO:0005634,CHD7,nucleus,1.0
4107,55636,GO:0005654,CHD7,nucleoplasm,1.0
4108,55636,GO:0005730,CHD7,nucleolus,1.0
4109,55636,GO:0006338,CHD7,chromatin remodeling,1.0
4110,55636,GO:0006355,CHD7,"regulation of transcription, DNA-templated",1.0
4111,55636,GO:0006364,CHD7,rRNA processing,1.0
4112,55636,GO:0007417,CHD7,central nervous system development,1.0
4113,55636,GO:0007512,CHD7,adult heart development,1.0
4114,55636,GO:0007605,CHD7,sensory perception of sound,1.0
4115,55636,GO:0007628,CHD7,adult walking behavior,1.0
4116,55636,GO:0008015,CHD7,blood circulation,1.0
4117,55636,GO:0009617,CHD7,response to bacterium,1.0
4118,55636,GO:0010880,CHD7,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,1.0
4119,55636,GO:0021545,CHD7,cranial nerve development,1.0
4120,55636,GO:0021553,CHD7,olfactory nerve development,1.0
4121,55636,GO:0021772,CHD7,olfactory bulb development,1.0
4122,55636,GO:0030217,CHD7,T cell differentiation,1.0
4123,55636,GO:0030540,CHD7,female genitalia development,1.0
4124,55636,GO:0032508,CHD7,DNA duplex unwinding,1.0
4125,55636,GO:0035116,CHD7,embryonic hindlimb morphogenesis,1.0
4126,55636,GO:0035909,CHD7,aorta morphogenesis,1.0
4127,55636,GO:0036302,CHD7,atrioventricular canal development,1.0
4128,55636,GO:0040018,CHD7,positive regulation of multicellular organism growth,1.0
4129,55636,GO:0042048,CHD7,olfactory behavior,1.0
4130,55636,GO:0042472,CHD7,inner ear morphogenesis,1.0
4131,55636,GO:0043584,CHD7,nose development,1.0
4132,55636,GO:0045944,CHD7,positive regulation of transcription by RNA polymerase II,1.0
4133,55636,GO:0048752,CHD7,semicircular canal morphogenesis,1.0
4134,55636,GO:0048806,CHD7,genitalia development,1.0
4135,55636,GO:0050767,CHD7,regulation of neurogenesis,1.0
4136,55636,GO:0050890,CHD7,cognition,1.0
4137,55636,GO:0060041,CHD7,retina development in camera-type eye,1.0
4138,55636,GO:0060123,CHD7,regulation of growth hormone secretion,1.0
4139,55636,GO:0060173,CHD7,limb development,1.0
4140,55636,GO:0060324,CHD7,face development,1.0
4141,55636,GO:0060384,CHD7,innervation,1.0
4142,55636,GO:0060411,CHD7,cardiac septum morphogenesis,1.0
4143,55636,GO:0060429,CHD7,epithelium development,1.0
4144,55636,GO:0062009,CHD7,secondary palate development,1.0
4145,55636,GO:1990841,CHD7,promoter-specific chromatin binding,1.0
4146,57680,GO:0000122,CHD8,negative regulation of transcription by RNA polymerase II,1.0
4147,57680,GO:0001701,CHD8,in utero embryonic development,1.0
4148,57680,GO:0002039,CHD8,p53 binding,1.0
4149,57680,GO:0003677,CHD8,DNA binding,1.0
4150,57680,GO:0003678,CHD8,DNA helicase activity,1.0
4151,57680,GO:0003682,CHD8,chromatin binding,1.0
4152,57680,GO:0005515,CHD8,protein binding,1.0
4153,57680,GO:0005524,CHD8,ATP binding,1.0
4154,57680,GO:0005634,CHD8,nucleus,1.0
4155,57680,GO:0005654,CHD8,nucleoplasm,1.0
4156,57680,GO:0005654,CHD8,nucleoplasm,1.0
4157,57680,GO:0005886,CHD8,plasma membrane,1.0
4158,57680,GO:0007420,CHD8,brain development,1.0
4159,57680,GO:0008013,CHD8,beta-catenin binding,1.0
4160,57680,GO:0008094,CHD8,DNA-dependent ATPase activity,1.0
4161,57680,GO:0016055,CHD8,Wnt signaling pathway,1.0
4162,57680,GO:0032508,CHD8,DNA duplex unwinding,1.0
4163,57680,GO:0032991,CHD8,protein-containing complex,1.0
4164,57680,GO:0035064,CHD8,methylated histone binding,1.0
4165,57680,GO:0035176,CHD8,social behavior,1.0
4166,57680,GO:0042393,CHD8,histone binding,1.0
4167,57680,GO:0043044,CHD8,ATP-dependent chromatin remodeling,1.0
4168,57680,GO:0045892,CHD8,"negative regulation of transcription, DNA-templated",1.0
4169,57680,GO:0045893,CHD8,"positive regulation of transcription, DNA-templated",1.0
4170,57680,GO:0045944,CHD8,positive regulation of transcription by RNA polymerase II,1.0
4171,57680,GO:0045945,CHD8,positive regulation of transcription by RNA polymerase III,1.0
4172,57680,GO:0048565,CHD8,digestive tract development,1.0
4173,57680,GO:0060134,CHD8,prepulse inhibition,1.0
4174,57680,GO:0070016,CHD8,armadillo repeat domain binding,1.0
4175,57680,GO:0071339,CHD8,MLL1 complex,1.0
4176,57680,GO:0090090,CHD8,negative regulation of canonical Wnt signaling pathway,1.0
4177,57680,GO:2000270,CHD8,negative regulation of fibroblast apoptotic process,1.0
4406,23152,GO:0000785,CIC,chromatin,1.0
4407,23152,GO:0000977,CIC,RNA polymerase II transcription regulatory region sequence-specific DNA binding,1.0
4408,23152,GO:0000981,CIC,"DNA-binding transcription factor activity, RNA polymerase II-specific",1.0
4409,23152,GO:0000981,CIC,"DNA-binding transcription factor activity, RNA polymerase II-specific",1.0
4410,23152,GO:0003677,CIC,DNA binding,1.0
4411,23152,GO:0003682,CIC,chromatin binding,1.0
4412,23152,GO:0005515,CIC,protein binding,1.0
4413,23152,GO:0005634,CIC,nucleus,1.0
4414,23152,GO:0005654,CIC,nucleoplasm,1.0
4415,23152,GO:0006357,CIC,regulation of transcription by RNA polymerase II,1.0
4416,23152,GO:0007420,CIC,brain development,1.0
4417,23152,GO:0007612,CIC,learning,1.0
4418,23152,GO:0007613,CIC,memory,1.0
4419,23152,GO:0032991,CIC,protein-containing complex,1.0
4420,23152,GO:0035176,CIC,social behavior,1.0
4421,23152,GO:0043231,CIC,intracellular membrane-bounded organelle,1.0
4422,23152,GO:0045892,CIC,"negative regulation of transcription, DNA-templated",1.0
4423,23152,GO:0048286,CIC,lung alveolus development,1.0
4630,4849,GO:0000289,CNOT3,nuclear-transcribed mRNA poly(A) tail shortening,1.0
4631,4849,GO:0000289,CNOT3,nuclear-transcribed mRNA poly(A) tail shortening,1.0
4632,4849,GO:0000932,CNOT3,P-body,1.0
4633,4849,GO:0000932,CNOT3,P-body,1.0
4634,4849,GO:0001829,CNOT3,trophectodermal cell differentiation,1.0
4635,4849,GO:0005515,CNOT3,protein binding,1.0
4636,4849,GO:0005634,CNOT3,nucleus,1.0
4637,4849,GO:0005829,CNOT3,cytosol,1.0
4638,4849,GO:0006355,CNOT3,"regulation of transcription, DNA-templated",1.0
4639,4849,GO:0006977,CNOT3,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest",1.0
4640,4849,GO:0030014,CNOT3,CCR4-NOT complex,1.0
4641,4849,GO:0030015,CNOT3,CCR4-NOT core complex,1.0
4642,4849,GO:0031047,CNOT3,gene silencing by RNA,1.0
4643,4849,GO:0090503,CNOT3,"RNA phosphodiester bond hydrolysis, exonucleolytic",1.0
4644,4849,GO:0120162,CNOT3,positive regulation of cold-induced thermogenesis,1.0
4645,4849,GO:2000036,CNOT3,regulation of stem cell population maintenance,1.0
4646,4849,GO:2000036,CNOT3,regulation of stem cell population maintenance,1.0
4834,1387,GO:0000122,CREBBP,negative regulation of transcription by RNA polymerase II,1.0
4835,1387,GO:0000123,CREBBP,histone acetyltransferase complex,1.0
4836,1387,GO:0000785,CREBBP,chromatin,1.0
4837,1387,GO:0001085,CREBBP,RNA polymerase II transcription factor binding,1.0
4838,1387,GO:0001085,CREBBP,RNA polymerase II transcription factor binding,1.0
4839,1387,GO:0001102,CREBBP,RNA polymerase II activating transcription factor binding,1.0
4840,1387,GO:0001666,CREBBP,response to hypoxia,1.0
4841,1387,GO:0002039,CREBBP,p53 binding,1.0
4842,1387,GO:0002223,CREBBP,stimulatory C-type lectin receptor signaling pathway,1.0
4843,1387,GO:0003682,CREBBP,chromatin binding,1.0
4844,1387,GO:0003684,CREBBP,damaged DNA binding,1.0
4845,1387,GO:0003713,CREBBP,transcription coactivator activity,1.0
4846,1387,GO:0003713,CREBBP,transcription coactivator activity,1.0
4847,1387,GO:0003713,CREBBP,transcription coactivator activity,1.0
4848,1387,GO:0003713,CREBBP,transcription coactivator activity,1.0
4849,1387,GO:0003714,CREBBP,transcription corepressor activity,1.0
4850,1387,GO:0004402,CREBBP,histone acetyltransferase activity,1.0
4851,1387,GO:0004402,CREBBP,histone acetyltransferase activity,1.0
4852,1387,GO:0004402,CREBBP,histone acetyltransferase activity,1.0
4853,1387,GO:0005515,CREBBP,protein binding,1.0
4854,1387,GO:0005634,CREBBP,nucleus,1.0
4855,1387,GO:0005634,CREBBP,nucleus,1.0
4856,1387,GO:0005654,CREBBP,nucleoplasm,1.0
4857,1387,GO:0005654,CREBBP,nucleoplasm,1.0
4858,1387,GO:0005667,CREBBP,transcription regulator complex,1.0
4859,1387,GO:0005737,CREBBP,cytoplasm,1.0
4860,1387,GO:0006355,CREBBP,"regulation of transcription, DNA-templated",1.0
4861,1387,GO:0006367,CREBBP,transcription initiation from RNA polymerase II promoter,1.0
4862,1387,GO:0006473,CREBBP,protein acetylation,1.0
4863,1387,GO:0006473,CREBBP,protein acetylation,1.0
4864,1387,GO:0007165,CREBBP,signal transduction,1.0
4865,1387,GO:0007219,CREBBP,Notch signaling pathway,1.0
4866,1387,GO:0007221,CREBBP,positive regulation of transcription of Notch receptor target,1.0
4867,1387,GO:0008134,CREBBP,transcription factor binding,1.0
4868,1387,GO:0008270,CREBBP,zinc ion binding,1.0
4869,1387,GO:0008589,CREBBP,regulation of smoothened signaling pathway,1.0
4870,1387,GO:0016032,CREBBP,viral process,1.0
4871,1387,GO:0016407,CREBBP,acetyltransferase activity,1.0
4872,1387,GO:0016407,CREBBP,acetyltransferase activity,1.0
4873,1387,GO:0016573,CREBBP,histone acetylation,1.0
4874,1387,GO:0016573,CREBBP,histone acetylation,1.0
4875,1387,GO:0016604,CREBBP,nuclear body,1.0
4876,1387,GO:0018076,CREBBP,N-terminal peptidyl-lysine acetylation,1.0
4877,1387,GO:0019216,CREBBP,regulation of lipid metabolic process,1.0
4878,1387,GO:0030511,CREBBP,positive regulation of transforming growth factor beta receptor signaling pathway,1.0
4879,1387,GO:0031490,CREBBP,chromatin DNA binding,1.0
4880,1387,GO:0031648,CREBBP,protein destabilization,1.0
4881,1387,GO:0032481,CREBBP,positive regulation of type I interferon production,1.0
4882,1387,GO:0034644,CREBBP,cellular response to UV,1.0
4883,1387,GO:0042592,CREBBP,homeostatic process,1.0
4884,1387,GO:0042733,CREBBP,embryonic digit morphogenesis,1.0
4885,1387,GO:0042981,CREBBP,regulation of apoptotic process,1.0
4886,1387,GO:0043426,CREBBP,MRF binding,1.0
4887,1387,GO:0045637,CREBBP,regulation of myeloid cell differentiation,1.0
4888,1387,GO:0045747,CREBBP,positive regulation of Notch signaling pathway,1.0
4889,1387,GO:0045893,CREBBP,"positive regulation of transcription, DNA-templated",1.0
4890,1387,GO:0045893,CREBBP,"positive regulation of transcription, DNA-templated",1.0
4891,1387,GO:0045944,CREBBP,positive regulation of transcription by RNA polymerase II,1.0
4892,1387,GO:0045944,CREBBP,positive regulation of transcription by RNA polymerase II,1.0
4893,1387,GO:0045944,CREBBP,positive regulation of transcription by RNA polymerase II,1.0
4894,1387,GO:0048511,CREBBP,rhythmic process,1.0
4895,1387,GO:0061418,CREBBP,regulation of transcription from RNA polymerase II promoter in response to hypoxia,1.0
4896,1387,GO:0061733,CREBBP,peptide-lysine-N-acetyltransferase activity,1.0
4897,1387,GO:0065003,CREBBP,protein-containing complex assembly,1.0
4898,1387,GO:1900034,CREBBP,regulation of cellular response to heat,1.0
4899,1387,GO:1904837,CREBBP,beta-catenin-TCF complex assembly,1.0
4900,1387,GO:1990258,CREBBP,histone glutamine methylation,1.0
4937,11151,GO:0001771,CORO1A,immunological synapse formation,1.0
4938,11151,GO:0001772,CORO1A,immunological synapse,1.0
4939,11151,GO:0001845,CORO1A,phagolysosome assembly,1.0
4940,11151,GO:0001891,CORO1A,phagocytic cup,1.0
4941,11151,GO:0003723,CORO1A,RNA binding,1.0
4942,11151,GO:0003779,CORO1A,actin binding,1.0
4943,11151,GO:0003785,CORO1A,actin monomer binding,1.0
4944,11151,GO:0005515,CORO1A,protein binding,1.0
4945,11151,GO:0005634,CORO1A,nucleus,1.0
4946,11151,GO:0005737,CORO1A,cytoplasm,1.0
4947,11151,GO:0005769,CORO1A,early endosome,1.0
4948,11151,GO:0005829,CORO1A,cytosol,1.0
4949,11151,GO:0005884,CORO1A,actin filament,1.0
4950,11151,GO:0005886,CORO1A,plasma membrane,1.0
4951,11151,GO:0005911,CORO1A,cell-cell junction,1.0
4952,11151,GO:0006909,CORO1A,phagocytosis,1.0
4953,11151,GO:0007015,CORO1A,actin filament organization,1.0
4954,11151,GO:0008022,CORO1A,protein C-terminus binding,1.0
4955,11151,GO:0008092,CORO1A,cytoskeletal protein binding,1.0
4956,11151,GO:0016020,CORO1A,membrane,1.0
4957,11151,GO:0016477,CORO1A,cell migration,1.0
4958,11151,GO:0030027,CORO1A,lamellipodium,1.0
4959,11151,GO:0030036,CORO1A,actin cytoskeleton organization,1.0
4960,11151,GO:0030335,CORO1A,positive regulation of cell migration,1.0
4961,11151,GO:0030595,CORO1A,leukocyte chemotaxis,1.0
4962,11151,GO:0030670,CORO1A,phagocytic vesicle membrane,1.0
4963,11151,GO:0030864,CORO1A,cortical actin cytoskeleton,1.0
4964,11151,GO:0030864,CORO1A,cortical actin cytoskeleton,1.0
4965,11151,GO:0031589,CORO1A,cell-substrate adhesion,1.0
4966,11151,GO:0032036,CORO1A,myosin heavy chain binding,1.0
4967,11151,GO:0032796,CORO1A,uropod organization,1.0
4968,11151,GO:0032956,CORO1A,regulation of actin cytoskeleton organization,1.0
4969,11151,GO:0032991,CORO1A,protein-containing complex,1.0
4970,11151,GO:0038180,CORO1A,nerve growth factor signaling pathway,1.0
4971,11151,GO:0042803,CORO1A,protein homodimerization activity,1.0
4972,11151,GO:0043029,CORO1A,T cell homeostasis,1.0
4973,11151,GO:0043320,CORO1A,natural killer cell degranulation,1.0
4974,11151,GO:0043524,CORO1A,negative regulation of neuron apoptotic process,1.0
4975,11151,GO:0043548,CORO1A,phosphatidylinositol 3-kinase binding,1.0
4976,11151,GO:0045087,CORO1A,innate immune response,1.0
4977,11151,GO:0045335,CORO1A,phagocytic vesicle,1.0
4978,11151,GO:0048873,CORO1A,homeostasis of number of cells within a tissue,1.0
4979,11151,GO:0050870,CORO1A,positive regulation of T cell activation,1.0
4980,11151,GO:0050918,CORO1A,positive chemotaxis,1.0
4981,11151,GO:0051015,CORO1A,actin filament binding,1.0
4982,11151,GO:0051015,CORO1A,actin filament binding,1.0
4983,11151,GO:0051015,CORO1A,actin filament binding,1.0
4984,11151,GO:0051126,CORO1A,negative regulation of actin nucleation,1.0
4985,11151,GO:0061502,CORO1A,early endosome to recycling endosome transport,1.0
4986,11151,GO:0070062,CORO1A,extracellular exosome,1.0
4987,11151,GO:0071353,CORO1A,cellular response to interleukin-4,1.0
4988,11151,GO:0098978,CORO1A,glutamatergic synapse,1.0
4989,7812,GO:0000932,CSDE1,P-body,1.0
4990,7812,GO:0003723,CSDE1,RNA binding,1.0
4991,7812,GO:0005515,CSDE1,protein binding,1.0
4992,7812,GO:0005794,CSDE1,Golgi apparatus,1.0
4993,7812,GO:0005829,CSDE1,cytosol,1.0
4994,7812,GO:0005886,CSDE1,plasma membrane,1.0
4995,7812,GO:0008584,CSDE1,male gonad development,1.0
4996,7812,GO:0010494,CSDE1,cytoplasmic stress granule,1.0
4997,7812,GO:0034063,CSDE1,stress granule assembly,1.0
4998,7812,GO:0070937,CSDE1,CRD-mediated mRNA stability complex,1.0
4999,7812,GO:0070966,CSDE1,"nuclear-transcribed mRNA catabolic process, no-go decay",1.0
5094,10664,GO:0000122,CTCF,negative regulation of transcription by RNA polymerase II,1.0
5095,10664,GO:0000122,CTCF,negative regulation of transcription by RNA polymerase II,1.0
5096,10664,GO:0000775,CTCF,"chromosome, centromeric region",1.0
5097,10664,GO:0000785,CTCF,chromatin,1.0
5098,10664,GO:0000793,CTCF,condensed chromosome,1.0
5099,10664,GO:0000976,CTCF,transcription regulatory region sequence-specific DNA binding,1.0
5100,10664,GO:0000978,CTCF,RNA polymerase II cis-regulatory region sequence-specific DNA binding,1.0
5101,10664,GO:0000978,CTCF,RNA polymerase II cis-regulatory region sequence-specific DNA binding,1.0
5102,10664,GO:0001227,CTCF,"DNA-binding transcription repressor activity, RNA polymerase II-specific",1.0
5103,10664,GO:0003700,CTCF,DNA-binding transcription factor activity,1.0
5104,10664,GO:0003700,CTCF,DNA-binding transcription factor activity,1.0
5105,10664,GO:0005515,CTCF,protein binding,1.0
5106,10664,GO:0005634,CTCF,nucleus,1.0
5107,10664,GO:0005654,CTCF,nucleoplasm,1.0
5108,10664,GO:0005730,CTCF,nucleolus,1.0
5109,10664,GO:0006306,CTCF,DNA methylation,1.0
5110,10664,GO:0006349,CTCF,regulation of gene expression by genetic imprinting,1.0
5111,10664,GO:0006357,CTCF,regulation of transcription by RNA polymerase II,1.0
5112,10664,GO:0007059,CTCF,chromosome segregation,1.0
5113,10664,GO:0008270,CTCF,zinc ion binding,1.0
5114,10664,GO:0008285,CTCF,negative regulation of cell population proliferation,1.0
5115,10664,GO:0010216,CTCF,maintenance of DNA methylation,1.0
5116,10664,GO:0010628,CTCF,positive regulation of gene expression,1.0
5117,10664,GO:0016584,CTCF,nucleosome positioning,1.0
5118,10664,GO:0031060,CTCF,regulation of histone methylation,1.0
5119,10664,GO:0035065,CTCF,regulation of histone acetylation,1.0
5120,10664,GO:0040029,CTCF,"regulation of gene expression, epigenetic",1.0
5121,10664,GO:0040029,CTCF,"regulation of gene expression, epigenetic",1.0
5122,10664,GO:0040030,CTCF,"regulation of molecular function, epigenetic",1.0
5123,10664,GO:0043035,CTCF,chromatin insulator sequence binding,1.0
5124,10664,GO:0043035,CTCF,chromatin insulator sequence binding,1.0
5125,10664,GO:0043565,CTCF,sequence-specific DNA binding,1.0
5126,10664,GO:0045892,CTCF,"negative regulation of transcription, DNA-templated",1.0
5127,10664,GO:0045893,CTCF,"positive regulation of transcription, DNA-templated",1.0
5128,10664,GO:0045893,CTCF,"positive regulation of transcription, DNA-templated",1.0
5129,10664,GO:0045893,CTCF,"positive regulation of transcription, DNA-templated",1.0
5130,10664,GO:0070602,CTCF,regulation of centromeric sister chromatid cohesion,1.0
5131,10664,GO:0071459,CTCF,"protein localization to chromosome, centromeric region",1.0
5132,10664,GO:0071514,CTCF,genetic imprinting,1.0
5207,1499,GO:0000122,CTNNB1,negative regulation of transcription by RNA polymerase II,1.0
5208,1499,GO:0000209,CTNNB1,protein polyubiquitination,1.0
5209,1499,GO:0000578,CTNNB1,embryonic axis specification,1.0
5210,1499,GO:0000791,CTNNB1,euchromatin,1.0
5211,1499,GO:0000904,CTNNB1,cell morphogenesis involved in differentiation,1.0
5212,1499,GO:0000922,CTNNB1,spindle pole,1.0
5213,1499,GO:0001085,CTNNB1,RNA polymerase II transcription factor binding,1.0
5214,1499,GO:0001085,CTNNB1,RNA polymerase II transcription factor binding,1.0
5215,1499,GO:0001102,CTNNB1,RNA polymerase II activating transcription factor binding,1.0
5216,1499,GO:0001569,CTNNB1,branching involved in blood vessel morphogenesis,1.0
5217,1499,GO:0001658,CTNNB1,branching involved in ureteric bud morphogenesis,1.0
5218,1499,GO:0001701,CTNNB1,in utero embryonic development,1.0
5219,1499,GO:0001702,CTNNB1,gastrulation with mouth forming second,1.0
5220,1499,GO:0001708,CTNNB1,cell fate specification,1.0
5221,1499,GO:0001711,CTNNB1,endodermal cell fate commitment,1.0
5222,1499,GO:0001764,CTNNB1,neuron migration,1.0
5223,1499,GO:0001837,CTNNB1,epithelial to mesenchymal transition,1.0
5224,1499,GO:0001840,CTNNB1,neural plate development,1.0
5225,1499,GO:0002052,CTNNB1,positive regulation of neuroblast proliferation,1.0
5226,1499,GO:0002053,CTNNB1,positive regulation of mesenchymal cell proliferation,1.0
5227,1499,GO:0002089,CTNNB1,lens morphogenesis in camera-type eye,1.0
5228,1499,GO:0003266,CTNNB1,regulation of secondary heart field cardioblast proliferation,1.0
5229,1499,GO:0003338,CTNNB1,metanephros morphogenesis,1.0
5230,1499,GO:0003340,CTNNB1,negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,1.0
5231,1499,GO:0003682,CTNNB1,chromatin binding,1.0
5232,1499,GO:0003713,CTNNB1,transcription coactivator activity,1.0
5233,1499,GO:0003713,CTNNB1,transcription coactivator activity,1.0
5234,1499,GO:0003713,CTNNB1,transcription coactivator activity,1.0
5235,1499,GO:0005515,CTNNB1,protein binding,1.0
5236,1499,GO:0005634,CTNNB1,nucleus,1.0
5237,1499,GO:0005654,CTNNB1,nucleoplasm,1.0
5238,1499,GO:0005667,CTNNB1,transcription regulator complex,1.0
5239,1499,GO:0005737,CTNNB1,cytoplasm,1.0
5240,1499,GO:0005813,CTNNB1,centrosome,1.0
5241,1499,GO:0005829,CTNNB1,cytosol,1.0
5242,1499,GO:0005829,CTNNB1,cytosol,1.0
5243,1499,GO:0005886,CTNNB1,plasma membrane,1.0
5244,1499,GO:0005911,CTNNB1,cell-cell junction,1.0
5245,1499,GO:0005912,CTNNB1,adherens junction,1.0
5246,1499,GO:0005912,CTNNB1,adherens junction,1.0
5247,1499,GO:0005916,CTNNB1,fascia adherens,1.0
5248,1499,GO:0005923,CTNNB1,bicellular tight junction,1.0
5249,1499,GO:0005925,CTNNB1,focal adhesion,1.0
5250,1499,GO:0005938,CTNNB1,cell cortex,1.0
5251,1499,GO:0007155,CTNNB1,cell adhesion,1.0
5252,1499,GO:0007160,CTNNB1,cell-matrix adhesion,1.0
5253,1499,GO:0007223,CTNNB1,"Wnt signaling pathway, calcium modulating pathway",1.0
5254,1499,GO:0007268,CTNNB1,chemical synaptic transmission,1.0
5255,1499,GO:0007398,CTNNB1,ectoderm development,1.0
5256,1499,GO:0007403,CTNNB1,glial cell fate determination,1.0
5257,1499,GO:0008013,CTNNB1,beta-catenin binding,1.0
5258,1499,GO:0008022,CTNNB1,protein C-terminus binding,1.0
5259,1499,GO:0008134,CTNNB1,transcription factor binding,1.0
5260,1499,GO:0008134,CTNNB1,transcription factor binding,1.0
5261,1499,GO:0008285,CTNNB1,negative regulation of cell population proliferation,1.0
5262,1499,GO:0009948,CTNNB1,anterior/posterior axis specification,1.0
5263,1499,GO:0009950,CTNNB1,dorsal/ventral axis specification,1.0
5264,1499,GO:0009954,CTNNB1,proximal/distal pattern formation,1.0
5265,1499,GO:0010718,CTNNB1,positive regulation of epithelial to mesenchymal transition,1.0
5266,1499,GO:0010909,CTNNB1,positive regulation of heparan sulfate proteoglycan biosynthetic process,1.0
5267,1499,GO:0016020,CTNNB1,membrane,1.0
5268,1499,GO:0016032,CTNNB1,viral process,1.0
5269,1499,GO:0016055,CTNNB1,Wnt signaling pathway,1.0
5270,1499,GO:0016323,CTNNB1,basolateral plasma membrane,1.0
5271,1499,GO:0016327,CTNNB1,apicolateral plasma membrane,1.0
5272,1499,GO:0016328,CTNNB1,lateral plasma membrane,1.0
5273,1499,GO:0016342,CTNNB1,catenin complex,1.0
5274,1499,GO:0016342,CTNNB1,catenin complex,1.0
5275,1499,GO:0016525,CTNNB1,negative regulation of angiogenesis,1.0
5276,1499,GO:0016600,CTNNB1,flotillin complex,1.0
5277,1499,GO:0019827,CTNNB1,stem cell population maintenance,1.0
5278,1499,GO:0019899,CTNNB1,enzyme binding,1.0
5279,1499,GO:0019900,CTNNB1,kinase binding,1.0
5280,1499,GO:0019901,CTNNB1,protein kinase binding,1.0
5281,1499,GO:0019903,CTNNB1,protein phosphatase binding,1.0
5282,1499,GO:0019903,CTNNB1,protein phosphatase binding,1.0
5283,1499,GO:0021819,CTNNB1,layer formation in cerebral cortex,1.0
5284,1499,GO:0022009,CTNNB1,central nervous system vasculogenesis,1.0
5285,1499,GO:0030018,CTNNB1,Z disc,1.0
5286,1499,GO:0030027,CTNNB1,lamellipodium,1.0
5287,1499,GO:0030054,CTNNB1,cell junction,1.0
5288,1499,GO:0030054,CTNNB1,cell junction,1.0
5289,1499,GO:0030316,CTNNB1,osteoclast differentiation,1.0
5290,1499,GO:0030331,CTNNB1,estrogen receptor binding,1.0
5291,1499,GO:0030539,CTNNB1,male genitalia development,1.0
5292,1499,GO:0030877,CTNNB1,beta-catenin destruction complex,1.0
5293,1499,GO:0030902,CTNNB1,hindbrain development,1.0
5294,1499,GO:0030997,CTNNB1,regulation of centriole-centriole cohesion,1.0
5295,1499,GO:0031016,CTNNB1,pancreas development,1.0
5296,1499,GO:0031069,CTNNB1,hair follicle morphogenesis,1.0
5297,1499,GO:0031528,CTNNB1,microvillus membrane,1.0
5298,1499,GO:0031641,CTNNB1,regulation of myelination,1.0
5299,1499,GO:0032212,CTNNB1,positive regulation of telomere maintenance via telomerase,1.0
5300,1499,GO:0032331,CTNNB1,negative regulation of chondrocyte differentiation,1.0
5301,1499,GO:0032355,CTNNB1,response to estradiol,1.0
5302,1499,GO:0032481,CTNNB1,positive regulation of type I interferon production,1.0
5303,1499,GO:0032968,CTNNB1,positive regulation of transcription elongation from RNA polymerase II promoter,1.0
5304,1499,GO:0032991,CTNNB1,protein-containing complex,1.0
5305,1499,GO:0032993,CTNNB1,protein-DNA complex,1.0
5306,1499,GO:0033077,CTNNB1,T cell differentiation in thymus,1.0
5307,1499,GO:0033234,CTNNB1,negative regulation of protein sumoylation,1.0
5308,1499,GO:0034333,CTNNB1,adherens junction assembly,1.0
5309,1499,GO:0034394,CTNNB1,protein localization to cell surface,1.0
5310,1499,GO:0034750,CTNNB1,Scrib-APC-beta-catenin complex,1.0
5311,1499,GO:0035050,CTNNB1,embryonic heart tube development,1.0
5312,1499,GO:0035112,CTNNB1,genitalia morphogenesis,1.0
5313,1499,GO:0035115,CTNNB1,embryonic forelimb morphogenesis,1.0
5314,1499,GO:0035116,CTNNB1,embryonic hindlimb morphogenesis,1.0
5315,1499,GO:0035257,CTNNB1,nuclear hormone receptor binding,1.0
5316,1499,GO:0035257,CTNNB1,nuclear hormone receptor binding,1.0
5317,1499,GO:0035257,CTNNB1,nuclear hormone receptor binding,1.0
5318,1499,GO:0035315,CTNNB1,hair cell differentiation,1.0
5319,1499,GO:0035635,CTNNB1,entry of bacterium into host cell,1.0
5320,1499,GO:0035995,CTNNB1,detection of muscle stretch,1.0
5321,1499,GO:0036023,CTNNB1,embryonic skeletal limb joint morphogenesis,1.0
5322,1499,GO:0036520,CTNNB1,astrocyte-dopaminergic neuron signaling,1.0
5323,1499,GO:0042129,CTNNB1,regulation of T cell proliferation,1.0
5324,1499,GO:0042475,CTNNB1,odontogenesis of dentin-containing tooth,1.0
5325,1499,GO:0042493,CTNNB1,response to drug,1.0
5326,1499,GO:0042733,CTNNB1,embryonic digit morphogenesis,1.0
5327,1499,GO:0042734,CTNNB1,presynaptic membrane,1.0
5328,1499,GO:0043065,CTNNB1,positive regulation of apoptotic process,1.0
5329,1499,GO:0043066,CTNNB1,negative regulation of apoptotic process,1.0
5330,1499,GO:0043123,CTNNB1,positive regulation of I-kappaB kinase/NF-kappaB signaling,1.0
5331,1499,GO:0043161,CTNNB1,proteasome-mediated ubiquitin-dependent protein catabolic process,1.0
5332,1499,GO:0043410,CTNNB1,positive regulation of MAPK cascade,1.0
5333,1499,GO:0043525,CTNNB1,positive regulation of neuron apoptotic process,1.0
5334,1499,GO:0044325,CTNNB1,ion channel binding,1.0
5335,1499,GO:0044334,CTNNB1,canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition,1.0
5336,1499,GO:0044336,CTNNB1,canonical Wnt signaling pathway involved in negative regulation of apoptotic process,1.0
5337,1499,GO:0044338,CTNNB1,canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation,1.0
5338,1499,GO:0045177,CTNNB1,apical part of cell,1.0
5339,1499,GO:0045202,CTNNB1,synapse,1.0
5340,1499,GO:0045211,CTNNB1,postsynaptic membrane,1.0
5341,1499,GO:0045294,CTNNB1,alpha-catenin binding,1.0
5342,1499,GO:0045294,CTNNB1,alpha-catenin binding,1.0
5343,1499,GO:0045296,CTNNB1,cadherin binding,1.0
5344,1499,GO:0045296,CTNNB1,cadherin binding,1.0
5345,1499,GO:0045296,CTNNB1,cadherin binding,1.0
5346,1499,GO:0045453,CTNNB1,bone resorption,1.0
5347,1499,GO:0045603,CTNNB1,positive regulation of endothelial cell differentiation,1.0
5348,1499,GO:0045669,CTNNB1,positive regulation of osteoblast differentiation,1.0
5349,1499,GO:0045671,CTNNB1,negative regulation of osteoclast differentiation,1.0
5350,1499,GO:0045743,CTNNB1,positive regulation of fibroblast growth factor receptor signaling pathway,1.0
5351,1499,GO:0045765,CTNNB1,regulation of angiogenesis,1.0
5352,1499,GO:0045892,CTNNB1,"negative regulation of transcription, DNA-templated",1.0
5353,1499,GO:0045893,CTNNB1,"positive regulation of transcription, DNA-templated",1.0
5354,1499,GO:0045893,CTNNB1,"positive regulation of transcription, DNA-templated",1.0
5355,1499,GO:0045944,CTNNB1,positive regulation of transcription by RNA polymerase II,1.0
5356,1499,GO:0045944,CTNNB1,positive regulation of transcription by RNA polymerase II,1.0
5357,1499,GO:0045944,CTNNB1,positive regulation of transcription by RNA polymerase II,1.0
5358,1499,GO:0045944,CTNNB1,positive regulation of transcription by RNA polymerase II,1.0
5359,1499,GO:0045944,CTNNB1,positive regulation of transcription by RNA polymerase II,1.0
5360,1499,GO:0045976,CTNNB1,"negative regulation of mitotic cell cycle, embryonic",1.0
5361,1499,GO:0046332,CTNNB1,SMAD binding,1.0
5362,1499,GO:0048096,CTNNB1,chromatin-mediated maintenance of transcription,1.0
5363,1499,GO:0048145,CTNNB1,regulation of fibroblast proliferation,1.0
5364,1499,GO:0048469,CTNNB1,cell maturation,1.0
5365,1499,GO:0048471,CTNNB1,perinuclear region of cytoplasm,1.0
5366,1499,GO:0048489,CTNNB1,synaptic vesicle transport,1.0
5367,1499,GO:0048538,CTNNB1,thymus development,1.0
5368,1499,GO:0048599,CTNNB1,oocyte development,1.0
5369,1499,GO:0048617,CTNNB1,embryonic foregut morphogenesis,1.0
5370,1499,GO:0048643,CTNNB1,positive regulation of skeletal muscle tissue development,1.0
5371,1499,GO:0048660,CTNNB1,regulation of smooth muscle cell proliferation,1.0
5372,1499,GO:0048715,CTNNB1,negative regulation of oligodendrocyte differentiation,1.0
5373,1499,GO:0050767,CTNNB1,regulation of neurogenesis,1.0
5374,1499,GO:0050808,CTNNB1,synapse organization,1.0
5375,1499,GO:0051091,CTNNB1,positive regulation of DNA-binding transcription factor activity,1.0
5376,1499,GO:0051145,CTNNB1,smooth muscle cell differentiation,1.0
5377,1499,GO:0051149,CTNNB1,positive regulation of muscle cell differentiation,1.0
5378,1499,GO:0051571,CTNNB1,positive regulation of histone H3-K4 methylation,1.0
5379,1499,GO:0051884,CTNNB1,regulation of timing of anagen,1.0
5380,1499,GO:0051973,CTNNB1,positive regulation of telomerase activity,1.0
5381,1499,GO:0060066,CTNNB1,oviduct development,1.0
5382,1499,GO:0060070,CTNNB1,canonical Wnt signaling pathway,1.0
5383,1499,GO:0060070,CTNNB1,canonical Wnt signaling pathway,1.0
5384,1499,GO:0060440,CTNNB1,trachea formation,1.0
5385,1499,GO:0060441,CTNNB1,epithelial tube branching involved in lung morphogenesis,1.0
5386,1499,GO:0060479,CTNNB1,lung cell differentiation,1.0
5387,1499,GO:0060484,CTNNB1,lung-associated mesenchyme development,1.0
5388,1499,GO:0060492,CTNNB1,lung induction,1.0
5389,1499,GO:0060742,CTNNB1,epithelial cell differentiation involved in prostate gland development,1.0
5390,1499,GO:0060769,CTNNB1,positive regulation of epithelial cell proliferation involved in prostate gland development,1.0
5391,1499,GO:0060789,CTNNB1,hair follicle placode formation,1.0
5392,1499,GO:0060828,CTNNB1,regulation of canonical Wnt signaling pathway,1.0
5393,1499,GO:0060916,CTNNB1,mesenchymal cell proliferation involved in lung development,1.0
5394,1499,GO:0061154,CTNNB1,endothelial tube morphogenesis,1.0
5395,1499,GO:0061198,CTNNB1,fungiform papilla formation,1.0
5396,1499,GO:0061324,CTNNB1,canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation,1.0
5397,1499,GO:0061549,CTNNB1,sympathetic ganglion development,1.0
5398,1499,GO:0061550,CTNNB1,cranial ganglion development,1.0
5399,1499,GO:0070062,CTNNB1,extracellular exosome,1.0
5400,1499,GO:0070369,CTNNB1,beta-catenin-TCF7L2 complex,1.0
5401,1499,GO:0070411,CTNNB1,I-SMAD binding,1.0
5402,1499,GO:0070491,CTNNB1,repressing transcription factor binding,1.0
5403,1499,GO:0070602,CTNNB1,regulation of centromeric sister chromatid cohesion,1.0
5404,1499,GO:0071363,CTNNB1,cellular response to growth factor stimulus,1.0
5405,1499,GO:0071681,CTNNB1,cellular response to indole-3-methanol,1.0
5406,1499,GO:0071944,CTNNB1,cell periphery,1.0
5407,1499,GO:0072033,CTNNB1,renal vesicle formation,1.0
5408,1499,GO:0072053,CTNNB1,renal inner medulla development,1.0
5409,1499,GO:0072054,CTNNB1,renal outer medulla development,1.0
5410,1499,GO:0072079,CTNNB1,nephron tubule formation,1.0
5411,1499,GO:0072182,CTNNB1,regulation of nephron tubule epithelial cell differentiation,1.0
5412,1499,GO:0090279,CTNNB1,regulation of calcium ion import,1.0
5413,1499,GO:0097091,CTNNB1,synaptic vesicle clustering,1.0
5414,1499,GO:0097718,CTNNB1,disordered domain specific binding,1.0
5415,1499,GO:0098609,CTNNB1,cell-cell adhesion,1.0
5416,1499,GO:0098685,CTNNB1,Schaffer collateral - CA1 synapse,1.0
5417,1499,GO:0098831,CTNNB1,presynaptic active zone cytoplasmic component,1.0
5418,1499,GO:1903204,CTNNB1,negative regulation of oxidative stress-induced neuron death,1.0
5419,1499,GO:1904501,CTNNB1,positive regulation of chromatin-mediated maintenance of transcription,1.0
5420,1499,GO:1904793,CTNNB1,regulation of euchromatin binding,1.0
5421,1499,GO:1904798,CTNNB1,positive regulation of core promoter binding,1.0
5422,1499,GO:1904837,CTNNB1,beta-catenin-TCF complex assembly,1.0
5423,1499,GO:1904886,CTNNB1,beta-catenin destruction complex disassembly,1.0
5424,1499,GO:1904888,CTNNB1,cranial skeletal system development,1.0
5425,1499,GO:1904948,CTNNB1,midbrain dopaminergic neuron differentiation,1.0
5426,1499,GO:1904954,CTNNB1,canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,1.0
5427,1499,GO:1990138,CTNNB1,neuron projection extension,1.0
5428,1499,GO:1990403,CTNNB1,embryonic brain development,1.0
5429,1499,GO:1990791,CTNNB1,dorsal root ganglion development,1.0
5430,1499,GO:1990907,CTNNB1,beta-catenin-TCF complex,1.0
5431,1499,GO:1990907,CTNNB1,beta-catenin-TCF complex,1.0
5432,1499,GO:1990909,CTNNB1,Wnt signalosome,1.0
5433,1499,GO:2000008,CTNNB1,regulation of protein localization to cell surface,1.0
5434,1499,GO:2000017,CTNNB1,positive regulation of determination of dorsal identity,1.0
5435,1499,GO:2000144,CTNNB1,"positive regulation of DNA-templated transcription, initiation",1.0
5436,1499,GO:2001234,CTNNB1,negative regulation of apoptotic signaling pathway,1.0
5464,8452,GO:0000082,CUL3,G1/S transition of mitotic cell cycle,1.0
5465,8452,GO:0000122,CUL3,negative regulation of transcription by RNA polymerase II,1.0
5466,8452,GO:0000139,CUL3,Golgi membrane,1.0
5467,8452,GO:0000165,CUL3,MAPK cascade,1.0
5468,8452,GO:0000209,CUL3,protein polyubiquitination,1.0
5469,8452,GO:0000922,CUL3,spindle pole,1.0
5470,8452,GO:0001831,CUL3,trophectodermal cellular morphogenesis,1.0
5471,8452,GO:0004842,CUL3,ubiquitin-protein transferase activity,1.0
5472,8452,GO:0005112,CUL3,Notch binding,1.0
5473,8452,GO:0005515,CUL3,protein binding,1.0
5474,8452,GO:0005634,CUL3,nucleus,1.0
5475,8452,GO:0005654,CUL3,nucleoplasm,1.0
5476,8452,GO:0005737,CUL3,cytoplasm,1.0
5477,8452,GO:0005813,CUL3,centrosome,1.0
5478,8452,GO:0005827,CUL3,polar microtubule,1.0
5479,8452,GO:0005829,CUL3,cytosol,1.0
5480,8452,GO:0005886,CUL3,plasma membrane,1.0
5481,8452,GO:0006511,CUL3,ubiquitin-dependent protein catabolic process,1.0
5482,8452,GO:0006513,CUL3,protein monoubiquitination,1.0
5483,8452,GO:0006888,CUL3,endoplasmic reticulum to Golgi vesicle-mediated transport,1.0
5484,8452,GO:0007080,CUL3,mitotic metaphase plate congression,1.0
5485,8452,GO:0007229,CUL3,integrin-mediated signaling pathway,1.0
5486,8452,GO:0007369,CUL3,gastrulation,1.0
5487,8452,GO:0008284,CUL3,positive regulation of cell population proliferation,1.0
5488,8452,GO:0016020,CUL3,membrane,1.0
5489,8452,GO:0016055,CUL3,Wnt signaling pathway,1.0
5490,8452,GO:0016477,CUL3,cell migration,1.0
5491,8452,GO:0016567,CUL3,protein ubiquitination,1.0
5492,8452,GO:0016567,CUL3,protein ubiquitination,1.0
5493,8452,GO:0017145,CUL3,stem cell division,1.0
5494,8452,GO:0030030,CUL3,cell projection organization,1.0
5495,8452,GO:0030332,CUL3,cyclin binding,1.0
5496,8452,GO:0031145,CUL3,anaphase-promoting complex-dependent catabolic process,1.0
5497,8452,GO:0031208,CUL3,POZ domain binding,1.0
5498,8452,GO:0031398,CUL3,positive regulation of protein ubiquitination,1.0
5499,8452,GO:0031461,CUL3,cullin-RING ubiquitin ligase complex,1.0
5500,8452,GO:0031463,CUL3,Cul3-RING ubiquitin ligase complex,1.0
5501,8452,GO:0031625,CUL3,ubiquitin protein ligase binding,1.0
5502,8452,GO:0031625,CUL3,ubiquitin protein ligase binding,1.0
5503,8452,GO:0031648,CUL3,protein destabilization,1.0
5504,8452,GO:0032467,CUL3,positive regulation of cytokinesis,1.0
5505,8452,GO:0035024,CUL3,negative regulation of Rho protein signal transduction,1.0
5506,8452,GO:0036126,CUL3,sperm flagellum,1.0
5507,8452,GO:0040016,CUL3,embryonic cleavage,1.0
5508,8452,GO:0043149,CUL3,stress fiber assembly,1.0
5509,8452,GO:0043161,CUL3,proteasome-mediated ubiquitin-dependent protein catabolic process,1.0
5510,8452,GO:0043687,CUL3,post-translational protein modification,1.0
5511,8452,GO:0044346,CUL3,fibroblast apoptotic process,1.0
5512,8452,GO:0045842,CUL3,positive regulation of mitotic metaphase/anaphase transition,1.0
5513,8452,GO:0048208,CUL3,COPII vesicle coating,1.0
5514,8452,GO:0051865,CUL3,protein autoubiquitination,1.0
5515,8452,GO:0061630,CUL3,ubiquitin protein ligase activity,1.0
5516,8452,GO:0070062,CUL3,extracellular exosome,1.0
5517,8452,GO:0071630,CUL3,nuclear protein quality control by the ubiquitin-proteasome system,1.0
5518,8452,GO:0072576,CUL3,liver morphogenesis,1.0
5519,8452,GO:0072686,CUL3,mitotic spindle,1.0
5520,8452,GO:0090090,CUL3,negative regulation of canonical Wnt signaling pathway,1.0
5521,8452,GO:0097193,CUL3,intrinsic apoptotic signaling pathway,1.0
5522,8452,GO:1901992,CUL3,positive regulation of mitotic cell cycle phase transition,1.0
5813,1654,GO:0003677,DDX3X,DNA binding,1.0
5814,1654,GO:0003678,DDX3X,DNA helicase activity,1.0
5815,1654,GO:0003723,DDX3X,RNA binding,1.0
5816,1654,GO:0003723,DDX3X,RNA binding,1.0
5817,1654,GO:0003723,DDX3X,RNA binding,1.0
5818,1654,GO:0003724,DDX3X,RNA helicase activity,1.0
5819,1654,GO:0003724,DDX3X,RNA helicase activity,1.0
5820,1654,GO:0003729,DDX3X,mRNA binding,1.0
5821,1654,GO:0003924,DDX3X,GTPase activity,1.0
5822,1654,GO:0005515,DDX3X,protein binding,1.0
5823,1654,GO:0005524,DDX3X,ATP binding,1.0
5824,1654,GO:0005576,DDX3X,extracellular region,1.0
5825,1654,GO:0005634,DDX3X,nucleus,1.0
5826,1654,GO:0005634,DDX3X,nucleus,1.0
5827,1654,GO:0005654,DDX3X,nucleoplasm,1.0
5828,1654,GO:0005737,DDX3X,cytoplasm,1.0
5829,1654,GO:0005737,DDX3X,cytoplasm,1.0
5830,1654,GO:0005813,DDX3X,centrosome,1.0
5831,1654,GO:0005829,DDX3X,cytosol,1.0
5832,1654,GO:0005852,DDX3X,eukaryotic translation initiation factor 3 complex,1.0
5833,1654,GO:0005886,DDX3X,plasma membrane,1.0
5834,1654,GO:0006413,DDX3X,translational initiation,1.0
5835,1654,GO:0007059,DDX3X,chromosome segregation,1.0
5836,1654,GO:0007276,DDX3X,gamete generation,1.0
5837,1654,GO:0008134,DDX3X,transcription factor binding,1.0
5838,1654,GO:0008143,DDX3X,poly(A) binding,1.0
5839,1654,GO:0008190,DDX3X,eukaryotic initiation factor 4E binding,1.0
5840,1654,GO:0008625,DDX3X,extrinsic apoptotic signaling pathway via death domain receptors,1.0
5841,1654,GO:0009615,DDX3X,response to virus,1.0
5842,1654,GO:0010494,DDX3X,cytoplasmic stress granule,1.0
5843,1654,GO:0010501,DDX3X,RNA secondary structure unwinding,1.0
5844,1654,GO:0010628,DDX3X,positive regulation of gene expression,1.0
5845,1654,GO:0016032,DDX3X,viral process,1.0
5846,1654,GO:0016055,DDX3X,Wnt signaling pathway,1.0
5847,1654,GO:0016887,DDX3X,ATPase activity,1.0
5848,1654,GO:0017111,DDX3X,nucleoside-triphosphatase activity,1.0
5849,1654,GO:0017148,DDX3X,negative regulation of translation,1.0
5850,1654,GO:0022627,DDX3X,cytosolic small ribosomal subunit,1.0
5851,1654,GO:0030027,DDX3X,lamellipodium,1.0
5852,1654,GO:0030154,DDX3X,cell differentiation,1.0
5853,1654,GO:0030307,DDX3X,positive regulation of cell growth,1.0
5854,1654,GO:0030308,DDX3X,negative regulation of cell growth,1.0
5855,1654,GO:0031252,DDX3X,cell leading edge,1.0
5856,1654,GO:0031333,DDX3X,negative regulation of protein-containing complex assembly,1.0
5857,1654,GO:0031369,DDX3X,translation initiation factor binding,1.0
5858,1654,GO:0031954,DDX3X,positive regulation of protein autophosphorylation,1.0
5859,1654,GO:0032508,DDX3X,DNA duplex unwinding,1.0
5860,1654,GO:0032727,DDX3X,positive regulation of interferon-alpha production,1.0
5861,1654,GO:0032728,DDX3X,positive regulation of interferon-beta production,1.0
5862,1654,GO:0032728,DDX3X,positive regulation of interferon-beta production,1.0
5863,1654,GO:0033592,DDX3X,RNA strand annealing activity,1.0
5864,1654,GO:0034063,DDX3X,stress granule assembly,1.0
5865,1654,GO:0034157,DDX3X,positive regulation of toll-like receptor 7 signaling pathway,1.0
5866,1654,GO:0034161,DDX3X,positive regulation of toll-like receptor 8 signaling pathway,1.0
5867,1654,GO:0034774,DDX3X,secretory granule lumen,1.0
5868,1654,GO:0035556,DDX3X,intracellular signal transduction,1.0
5869,1654,GO:0035613,DDX3X,RNA stem-loop binding,1.0
5870,1654,GO:0036493,DDX3X,positive regulation of translation in response to endoplasmic reticulum stress,1.0
5871,1654,GO:0042256,DDX3X,mature ribosome assembly,1.0
5872,1654,GO:0043015,DDX3X,gamma-tubulin binding,1.0
5873,1654,GO:0043024,DDX3X,ribosomal small subunit binding,1.0
5874,1654,GO:0043065,DDX3X,positive regulation of apoptotic process,1.0
5875,1654,GO:0043066,DDX3X,negative regulation of apoptotic process,1.0
5876,1654,GO:0043154,DDX3X,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,1.0
5877,1654,GO:0043186,DDX3X,P granule,1.0
5878,1654,GO:0043273,DDX3X,CTPase activity,1.0
5879,1654,GO:0043280,DDX3X,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,1.0
5880,1654,GO:0043312,DDX3X,neutrophil degranulation,1.0
5881,1654,GO:0043539,DDX3X,protein serine/threonine kinase activator activity,1.0
5882,1654,GO:0045070,DDX3X,positive regulation of viral genome replication,1.0
5883,1654,GO:0045087,DDX3X,innate immune response,1.0
5884,1654,GO:0045296,DDX3X,cadherin binding,1.0
5885,1654,GO:0045727,DDX3X,positive regulation of translation,1.0
5886,1654,GO:0045727,DDX3X,positive regulation of translation,1.0
5887,1654,GO:0045944,DDX3X,positive regulation of transcription by RNA polymerase II,1.0
5888,1654,GO:0045944,DDX3X,positive regulation of transcription by RNA polymerase II,1.0
5889,1654,GO:0045948,DDX3X,positive regulation of translational initiation,1.0
5890,1654,GO:0048027,DDX3X,mRNA 5'-UTR binding,1.0
5891,1654,GO:0055088,DDX3X,lipid homeostasis,1.0
5892,1654,GO:0070062,DDX3X,extracellular exosome,1.0
5893,1654,GO:0071243,DDX3X,cellular response to arsenic-containing substance,1.0
5894,1654,GO:0071470,DDX3X,cellular response to osmotic stress,1.0
5895,1654,GO:0071651,DDX3X,positive regulation of chemokine (C-C motif) ligand 5 production,1.0
5896,1654,GO:0071902,DDX3X,positive regulation of protein serine/threonine kinase activity,1.0
5897,1654,GO:0072559,DDX3X,NLRP3 inflammasome complex,1.0
5898,1654,GO:0090263,DDX3X,positive regulation of canonical Wnt signaling pathway,1.0
5899,1654,GO:0097193,DDX3X,intrinsic apoptotic signaling pathway,1.0
5900,1654,GO:0098586,DDX3X,cellular response to virus,1.0
5901,1654,GO:1900087,DDX3X,positive regulation of G1/S transition of mitotic cell cycle,1.0
5902,1654,GO:1900227,DDX3X,positive regulation of NLRP3 inflammasome complex assembly,1.0
5903,1654,GO:1901223,DDX3X,negative regulation of NIK/NF-kappaB signaling,1.0
5904,1654,GO:1901224,DDX3X,positive regulation of NIK/NF-kappaB signaling,1.0
5905,1654,GO:1901985,DDX3X,positive regulation of protein acetylation,1.0
5906,1654,GO:1902042,DDX3X,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,1.0
5907,1654,GO:1902523,DDX3X,positive regulation of protein K63-linked ubiquitination,1.0
5908,1654,GO:1903608,DDX3X,protein localization to cytoplasmic stress granule,1.0
5909,1654,GO:1904813,DDX3X,ficolin-1-rich granule lumen,1.0
5910,1654,GO:2001243,DDX3X,negative regulation of intrinsic apoptotic signaling pathway,1.0
5918,10522,GO:0000122,DEAF1,negative regulation of transcription by RNA polymerase II,1.0
5919,10522,GO:0000785,DEAF1,chromatin,1.0
5920,10522,GO:0000977,DEAF1,RNA polymerase II transcription regulatory region sequence-specific DNA binding,1.0
5921,10522,GO:0000981,DEAF1,"DNA-binding transcription factor activity, RNA polymerase II-specific",1.0
5922,10522,GO:0000981,DEAF1,"DNA-binding transcription factor activity, RNA polymerase II-specific",1.0
5923,10522,GO:0001227,DEAF1,"DNA-binding transcription repressor activity, RNA polymerase II-specific",1.0
5924,10522,GO:0001650,DEAF1,fibrillar center,1.0
5925,10522,GO:0001843,DEAF1,neural tube closure,1.0
5926,10522,GO:0005515,DEAF1,protein binding,1.0
5927,10522,GO:0005576,DEAF1,extracellular region,1.0
5928,10522,GO:0005634,DEAF1,nucleus,1.0
5929,10522,GO:0005654,DEAF1,nucleoplasm,1.0
5930,10522,GO:0005737,DEAF1,cytoplasm,1.0
5931,10522,GO:0006357,DEAF1,regulation of transcription by RNA polymerase II,1.0
5932,10522,GO:0006366,DEAF1,transcription by RNA polymerase II,1.0
5933,10522,GO:0007281,DEAF1,germ cell development,1.0
5934,10522,GO:0009653,DEAF1,anatomical structure morphogenesis,1.0
5935,10522,GO:0033599,DEAF1,regulation of mammary gland epithelial cell proliferation,1.0
5936,10522,GO:0045892,DEAF1,"negative regulation of transcription, DNA-templated",1.0
5937,10522,GO:0045893,DEAF1,"positive regulation of transcription, DNA-templated",1.0
5938,10522,GO:0046872,DEAF1,metal ion binding,1.0
5939,10522,GO:0048706,DEAF1,embryonic skeletal system development,1.0
5970,1717,GO:0001568,DHCR7,blood vessel development,1.0
5971,1717,GO:0005515,DHCR7,protein binding,1.0
5972,1717,GO:0005640,DHCR7,nuclear outer membrane,1.0
5973,1717,GO:0005783,DHCR7,endoplasmic reticulum,1.0
5974,1717,GO:0005789,DHCR7,endoplasmic reticulum membrane,1.0
5975,1717,GO:0005829,DHCR7,cytosol,1.0
5976,1717,GO:0006695,DHCR7,cholesterol biosynthetic process,1.0
5977,1717,GO:0006695,DHCR7,cholesterol biosynthetic process,1.0
5978,1717,GO:0009791,DHCR7,post-embryonic development,1.0
5979,1717,GO:0009918,DHCR7,sterol delta7 reductase activity,1.0
5980,1717,GO:0016020,DHCR7,membrane,1.0
5981,1717,GO:0016126,DHCR7,sterol biosynthetic process,1.0
5982,1717,GO:0016132,DHCR7,brassinosteroid biosynthetic process,1.0
5983,1717,GO:0016627,DHCR7,"oxidoreductase activity, acting on the CH-CH group of donors",1.0
5984,1717,GO:0030154,DHCR7,cell differentiation,1.0
5985,1717,GO:0030176,DHCR7,integral component of endoplasmic reticulum membrane,1.0
5986,1717,GO:0030324,DHCR7,lung development,1.0
5987,1717,GO:0033489,DHCR7,cholesterol biosynthetic process via desmosterol,1.0
5988,1717,GO:0033490,DHCR7,cholesterol biosynthetic process via lathosterol,1.0
5989,1717,GO:0035264,DHCR7,multicellular organism growth,1.0
5990,1717,GO:0042127,DHCR7,regulation of cell population proliferation,1.0
5991,1717,GO:0045540,DHCR7,regulation of cholesterol biosynthetic process,1.0
5992,1717,GO:0047598,DHCR7,7-dehydrocholesterol reductase activity,1.0
5993,1717,GO:0047598,DHCR7,7-dehydrocholesterol reductase activity,1.0
5994,1717,GO:0047598,DHCR7,7-dehydrocholesterol reductase activity,1.0
5995,1717,GO:0050661,DHCR7,NADP binding,1.0
5996,1717,GO:0055114,DHCR7,oxidation-reduction process,1.0
6013,23181,GO:0005515,DIP2A,protein binding,1.0
6014,23181,GO:0005634,DIP2A,nucleus,1.0
6015,23181,GO:0007275,DIP2A,multicellular organism development,1.0
6016,23181,GO:0009986,DIP2A,cell surface,1.0
6017,23181,GO:0009986,DIP2A,cell surface,1.0
6018,23181,GO:0010629,DIP2A,negative regulation of gene expression,1.0
6019,23181,GO:0016020,DIP2A,membrane,1.0
6261,1742,GO:0000165,DLG4,MAPK cascade,1.0
6262,1742,GO:0002091,DLG4,negative regulation of receptor internalization,1.0
6263,1742,GO:0005515,DLG4,protein binding,1.0
6264,1742,GO:0005737,DLG4,cytoplasm,1.0
6265,1742,GO:0005783,DLG4,endoplasmic reticulum,1.0
6266,1742,GO:0005829,DLG4,cytosol,1.0
6267,1742,GO:0005886,DLG4,plasma membrane,1.0
6268,1742,GO:0005886,DLG4,plasma membrane,1.0
6269,1742,GO:0007165,DLG4,signal transduction,1.0
6270,1742,GO:0007204,DLG4,positive regulation of cytosolic calcium ion concentration,1.0
6271,1742,GO:0007268,DLG4,chemical synaptic transmission,1.0
6272,1742,GO:0007399,DLG4,nervous system development,1.0
6273,1742,GO:0007612,DLG4,learning,1.0
6274,1742,GO:0008021,DLG4,synaptic vesicle,1.0
6275,1742,GO:0008022,DLG4,protein C-terminus binding,1.0
6276,1742,GO:0008076,DLG4,voltage-gated potassium channel complex,1.0
6277,1742,GO:0008328,DLG4,ionotropic glutamate receptor complex,1.0
6278,1742,GO:0008328,DLG4,ionotropic glutamate receptor complex,1.0
6279,1742,GO:0014069,DLG4,postsynaptic density,1.0
6280,1742,GO:0016188,DLG4,synaptic vesicle maturation,1.0
6281,1742,GO:0019900,DLG4,kinase binding,1.0
6282,1742,GO:0019903,DLG4,protein phosphatase binding,1.0
6283,1742,GO:0030054,DLG4,cell junction,1.0
6284,1742,GO:0030054,DLG4,cell junction,1.0
6285,1742,GO:0030165,DLG4,PDZ domain binding,1.0
6286,1742,GO:0030666,DLG4,endocytic vesicle membrane,1.0
6287,1742,GO:0030863,DLG4,cortical cytoskeleton,1.0
6288,1742,GO:0031234,DLG4,extrinsic component of cytoplasmic side of plasma membrane,1.0
6289,1742,GO:0031594,DLG4,neuromuscular junction,1.0
6290,1742,GO:0031697,DLG4,beta-1 adrenergic receptor binding,1.0
6291,1742,GO:0031748,DLG4,D1 dopamine receptor binding,1.0
6292,1742,GO:0031812,DLG4,P2Y1 nucleotide receptor binding,1.0
6293,1742,GO:0032281,DLG4,AMPA glutamate receptor complex,1.0
6294,1742,GO:0032839,DLG4,dendrite cytoplasm,1.0
6295,1742,GO:0033130,DLG4,acetylcholine receptor binding,1.0
6296,1742,GO:0035176,DLG4,social behavior,1.0
6297,1742,GO:0035255,DLG4,ionotropic glutamate receptor binding,1.0
6298,1742,GO:0035418,DLG4,protein localization to synapse,1.0
6299,1742,GO:0035641,DLG4,locomotory exploration behavior,1.0
6300,1742,GO:0035865,DLG4,cellular response to potassium ion,1.0
6301,1742,GO:0043005,DLG4,neuron projection,1.0
6302,1742,GO:0043113,DLG4,receptor clustering,1.0
6303,1742,GO:0043197,DLG4,dendritic spine,1.0
6304,1742,GO:0044224,DLG4,juxtaparanode region of axon,1.0
6305,1742,GO:0044300,DLG4,cerebellar mossy fiber,1.0
6306,1742,GO:0044306,DLG4,neuron projection terminus,1.0
6307,1742,GO:0044309,DLG4,neuron spine,1.0
6308,1742,GO:0044877,DLG4,protein-containing complex binding,1.0
6309,1742,GO:0045184,DLG4,establishment of protein localization,1.0
6310,1742,GO:0045202,DLG4,synapse,1.0
6311,1742,GO:0045211,DLG4,postsynaptic membrane,1.0
6312,1742,GO:0048169,DLG4,regulation of long-term neuronal synaptic plasticity,1.0
6313,1742,GO:0050806,DLG4,positive regulation of synaptic transmission,1.0
6314,1742,GO:0050885,DLG4,neuromuscular process controlling balance,1.0
6315,1742,GO:0060076,DLG4,excitatory synapse,1.0
6316,1742,GO:0060997,DLG4,dendritic spine morphogenesis,1.0
6317,1742,GO:0061098,DLG4,positive regulation of protein tyrosine kinase activity,1.0
6318,1742,GO:0061098,DLG4,positive regulation of protein tyrosine kinase activity,1.0
6319,1742,GO:0065003,DLG4,protein-containing complex assembly,1.0
6320,1742,GO:0071625,DLG4,vocalization behavior,1.0
6321,1742,GO:0097060,DLG4,synaptic membrane,1.0
6322,1742,GO:0097109,DLG4,neuroligin family protein binding,1.0
6323,1742,GO:0097110,DLG4,scaffold protein binding,1.0
6324,1742,GO:0097113,DLG4,AMPA glutamate receptor clustering,1.0
6325,1742,GO:0097113,DLG4,AMPA glutamate receptor clustering,1.0
6326,1742,GO:0097113,DLG4,AMPA glutamate receptor clustering,1.0
6327,1742,GO:0097120,DLG4,receptor localization to synapse,1.0
6328,1742,GO:0097120,DLG4,receptor localization to synapse,1.0
6329,1742,GO:0098609,DLG4,cell-cell adhesion,1.0
6330,1742,GO:0098839,DLG4,postsynaptic density membrane,1.0
6331,1742,GO:0098970,DLG4,postsynaptic neurotransmitter receptor diffusion trapping,1.0
6332,1742,GO:0098978,DLG4,glutamatergic synapse,1.0
6333,1742,GO:0150012,DLG4,positive regulation of neuron projection arborization,1.0
6334,1742,GO:2000310,DLG4,regulation of NMDA receptor activity,1.0
6335,1742,GO:2000310,DLG4,regulation of NMDA receptor activity,1.0
6336,1742,GO:2000463,DLG4,positive regulation of excitatory postsynaptic potential,1.0
6337,1742,GO:2000821,DLG4,regulation of grooming behavior,1.0
6535,1760,GO:0002028,DMPK,regulation of sodium ion transport,1.0
6536,1760,GO:0004674,DMPK,protein serine/threonine kinase activity,1.0
6537,1760,GO:0004674,DMPK,protein serine/threonine kinase activity,1.0
6538,1760,GO:0005515,DMPK,protein binding,1.0
6539,1760,GO:0005524,DMPK,ATP binding,1.0
6540,1760,GO:0005640,DMPK,nuclear outer membrane,1.0
6541,1760,GO:0005789,DMPK,endoplasmic reticulum membrane,1.0
6542,1760,GO:0005829,DMPK,cytosol,1.0
6543,1760,GO:0005886,DMPK,plasma membrane,1.0
6544,1760,GO:0006468,DMPK,protein phosphorylation,1.0
6545,1760,GO:0006874,DMPK,cellular calcium ion homeostasis,1.0
6546,1760,GO:0006874,DMPK,cellular calcium ion homeostasis,1.0
6547,1760,GO:0006998,DMPK,nuclear envelope organization,1.0
6548,1760,GO:0006998,DMPK,nuclear envelope organization,1.0
6549,1760,GO:0008016,DMPK,regulation of heart contraction,1.0
6550,1760,GO:0008016,DMPK,regulation of heart contraction,1.0
6551,1760,GO:0010657,DMPK,muscle cell apoptotic process,1.0
6552,1760,GO:0010830,DMPK,regulation of myotube differentiation,1.0
6553,1760,GO:0014722,DMPK,regulation of skeletal muscle contraction by calcium ion signaling,1.0
6554,1760,GO:0014853,DMPK,regulation of excitatory postsynaptic membrane potential involved in skeletal muscle contraction,1.0
6555,1760,GO:0017020,DMPK,myosin phosphatase regulator activity,1.0
6556,1760,GO:0018105,DMPK,peptidyl-serine phosphorylation,1.0
6557,1760,GO:0031307,DMPK,integral component of mitochondrial outer membrane,1.0
6558,1760,GO:0031965,DMPK,nuclear membrane,1.0
6559,1760,GO:0033017,DMPK,sarcoplasmic reticulum membrane,1.0
6560,1760,GO:0033017,DMPK,sarcoplasmic reticulum membrane,1.0
6561,1760,GO:0035556,DMPK,intracellular signal transduction,1.0
6562,1760,GO:0043666,DMPK,regulation of phosphoprotein phosphatase activity,1.0
6563,1760,GO:0046872,DMPK,metal ion binding,1.0
6564,1760,GO:0051823,DMPK,regulation of synapse structural plasticity,1.0
6565,1760,GO:0106310,DMPK,protein serine kinase activity,1.0
6566,1760,GO:0106311,DMPK,protein threonine kinase activity,1.0
6567,1760,GO:1903779,DMPK,regulation of cardiac conduction,1.0
6633,1788,GO:0000122,DNMT3A,negative regulation of transcription by RNA polymerase II,1.0
6634,1788,GO:0000122,DNMT3A,negative regulation of transcription by RNA polymerase II,1.0
6635,1788,GO:0000278,DNMT3A,mitotic cell cycle,1.0
6636,1788,GO:0000775,DNMT3A,"chromosome, centromeric region",1.0
6637,1788,GO:0000791,DNMT3A,euchromatin,1.0
6638,1788,GO:0000792,DNMT3A,heterochromatin,1.0
6639,1788,GO:0000978,DNMT3A,RNA polymerase II cis-regulatory region sequence-specific DNA binding,1.0
6640,1788,GO:0001741,DNMT3A,XY body,1.0
6641,1788,GO:0003677,DNMT3A,DNA binding,1.0
6642,1788,GO:0003682,DNMT3A,chromatin binding,1.0
6643,1788,GO:0003714,DNMT3A,transcription corepressor activity,1.0
6644,1788,GO:0003886,DNMT3A,DNA (cytosine-5-)-methyltransferase activity,1.0
6645,1788,GO:0005515,DNMT3A,protein binding,1.0
6646,1788,GO:0005634,DNMT3A,nucleus,1.0
6647,1788,GO:0005654,DNMT3A,nucleoplasm,1.0
6648,1788,GO:0005654,DNMT3A,nucleoplasm,1.0
6649,1788,GO:0005737,DNMT3A,cytoplasm,1.0
6650,1788,GO:0006306,DNMT3A,DNA methylation,1.0
6651,1788,GO:0006306,DNMT3A,DNA methylation,1.0
6652,1788,GO:0006346,DNMT3A,DNA methylation-dependent heterochromatin assembly,1.0
6653,1788,GO:0006349,DNMT3A,regulation of gene expression by genetic imprinting,1.0
6654,1788,GO:0007283,DNMT3A,spermatogenesis,1.0
6655,1788,GO:0007568,DNMT3A,aging,1.0
6656,1788,GO:0008134,DNMT3A,transcription factor binding,1.0
6657,1788,GO:0009008,DNMT3A,DNA-methyltransferase activity,1.0
6658,1788,GO:0009636,DNMT3A,response to toxic substance,1.0
6659,1788,GO:0010212,DNMT3A,response to ionizing radiation,1.0
6660,1788,GO:0010288,DNMT3A,response to lead ion,1.0
6661,1788,GO:0010942,DNMT3A,positive regulation of cell death,1.0
6662,1788,GO:0016363,DNMT3A,nuclear matrix,1.0
6663,1788,GO:0030182,DNMT3A,neuron differentiation,1.0
6664,1788,GO:0032355,DNMT3A,response to estradiol,1.0
6665,1788,GO:0033189,DNMT3A,response to vitamin A,1.0
6666,1788,GO:0042220,DNMT3A,response to cocaine,1.0
6667,1788,GO:0042493,DNMT3A,response to drug,1.0
6668,1788,GO:0042802,DNMT3A,identical protein binding,1.0
6669,1788,GO:0043045,DNMT3A,DNA methylation involved in embryo development,1.0
6670,1788,GO:0043046,DNMT3A,DNA methylation involved in gamete generation,1.0
6671,1788,GO:0045814,DNMT3A,"negative regulation of gene expression, epigenetic",1.0
6672,1788,GO:0046872,DNMT3A,metal ion binding,1.0
6673,1788,GO:0071230,DNMT3A,cellular response to amino acid stimulus,1.0
6674,1788,GO:0071361,DNMT3A,cellular response to ethanol,1.0
6675,1788,GO:0071456,DNMT3A,cellular response to hypoxia,1.0
6676,1788,GO:0090116,DNMT3A,C-5 methylation of cytosine,1.0
6677,1788,GO:0097284,DNMT3A,hepatocyte apoptotic process,1.0
6852,1808,GO:0004157,DPYSL2,dihydropyrimidinase activity,1.0
6853,1808,GO:0005515,DPYSL2,protein binding,1.0
6854,1808,GO:0005829,DPYSL2,cytosol,1.0
6855,1808,GO:0005829,DPYSL2,cytosol,1.0
6856,1808,GO:0005874,DPYSL2,microtubule,1.0
6857,1808,GO:0005886,DPYSL2,plasma membrane,1.0
6858,1808,GO:0006139,DPYSL2,nucleobase-containing compound metabolic process,1.0
6859,1808,GO:0006208,DPYSL2,pyrimidine nucleobase catabolic process,1.0
6860,1808,GO:0006897,DPYSL2,endocytosis,1.0
6861,1808,GO:0007010,DPYSL2,cytoskeleton organization,1.0
6862,1808,GO:0007165,DPYSL2,signal transduction,1.0
6863,1808,GO:0007399,DPYSL2,nervous system development,1.0
6864,1808,GO:0007411,DPYSL2,axon guidance,1.0
6865,1808,GO:0007420,DPYSL2,brain development,1.0
6866,1808,GO:0008017,DPYSL2,microtubule binding,1.0
6867,1808,GO:0016020,DPYSL2,membrane,1.0
6868,1808,GO:0030516,DPYSL2,regulation of axon extension,1.0
6869,1808,GO:0042802,DPYSL2,identical protein binding,1.0
6870,1808,GO:0070062,DPYSL2,extracellular exosome,1.0
7102,1826,GO:0005515,DSCAM,protein binding,1.0
7103,1826,GO:0005576,DSCAM,extracellular region,1.0
7104,1826,GO:0005886,DSCAM,plasma membrane,1.0
7105,1826,GO:0005886,DSCAM,plasma membrane,1.0
7106,1826,GO:0005886,DSCAM,plasma membrane,1.0
7107,1826,GO:0005887,DSCAM,integral component of plasma membrane,1.0
7108,1826,GO:0007155,DSCAM,cell adhesion,1.0
7109,1826,GO:0007156,DSCAM,homophilic cell adhesion via plasma membrane adhesion molecules,1.0
7110,1826,GO:0007156,DSCAM,homophilic cell adhesion via plasma membrane adhesion molecules,1.0
7111,1826,GO:0007162,DSCAM,negative regulation of cell adhesion,1.0
7112,1826,GO:0007399,DSCAM,nervous system development,1.0
7113,1826,GO:0007411,DSCAM,axon guidance,1.0
7114,1826,GO:0007411,DSCAM,axon guidance,1.0
7115,1826,GO:0007416,DSCAM,synapse assembly,1.0
7116,1826,GO:0007626,DSCAM,locomotory behavior,1.0
7117,1826,GO:0010842,DSCAM,retina layer formation,1.0
7118,1826,GO:0016020,DSCAM,membrane,1.0
7119,1826,GO:0030424,DSCAM,axon,1.0
7120,1826,GO:0030424,DSCAM,axon,1.0
7121,1826,GO:0030425,DSCAM,dendrite,1.0
7122,1826,GO:0030426,DSCAM,growth cone,1.0
7123,1826,GO:0038007,DSCAM,netrin-activated signaling pathway,1.0
7124,1826,GO:0042327,DSCAM,positive regulation of phosphorylation,1.0
7125,1826,GO:0043025,DSCAM,neuronal cell body,1.0
7126,1826,GO:0045202,DSCAM,synapse,1.0
7127,1826,GO:0048813,DSCAM,dendrite morphogenesis,1.0
7128,1826,GO:0048842,DSCAM,positive regulation of axon extension involved in axon guidance,1.0
7129,1826,GO:0060060,DSCAM,post-embryonic retina morphogenesis in camera-type eye,1.0
7130,1826,GO:0060219,DSCAM,camera-type eye photoreceptor cell differentiation,1.0
7131,1826,GO:0070593,DSCAM,dendrite self-avoidance,1.0
7132,1826,GO:0070593,DSCAM,dendrite self-avoidance,1.0
7133,1826,GO:0098632,DSCAM,cell-cell adhesion mediator activity,1.0
7134,1826,GO:1990782,DSCAM,protein tyrosine kinase binding,1.0
7135,1826,GO:1990890,DSCAM,netrin receptor binding,1.0
7243,1778,GO:0000086,DYNC1H1,G2/M transition of mitotic cell cycle,1.0
7244,1778,GO:0000278,DYNC1H1,mitotic cell cycle,1.0
7245,1778,GO:0003723,DYNC1H1,RNA binding,1.0
7246,1778,GO:0005515,DYNC1H1,protein binding,1.0
7247,1778,GO:0005524,DYNC1H1,ATP binding,1.0
7248,1778,GO:0005576,DYNC1H1,extracellular region,1.0
7249,1778,GO:0005813,DYNC1H1,centrosome,1.0
7250,1778,GO:0005829,DYNC1H1,cytosol,1.0
7251,1778,GO:0005868,DYNC1H1,cytoplasmic dynein complex,1.0
7252,1778,GO:0005868,DYNC1H1,cytoplasmic dynein complex,1.0
7253,1778,GO:0005868,DYNC1H1,cytoplasmic dynein complex,1.0
7254,1778,GO:0005874,DYNC1H1,microtubule,1.0
7255,1778,GO:0005881,DYNC1H1,cytoplasmic microtubule,1.0
7256,1778,GO:0005938,DYNC1H1,cell cortex,1.0
7257,1778,GO:0006888,DYNC1H1,endoplasmic reticulum to Golgi vesicle-mediated transport,1.0
7258,1778,GO:0007018,DYNC1H1,microtubule-based movement,1.0
7259,1778,GO:0007052,DYNC1H1,mitotic spindle organization,1.0
7260,1778,GO:0007097,DYNC1H1,nuclear migration,1.0
7261,1778,GO:0008090,DYNC1H1,retrograde axonal transport,1.0
7262,1778,GO:0008569,DYNC1H1,"ATP-dependent microtubule motor activity, minus-end-directed",1.0
7263,1778,GO:0010389,DYNC1H1,regulation of G2/M transition of mitotic cell cycle,1.0
7264,1778,GO:0016020,DYNC1H1,membrane,1.0
7265,1778,GO:0019886,DYNC1H1,antigen processing and presentation of exogenous peptide antigen via MHC class II,1.0
7266,1778,GO:0030175,DYNC1H1,filopodium,1.0
7267,1778,GO:0030286,DYNC1H1,dynein complex,1.0
7268,1778,GO:0031122,DYNC1H1,cytoplasmic microtubule organization,1.0
7269,1778,GO:0032388,DYNC1H1,positive regulation of intracellular transport,1.0
7270,1778,GO:0033962,DYNC1H1,P-body assembly,1.0
7271,1778,GO:0034063,DYNC1H1,stress granule assembly,1.0
7272,1778,GO:0035578,DYNC1H1,azurophil granule lumen,1.0
7273,1778,GO:0043312,DYNC1H1,neutrophil degranulation,1.0
7274,1778,GO:0045505,DYNC1H1,dynein intermediate chain binding,1.0
7275,1778,GO:0051293,DYNC1H1,establishment of spindle localization,1.0
7276,1778,GO:0051293,DYNC1H1,establishment of spindle localization,1.0
7277,1778,GO:0051301,DYNC1H1,cell division,1.0
7278,1778,GO:0051959,DYNC1H1,dynein light intermediate chain binding,1.0
7279,1778,GO:0051959,DYNC1H1,dynein light intermediate chain binding,1.0
7280,1778,GO:0060236,DYNC1H1,regulation of mitotic spindle organization,1.0
7281,1778,GO:0070062,DYNC1H1,extracellular exosome,1.0
7282,1778,GO:0072382,DYNC1H1,minus-end-directed vesicle transport along microtubule,1.0
7283,1778,GO:0090235,DYNC1H1,regulation of metaphase plate congression,1.0
7284,1778,GO:0097711,DYNC1H1,ciliary basal body-plasma membrane docking,1.0
7285,1778,GO:0120162,DYNC1H1,positive regulation of cold-induced thermogenesis,1.0
7286,1778,GO:1904115,DYNC1H1,axon cytoplasm,1.0
7287,1778,GO:1905832,DYNC1H1,positive regulation of spindle assembly,1.0
7288,1859,GO:0000381,DYRK1A,"regulation of alternative mRNA splicing, via spliceosome",1.0
7289,1859,GO:0003713,DYRK1A,transcription coactivator activity,1.0
7290,1859,GO:0004672,DYRK1A,protein kinase activity,1.0
7291,1859,GO:0004674,DYRK1A,protein serine/threonine kinase activity,1.0
7292,1859,GO:0004674,DYRK1A,protein serine/threonine kinase activity,1.0
7293,1859,GO:0004674,DYRK1A,protein serine/threonine kinase activity,1.0
7294,1859,GO:0004674,DYRK1A,protein serine/threonine kinase activity,1.0
7295,1859,GO:0004712,DYRK1A,protein serine/threonine/tyrosine kinase activity,1.0
7296,1859,GO:0004713,DYRK1A,protein tyrosine kinase activity,1.0
7297,1859,GO:0004715,DYRK1A,non-membrane spanning protein tyrosine kinase activity,1.0
7298,1859,GO:0005515,DYRK1A,protein binding,1.0
7299,1859,GO:0005524,DYRK1A,ATP binding,1.0
7300,1859,GO:0005634,DYRK1A,nucleus,1.0
7301,1859,GO:0005634,DYRK1A,nucleus,1.0
7302,1859,GO:0005634,DYRK1A,nucleus,1.0
7303,1859,GO:0005654,DYRK1A,nucleoplasm,1.0
7304,1859,GO:0005737,DYRK1A,cytoplasm,1.0
7305,1859,GO:0005737,DYRK1A,cytoplasm,1.0
7306,1859,GO:0005737,DYRK1A,cytoplasm,1.0
7307,1859,GO:0005856,DYRK1A,cytoskeleton,1.0
7308,1859,GO:0006468,DYRK1A,protein phosphorylation,1.0
7309,1859,GO:0006468,DYRK1A,protein phosphorylation,1.0
7310,1859,GO:0007399,DYRK1A,nervous system development,1.0
7311,1859,GO:0007623,DYRK1A,circadian rhythm,1.0
7312,1859,GO:0016032,DYRK1A,viral process,1.0
7313,1859,GO:0016607,DYRK1A,nuclear speck,1.0
7314,1859,GO:0016607,DYRK1A,nuclear speck,1.0
7315,1859,GO:0018105,DYRK1A,peptidyl-serine phosphorylation,1.0
7316,1859,GO:0018105,DYRK1A,peptidyl-serine phosphorylation,1.0
7317,1859,GO:0018105,DYRK1A,peptidyl-serine phosphorylation,1.0
7318,1859,GO:0018107,DYRK1A,peptidyl-threonine phosphorylation,1.0
7319,1859,GO:0018107,DYRK1A,peptidyl-threonine phosphorylation,1.0
7320,1859,GO:0018108,DYRK1A,peptidyl-tyrosine phosphorylation,1.0
7321,1859,GO:0018108,DYRK1A,peptidyl-tyrosine phosphorylation,1.0
7322,1859,GO:0030424,DYRK1A,axon,1.0
7323,1859,GO:0030425,DYRK1A,dendrite,1.0
7324,1859,GO:0031115,DYRK1A,negative regulation of microtubule polymerization,1.0
7325,1859,GO:0033120,DYRK1A,positive regulation of RNA splicing,1.0
7326,1859,GO:0034205,DYRK1A,amyloid-beta formation,1.0
7327,1859,GO:0036289,DYRK1A,peptidyl-serine autophosphorylation,1.0
7328,1859,GO:0038083,DYRK1A,peptidyl-tyrosine autophosphorylation,1.0
7329,1859,GO:0038083,DYRK1A,peptidyl-tyrosine autophosphorylation,1.0
7330,1859,GO:0042802,DYRK1A,identical protein binding,1.0
7331,1859,GO:0043518,DYRK1A,"negative regulation of DNA damage response, signal transduction by p53 class mediator",1.0
7332,1859,GO:0043621,DYRK1A,protein self-association,1.0
7333,1859,GO:0045893,DYRK1A,"positive regulation of transcription, DNA-templated",1.0
7334,1859,GO:0046777,DYRK1A,protein autophosphorylation,1.0
7335,1859,GO:0048025,DYRK1A,"negative regulation of mRNA splicing, via spliceosome",1.0
7336,1859,GO:0048156,DYRK1A,tau protein binding,1.0
7337,1859,GO:0048156,DYRK1A,tau protein binding,1.0
7338,1859,GO:0050321,DYRK1A,tau-protein kinase activity,1.0
7339,1859,GO:0090312,DYRK1A,positive regulation of protein deacetylation,1.0
7340,1859,GO:1990904,DYRK1A,ribonucleoprotein complex,1.0
7473,253738,GO:0000785,EBF3,chromatin,1.0
7474,253738,GO:0000785,EBF3,chromatin,1.0
7475,253738,GO:0000978,EBF3,RNA polymerase II cis-regulatory region sequence-specific DNA binding,1.0
7476,253738,GO:0000978,EBF3,RNA polymerase II cis-regulatory region sequence-specific DNA binding,1.0
7477,253738,GO:0000981,EBF3,"DNA-binding transcription factor activity, RNA polymerase II-specific",1.0
7478,253738,GO:0000981,EBF3,"DNA-binding transcription factor activity, RNA polymerase II-specific",1.0
7479,253738,GO:0005634,EBF3,nucleus,1.0
7480,253738,GO:0006357,EBF3,regulation of transcription by RNA polymerase II,1.0
7481,253738,GO:0007275,EBF3,multicellular organism development,1.0
7482,253738,GO:0045893,EBF3,"positive regulation of transcription, DNA-templated",1.0
7483,253738,GO:0046872,EBF3,metal ion binding,1.0
7484,253738,GO:0046983,EBF3,protein dimerization activity,1.0
7534,79813,GO:0000122,EHMT1,negative regulation of transcription by RNA polymerase II,1.0
7535,79813,GO:0001226,EHMT1,RNA polymerase II transcription corepressor binding,1.0
7536,79813,GO:0002039,EHMT1,p53 binding,1.0
7537,79813,GO:0005515,EHMT1,protein binding,1.0
7538,79813,GO:0005634,EHMT1,nucleus,1.0
7539,79813,GO:0005634,EHMT1,nucleus,1.0
7540,79813,GO:0005634,EHMT1,nucleus,1.0
7541,79813,GO:0005654,EHMT1,nucleoplasm,1.0
7542,79813,GO:0005654,EHMT1,nucleoplasm,1.0
7543,79813,GO:0005694,EHMT1,chromosome,1.0
7544,79813,GO:0006306,EHMT1,DNA methylation,1.0
7545,79813,GO:0006325,EHMT1,chromatin organization,1.0
7546,79813,GO:0008168,EHMT1,methyltransferase activity,1.0
7547,79813,GO:0008270,EHMT1,zinc ion binding,1.0
7548,79813,GO:0016279,EHMT1,protein-lysine N-methyltransferase activity,1.0
7549,79813,GO:0016571,EHMT1,histone methylation,1.0
7550,79813,GO:0016604,EHMT1,nuclear body,1.0
7551,79813,GO:0018024,EHMT1,histone-lysine N-methyltransferase activity,1.0
7552,79813,GO:0018026,EHMT1,peptidyl-lysine monomethylation,1.0
7553,79813,GO:0018027,EHMT1,peptidyl-lysine dimethylation,1.0
7554,79813,GO:0045892,EHMT1,"negative regulation of transcription, DNA-templated",1.0
7555,79813,GO:0045995,EHMT1,regulation of embryonic development,1.0
7556,79813,GO:0046974,EHMT1,histone methyltransferase activity (H3-K9 specific),1.0
7557,79813,GO:0046976,EHMT1,histone methyltransferase activity (H3-K27 specific),1.0
7558,79813,GO:0051567,EHMT1,histone H3-K9 methylation,1.0
7559,79813,GO:0070317,EHMT1,negative regulation of G0 to G1 transition,1.0
7560,79813,GO:0070734,EHMT1,histone H3-K27 methylation,1.0
7561,79813,GO:0070742,EHMT1,C2H2 zinc finger domain binding,1.0
7562,79813,GO:0120162,EHMT1,positive regulation of cold-induced thermogenesis,1.0
7563,79813,GO:1901796,EHMT1,regulation of signal transduction by p53 class mediator,1.0
7587,8666,GO:0001732,EIF3G,formation of cytoplasmic translation initiation complex,1.0
7588,8666,GO:0003723,EIF3G,RNA binding,1.0
7589,8666,GO:0003723,EIF3G,RNA binding,1.0
7590,8666,GO:0003743,EIF3G,translation initiation factor activity,1.0
7591,8666,GO:0003743,EIF3G,translation initiation factor activity,1.0
7592,8666,GO:0005515,EIF3G,protein binding,1.0
7593,8666,GO:0005634,EIF3G,nucleus,1.0
7594,8666,GO:0005737,EIF3G,cytoplasm,1.0
7595,8666,GO:0005829,EIF3G,cytosol,1.0
7596,8666,GO:0005829,EIF3G,cytosol,1.0
7597,8666,GO:0005852,EIF3G,eukaryotic translation initiation factor 3 complex,1.0
7598,8666,GO:0006413,EIF3G,translational initiation,1.0
7599,8666,GO:0006413,EIF3G,translational initiation,1.0
7600,8666,GO:0006413,EIF3G,translational initiation,1.0
7601,8666,GO:0016282,EIF3G,eukaryotic 43S preinitiation complex,1.0
7602,8666,GO:0033290,EIF3G,eukaryotic 48S preinitiation complex,1.0
7603,8666,GO:0048471,EIF3G,perinuclear region of cytoplasm,1.0
7604,8666,GO:0075525,EIF3G,viral translational termination-reinitiation,1.0
7709,1995,GO:0007399,ELAVL3,nervous system development,1.0
7710,1995,GO:0030154,ELAVL3,cell differentiation,1.0
7711,1995,GO:0035925,ELAVL3,mRNA 3'-UTR AU-rich region binding,1.0
7712,1995,GO:1990904,ELAVL3,ribonucleoprotein complex,1.0
7748,2033,GO:0000122,EP300,negative regulation of transcription by RNA polymerase II,1.0
7749,2033,GO:0000123,EP300,histone acetyltransferase complex,1.0
7750,2033,GO:0000977,EP300,RNA polymerase II transcription regulatory region sequence-specific DNA binding,1.0
7751,2033,GO:0000978,EP300,RNA polymerase II cis-regulatory region sequence-specific DNA binding,1.0
7752,2033,GO:0001085,EP300,RNA polymerase II transcription factor binding,1.0
7753,2033,GO:0001102,EP300,RNA polymerase II activating transcription factor binding,1.0
7754,2033,GO:0001666,EP300,response to hypoxia,1.0
7755,2033,GO:0001756,EP300,somitogenesis,1.0
7756,2033,GO:0001966,EP300,thigmotaxis,1.0
7757,2033,GO:0002039,EP300,p53 binding,1.0
7758,2033,GO:0002209,EP300,behavioral defense response,1.0
7759,2033,GO:0002223,EP300,stimulatory C-type lectin receptor signaling pathway,1.0
7760,2033,GO:0003677,EP300,DNA binding,1.0
7761,2033,GO:0003682,EP300,chromatin binding,1.0
7762,2033,GO:0003682,EP300,chromatin binding,1.0
7763,2033,GO:0003684,EP300,damaged DNA binding,1.0
7764,2033,GO:0003713,EP300,transcription coactivator activity,1.0
7765,2033,GO:0003713,EP300,transcription coactivator activity,1.0
7766,2033,GO:0003713,EP300,transcription coactivator activity,1.0
7767,2033,GO:0003713,EP300,transcription coactivator activity,1.0
7768,2033,GO:0003713,EP300,transcription coactivator activity,1.0
7769,2033,GO:0004402,EP300,histone acetyltransferase activity,1.0
7770,2033,GO:0004402,EP300,histone acetyltransferase activity,1.0
7771,2033,GO:0004402,EP300,histone acetyltransferase activity,1.0
7772,2033,GO:0004468,EP300,"lysine N-acetyltransferase activity, acting on acetyl phosphate as donor",1.0
7773,2033,GO:0005515,EP300,protein binding,1.0
7774,2033,GO:0005634,EP300,nucleus,1.0
7775,2033,GO:0005654,EP300,nucleoplasm,1.0
7776,2033,GO:0005654,EP300,nucleoplasm,1.0
7777,2033,GO:0005667,EP300,transcription regulator complex,1.0
7778,2033,GO:0005694,EP300,chromosome,1.0
7779,2033,GO:0005829,EP300,cytosol,1.0
7780,2033,GO:0006110,EP300,regulation of glycolytic process,1.0
7781,2033,GO:0006283,EP300,transcription-coupled nucleotide-excision repair,1.0
7782,2033,GO:0006355,EP300,"regulation of transcription, DNA-templated",1.0
7783,2033,GO:0006473,EP300,protein acetylation,1.0
7784,2033,GO:0006473,EP300,protein acetylation,1.0
7785,2033,GO:0006475,EP300,internal protein amino acid acetylation,1.0
7786,2033,GO:0006915,EP300,apoptotic process,1.0
7787,2033,GO:0006977,EP300,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest",1.0
7788,2033,GO:0006990,EP300,positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response,1.0
7789,2033,GO:0007219,EP300,Notch signaling pathway,1.0
7790,2033,GO:0007221,EP300,positive regulation of transcription of Notch receptor target,1.0
7791,2033,GO:0007399,EP300,nervous system development,1.0
7792,2033,GO:0007507,EP300,heart development,1.0
7793,2033,GO:0007519,EP300,skeletal muscle tissue development,1.0
7794,2033,GO:0007611,EP300,learning or memory,1.0
7795,2033,GO:0007623,EP300,circadian rhythm,1.0
7796,2033,GO:0008013,EP300,beta-catenin binding,1.0
7797,2033,GO:0008022,EP300,protein C-terminus binding,1.0
7798,2033,GO:0008134,EP300,transcription factor binding,1.0
7799,2033,GO:0008270,EP300,zinc ion binding,1.0
7800,2033,GO:0009887,EP300,animal organ morphogenesis,1.0
7801,2033,GO:0010506,EP300,regulation of autophagy,1.0
7802,2033,GO:0010742,EP300,macrophage derived foam cell differentiation,1.0
7803,2033,GO:0010821,EP300,regulation of mitochondrion organization,1.0
7804,2033,GO:0010976,EP300,positive regulation of neuron projection development,1.0
7805,2033,GO:0016032,EP300,viral process,1.0
7806,2033,GO:0016407,EP300,acetyltransferase activity,1.0
7807,2033,GO:0016407,EP300,acetyltransferase activity,1.0
7808,2033,GO:0016407,EP300,acetyltransferase activity,1.0
7809,2033,GO:0016573,EP300,histone acetylation,1.0
7810,2033,GO:0016573,EP300,histone acetylation,1.0
7811,2033,GO:0016579,EP300,protein deubiquitination,1.0
7812,2033,GO:0016746,EP300,"transferase activity, transferring acyl groups",1.0
7813,2033,GO:0018076,EP300,N-terminal peptidyl-lysine acetylation,1.0
7814,2033,GO:0018393,EP300,internal peptidyl-lysine acetylation,1.0
7815,2033,GO:0018394,EP300,peptidyl-lysine acetylation,1.0
7816,2033,GO:0030183,EP300,B cell differentiation,1.0
7817,2033,GO:0030220,EP300,platelet formation,1.0
7818,2033,GO:0030324,EP300,lung development,1.0
7819,2033,GO:0030511,EP300,positive regulation of transforming growth factor beta receptor signaling pathway,1.0
7820,2033,GO:0031333,EP300,negative regulation of protein-containing complex assembly,1.0
7821,2033,GO:0031490,EP300,chromatin DNA binding,1.0
7822,2033,GO:0031648,EP300,protein destabilization,1.0
7823,2033,GO:0032092,EP300,positive regulation of protein binding,1.0
7824,2033,GO:0032481,EP300,positive regulation of type I interferon production,1.0
7825,2033,GO:0032993,EP300,protein-DNA complex,1.0
7826,2033,GO:0033613,EP300,activating transcription factor binding,1.0
7827,2033,GO:0034644,EP300,cellular response to UV,1.0
7828,2033,GO:0035257,EP300,nuclear hormone receptor binding,1.0
7829,2033,GO:0035264,EP300,multicellular organism growth,1.0
7830,2033,GO:0035855,EP300,megakaryocyte development,1.0
7831,2033,GO:0036268,EP300,swimming,1.0
7832,2033,GO:0042771,EP300,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,1.0
7833,2033,GO:0043627,EP300,response to estrogen,1.0
7834,2033,GO:0043923,EP300,positive regulation by host of viral transcription,1.0
7835,2033,GO:0043967,EP300,histone H4 acetylation,1.0
7836,2033,GO:0043969,EP300,histone H2B acetylation,1.0
7837,2033,GO:0045444,EP300,fat cell differentiation,1.0
7838,2033,GO:0045652,EP300,regulation of megakaryocyte differentiation,1.0
7839,2033,GO:0045721,EP300,negative regulation of gluconeogenesis,1.0
7840,2033,GO:0045747,EP300,positive regulation of Notch signaling pathway,1.0
7841,2033,GO:0045815,EP300,"positive regulation of gene expression, epigenetic",1.0
7842,2033,GO:0045815,EP300,"positive regulation of gene expression, epigenetic",1.0
7843,2033,GO:0045893,EP300,"positive regulation of transcription, DNA-templated",1.0
7844,2033,GO:0045944,EP300,positive regulation of transcription by RNA polymerase II,1.0
7845,2033,GO:0045944,EP300,positive regulation of transcription by RNA polymerase II,1.0
7846,2033,GO:0045944,EP300,positive regulation of transcription by RNA polymerase II,1.0
7847,2033,GO:0045944,EP300,positive regulation of transcription by RNA polymerase II,1.0
7848,2033,GO:0048156,EP300,tau protein binding,1.0
7849,2033,GO:0050681,EP300,androgen receptor binding,1.0
7850,2033,GO:0050821,EP300,protein stabilization,1.0
7851,2033,GO:0051059,EP300,NF-kappaB binding,1.0
7852,2033,GO:0051091,EP300,positive regulation of DNA-binding transcription factor activity,1.0
7853,2033,GO:0051726,EP300,regulation of cell cycle,1.0
7854,2033,GO:0060325,EP300,face morphogenesis,1.0
7855,2033,GO:0060765,EP300,regulation of androgen receptor signaling pathway,1.0
7856,2033,GO:0061418,EP300,regulation of transcription from RNA polymerase II promoter in response to hypoxia,1.0
7857,2033,GO:0061733,EP300,peptide-lysine-N-acetyltransferase activity,1.0
7858,2033,GO:0061920,EP300,protein propionyltransferase activity,1.0
7859,2033,GO:0061921,EP300,peptidyl-lysine propionylation,1.0
7860,2033,GO:0090043,EP300,regulation of tubulin deacetylation,1.0
7861,2033,GO:0097157,EP300,pre-mRNA intronic binding,1.0
7862,2033,GO:0097677,EP300,STAT family protein binding,1.0
7863,2033,GO:0140065,EP300,peptide butyryltransferase activity,1.0
7864,2033,GO:0140066,EP300,peptidyl-lysine crotonylation,1.0
7865,2033,GO:0140067,EP300,peptidyl-lysine butyrylation,1.0
7866,2033,GO:0140068,EP300,histone crotonyltransferase activity,1.0
7867,2033,GO:0140069,EP300,histone butyryltransferase activity,1.0
7868,2033,GO:1900034,EP300,regulation of cellular response to heat,1.0
7869,2033,GO:1901224,EP300,positive regulation of NIK/NF-kappaB signaling,1.0
7870,2033,GO:1901796,EP300,regulation of signal transduction by p53 class mediator,1.0
7871,2033,GO:1904837,EP300,beta-catenin-TCF complex assembly,1.0
7872,2033,GO:1905636,EP300,positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding,1.0
8531,2332,GO:0000381,FMR1,"regulation of alternative mRNA splicing, via spliceosome",1.0
8532,2332,GO:0000381,FMR1,"regulation of alternative mRNA splicing, via spliceosome",1.0
8533,2332,GO:0000775,FMR1,"chromosome, centromeric region",1.0
8534,2332,GO:0001934,FMR1,positive regulation of protein phosphorylation,1.0
8535,2332,GO:0002092,FMR1,positive regulation of receptor internalization,1.0
8536,2332,GO:0002151,FMR1,G-quadruplex RNA binding,1.0
8537,2332,GO:0003682,FMR1,chromatin binding,1.0
8538,2332,GO:0003723,FMR1,RNA binding,1.0
8539,2332,GO:0003723,FMR1,RNA binding,1.0
8540,2332,GO:0003723,FMR1,RNA binding,1.0
8541,2332,GO:0003729,FMR1,mRNA binding,1.0
8542,2332,GO:0003730,FMR1,mRNA 3'-UTR binding,1.0
8543,2332,GO:0003730,FMR1,mRNA 3'-UTR binding,1.0
8544,2332,GO:0005515,FMR1,protein binding,1.0
8545,2332,GO:0005634,FMR1,nucleus,1.0
8546,2332,GO:0005634,FMR1,nucleus,1.0
8547,2332,GO:0005634,FMR1,nucleus,1.0
8548,2332,GO:0005654,FMR1,nucleoplasm,1.0
8549,2332,GO:0005694,FMR1,chromosome,1.0
8550,2332,GO:0005730,FMR1,nucleolus,1.0
8551,2332,GO:0005730,FMR1,nucleolus,1.0
8552,2332,GO:0005737,FMR1,cytoplasm,1.0
8553,2332,GO:0005737,FMR1,cytoplasm,1.0
8554,2332,GO:0005829,FMR1,cytosol,1.0
8555,2332,GO:0005844,FMR1,polysome,1.0
8556,2332,GO:0005844,FMR1,polysome,1.0
8557,2332,GO:0005844,FMR1,polysome,1.0
8558,2332,GO:0005845,FMR1,mRNA cap binding complex,1.0
8559,2332,GO:0006397,FMR1,mRNA processing,1.0
8560,2332,GO:0006974,FMR1,cellular response to DNA damage stimulus,1.0
8561,2332,GO:0007215,FMR1,glutamate receptor signaling pathway,1.0
8562,2332,GO:0008017,FMR1,microtubule binding,1.0
8563,2332,GO:0008266,FMR1,poly(U) RNA binding,1.0
8564,2332,GO:0008380,FMR1,RNA splicing,1.0
8565,2332,GO:0010369,FMR1,chromocenter,1.0
8566,2332,GO:0010494,FMR1,cytoplasmic stress granule,1.0
8567,2332,GO:0014069,FMR1,postsynaptic density,1.0
8568,2332,GO:0014069,FMR1,postsynaptic density,1.0
8569,2332,GO:0015030,FMR1,Cajal body,1.0
8570,2332,GO:0016020,FMR1,membrane,1.0
8571,2332,GO:0016020,FMR1,membrane,1.0
8572,2332,GO:0016032,FMR1,viral process,1.0
8573,2332,GO:0017148,FMR1,negative regulation of translation,1.0
8574,2332,GO:0019897,FMR1,extrinsic component of plasma membrane,1.0
8575,2332,GO:0030371,FMR1,translation repressor activity,1.0
8576,2332,GO:0030424,FMR1,axon,1.0
8577,2332,GO:0030424,FMR1,axon,1.0
8578,2332,GO:0030425,FMR1,dendrite,1.0
8579,2332,GO:0030426,FMR1,growth cone,1.0
8580,2332,GO:0030426,FMR1,growth cone,1.0
8581,2332,GO:0031047,FMR1,gene silencing by RNA,1.0
8582,2332,GO:0031369,FMR1,translation initiation factor binding,1.0
8583,2332,GO:0032433,FMR1,filopodium tip,1.0
8584,2332,GO:0032797,FMR1,SMN complex,1.0
8585,2332,GO:0033129,FMR1,positive regulation of histone phosphorylation,1.0
8586,2332,GO:0033592,FMR1,RNA strand annealing activity,1.0
8587,2332,GO:0034046,FMR1,poly(G) binding,1.0
8588,2332,GO:0034644,FMR1,cellular response to UV,1.0
8589,2332,GO:0035064,FMR1,methylated histone binding,1.0
8590,2332,GO:0035197,FMR1,siRNA binding,1.0
8591,2332,GO:0035198,FMR1,miRNA binding,1.0
8592,2332,GO:0035613,FMR1,RNA stem-loop binding,1.0
8593,2332,GO:0036464,FMR1,cytoplasmic ribonucleoprotein granule,1.0
8594,2332,GO:0036464,FMR1,cytoplasmic ribonucleoprotein granule,1.0
8595,2332,GO:0042734,FMR1,presynaptic membrane,1.0
8596,2332,GO:0042788,FMR1,polysomal ribosome,1.0
8597,2332,GO:0042802,FMR1,identical protein binding,1.0
8598,2332,GO:0042802,FMR1,identical protein binding,1.0
8599,2332,GO:0042803,FMR1,protein homodimerization activity,1.0
8600,2332,GO:0042803,FMR1,protein homodimerization activity,1.0
8601,2332,GO:0042995,FMR1,cell projection,1.0
8602,2332,GO:0043005,FMR1,neuron projection,1.0
8603,2332,GO:0043022,FMR1,ribosome binding,1.0
8604,2332,GO:0043025,FMR1,neuronal cell body,1.0
8605,2332,GO:0043197,FMR1,dendritic spine,1.0
8606,2332,GO:0043197,FMR1,dendritic spine,1.0
8607,2332,GO:0043204,FMR1,perikaryon,1.0
8608,2332,GO:0043204,FMR1,perikaryon,1.0
8609,2332,GO:0043488,FMR1,regulation of mRNA stability,1.0
8610,2332,GO:0043488,FMR1,regulation of mRNA stability,1.0
8611,2332,GO:0043679,FMR1,axon terminus,1.0
8612,2332,GO:0044325,FMR1,ion channel binding,1.0
8613,2332,GO:0044326,FMR1,dendritic spine neck,1.0
8614,2332,GO:0044830,FMR1,modulation by host of viral RNA genome replication,1.0
8615,2332,GO:0045182,FMR1,translation regulator activity,1.0
8616,2332,GO:0045202,FMR1,synapse,1.0
8617,2332,GO:0045211,FMR1,postsynaptic membrane,1.0
8618,2332,GO:0045727,FMR1,positive regulation of translation,1.0
8619,2332,GO:0045727,FMR1,positive regulation of translation,1.0
8620,2332,GO:0045947,FMR1,negative regulation of translational initiation,1.0
8621,2332,GO:0046928,FMR1,regulation of neurotransmitter secretion,1.0
8622,2332,GO:0046982,FMR1,protein heterodimerization activity,1.0
8623,2332,GO:0048027,FMR1,mRNA 5'-UTR binding,1.0
8624,2332,GO:0048471,FMR1,perinuclear region of cytoplasm,1.0
8625,2332,GO:0051028,FMR1,mRNA transport,1.0
8626,2332,GO:0051489,FMR1,regulation of filopodium assembly,1.0
8627,2332,GO:0051489,FMR1,regulation of filopodium assembly,1.0
8628,2332,GO:0051491,FMR1,positive regulation of filopodium assembly,1.0
8629,2332,GO:0060964,FMR1,regulation of gene silencing by miRNA,1.0
8630,2332,GO:0060998,FMR1,regulation of dendritic spine development,1.0
8631,2332,GO:0060999,FMR1,positive regulation of dendritic spine development,1.0
8632,2332,GO:0070840,FMR1,dynein complex binding,1.0
8633,2332,GO:0071598,FMR1,neuronal ribonucleoprotein granule,1.0
8634,2332,GO:0072711,FMR1,cellular response to hydroxyurea,1.0
8635,2332,GO:0097386,FMR1,glial cell projection,1.0
8636,2332,GO:0098586,FMR1,cellular response to virus,1.0
8637,2332,GO:0098793,FMR1,presynapse,1.0
8638,2332,GO:0098793,FMR1,presynapse,1.0
8639,2332,GO:0098794,FMR1,postsynapse,1.0
8640,2332,GO:0098908,FMR1,regulation of neuronal action potential,1.0
8641,2332,GO:1900453,FMR1,negative regulation of long-term synaptic depression,1.0
8642,2332,GO:1901254,FMR1,positive regulation of intracellular transport of viral material,1.0
8643,2332,GO:1901386,FMR1,negative regulation of voltage-gated calcium channel activity,1.0
8644,2332,GO:1901800,FMR1,positive regulation of proteasomal protein catabolic process,1.0
8645,2332,GO:1902373,FMR1,negative regulation of mRNA catabolic process,1.0
8646,2332,GO:1902416,FMR1,positive regulation of mRNA binding,1.0
8647,2332,GO:1902737,FMR1,dendritic filopodium,1.0
8648,2332,GO:1902737,FMR1,dendritic filopodium,1.0
8649,2332,GO:1990124,FMR1,messenger ribonucleoprotein complex,1.0
8650,2332,GO:1990812,FMR1,growth cone filopodium,1.0
8651,2332,GO:1990825,FMR1,sequence-specific mRNA binding,1.0
8652,2332,GO:1990904,FMR1,ribonucleoprotein complex,1.0
8653,2332,GO:2000301,FMR1,negative regulation of synaptic vesicle exocytosis,1.0
8654,2332,GO:2000637,FMR1,positive regulation of gene silencing by miRNA,1.0
8655,2332,GO:2000766,FMR1,negative regulation of cytoplasmic translation,1.0
8656,2332,GO:2001022,FMR1,positive regulation of response to DNA damage stimulus,1.0
8657,2332,GO:2001022,FMR1,positive regulation of response to DNA damage stimulus,1.0
8658,2290,GO:0000122,FOXG1,negative regulation of transcription by RNA polymerase II,1.0
8659,2290,GO:0000785,FOXG1,chromatin,1.0
8660,2290,GO:0000981,FOXG1,"DNA-binding transcription factor activity, RNA polymerase II-specific",1.0
8661,2290,GO:0002052,FOXG1,positive regulation of neuroblast proliferation,1.0
8662,2290,GO:0003677,FOXG1,DNA binding,1.0
8663,2290,GO:0005515,FOXG1,protein binding,1.0
8664,2290,GO:0005634,FOXG1,nucleus,1.0
8665,2290,GO:0005654,FOXG1,nucleoplasm,1.0
8666,2290,GO:0006357,FOXG1,regulation of transcription by RNA polymerase II,1.0
8667,2290,GO:0007346,FOXG1,regulation of mitotic cell cycle,1.0
8668,2290,GO:0007420,FOXG1,brain development,1.0
8669,2290,GO:0007568,FOXG1,aging,1.0
8670,2290,GO:0009953,FOXG1,dorsal/ventral pattern formation,1.0
8671,2290,GO:0016199,FOXG1,axon midline choice point recognition,1.0
8672,2290,GO:0021852,FOXG1,pyramidal neuron migration,1.0
8673,2290,GO:0042472,FOXG1,inner ear morphogenesis,1.0
8674,2290,GO:0045665,FOXG1,negative regulation of neuron differentiation,1.0
8675,2290,GO:0045666,FOXG1,positive regulation of neuron differentiation,1.0
8676,2290,GO:0045787,FOXG1,positive regulation of cell cycle,1.0
8677,2290,GO:0045892,FOXG1,"negative regulation of transcription, DNA-templated",1.0
8678,2290,GO:0048664,FOXG1,neuron fate determination,1.0
8679,2290,GO:1990837,FOXG1,sequence-specific double-stranded DNA binding,1.0
8680,2290,GO:1990837,FOXG1,sequence-specific double-stranded DNA binding,1.0
8681,27086,GO:0000122,FOXP1,negative regulation of transcription by RNA polymerase II,1.0
8682,27086,GO:0000785,FOXP1,chromatin,1.0
8683,27086,GO:0000978,FOXP1,RNA polymerase II cis-regulatory region sequence-specific DNA binding,1.0
8684,27086,GO:0000981,FOXP1,"DNA-binding transcription factor activity, RNA polymerase II-specific",1.0
8685,27086,GO:0000981,FOXP1,"DNA-binding transcription factor activity, RNA polymerase II-specific",1.0
8686,27086,GO:0001046,FOXP1,core promoter sequence-specific DNA binding,1.0
8687,27086,GO:0001227,FOXP1,"DNA-binding transcription repressor activity, RNA polymerase II-specific",1.0
8688,27086,GO:0002903,FOXP1,negative regulation of B cell apoptotic process,1.0
8689,27086,GO:0005515,FOXP1,protein binding,1.0
8690,27086,GO:0005634,FOXP1,nucleus,1.0
8691,27086,GO:0005634,FOXP1,nucleus,1.0
8692,27086,GO:0005654,FOXP1,nucleoplasm,1.0
8693,27086,GO:0005654,FOXP1,nucleoplasm,1.0
8694,27086,GO:0006357,FOXP1,regulation of transcription by RNA polymerase II,1.0
8695,27086,GO:0006974,FOXP1,cellular response to DNA damage stimulus,1.0
8696,27086,GO:0010468,FOXP1,regulation of gene expression,1.0
8697,27086,GO:0010595,FOXP1,positive regulation of endothelial cell migration,1.0
8698,27086,GO:0010629,FOXP1,negative regulation of gene expression,1.0
8699,27086,GO:0030316,FOXP1,osteoclast differentiation,1.0
8700,27086,GO:0032496,FOXP1,response to lipopolysaccharide,1.0
8701,27086,GO:0032625,FOXP1,interleukin-21 production,1.0
8702,27086,GO:0032651,FOXP1,regulation of interleukin-1 beta production,1.0
8703,27086,GO:0032655,FOXP1,regulation of interleukin-12 production,1.0
8704,27086,GO:0032680,FOXP1,regulation of tumor necrosis factor production,1.0
8705,27086,GO:0035019,FOXP1,somatic stem cell population maintenance,1.0
8706,27086,GO:0036035,FOXP1,osteoclast development,1.0
8707,27086,GO:0042116,FOXP1,macrophage activation,1.0
8708,27086,GO:0042117,FOXP1,monocyte activation,1.0
8709,27086,GO:0042118,FOXP1,endothelial cell activation,1.0
8710,27086,GO:0042802,FOXP1,identical protein binding,1.0
8711,27086,GO:0043621,FOXP1,protein self-association,1.0
8712,27086,GO:0045655,FOXP1,regulation of monocyte differentiation,1.0
8713,27086,GO:0045892,FOXP1,"negative regulation of transcription, DNA-templated",1.0
8714,27086,GO:0045892,FOXP1,"negative regulation of transcription, DNA-templated",1.0
8715,27086,GO:0046872,FOXP1,metal ion binding,1.0
8716,27086,GO:0048661,FOXP1,positive regulation of smooth muscle cell proliferation,1.0
8717,27086,GO:0050681,FOXP1,androgen receptor binding,1.0
8718,27086,GO:0050727,FOXP1,regulation of inflammatory response,1.0
8719,27086,GO:0050861,FOXP1,positive regulation of B cell receptor signaling pathway,1.0
8720,27086,GO:0060766,FOXP1,negative regulation of androgen receptor signaling pathway,1.0
8721,27086,GO:0061470,FOXP1,T follicular helper cell differentiation,1.0
8722,27086,GO:1900424,FOXP1,regulation of defense response to bacterium,1.0
8723,27086,GO:1901256,FOXP1,regulation of macrophage colony-stimulating factor production,1.0
8724,27086,GO:1901509,FOXP1,regulation of endothelial tube morphogenesis,1.0
8725,27086,GO:1990837,FOXP1,sequence-specific double-stranded DNA binding,1.0
8726,27086,GO:2000341,FOXP1,regulation of chemokine (C-X-C motif) ligand 2 production,1.0
8845,93986,GO:0000122,FOXP2,negative regulation of transcription by RNA polymerase II,1.0
8846,93986,GO:0000785,FOXP2,chromatin,1.0
8847,93986,GO:0000978,FOXP2,RNA polymerase II cis-regulatory region sequence-specific DNA binding,1.0
8848,93986,GO:0000978,FOXP2,RNA polymerase II cis-regulatory region sequence-specific DNA binding,1.0
8849,93986,GO:0000981,FOXP2,"DNA-binding transcription factor activity, RNA polymerase II-specific",1.0
8850,93986,GO:0000981,FOXP2,"DNA-binding transcription factor activity, RNA polymerase II-specific",1.0
8851,93986,GO:0001227,FOXP2,"DNA-binding transcription repressor activity, RNA polymerase II-specific",1.0
8852,93986,GO:0001227,FOXP2,"DNA-binding transcription repressor activity, RNA polymerase II-specific",1.0
8853,93986,GO:0002053,FOXP2,positive regulation of mesenchymal cell proliferation,1.0
8854,93986,GO:0003677,FOXP2,DNA binding,1.0
8855,93986,GO:0003700,FOXP2,DNA-binding transcription factor activity,1.0
8856,93986,GO:0005515,FOXP2,protein binding,1.0
8857,93986,GO:0005634,FOXP2,nucleus,1.0
8858,93986,GO:0006357,FOXP2,regulation of transcription by RNA polymerase II,1.0
8859,93986,GO:0007519,FOXP2,skeletal muscle tissue development,1.0
8860,93986,GO:0009791,FOXP2,post-embryonic development,1.0
8861,93986,GO:0021549,FOXP2,cerebellum development,1.0
8862,93986,GO:0021757,FOXP2,caudate nucleus development,1.0
8863,93986,GO:0021758,FOXP2,putamen development,1.0
8864,93986,GO:0021987,FOXP2,cerebral cortex development,1.0
8865,93986,GO:0033574,FOXP2,response to testosterone,1.0
8866,93986,GO:0042297,FOXP2,vocal learning,1.0
8867,93986,GO:0042802,FOXP2,identical protein binding,1.0
8868,93986,GO:0042803,FOXP2,protein homodimerization activity,1.0
8869,93986,GO:0043010,FOXP2,camera-type eye development,1.0
8870,93986,GO:0043565,FOXP2,sequence-specific DNA binding,1.0
8871,93986,GO:0045892,FOXP2,"negative regulation of transcription, DNA-templated",1.0
8872,93986,GO:0046872,FOXP2,metal ion binding,1.0
8873,93986,GO:0048286,FOXP2,lung alveolus development,1.0
8874,93986,GO:0048745,FOXP2,smooth muscle tissue development,1.0
8875,93986,GO:0050681,FOXP2,androgen receptor binding,1.0
8876,93986,GO:0060013,FOXP2,righting reflex,1.0
8877,93986,GO:0060501,FOXP2,positive regulation of epithelial cell proliferation involved in lung morphogenesis,1.0
8878,93986,GO:0098582,FOXP2,innate vocalization behavior,1.0
8983,2562,GO:0004890,GABRB3,GABA-A receptor activity,1.0
8984,2562,GO:0005254,GABRB3,chloride channel activity,1.0
8985,2562,GO:0005886,GABRB3,plasma membrane,1.0
8986,2562,GO:0005886,GABRB3,plasma membrane,1.0
8987,2562,GO:0005887,GABRB3,integral component of plasma membrane,1.0
8988,2562,GO:0005887,GABRB3,integral component of plasma membrane,1.0
8989,2562,GO:0007165,GABRB3,signal transduction,1.0
8990,2562,GO:0007214,GABRB3,gamma-aminobutyric acid signaling pathway,1.0
8991,2562,GO:0007268,GABRB3,chemical synaptic transmission,1.0
8992,2562,GO:0007605,GABRB3,sensory perception of sound,1.0
8993,2562,GO:0022851,GABRB3,GABA-gated chloride ion channel activity,1.0
8994,2562,GO:0022851,GABRB3,GABA-gated chloride ion channel activity,1.0
8995,2562,GO:0022851,GABRB3,GABA-gated chloride ion channel activity,1.0
8996,2562,GO:0030594,GABRB3,neurotransmitter receptor activity,1.0
8997,2562,GO:0030659,GABRB3,cytoplasmic vesicle membrane,1.0
8998,2562,GO:0034220,GABRB3,ion transmembrane transport,1.0
8999,2562,GO:0034707,GABRB3,chloride channel complex,1.0
9000,2562,GO:0042391,GABRB3,regulation of membrane potential,1.0
9001,2562,GO:0042802,GABRB3,identical protein binding,1.0
9002,2562,GO:0043005,GABRB3,neuron projection,1.0
9003,2562,GO:0043524,GABRB3,negative regulation of neuron apoptotic process,1.0
9004,2562,GO:0045202,GABRB3,synapse,1.0
9005,2562,GO:0045211,GABRB3,postsynaptic membrane,1.0
9006,2562,GO:0050877,GABRB3,nervous system process,1.0
9007,2562,GO:0060021,GABRB3,roof of mouth development,1.0
9008,2562,GO:0060080,GABRB3,inhibitory postsynaptic potential,1.0
9009,2562,GO:0060119,GABRB3,inner ear receptor cell development,1.0
9010,2562,GO:0060384,GABRB3,innervation,1.0
9011,2562,GO:0071420,GABRB3,cellular response to histamine,1.0
9012,2562,GO:0090102,GABRB3,cochlea development,1.0
9013,2562,GO:0098982,GABRB3,GABA-ergic synapse,1.0
9014,2562,GO:1902476,GABRB3,chloride transmembrane transport,1.0
9015,2562,GO:1902476,GABRB3,chloride transmembrane transport,1.0
9016,2562,GO:1902476,GABRB3,chloride transmembrane transport,1.0
9017,2562,GO:1902476,GABRB3,chloride transmembrane transport,1.0
9018,2562,GO:1902711,GABRB3,GABA-A receptor complex,1.0
9019,2562,GO:1902711,GABRB3,GABA-A receptor complex,1.0
9020,2562,GO:1902711,GABRB3,GABA-A receptor complex,1.0
9021,2562,GO:1902711,GABRB3,GABA-A receptor complex,1.0
9022,2562,GO:1904315,GABRB3,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential,1.0
9023,2562,GO:1904862,GABRB3,inhibitory synapse assembly,1.0
9131,64599,GO:0005515,GIGYF1,protein binding,1.0
9132,64599,GO:0008150,GIGYF1,biological_process,1.0
9133,64599,GO:0032991,GIGYF1,protein-containing complex,1.0
9134,64599,GO:0048009,GIGYF1,insulin-like growth factor receptor signaling pathway,1.0
9135,26058,GO:0003723,GIGYF2,RNA binding,1.0
9136,26058,GO:0005515,GIGYF2,protein binding,1.0
9137,26058,GO:0005768,GIGYF2,endosome,1.0
9138,26058,GO:0005783,GIGYF2,endoplasmic reticulum,1.0
9139,26058,GO:0005794,GIGYF2,Golgi apparatus,1.0
9140,26058,GO:0005829,GIGYF2,cytosol,1.0
9141,26058,GO:0007631,GIGYF2,feeding behavior,1.0
9142,26058,GO:0008344,GIGYF2,adult locomotory behavior,1.0
9143,26058,GO:0009791,GIGYF2,post-embryonic development,1.0
9144,26058,GO:0010494,GIGYF2,cytoplasmic stress granule,1.0
9145,26058,GO:0016020,GIGYF2,membrane,1.0
9146,26058,GO:0016021,GIGYF2,integral component of membrane,1.0
9147,26058,GO:0016441,GIGYF2,posttranscriptional gene silencing,1.0
9148,26058,GO:0017148,GIGYF2,negative regulation of translation,1.0
9149,26058,GO:0021522,GIGYF2,spinal cord motor neuron differentiation,1.0
9150,26058,GO:0031571,GIGYF2,mitotic G1 DNA damage checkpoint,1.0
9151,26058,GO:0032991,GIGYF2,protein-containing complex,1.0
9152,26058,GO:0035264,GIGYF2,multicellular organism growth,1.0
9153,26058,GO:0043204,GIGYF2,perikaryon,1.0
9154,26058,GO:0044267,GIGYF2,cellular protein metabolic process,1.0
9155,26058,GO:0045296,GIGYF2,cadherin binding,1.0
9156,26058,GO:0048009,GIGYF2,insulin-like growth factor receptor signaling pathway,1.0
9157,26058,GO:0048873,GIGYF2,homeostasis of number of cells within a tissue,1.0
9158,26058,GO:0050881,GIGYF2,musculoskeletal movement,1.0
9159,26058,GO:0050885,GIGYF2,neuromuscular process controlling balance,1.0
9160,26058,GO:0061157,GIGYF2,mRNA destabilization,1.0
9161,26058,GO:0070064,GIGYF2,proline-rich region binding,1.0
9162,26058,GO:1990635,GIGYF2,proximal dendrite,1.0
9524,2891,GO:0001540,GRIA2,amyloid-beta binding,1.0
9525,2891,GO:0001540,GRIA2,amyloid-beta binding,1.0
9526,2891,GO:0004970,GRIA2,ionotropic glutamate receptor activity,1.0
9527,2891,GO:0004971,GRIA2,AMPA glutamate receptor activity,1.0
9528,2891,GO:0004971,GRIA2,AMPA glutamate receptor activity,1.0
9529,2891,GO:0004971,GRIA2,AMPA glutamate receptor activity,1.0
9530,2891,GO:0005515,GRIA2,protein binding,1.0
9531,2891,GO:0005789,GRIA2,endoplasmic reticulum membrane,1.0
9532,2891,GO:0005886,GRIA2,plasma membrane,1.0
9533,2891,GO:0005886,GRIA2,plasma membrane,1.0
9534,2891,GO:0005887,GRIA2,integral component of plasma membrane,1.0
9535,2891,GO:0007165,GRIA2,signal transduction,1.0
9536,2891,GO:0007268,GRIA2,chemical synaptic transmission,1.0
9537,2891,GO:0009897,GRIA2,external side of plasma membrane,1.0
9538,2891,GO:0014069,GRIA2,postsynaptic density,1.0
9539,2891,GO:0015276,GRIA2,ligand-gated ion channel activity,1.0
9540,2891,GO:0030425,GRIA2,dendrite,1.0
9541,2891,GO:0030666,GRIA2,endocytic vesicle membrane,1.0
9542,2891,GO:0032279,GRIA2,asymmetric synapse,1.0
9543,2891,GO:0032281,GRIA2,AMPA glutamate receptor complex,1.0
9544,2891,GO:0032281,GRIA2,AMPA glutamate receptor complex,1.0
9545,2891,GO:0034220,GRIA2,ion transmembrane transport,1.0
9546,2891,GO:0035235,GRIA2,ionotropic glutamate receptor signaling pathway,1.0
9547,2891,GO:0035249,GRIA2,"synaptic transmission, glutamatergic",1.0
9548,2891,GO:0038023,GRIA2,signaling receptor activity,1.0
9549,2891,GO:0043025,GRIA2,neuronal cell body,1.0
9550,2891,GO:0043197,GRIA2,dendritic spine,1.0
9551,2891,GO:0043197,GRIA2,dendritic spine,1.0
9552,2891,GO:0060076,GRIA2,excitatory synapse,1.0
9553,2891,GO:0098794,GRIA2,postsynapse,1.0
9554,2891,GO:0098839,GRIA2,postsynaptic density membrane,1.0
9555,2891,GO:0098843,GRIA2,postsynaptic endocytic zone,1.0
9556,2891,GO:2000310,GRIA2,regulation of NMDA receptor activity,1.0
9791,2561,GO:0004890,GABRB2,GABA-A receptor activity,1.0
9792,2561,GO:0004890,GABRB2,GABA-A receptor activity,1.0
9793,2561,GO:0005237,GABRB2,inhibitory extracellular ligand-gated ion channel activity,1.0
9794,2561,GO:0005254,GABRB2,chloride channel activity,1.0
9795,2561,GO:0005254,GABRB2,chloride channel activity,1.0
9796,2561,GO:0005829,GABRB2,cytosol,1.0
9797,2561,GO:0005886,GABRB2,plasma membrane,1.0
9798,2561,GO:0005886,GABRB2,plasma membrane,1.0
9799,2561,GO:0005887,GABRB2,integral component of plasma membrane,1.0
9800,2561,GO:0005887,GABRB2,integral component of plasma membrane,1.0
9801,2561,GO:0007165,GABRB2,signal transduction,1.0
9802,2561,GO:0007214,GABRB2,gamma-aminobutyric acid signaling pathway,1.0
9803,2561,GO:0007268,GABRB2,chemical synaptic transmission,1.0
9804,2561,GO:0007605,GABRB2,sensory perception of sound,1.0
9805,2561,GO:0016917,GABRB2,GABA receptor activity,1.0
9806,2561,GO:0022851,GABRB2,GABA-gated chloride ion channel activity,1.0
9807,2561,GO:0030594,GABRB2,neurotransmitter receptor activity,1.0
9808,2561,GO:0030659,GABRB2,cytoplasmic vesicle membrane,1.0
9809,2561,GO:0034220,GABRB2,ion transmembrane transport,1.0
9810,2561,GO:0034707,GABRB2,chloride channel complex,1.0
9811,2561,GO:0042391,GABRB2,regulation of membrane potential,1.0
9812,2561,GO:0043005,GABRB2,neuron projection,1.0
9813,2561,GO:0043524,GABRB2,negative regulation of neuron apoptotic process,1.0
9814,2561,GO:0045202,GABRB2,synapse,1.0
9815,2561,GO:0050877,GABRB2,nervous system process,1.0
9816,2561,GO:0051932,GABRB2,"synaptic transmission, GABAergic",1.0
9817,2561,GO:0060078,GABRB2,regulation of postsynaptic membrane potential,1.0
9818,2561,GO:0060119,GABRB2,inner ear receptor cell development,1.0
9819,2561,GO:0060384,GABRB2,innervation,1.0
9820,2561,GO:0070062,GABRB2,extracellular exosome,1.0
9821,2561,GO:0071420,GABRB2,cellular response to histamine,1.0
9822,2561,GO:0090102,GABRB2,cochlea development,1.0
9823,2561,GO:0098982,GABRB2,GABA-ergic synapse,1.0
9824,2561,GO:0099060,GABRB2,integral component of postsynaptic specialization membrane,1.0
9825,2561,GO:1902476,GABRB2,chloride transmembrane transport,1.0
9826,2561,GO:1902476,GABRB2,chloride transmembrane transport,1.0
9827,2561,GO:1902711,GABRB2,GABA-A receptor complex,1.0
9828,2561,GO:1902711,GABRB2,GABA-A receptor complex,1.0
9829,2561,GO:1904315,GABRB2,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential,1.0
9830,2561,GO:1904862,GABRB2,inhibitory synapse assembly,1.0
9861,2670,GO:0005200,GFAP,structural constituent of cytoskeleton,1.0
9862,2670,GO:0005515,GFAP,protein binding,1.0
9863,2670,GO:0005737,GFAP,cytoplasm,1.0
9864,2670,GO:0005764,GFAP,lysosome,1.0
9865,2670,GO:0005829,GFAP,cytosol,1.0
9866,2670,GO:0005882,GFAP,intermediate filament,1.0
9867,2670,GO:0042802,GFAP,identical protein binding,1.0
9868,2670,GO:0043254,GFAP,regulation of protein-containing complex assembly,1.0
9869,2670,GO:0045109,GFAP,intermediate filament organization,1.0
9870,2670,GO:0045111,GFAP,intermediate filament cytoskeleton,1.0
9871,2670,GO:1904714,GFAP,regulation of chaperone-mediated autophagy,1.0
9872,2670,GO:1904714,GFAP,regulation of chaperone-mediated autophagy,1.0
9873,2770,GO:0000287,GNAI1,magnesium ion binding,1.0
9874,2770,GO:0001664,GNAI1,G protein-coupled receptor binding,1.0
9875,2770,GO:0001664,GNAI1,G protein-coupled receptor binding,1.0
9876,2770,GO:0003924,GNAI1,GTPase activity,1.0
9877,2770,GO:0003924,GNAI1,GTPase activity,1.0
9878,2770,GO:0003924,GNAI1,GTPase activity,1.0
9879,2770,GO:0005515,GNAI1,protein binding,1.0
9880,2770,GO:0005525,GNAI1,GTP binding,1.0
9881,2770,GO:0005634,GNAI1,nucleus,1.0
9882,2770,GO:0005737,GNAI1,cytoplasm,1.0
9883,2770,GO:0005765,GNAI1,lysosomal membrane,1.0
9884,2770,GO:0005813,GNAI1,centrosome,1.0
9885,2770,GO:0005834,GNAI1,heterotrimeric G-protein complex,1.0
9886,2770,GO:0005886,GNAI1,plasma membrane,1.0
9887,2770,GO:0005886,GNAI1,plasma membrane,1.0
9888,2770,GO:0006457,GNAI1,protein folding,1.0
9889,2770,GO:0007049,GNAI1,cell cycle,1.0
9890,2770,GO:0007186,GNAI1,G protein-coupled receptor signaling pathway,1.0
9891,2770,GO:0007186,GNAI1,G protein-coupled receptor signaling pathway,1.0
9892,2770,GO:0007188,GNAI1,adenylate cyclase-modulating G protein-coupled receptor signaling pathway,1.0
9893,2770,GO:0007193,GNAI1,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway,1.0
9894,2770,GO:0019003,GNAI1,GDP binding,1.0
9895,2770,GO:0030496,GNAI1,midbody,1.0
9896,2770,GO:0031683,GNAI1,G-protein beta/gamma-subunit complex binding,1.0
9897,2770,GO:0031821,GNAI1,G protein-coupled serotonin receptor binding,1.0
9898,2770,GO:0032794,GNAI1,GTPase activating protein binding,1.0
9899,2770,GO:0043434,GNAI1,response to peptide hormone,1.0
9900,2770,GO:0043949,GNAI1,regulation of cAMP-mediated signaling,1.0
9901,2770,GO:0045121,GNAI1,membrane raft,1.0
9902,2770,GO:0050805,GNAI1,negative regulation of synaptic transmission,1.0
9903,2770,GO:0051301,GNAI1,cell division,1.0
9904,2770,GO:0060236,GNAI1,regulation of mitotic spindle organization,1.0
9905,2770,GO:0070062,GNAI1,extracellular exosome,1.0
9906,2770,GO:0099738,GNAI1,cell cortex region,1.0
9907,2770,GO:1904322,GNAI1,cellular response to forskolin,1.0
9908,2770,GO:1904778,GNAI1,positive regulation of protein localization to cell cortex,1.0
10149,2904,GO:0000165,GRIN2B,MAPK cascade,1.0
10150,2904,GO:0001540,GRIN2B,amyloid-beta binding,1.0
10151,2904,GO:0004972,GRIN2B,NMDA glutamate receptor activity,1.0
10152,2904,GO:0004972,GRIN2B,NMDA glutamate receptor activity,1.0
10153,2904,GO:0004972,GRIN2B,NMDA glutamate receptor activity,1.0
10154,2904,GO:0004972,GRIN2B,NMDA glutamate receptor activity,1.0
10155,2904,GO:0005515,GRIN2B,protein binding,1.0
10156,2904,GO:0005737,GRIN2B,cytoplasm,1.0
10157,2904,GO:0005764,GRIN2B,lysosome,1.0
10158,2904,GO:0005770,GRIN2B,late endosome,1.0
10159,2904,GO:0005856,GRIN2B,cytoskeleton,1.0
10160,2904,GO:0005886,GRIN2B,plasma membrane,1.0
10161,2904,GO:0005886,GRIN2B,plasma membrane,1.0
10162,2904,GO:0005886,GRIN2B,plasma membrane,1.0
10163,2904,GO:0005886,GRIN2B,plasma membrane,1.0
10164,2904,GO:0005887,GRIN2B,integral component of plasma membrane,1.0
10165,2904,GO:0007215,GRIN2B,glutamate receptor signaling pathway,1.0
10166,2904,GO:0007268,GRIN2B,chemical synaptic transmission,1.0
10167,2904,GO:0007275,GRIN2B,multicellular organism development,1.0
10168,2904,GO:0007420,GRIN2B,brain development,1.0
10169,2904,GO:0007611,GRIN2B,learning or memory,1.0
10170,2904,GO:0008270,GRIN2B,zinc ion binding,1.0
10171,2904,GO:0009986,GRIN2B,cell surface,1.0
10172,2904,GO:0014069,GRIN2B,postsynaptic density,1.0
10173,2904,GO:0015276,GRIN2B,ligand-gated ion channel activity,1.0
10174,2904,GO:0016594,GRIN2B,glycine binding,1.0
10175,2904,GO:0016595,GRIN2B,glutamate binding,1.0
10176,2904,GO:0017146,GRIN2B,NMDA selective glutamate receptor complex,1.0
10177,2904,GO:0017146,GRIN2B,NMDA selective glutamate receptor complex,1.0
10178,2904,GO:0017146,GRIN2B,NMDA selective glutamate receptor complex,1.0
10179,2904,GO:0019722,GRIN2B,calcium-mediated signaling,1.0
10180,2904,GO:0022849,GRIN2B,glutamate-gated calcium ion channel activity,1.0
10181,2904,GO:0022849,GRIN2B,glutamate-gated calcium ion channel activity,1.0
10182,2904,GO:0035235,GRIN2B,ionotropic glutamate receptor signaling pathway,1.0
10183,2904,GO:0038023,GRIN2B,signaling receptor activity,1.0
10184,2904,GO:0043005,GRIN2B,neuron projection,1.0
10185,2904,GO:0045211,GRIN2B,postsynaptic membrane,1.0
10186,2904,GO:0045471,GRIN2B,response to ethanol,1.0
10187,2904,GO:0048013,GRIN2B,ephrin receptor signaling pathway,1.0
10188,2904,GO:0048167,GRIN2B,regulation of synaptic plasticity,1.0
10189,2904,GO:0051290,GRIN2B,protein heterotetramerization,1.0
10190,2904,GO:0060079,GRIN2B,excitatory postsynaptic potential,1.0
10191,2904,GO:0060291,GRIN2B,long-term synaptic potentiation,1.0
10192,2904,GO:0097060,GRIN2B,synaptic membrane,1.0
10193,2904,GO:0097553,GRIN2B,calcium ion transmembrane import into cytosol,1.0
10194,2904,GO:0097553,GRIN2B,calcium ion transmembrane import into cytosol,1.0
10195,2904,GO:0098839,GRIN2B,postsynaptic density membrane,1.0
10196,2904,GO:0098976,GRIN2B,excitatory chemical synaptic transmission,1.0
10197,2904,GO:1901216,GRIN2B,positive regulation of neuron death,1.0
10198,2904,GO:1902951,GRIN2B,negative regulation of dendritic spine maintenance,1.0
10199,2904,GO:2000310,GRIN2B,regulation of NMDA receptor activity,1.0
10200,2904,GO:2001056,GRIN2B,positive regulation of cysteine-type endopeptidase activity,1.0
10515,3069,GO:0003723,HDLBP,RNA binding,1.0
10516,3069,GO:0003729,HDLBP,mRNA binding,1.0
10517,3069,GO:0005515,HDLBP,protein binding,1.0
10518,3069,GO:0005634,HDLBP,nucleus,1.0
10519,3069,GO:0005737,HDLBP,cytoplasm,1.0
10520,3069,GO:0005829,HDLBP,cytosol,1.0
10521,3069,GO:0005844,HDLBP,polysome,1.0
10522,3069,GO:0005886,HDLBP,plasma membrane,1.0
10523,3069,GO:0006869,HDLBP,lipid transport,1.0
10524,3069,GO:0008203,HDLBP,cholesterol metabolic process,1.0
10525,3069,GO:0008289,HDLBP,lipid binding,1.0
10526,3069,GO:0034364,HDLBP,high-density lipoprotein particle,1.0
10527,3069,GO:0034384,HDLBP,high-density lipoprotein particle clearance,1.0
10528,3069,GO:0045296,HDLBP,cadherin binding,1.0
10529,283450,GO:0004842,HECTD4,ubiquitin-protein transferase activity,1.0
10530,283450,GO:0005515,HECTD4,protein binding,1.0
10531,283450,GO:0006006,HECTD4,glucose metabolic process,1.0
10532,283450,GO:0016021,HECTD4,integral component of membrane,1.0
10533,283450,GO:0016567,HECTD4,protein ubiquitination,1.0
10534,283450,GO:0042593,HECTD4,glucose homeostasis,1.0
10574,3097,GO:0000978,HIVEP2,RNA polymerase II cis-regulatory region sequence-specific DNA binding,1.0
10575,3097,GO:0000981,HIVEP2,"DNA-binding transcription factor activity, RNA polymerase II-specific",1.0
10576,3097,GO:0003677,HIVEP2,DNA binding,1.0
10577,3097,GO:0005634,HIVEP2,nucleus,1.0
10578,3097,GO:0005654,HIVEP2,nucleoplasm,1.0
10579,3097,GO:0006357,HIVEP2,regulation of transcription by RNA polymerase II,1.0
10580,3097,GO:0046872,HIVEP2,metal ion binding,1.0
10614,3188,GO:0000398,HNRNPH2,"mRNA splicing, via spliceosome",1.0
10615,3188,GO:0003723,HNRNPH2,RNA binding,1.0
10616,3188,GO:0003723,HNRNPH2,RNA binding,1.0
10617,3188,GO:0005515,HNRNPH2,protein binding,1.0
10618,3188,GO:0005634,HNRNPH2,nucleus,1.0
10619,3188,GO:0005654,HNRNPH2,nucleoplasm,1.0
10620,3188,GO:0005654,HNRNPH2,nucleoplasm,1.0
10621,3188,GO:0005654,HNRNPH2,nucleoplasm,1.0
10622,3188,GO:0005829,HNRNPH2,cytosol,1.0
10623,3188,GO:0016020,HNRNPH2,membrane,1.0
10624,3188,GO:0016070,HNRNPH2,RNA metabolic process,1.0
10625,3188,GO:0043484,HNRNPH2,regulation of RNA splicing,1.0
10626,3188,GO:1990904,HNRNPH2,ribonucleoprotein complex,1.0
10627,3188,GO:1990904,HNRNPH2,ribonucleoprotein complex,1.0
10628,3192,GO:0000122,HNRNPU,negative regulation of transcription by RNA polymerase II,1.0
10629,3192,GO:0000122,HNRNPU,negative regulation of transcription by RNA polymerase II,1.0
10630,3192,GO:0000228,HNRNPU,nuclear chromosome,1.0
10631,3192,GO:0000228,HNRNPU,nuclear chromosome,1.0
10632,3192,GO:0000381,HNRNPU,"regulation of alternative mRNA splicing, via spliceosome",1.0
10633,3192,GO:0000381,HNRNPU,"regulation of alternative mRNA splicing, via spliceosome",1.0
10634,3192,GO:0000398,HNRNPU,"mRNA splicing, via spliceosome",1.0
10635,3192,GO:0000398,HNRNPU,"mRNA splicing, via spliceosome",1.0
10636,3192,GO:0000776,HNRNPU,kinetochore,1.0
10637,3192,GO:0000776,HNRNPU,kinetochore,1.0
10638,3192,GO:0000777,HNRNPU,condensed chromosome kinetochore,1.0
10639,3192,GO:0000922,HNRNPU,spindle pole,1.0
10640,3192,GO:0000978,HNRNPU,RNA polymerase II cis-regulatory region sequence-specific DNA binding,1.0
10641,3192,GO:0000978,HNRNPU,RNA polymerase II cis-regulatory region sequence-specific DNA binding,1.0
10642,3192,GO:0000993,HNRNPU,RNA polymerase II complex binding,1.0
10643,3192,GO:0001097,HNRNPU,TFIIH-class transcription factor complex binding,1.0
10644,3192,GO:0001097,HNRNPU,TFIIH-class transcription factor complex binding,1.0
10645,3192,GO:0001649,HNRNPU,osteoblast differentiation,1.0
10646,3192,GO:0003677,HNRNPU,DNA binding,1.0
10647,3192,GO:0003682,HNRNPU,chromatin binding,1.0
10648,3192,GO:0003690,HNRNPU,double-stranded DNA binding,1.0
10649,3192,GO:0003697,HNRNPU,single-stranded DNA binding,1.0
10650,3192,GO:0003714,HNRNPU,transcription corepressor activity,1.0
10651,3192,GO:0003714,HNRNPU,transcription corepressor activity,1.0
10652,3192,GO:0003723,HNRNPU,RNA binding,1.0
10653,3192,GO:0003723,HNRNPU,RNA binding,1.0
10654,3192,GO:0003723,HNRNPU,RNA binding,1.0
10655,3192,GO:0003723,HNRNPU,RNA binding,1.0
10656,3192,GO:0003725,HNRNPU,double-stranded RNA binding,1.0
10657,3192,GO:0003727,HNRNPU,single-stranded RNA binding,1.0
10658,3192,GO:0003730,HNRNPU,mRNA 3'-UTR binding,1.0
10659,3192,GO:0003779,HNRNPU,actin binding,1.0
10660,3192,GO:0005515,HNRNPU,protein binding,1.0
10661,3192,GO:0005524,HNRNPU,ATP binding,1.0
10662,3192,GO:0005634,HNRNPU,nucleus,1.0
10663,3192,GO:0005654,HNRNPU,nucleoplasm,1.0
10664,3192,GO:0005654,HNRNPU,nucleoplasm,1.0
10665,3192,GO:0005654,HNRNPU,nucleoplasm,1.0
10666,3192,GO:0005697,HNRNPU,telomerase holoenzyme complex,1.0
10667,3192,GO:0005697,HNRNPU,telomerase holoenzyme complex,1.0
10668,3192,GO:0005813,HNRNPU,centrosome,1.0
10669,3192,GO:0005813,HNRNPU,centrosome,1.0
10670,3192,GO:0006325,HNRNPU,chromatin organization,1.0
10671,3192,GO:0006396,HNRNPU,RNA processing,1.0
10672,3192,GO:0007049,HNRNPU,cell cycle,1.0
10673,3192,GO:0007346,HNRNPU,regulation of mitotic cell cycle,1.0
10674,3192,GO:0008143,HNRNPU,poly(A) binding,1.0
10675,3192,GO:0009048,HNRNPU,dosage compensation by inactivation of X chromosome,1.0
10676,3192,GO:0009986,HNRNPU,cell surface,1.0
10677,3192,GO:0016020,HNRNPU,membrane,1.0
10678,3192,GO:0016032,HNRNPU,viral process,1.0
10679,3192,GO:0016070,HNRNPU,RNA metabolic process,1.0
10680,3192,GO:0016363,HNRNPU,nuclear matrix,1.0
10681,3192,GO:0016363,HNRNPU,nuclear matrix,1.0
10682,3192,GO:0016607,HNRNPU,nuclear speck,1.0
10683,3192,GO:0016607,HNRNPU,nuclear speck,1.0
10684,3192,GO:0017069,HNRNPU,snRNA binding,1.0
10685,3192,GO:0017069,HNRNPU,snRNA binding,1.0
10686,3192,GO:0017130,HNRNPU,poly(C) RNA binding,1.0
10687,3192,GO:0017130,HNRNPU,poly(C) RNA binding,1.0
10688,3192,GO:0030496,HNRNPU,midbody,1.0
10689,3192,GO:0031490,HNRNPU,chromatin DNA binding,1.0
10690,3192,GO:0032211,HNRNPU,negative regulation of telomere maintenance via telomerase,1.0
10691,3192,GO:0032211,HNRNPU,negative regulation of telomere maintenance via telomerase,1.0
10692,3192,GO:0032839,HNRNPU,dendrite cytoplasm,1.0
10693,3192,GO:0032922,HNRNPU,circadian regulation of gene expression,1.0
10694,3192,GO:0032991,HNRNPU,protein-containing complex,1.0
10695,3192,GO:0033673,HNRNPU,negative regulation of kinase activity,1.0
10696,3192,GO:0034046,HNRNPU,poly(G) binding,1.0
10697,3192,GO:0034046,HNRNPU,poly(G) binding,1.0
10698,3192,GO:0034244,HNRNPU,negative regulation of transcription elongation from RNA polymerase II promoter,1.0
10699,3192,GO:0036002,HNRNPU,pre-mRNA binding,1.0
10700,3192,GO:0036002,HNRNPU,pre-mRNA binding,1.0
10701,3192,GO:0036464,HNRNPU,cytoplasmic ribonucleoprotein granule,1.0
10702,3192,GO:0036464,HNRNPU,cytoplasmic ribonucleoprotein granule,1.0
10703,3192,GO:0042802,HNRNPU,identical protein binding,1.0
10704,3192,GO:0043021,HNRNPU,ribonucleoprotein complex binding,1.0
10705,3192,GO:0043021,HNRNPU,ribonucleoprotein complex binding,1.0
10706,3192,GO:0044877,HNRNPU,protein-containing complex binding,1.0
10707,3192,GO:0045944,HNRNPU,positive regulation of transcription by RNA polymerase II,1.0
10708,3192,GO:0045944,HNRNPU,positive regulation of transcription by RNA polymerase II,1.0
10709,3192,GO:0045944,HNRNPU,positive regulation of transcription by RNA polymerase II,1.0
10710,3192,GO:0048255,HNRNPU,mRNA stabilization,1.0
10711,3192,GO:0051301,HNRNPU,cell division,1.0
10712,3192,GO:0051457,HNRNPU,maintenance of protein location in nucleus,1.0
10713,3192,GO:0055013,HNRNPU,cardiac muscle cell development,1.0
10714,3192,GO:0070034,HNRNPU,telomerase RNA binding,1.0
10715,3192,GO:0070934,HNRNPU,CRD-mediated mRNA stabilization,1.0
10716,3192,GO:0070934,HNRNPU,CRD-mediated mRNA stabilization,1.0
10717,3192,GO:0070937,HNRNPU,CRD-mediated mRNA stability complex,1.0
10718,3192,GO:0070937,HNRNPU,CRD-mediated mRNA stability complex,1.0
10719,3192,GO:0071013,HNRNPU,catalytic step 2 spliceosome,1.0
10720,3192,GO:0071013,HNRNPU,catalytic step 2 spliceosome,1.0
10721,3192,GO:0071385,HNRNPU,cellular response to glucocorticoid stimulus,1.0
10722,3192,GO:0072686,HNRNPU,mitotic spindle,1.0
10723,3192,GO:0090336,HNRNPU,positive regulation of brown fat cell differentiation,1.0
10724,3192,GO:0090575,HNRNPU,RNA polymerase II transcription regulator complex,1.0
10725,3192,GO:0090575,HNRNPU,RNA polymerase II transcription regulator complex,1.0
10726,3192,GO:0098577,HNRNPU,inactive sex chromosome,1.0
10727,3192,GO:0098577,HNRNPU,inactive sex chromosome,1.0
10728,3192,GO:0098963,HNRNPU,dendritic transport of messenger ribonucleoprotein complex,1.0
10729,3192,GO:0099122,HNRNPU,RNA polymerase II C-terminal domain binding,1.0
10730,3192,GO:0099122,HNRNPU,RNA polymerase II C-terminal domain binding,1.0
10731,3192,GO:1901673,HNRNPU,regulation of mitotic spindle assembly,1.0
10732,3192,GO:1901673,HNRNPU,regulation of mitotic spindle assembly,1.0
10733,3192,GO:1902275,HNRNPU,regulation of chromatin organization,1.0
10734,3192,GO:1902275,HNRNPU,regulation of chromatin organization,1.0
10735,3192,GO:1902425,HNRNPU,positive regulation of attachment of mitotic spindle microtubules to kinetochore,1.0
10736,3192,GO:1902425,HNRNPU,positive regulation of attachment of mitotic spindle microtubules to kinetochore,1.0
10737,3192,GO:1902889,HNRNPU,protein localization to spindle microtubule,1.0
10738,3192,GO:1990023,HNRNPU,mitotic spindle midzone,1.0
10739,3192,GO:1990023,HNRNPU,mitotic spindle midzone,1.0
10740,3192,GO:1990280,HNRNPU,RNA localization to chromatin,1.0
10741,3192,GO:1990280,HNRNPU,RNA localization to chromatin,1.0
10742,3192,GO:1990498,HNRNPU,mitotic spindle microtubule,1.0
10743,3192,GO:1990498,HNRNPU,mitotic spindle microtubule,1.0
10744,3192,GO:1990830,HNRNPU,cellular response to leukemia inhibitory factor,1.0
10745,3192,GO:1990837,HNRNPU,sequence-specific double-stranded DNA binding,1.0
10746,3192,GO:1990841,HNRNPU,promoter-specific chromatin binding,1.0
10747,3192,GO:1990841,HNRNPU,promoter-specific chromatin binding,1.0
10748,3192,GO:1990845,HNRNPU,adaptive thermogenesis,1.0
10749,3192,GO:1990904,HNRNPU,ribonucleoprotein complex,1.0
10750,3192,GO:2000373,HNRNPU,positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity,1.0
10751,3192,GO:2000648,HNRNPU,positive regulation of stem cell proliferation,1.0
10752,3192,GO:2000737,HNRNPU,negative regulation of stem cell differentiation,1.0
10753,3192,GO:2000737,HNRNPU,negative regulation of stem cell differentiation,1.0
10804,3265,GO:0000139,HRAS,Golgi membrane,1.0
10805,3265,GO:0000165,HRAS,MAPK cascade,1.0
10806,3265,GO:0001889,HRAS,liver development,1.0
10807,3265,GO:0001934,HRAS,positive regulation of protein phosphorylation,1.0
10808,3265,GO:0002223,HRAS,stimulatory C-type lectin receptor signaling pathway,1.0
10809,3265,GO:0003924,HRAS,GTPase activity,1.0
10810,3265,GO:0003924,HRAS,GTPase activity,1.0
10811,3265,GO:0003924,HRAS,GTPase activity,1.0
10812,3265,GO:0005515,HRAS,protein binding,1.0
10813,3265,GO:0005525,HRAS,GTP binding,1.0
10814,3265,GO:0005525,HRAS,GTP binding,1.0
10815,3265,GO:0005525,HRAS,GTP binding,1.0
10816,3265,GO:0005654,HRAS,nucleoplasm,1.0
10817,3265,GO:0005737,HRAS,cytoplasm,1.0
10818,3265,GO:0005794,HRAS,Golgi apparatus,1.0
10819,3265,GO:0005829,HRAS,cytosol,1.0
10820,3265,GO:0005886,HRAS,plasma membrane,1.0
10821,3265,GO:0005886,HRAS,plasma membrane,1.0
10822,3265,GO:0005886,HRAS,plasma membrane,1.0
10823,3265,GO:0006897,HRAS,endocytosis,1.0
10824,3265,GO:0006935,HRAS,chemotaxis,1.0
10825,3265,GO:0007050,HRAS,cell cycle arrest,1.0
10826,3265,GO:0007050,HRAS,cell cycle arrest,1.0
10827,3265,GO:0007093,HRAS,mitotic cell cycle checkpoint,1.0
10828,3265,GO:0007165,HRAS,signal transduction,1.0
10829,3265,GO:0007166,HRAS,cell surface receptor signaling pathway,1.0
10830,3265,GO:0007265,HRAS,Ras protein signal transduction,1.0
10831,3265,GO:0007265,HRAS,Ras protein signal transduction,1.0
10832,3265,GO:0007265,HRAS,Ras protein signal transduction,1.0
10833,3265,GO:0008022,HRAS,protein C-terminus binding,1.0
10834,3265,GO:0008284,HRAS,positive regulation of cell population proliferation,1.0
10835,3265,GO:0008285,HRAS,negative regulation of cell population proliferation,1.0
10836,3265,GO:0009887,HRAS,animal organ morphogenesis,1.0
10837,3265,GO:0010629,HRAS,negative regulation of gene expression,1.0
10838,3265,GO:0010863,HRAS,positive regulation of phospholipase C activity,1.0
10839,3265,GO:0019003,HRAS,GDP binding,1.0
10840,3265,GO:0019003,HRAS,GDP binding,1.0
10841,3265,GO:0030335,HRAS,positive regulation of cell migration,1.0
10842,3265,GO:0032729,HRAS,positive regulation of interferon-gamma production,1.0
10843,3265,GO:0034260,HRAS,negative regulation of GTPase activity,1.0
10844,3265,GO:0035900,HRAS,response to isolation stress,1.0
10845,3265,GO:0042088,HRAS,T-helper 1 type immune response,1.0
10846,3265,GO:0042832,HRAS,defense response to protozoan,1.0
10847,3265,GO:0043406,HRAS,positive regulation of MAP kinase activity,1.0
10848,3265,GO:0043410,HRAS,positive regulation of MAPK cascade,1.0
10849,3265,GO:0043524,HRAS,negative regulation of neuron apoptotic process,1.0
10850,3265,GO:0043547,HRAS,positive regulation of GTPase activity,1.0
10851,3265,GO:0044877,HRAS,protein-containing complex binding,1.0
10852,3265,GO:0045740,HRAS,positive regulation of DNA replication,1.0
10853,3265,GO:0045944,HRAS,positive regulation of transcription by RNA polymerase II,1.0
10854,3265,GO:0046330,HRAS,positive regulation of JNK cascade,1.0
10855,3265,GO:0046579,HRAS,positive regulation of Ras protein signal transduction,1.0
10856,3265,GO:0048013,HRAS,ephrin receptor signaling pathway,1.0
10857,3265,GO:0048169,HRAS,regulation of long-term neuronal synaptic plasticity,1.0
10858,3265,GO:0048471,HRAS,perinuclear region of cytoplasm,1.0
10859,3265,GO:0050679,HRAS,positive regulation of epithelial cell proliferation,1.0
10860,3265,GO:0050852,HRAS,T cell receptor signaling pathway,1.0
10861,3265,GO:0070374,HRAS,positive regulation of ERK1 and ERK2 cascade,1.0
10862,3265,GO:0071480,HRAS,cellular response to gamma radiation,1.0
10863,3265,GO:0090303,HRAS,positive regulation of wound healing,1.0
10864,3265,GO:0090314,HRAS,positive regulation of protein targeting to membrane,1.0
10865,3265,GO:0090398,HRAS,cellular senescence,1.0
10866,3265,GO:0090398,HRAS,cellular senescence,1.0
10867,3265,GO:0097193,HRAS,intrinsic apoptotic signaling pathway,1.0
10868,3265,GO:0098696,HRAS,regulation of neurotransmitter receptor localization to postsynaptic specialization membrane,1.0
10869,3265,GO:0098696,HRAS,regulation of neurotransmitter receptor localization to postsynaptic specialization membrane,1.0
10870,3265,GO:0098978,HRAS,glutamatergic synapse,1.0
10871,3265,GO:0098978,HRAS,glutamatergic synapse,1.0
10872,3265,GO:1900029,HRAS,positive regulation of ruffle assembly,1.0
10873,3265,GO:2000251,HRAS,positive regulation of actin cytoskeleton reorganization,1.0
10874,3265,GO:2000630,HRAS,positive regulation of miRNA metabolic process,1.0
11448,23096,GO:0005085,IQSEC2,guanyl-nucleotide exchange factor activity,1.0
11449,23096,GO:0005737,IQSEC2,cytoplasm,1.0
11450,23096,GO:0030036,IQSEC2,actin cytoskeleton organization,1.0
11451,23096,GO:0032012,IQSEC2,regulation of ARF protein signal transduction,1.0
11452,23096,GO:0050804,IQSEC2,modulation of chemical synaptic transmission,1.0
11453,23096,GO:0050804,IQSEC2,modulation of chemical synaptic transmission,1.0
11454,23096,GO:0098685,IQSEC2,Schaffer collateral - CA1 synapse,1.0
11455,23096,GO:0098685,IQSEC2,Schaffer collateral - CA1 synapse,1.0
11456,23096,GO:0098696,IQSEC2,regulation of neurotransmitter receptor localization to postsynaptic specialization membrane,1.0
11457,23096,GO:0098696,IQSEC2,regulation of neurotransmitter receptor localization to postsynaptic specialization membrane,1.0
11458,64207,GO:0000122,IRF2BPL,negative regulation of transcription by RNA polymerase II,1.0
11459,64207,GO:0003714,IRF2BPL,transcription corepressor activity,1.0
11460,64207,GO:0005515,IRF2BPL,protein binding,1.0
11461,64207,GO:0005615,IRF2BPL,extracellular space,1.0
11462,64207,GO:0005634,IRF2BPL,nucleus,1.0
11463,64207,GO:0005634,IRF2BPL,nucleus,1.0
11464,64207,GO:0005634,IRF2BPL,nucleus,1.0
11465,64207,GO:0005654,IRF2BPL,nucleoplasm,1.0
11466,64207,GO:0006357,IRF2BPL,regulation of transcription by RNA polymerase II,1.0
11467,64207,GO:0007399,IRF2BPL,nervous system development,1.0
11468,64207,GO:0016567,IRF2BPL,protein ubiquitination,1.0
11469,64207,GO:0045944,IRF2BPL,positive regulation of transcription by RNA polymerase II,1.0
11470,64207,GO:0046543,IRF2BPL,development of secondary female sexual characteristics,1.0
11471,64207,GO:0046872,IRF2BPL,metal ion binding,1.0
11472,64207,GO:0061630,IRF2BPL,ubiquitin protein ligase activity,1.0
11728,284058,GO:0000123,KANSL1,histone acetyltransferase complex,1.0
11729,284058,GO:0000777,KANSL1,condensed chromosome kinetochore,1.0
11730,284058,GO:0005515,KANSL1,protein binding,1.0
11731,284058,GO:0005634,KANSL1,nucleus,1.0
11732,284058,GO:0005654,KANSL1,nucleoplasm,1.0
11733,284058,GO:0005654,KANSL1,nucleoplasm,1.0
11734,284058,GO:0035035,KANSL1,histone acetyltransferase binding,1.0
11735,284058,GO:0043981,KANSL1,histone H4-K5 acetylation,1.0
11736,284058,GO:0043982,KANSL1,histone H4-K8 acetylation,1.0
11737,284058,GO:0043984,KANSL1,histone H4-K16 acetylation,1.0
11738,284058,GO:0043995,KANSL1,histone acetyltransferase activity (H4-K5 specific),1.0
11739,284058,GO:0043995,KANSL1,histone acetyltransferase activity (H4-K5 specific),1.0
11740,284058,GO:0043996,KANSL1,histone acetyltransferase activity (H4-K8 specific),1.0
11741,284058,GO:0043996,KANSL1,histone acetyltransferase activity (H4-K8 specific),1.0
11742,284058,GO:0044545,KANSL1,NSL complex,1.0
11743,284058,GO:0046972,KANSL1,histone acetyltransferase activity (H4-K16 specific),1.0
11744,284058,GO:0046972,KANSL1,histone acetyltransferase activity (H4-K16 specific),1.0
11745,284058,GO:0071339,KANSL1,MLL1 complex,1.0
11857,83473,GO:0000922,KATNAL2,spindle pole,1.0
11858,83473,GO:0005515,KATNAL2,protein binding,1.0
11859,83473,GO:0005524,KATNAL2,ATP binding,1.0
11860,83473,GO:0005634,KATNAL2,nucleus,1.0
11861,83473,GO:0005737,KATNAL2,cytoplasm,1.0
11862,83473,GO:0005819,KATNAL2,spindle,1.0
11863,83473,GO:0005874,KATNAL2,microtubule,1.0
11864,83473,GO:0008017,KATNAL2,microtubule binding,1.0
11865,83473,GO:0008568,KATNAL2,microtubule-severing ATPase activity,1.0
11866,83473,GO:0016853,KATNAL2,isomerase activity,1.0
11867,83473,GO:0016887,KATNAL2,ATPase activity,1.0
11868,83473,GO:0031122,KATNAL2,cytoplasmic microtubule organization,1.0
11869,83473,GO:0051013,KATNAL2,microtubule severing,1.0
11870,3745,GO:0001508,KCNB1,action potential,1.0
11871,3745,GO:0001508,KCNB1,action potential,1.0
11872,3745,GO:0005249,KCNB1,voltage-gated potassium channel activity,1.0
11873,3745,GO:0005251,KCNB1,delayed rectifier potassium channel activity,1.0
11874,3745,GO:0005251,KCNB1,delayed rectifier potassium channel activity,1.0
11875,3745,GO:0005251,KCNB1,delayed rectifier potassium channel activity,1.0
11876,3745,GO:0005515,KCNB1,protein binding,1.0
11877,3745,GO:0005886,KCNB1,plasma membrane,1.0
11878,3745,GO:0005886,KCNB1,plasma membrane,1.0
11879,3745,GO:0006904,KCNB1,vesicle docking involved in exocytosis,1.0
11880,3745,GO:0007215,KCNB1,glutamate receptor signaling pathway,1.0
11881,3745,GO:0008076,KCNB1,voltage-gated potassium channel complex,1.0
11882,3745,GO:0008076,KCNB1,voltage-gated potassium channel complex,1.0
11883,3745,GO:0008076,KCNB1,voltage-gated potassium channel complex,1.0
11884,3745,GO:0010701,KCNB1,positive regulation of norepinephrine secretion,1.0
11885,3745,GO:0016021,KCNB1,integral component of membrane,1.0
11886,3745,GO:0016328,KCNB1,lateral plasma membrane,1.0
11887,3745,GO:0030424,KCNB1,axon,1.0
11888,3745,GO:0030424,KCNB1,axon,1.0
11889,3745,GO:0030425,KCNB1,dendrite,1.0
11890,3745,GO:0031669,KCNB1,cellular response to nutrient levels,1.0
11891,3745,GO:0032590,KCNB1,dendrite membrane,1.0
11892,3745,GO:0032809,KCNB1,neuronal cell body membrane,1.0
11893,3745,GO:0032809,KCNB1,neuronal cell body membrane,1.0
11894,3745,GO:0033605,KCNB1,positive regulation of catecholamine secretion,1.0
11895,3745,GO:0034765,KCNB1,regulation of ion transmembrane transport,1.0
11896,3745,GO:0042383,KCNB1,sarcolemma,1.0
11897,3745,GO:0042593,KCNB1,glucose homeostasis,1.0
11898,3745,GO:0043204,KCNB1,perikaryon,1.0
11899,3745,GO:0044325,KCNB1,ion channel binding,1.0
11900,3745,GO:0045211,KCNB1,postsynaptic membrane,1.0
11901,3745,GO:0045956,KCNB1,positive regulation of calcium ion-dependent exocytosis,1.0
11902,3745,GO:0046676,KCNB1,negative regulation of insulin secretion,1.0
11903,3745,GO:0046982,KCNB1,protein heterodimerization activity,1.0
11904,3745,GO:0050796,KCNB1,regulation of insulin secretion,1.0
11905,3745,GO:0051260,KCNB1,protein homooligomerization,1.0
11906,3745,GO:0071333,KCNB1,cellular response to glucose stimulus,1.0
11907,3745,GO:0071805,KCNB1,potassium ion transmembrane transport,1.0
11908,3745,GO:0071805,KCNB1,potassium ion transmembrane transport,1.0
11909,3745,GO:0071805,KCNB1,potassium ion transmembrane transport,1.0
11910,3745,GO:0072659,KCNB1,protein localization to plasma membrane,1.0
11911,3745,GO:0090314,KCNB1,positive regulation of protein targeting to membrane,1.0
11912,3745,GO:0090314,KCNB1,positive regulation of protein targeting to membrane,1.0
11913,3745,GO:0098900,KCNB1,regulation of action potential,1.0
11914,3745,GO:1900454,KCNB1,positive regulation of long-term synaptic depression,1.0
11915,3745,GO:2000671,KCNB1,regulation of motor neuron apoptotic process,1.0
12196,3786,GO:0005249,KCNQ3,voltage-gated potassium channel activity,1.0
12197,3786,GO:0005249,KCNQ3,voltage-gated potassium channel activity,1.0
12198,3786,GO:0005251,KCNQ3,delayed rectifier potassium channel activity,1.0
12199,3786,GO:0005515,KCNQ3,protein binding,1.0
12200,3786,GO:0005516,KCNQ3,calmodulin binding,1.0
12201,3786,GO:0005516,KCNQ3,calmodulin binding,1.0
12202,3786,GO:0005886,KCNQ3,plasma membrane,1.0
12203,3786,GO:0005886,KCNQ3,plasma membrane,1.0
12204,3786,GO:0005887,KCNQ3,integral component of plasma membrane,1.0
12205,3786,GO:0007268,KCNQ3,chemical synaptic transmission,1.0
12206,3786,GO:0008076,KCNQ3,voltage-gated potassium channel complex,1.0
12207,3786,GO:0008076,KCNQ3,voltage-gated potassium channel complex,1.0
12208,3786,GO:0009986,KCNQ3,cell surface,1.0
12209,3786,GO:0016021,KCNQ3,integral component of membrane,1.0
12210,3786,GO:0033268,KCNQ3,node of Ranvier,1.0
12211,3786,GO:0034765,KCNQ3,regulation of ion transmembrane transport,1.0
12212,3786,GO:0043194,KCNQ3,axon initial segment,1.0
12213,3786,GO:0043194,KCNQ3,axon initial segment,1.0
12214,3786,GO:0045202,KCNQ3,synapse,1.0
12215,3786,GO:0060081,KCNQ3,membrane hyperpolarization,1.0
12216,3786,GO:0071805,KCNQ3,potassium ion transmembrane transport,1.0
12217,3786,GO:0071805,KCNQ3,potassium ion transmembrane transport,1.0
12285,51780,GO:0000118,KDM3B,histone deacetylase complex,1.0
12286,51780,GO:0000785,KDM3B,chromatin,1.0
12287,51780,GO:0003712,KDM3B,transcription coregulator activity,1.0
12288,51780,GO:0005654,KDM3B,nucleoplasm,1.0
12289,51780,GO:0005654,KDM3B,nucleoplasm,1.0
12290,51780,GO:0006357,KDM3B,regulation of transcription by RNA polymerase II,1.0
12291,51780,GO:0016209,KDM3B,antioxidant activity,1.0
12292,51780,GO:0031490,KDM3B,chromatin DNA binding,1.0
12293,51780,GO:0032454,KDM3B,histone demethylase activity (H3-K9 specific),1.0
12294,51780,GO:0033169,KDM3B,histone H3-K9 demethylation,1.0
12295,51780,GO:0046872,KDM3B,metal ion binding,1.0
12296,51780,GO:0051213,KDM3B,dioxygenase activity,1.0
12297,51780,GO:0055114,KDM3B,oxidation-reduction process,1.0
12298,51780,GO:0072718,KDM3B,response to cisplatin,1.0
12299,51780,GO:0098869,KDM3B,cellular oxidant detoxification,1.0
12342,10765,GO:0003677,KDM5B,DNA binding,1.0
12343,10765,GO:0003714,KDM5B,transcription corepressor activity,1.0
12344,10765,GO:0005515,KDM5B,protein binding,1.0
12345,10765,GO:0005634,KDM5B,nucleus,1.0
12346,10765,GO:0005654,KDM5B,nucleoplasm,1.0
12347,10765,GO:0005654,KDM5B,nucleoplasm,1.0
12348,10765,GO:0005829,KDM5B,cytosol,1.0
12349,10765,GO:0006338,KDM5B,chromatin remodeling,1.0
12350,10765,GO:0006357,KDM5B,regulation of transcription by RNA polymerase II,1.0
12351,10765,GO:0007338,KDM5B,single fertilization,1.0
12352,10765,GO:0008270,KDM5B,zinc ion binding,1.0
12353,10765,GO:0008270,KDM5B,zinc ion binding,1.0
12354,10765,GO:0009791,KDM5B,post-embryonic development,1.0
12355,10765,GO:0010628,KDM5B,positive regulation of gene expression,1.0
12356,10765,GO:0032452,KDM5B,histone demethylase activity,1.0
12357,10765,GO:0032453,KDM5B,histone demethylase activity (H3-K4 specific),1.0
12358,10765,GO:0032453,KDM5B,histone demethylase activity (H3-K4 specific),1.0
12359,10765,GO:0033601,KDM5B,positive regulation of mammary gland epithelial cell proliferation,1.0
12360,10765,GO:0034647,KDM5B,histone demethylase activity (H3-trimethyl-K4 specific),1.0
12361,10765,GO:0034647,KDM5B,histone demethylase activity (H3-trimethyl-K4 specific),1.0
12362,10765,GO:0034647,KDM5B,histone demethylase activity (H3-trimethyl-K4 specific),1.0
12363,10765,GO:0034648,KDM5B,histone demethylase activity (H3-dimethyl-K4 specific),1.0
12364,10765,GO:0034720,KDM5B,histone H3-K4 demethylation,1.0
12365,10765,GO:0034720,KDM5B,histone H3-K4 demethylation,1.0
12366,10765,GO:0034721,KDM5B,"histone H3-K4 demethylation, trimethyl-H3-K4-specific",1.0
12367,10765,GO:0035097,KDM5B,histone methyltransferase complex,1.0
12368,10765,GO:0042393,KDM5B,histone binding,1.0
12369,10765,GO:0045892,KDM5B,"negative regulation of transcription, DNA-templated",1.0
12370,10765,GO:0048511,KDM5B,rhythmic process,1.0
12371,10765,GO:0051213,KDM5B,dioxygenase activity,1.0
12372,10765,GO:0055114,KDM5B,oxidation-reduction process,1.0
12373,10765,GO:0060444,KDM5B,branching involved in mammary gland duct morphogenesis,1.0
12374,10765,GO:0060763,KDM5B,mammary duct terminal end bud growth,1.0
12375,10765,GO:0061038,KDM5B,uterus morphogenesis,1.0
12376,10765,GO:1990830,KDM5B,cellular response to leukemia inhibitory factor,1.0
12377,10765,GO:1990837,KDM5B,sequence-specific double-stranded DNA binding,1.0
12378,10765,GO:2000864,KDM5B,regulation of estradiol secretion,1.0
12426,23135,GO:0000785,KDM6B,chromatin,1.0
12427,23135,GO:0000978,KDM6B,RNA polymerase II cis-regulatory region sequence-specific DNA binding,1.0
12428,23135,GO:0002437,KDM6B,inflammatory response to antigenic stimulus,1.0
12429,23135,GO:0005515,KDM6B,protein binding,1.0
12430,23135,GO:0005634,KDM6B,nucleus,1.0
12431,23135,GO:0005654,KDM6B,nucleoplasm,1.0
12432,23135,GO:0006338,KDM6B,chromatin remodeling,1.0
12433,23135,GO:0008013,KDM6B,beta-catenin binding,1.0
12434,23135,GO:0014823,KDM6B,response to activity,1.0
12435,23135,GO:0021766,KDM6B,hippocampus development,1.0
12436,23135,GO:0031490,KDM6B,chromatin DNA binding,1.0
12437,23135,GO:0044666,KDM6B,MLL3/4 complex,1.0
12438,23135,GO:0045165,KDM6B,cell fate commitment,1.0
12439,23135,GO:0045446,KDM6B,endothelial cell differentiation,1.0
12440,23135,GO:0045944,KDM6B,positive regulation of transcription by RNA polymerase II,1.0
12441,23135,GO:0046872,KDM6B,metal ion binding,1.0
12442,23135,GO:0048333,KDM6B,mesodermal cell differentiation,1.0
12443,23135,GO:0051213,KDM6B,dioxygenase activity,1.0
12444,23135,GO:0055007,KDM6B,cardiac muscle cell differentiation,1.0
12445,23135,GO:0055114,KDM6B,oxidation-reduction process,1.0
12446,23135,GO:0060992,KDM6B,response to fungicide,1.0
12447,23135,GO:0070301,KDM6B,cellular response to hydrogen peroxide,1.0
12448,23135,GO:0071557,KDM6B,histone H3-K27 demethylation,1.0
12449,23135,GO:0071558,KDM6B,histone demethylase activity (H3-K27 specific),1.0
12450,23135,GO:0071558,KDM6B,histone demethylase activity (H3-K27 specific),1.0
12451,23135,GO:0120162,KDM6B,positive regulation of cold-induced thermogenesis,1.0
12595,4297,GO:0003680,KMT2A,minor groove of adenine-thymine-rich DNA binding,1.0
12596,4297,GO:0005515,KMT2A,protein binding,1.0
12597,4297,GO:0005634,KMT2A,nucleus,1.0
12598,4297,GO:0005634,KMT2A,nucleus,1.0
12599,4297,GO:0005654,KMT2A,nucleoplasm,1.0
12600,4297,GO:0005654,KMT2A,nucleoplasm,1.0
12601,4297,GO:0005829,KMT2A,cytosol,1.0
12602,4297,GO:0006915,KMT2A,apoptotic process,1.0
12603,4297,GO:0008270,KMT2A,zinc ion binding,1.0
12604,4297,GO:0032411,KMT2A,positive regulation of transporter activity,1.0
12605,4297,GO:0032922,KMT2A,circadian regulation of gene expression,1.0
12606,4297,GO:0035097,KMT2A,histone methyltransferase complex,1.0
12607,4297,GO:0035097,KMT2A,histone methyltransferase complex,1.0
12608,4297,GO:0035162,KMT2A,embryonic hemopoiesis,1.0
12609,4297,GO:0042800,KMT2A,histone methyltransferase activity (H3-K4 specific),1.0
12610,4297,GO:0042800,KMT2A,histone methyltransferase activity (H3-K4 specific),1.0
12611,4297,GO:0042800,KMT2A,histone methyltransferase activity (H3-K4 specific),1.0
12612,4297,GO:0042800,KMT2A,histone methyltransferase activity (H3-K4 specific),1.0
12613,4297,GO:0042802,KMT2A,identical protein binding,1.0
12614,4297,GO:0042803,KMT2A,protein homodimerization activity,1.0
12615,4297,GO:0043984,KMT2A,histone H4-K16 acetylation,1.0
12616,4297,GO:0044648,KMT2A,histone H3-K4 dimethylation,1.0
12617,4297,GO:0045322,KMT2A,unmethylated CpG binding,1.0
12618,4297,GO:0045652,KMT2A,regulation of megakaryocyte differentiation,1.0
12619,4297,GO:0045893,KMT2A,"positive regulation of transcription, DNA-templated",1.0
12620,4297,GO:0045893,KMT2A,"positive regulation of transcription, DNA-templated",1.0
12621,4297,GO:0045944,KMT2A,positive regulation of transcription by RNA polymerase II,1.0
12622,4297,GO:0045944,KMT2A,positive regulation of transcription by RNA polymerase II,1.0
12623,4297,GO:0051568,KMT2A,histone H3-K4 methylation,1.0
12624,4297,GO:0051568,KMT2A,histone H3-K4 methylation,1.0
12625,4297,GO:0051568,KMT2A,histone H3-K4 methylation,1.0
12626,4297,GO:0051571,KMT2A,positive regulation of histone H3-K4 methylation,1.0
12627,4297,GO:0065003,KMT2A,protein-containing complex assembly,1.0
12628,4297,GO:0070577,KMT2A,lysine-acetylated histone binding,1.0
12629,4297,GO:0071339,KMT2A,MLL1 complex,1.0
12630,4297,GO:0071440,KMT2A,regulation of histone H3-K14 acetylation,1.0
12631,4297,GO:0080182,KMT2A,histone H3-K4 trimethylation,1.0
12632,4297,GO:0097692,KMT2A,histone H3-K4 monomethylation,1.0
12633,4297,GO:1902036,KMT2A,regulation of hematopoietic stem cell differentiation,1.0
12634,4297,GO:1905642,KMT2A,negative regulation of DNA methylation,1.0
12635,4297,GO:2000615,KMT2A,regulation of histone H3-K9 acetylation,1.0
12636,4297,GO:2001040,KMT2A,positive regulation of cellular response to drug,1.0
12637,58508,GO:0003677,KMT2C,DNA binding,1.0
12638,58508,GO:0003713,KMT2C,transcription coactivator activity,1.0
12639,58508,GO:0003723,KMT2C,RNA binding,1.0
12640,58508,GO:0005515,KMT2C,protein binding,1.0
12641,58508,GO:0005634,KMT2C,nucleus,1.0
12642,58508,GO:0005654,KMT2C,nucleoplasm,1.0
12643,58508,GO:0016746,KMT2C,"transferase activity, transferring acyl groups",1.0
12644,58508,GO:0035097,KMT2C,histone methyltransferase complex,1.0
12645,58508,GO:0042054,KMT2C,histone methyltransferase activity,1.0
12646,58508,GO:0042393,KMT2C,histone binding,1.0
12647,58508,GO:0042800,KMT2C,histone methyltransferase activity (H3-K4 specific),1.0
12648,58508,GO:0042800,KMT2C,histone methyltransferase activity (H3-K4 specific),1.0
12649,58508,GO:0044666,KMT2C,MLL3/4 complex,1.0
12650,58508,GO:0044666,KMT2C,MLL3/4 complex,1.0
12651,58508,GO:0045652,KMT2C,regulation of megakaryocyte differentiation,1.0
12652,58508,GO:0045944,KMT2C,positive regulation of transcription by RNA polymerase II,1.0
12653,58508,GO:0046872,KMT2C,metal ion binding,1.0
12654,58508,GO:0097692,KMT2C,histone H3-K4 monomethylation,1.0
12655,55904,GO:0000785,KMT2E,chromatin,1.0
12656,55904,GO:0002446,KMT2E,neutrophil mediated immunity,1.0
12657,55904,GO:0005515,KMT2E,protein binding,1.0
12658,55904,GO:0005634,KMT2E,nucleus,1.0
12659,55904,GO:0005654,KMT2E,nucleoplasm,1.0
12660,55904,GO:0005654,KMT2E,nucleoplasm,1.0
12661,55904,GO:0005737,KMT2E,cytoplasm,1.0
12662,55904,GO:0005815,KMT2E,microtubule organizing center,1.0
12663,55904,GO:0005886,KMT2E,plasma membrane,1.0
12664,55904,GO:0006306,KMT2E,DNA methylation,1.0
12665,55904,GO:0007050,KMT2E,cell cycle arrest,1.0
12666,55904,GO:0016604,KMT2E,nuclear body,1.0
12667,55904,GO:0016607,KMT2E,nuclear speck,1.0
12668,55904,GO:0018024,KMT2E,histone-lysine N-methyltransferase activity,1.0
12669,55904,GO:0019899,KMT2E,enzyme binding,1.0
12670,55904,GO:0030218,KMT2E,erythrocyte differentiation,1.0
12671,55904,GO:0032991,KMT2E,protein-containing complex,1.0
12672,55904,GO:0034968,KMT2E,histone lysine methylation,1.0
12673,55904,GO:0035064,KMT2E,methylated histone binding,1.0
12674,55904,GO:0035064,KMT2E,methylated histone binding,1.0
12675,55904,GO:0035327,KMT2E,transcriptionally active chromatin,1.0
12676,55904,GO:0042119,KMT2E,neutrophil activation,1.0
12677,55904,GO:0043231,KMT2E,intracellular membrane-bounded organelle,1.0
12678,55904,GO:0045652,KMT2E,regulation of megakaryocyte differentiation,1.0
12679,55904,GO:0045893,KMT2E,"positive regulation of transcription, DNA-templated",1.0
12680,55904,GO:0046872,KMT2E,metal ion binding,1.0
12681,55904,GO:1900087,KMT2E,positive regulation of G1/S transition of mitotic cell cycle,1.0
12682,55904,GO:1905437,KMT2E,positive regulation of histone H3-K4 trimethylation,1.0
12683,51111,GO:0000779,KMT5B,"condensed chromosome, centromeric region",1.0
12684,51111,GO:0003682,KMT5B,chromatin binding,1.0
12685,51111,GO:0005515,KMT5B,protein binding,1.0
12686,51111,GO:0005634,KMT5B,nucleus,1.0
12687,51111,GO:0005654,KMT5B,nucleoplasm,1.0
12688,51111,GO:0005654,KMT5B,nucleoplasm,1.0
12689,51111,GO:0006281,KMT5B,DNA repair,1.0
12690,51111,GO:0007517,KMT5B,muscle organ development,1.0
12691,51111,GO:0018024,KMT5B,histone-lysine N-methyltransferase activity,1.0
12692,51111,GO:0034773,KMT5B,histone H4-K20 trimethylation,1.0
12693,51111,GO:0042799,KMT5B,histone methyltransferase activity (H4-K20 specific),1.0
12694,51111,GO:0042799,KMT5B,histone methyltransferase activity (H4-K20 specific),1.0
12695,51111,GO:0042799,KMT5B,histone methyltransferase activity (H4-K20 specific),1.0
12696,51111,GO:0045830,KMT5B,positive regulation of isotype switching,1.0
12697,51111,GO:0046872,KMT5B,metal ion binding,1.0
12698,51111,GO:1904047,KMT5B,S-adenosyl-L-methionine binding,1.0
12699,51111,GO:2001034,KMT5B,positive regulation of double-strand break repair via nonhomologous end joining,1.0
12700,9778,GO:0005524,KIAA0232,ATP binding,1.0
12859,8861,GO:0000122,LDB1,negative regulation of transcription by RNA polymerase II,1.0
12860,8861,GO:0000785,LDB1,chromatin,1.0
12861,8861,GO:0000972,LDB1,transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery,1.0
12862,8861,GO:0001102,LDB1,RNA polymerase II activating transcription factor binding,1.0
12863,8861,GO:0001102,LDB1,RNA polymerase II activating transcription factor binding,1.0
12864,8861,GO:0003712,LDB1,transcription coregulator activity,1.0
12865,8861,GO:0005515,LDB1,protein binding,1.0
12866,8861,GO:0005634,LDB1,nucleus,1.0
12867,8861,GO:0005634,LDB1,nucleus,1.0
12868,8861,GO:0005654,LDB1,nucleoplasm,1.0
12869,8861,GO:0005667,LDB1,transcription regulator complex,1.0
12870,8861,GO:0005667,LDB1,transcription regulator complex,1.0
12871,8861,GO:0006355,LDB1,"regulation of transcription, DNA-templated",1.0
12872,8861,GO:0007275,LDB1,multicellular organism development,1.0
12873,8861,GO:0007399,LDB1,nervous system development,1.0
12874,8861,GO:0019899,LDB1,enzyme binding,1.0
12875,8861,GO:0030182,LDB1,neuron differentiation,1.0
12876,8861,GO:0030274,LDB1,LIM domain binding,1.0
12877,8861,GO:0030274,LDB1,LIM domain binding,1.0
12878,8861,GO:0030274,LDB1,LIM domain binding,1.0
12879,8861,GO:0030334,LDB1,regulation of cell migration,1.0
12880,8861,GO:0031252,LDB1,cell leading edge,1.0
12881,8861,GO:0032991,LDB1,protein-containing complex,1.0
12882,8861,GO:0034243,LDB1,regulation of transcription elongation from RNA polymerase II promoter,1.0
12883,8861,GO:0042803,LDB1,protein homodimerization activity,1.0
12884,8861,GO:0043549,LDB1,regulation of kinase activity,1.0
12885,8861,GO:0043973,LDB1,histone H3-K4 acetylation,1.0
12886,8861,GO:0045647,LDB1,negative regulation of erythrocyte differentiation,1.0
12887,8861,GO:0045892,LDB1,"negative regulation of transcription, DNA-templated",1.0
12888,8861,GO:0045944,LDB1,positive regulation of transcription by RNA polymerase II,1.0
12889,8861,GO:0045944,LDB1,positive regulation of transcription by RNA polymerase II,1.0
12890,8861,GO:0045944,LDB1,positive regulation of transcription by RNA polymerase II,1.0
12891,8861,GO:0046985,LDB1,positive regulation of hemoglobin biosynthetic process,1.0
12892,8861,GO:0051893,LDB1,regulation of focal adhesion assembly,1.0
12893,8861,GO:0140297,LDB1,DNA-binding transcription factor binding,1.0
12894,8861,GO:1902036,LDB1,regulation of hematopoietic stem cell differentiation,1.0
12895,8861,GO:1990907,LDB1,beta-catenin-TCF complex,1.0
13407,8216,GO:0005515,LZTR1,protein binding,1.0
13408,8216,GO:0005794,LZTR1,Golgi apparatus,1.0
13409,8216,GO:0005794,LZTR1,Golgi apparatus,1.0
13410,8216,GO:0012505,LZTR1,endomembrane system,1.0
13411,8216,GO:0016567,LZTR1,protein ubiquitination,1.0
13412,8216,GO:0016567,LZTR1,protein ubiquitination,1.0
13413,8216,GO:0031267,LZTR1,small GTPase binding,1.0
13414,8216,GO:0031463,LZTR1,Cul3-RING ubiquitin ligase complex,1.0
13415,8216,GO:0046580,LZTR1,negative regulation of Ras protein signal transduction,1.0
13416,8216,GO:0055038,LZTR1,recycling endosome membrane,1.0
13434,54551,GO:0004842,MAGEL2,ubiquitin-protein transferase activity,1.0
13435,54551,GO:0005515,MAGEL2,protein binding,1.0
13436,54551,GO:0005634,MAGEL2,nucleus,1.0
13437,54551,GO:0005768,MAGEL2,endosome,1.0
13438,54551,GO:0005769,MAGEL2,early endosome,1.0
13439,54551,GO:0005829,MAGEL2,cytosol,1.0
13440,54551,GO:0030904,MAGEL2,retromer complex,1.0
13441,54551,GO:0034314,MAGEL2,Arp2/3 complex-mediated actin nucleation,1.0
13442,54551,GO:0042147,MAGEL2,"retrograde transport, endosome to Golgi",1.0
13443,54551,GO:0042752,MAGEL2,regulation of circadian rhythm,1.0
13444,54551,GO:0045892,MAGEL2,"negative regulation of transcription, DNA-templated",1.0
13445,54551,GO:0048511,MAGEL2,rhythmic process,1.0
13446,54551,GO:0051127,MAGEL2,positive regulation of actin nucleation,1.0
13447,54551,GO:0070534,MAGEL2,protein K63-linked ubiquitination,1.0
13668,55777,GO:0003677,MBD5,DNA binding,1.0
13669,55777,GO:0003682,MBD5,chromatin binding,1.0
13670,55777,GO:0003682,MBD5,chromatin binding,1.0
13671,55777,GO:0005634,MBD5,nucleus,1.0
13672,55777,GO:0005634,MBD5,nucleus,1.0
13673,55777,GO:0005654,MBD5,nucleoplasm,1.0
13674,55777,GO:0005654,MBD5,nucleoplasm,1.0
13675,55777,GO:0005694,MBD5,chromosome,1.0
13676,55777,GO:0007399,MBD5,nervous system development,1.0
13677,55777,GO:0010369,MBD5,chromocenter,1.0
13678,55777,GO:0010369,MBD5,chromocenter,1.0
13679,55777,GO:0016579,MBD5,protein deubiquitination,1.0
13680,55777,GO:0030496,MBD5,midbody,1.0
13681,55777,GO:0040014,MBD5,regulation of multicellular organism growth,1.0
13682,55777,GO:0042593,MBD5,glucose homeostasis,1.0
13683,55777,GO:0050795,MBD5,regulation of behavior,1.0
13684,55777,GO:0060399,MBD5,positive regulation of growth hormone receptor signaling pathway,1.0
13685,55777,GO:0070062,MBD5,extracellular exosome,1.0
13699,79143,GO:0003841,MBOAT7,1-acylglycerol-3-phosphate O-acyltransferase activity,1.0
13700,79143,GO:0005515,MBOAT7,protein binding,1.0
13701,79143,GO:0005783,MBOAT7,endoplasmic reticulum,1.0
13702,79143,GO:0005789,MBOAT7,endoplasmic reticulum membrane,1.0
13703,79143,GO:0006661,MBOAT7,phosphatidylinositol biosynthetic process,1.0
13704,79143,GO:0006661,MBOAT7,phosphatidylinositol biosynthetic process,1.0
13705,79143,GO:0008374,MBOAT7,O-acyltransferase activity,1.0
13706,79143,GO:0008374,MBOAT7,O-acyltransferase activity,1.0
13707,79143,GO:0008374,MBOAT7,O-acyltransferase activity,1.0
13708,79143,GO:0016020,MBOAT7,membrane,1.0
13709,79143,GO:0016020,MBOAT7,membrane,1.0
13710,79143,GO:0016021,MBOAT7,integral component of membrane,1.0
13711,79143,GO:0016746,MBOAT7,"transferase activity, transferring acyl groups",1.0
13712,79143,GO:0021591,MBOAT7,ventricular system development,1.0
13713,79143,GO:0021819,MBOAT7,layer formation in cerebral cortex,1.0
13714,79143,GO:0030258,MBOAT7,lipid modification,1.0
13715,79143,GO:0036149,MBOAT7,phosphatidylinositol acyl-chain remodeling,1.0
13716,79143,GO:0036149,MBOAT7,phosphatidylinositol acyl-chain remodeling,1.0
13717,79143,GO:0036149,MBOAT7,phosphatidylinositol acyl-chain remodeling,1.0
13718,79143,GO:0036151,MBOAT7,phosphatidylcholine acyl-chain remodeling,1.0
13719,79143,GO:0044233,MBOAT7,mitochondria-associated endoplasmic reticulum membrane,1.0
13720,79143,GO:0044233,MBOAT7,mitochondria-associated endoplasmic reticulum membrane,1.0
13721,79143,GO:0047144,MBOAT7,2-acylglycerol-3-phosphate O-acyltransferase activity,1.0
13722,79143,GO:0071617,MBOAT7,lysophospholipid acyltransferase activity,1.0
13723,79143,GO:0071617,MBOAT7,lysophospholipid acyltransferase activity,1.0
13724,79143,GO:0090207,MBOAT7,regulation of triglyceride metabolic process,1.0
13725,79143,GO:0090207,MBOAT7,regulation of triglyceride metabolic process,1.0
13794,4204,GO:0000122,MECP2,negative regulation of transcription by RNA polymerase II,1.0
13795,4204,GO:0000792,MECP2,heterochromatin,1.0
13796,4204,GO:0000792,MECP2,heterochromatin,1.0
13797,4204,GO:0003677,MECP2,DNA binding,1.0
13798,4204,GO:0003682,MECP2,chromatin binding,1.0
13799,4204,GO:0003714,MECP2,transcription corepressor activity,1.0
13800,4204,GO:0003723,MECP2,RNA binding,1.0
13801,4204,GO:0005515,MECP2,protein binding,1.0
13802,4204,GO:0005615,MECP2,extracellular space,1.0
13803,4204,GO:0005634,MECP2,nucleus,1.0
13804,4204,GO:0005634,MECP2,nucleus,1.0
13805,4204,GO:0005654,MECP2,nucleoplasm,1.0
13806,4204,GO:0005654,MECP2,nucleoplasm,1.0
13807,4204,GO:0005813,MECP2,centrosome,1.0
13808,4204,GO:0006349,MECP2,regulation of gene expression by genetic imprinting,1.0
13809,4204,GO:0006367,MECP2,transcription initiation from RNA polymerase II promoter,1.0
13810,4204,GO:0007052,MECP2,mitotic spindle organization,1.0
13811,4204,GO:0008284,MECP2,positive regulation of cell population proliferation,1.0
13812,4204,GO:0008327,MECP2,methyl-CpG binding,1.0
13813,4204,GO:0010385,MECP2,double-stranded methylated DNA binding,1.0
13814,4204,GO:0010385,MECP2,double-stranded methylated DNA binding,1.0
13815,4204,GO:0010629,MECP2,negative regulation of gene expression,1.0
13816,4204,GO:0010971,MECP2,positive regulation of G2/M transition of mitotic cell cycle,1.0
13817,4204,GO:0016525,MECP2,negative regulation of angiogenesis,1.0
13818,4204,GO:0019904,MECP2,protein domain specific binding,1.0
13819,4204,GO:0043537,MECP2,negative regulation of blood vessel endothelial cell migration,1.0
13820,4204,GO:0045892,MECP2,"negative regulation of transcription, DNA-templated",1.0
13821,4204,GO:0047485,MECP2,protein N-terminus binding,1.0
13822,4204,GO:0090063,MECP2,positive regulation of microtubule nucleation,1.0
13823,4204,GO:0098794,MECP2,postsynapse,1.0
13824,4204,GO:1905643,MECP2,positive regulation of DNA methylation,1.0
13847,57689,GO:0005515,LRRC4C,protein binding,1.0
13848,57689,GO:0005615,LRRC4C,extracellular space,1.0
13849,57689,GO:0016020,LRRC4C,membrane,1.0
13850,57689,GO:0016021,LRRC4C,integral component of membrane,1.0
13851,57689,GO:0045211,LRRC4C,postsynaptic membrane,1.0
13852,57689,GO:0050770,LRRC4C,regulation of axonogenesis,1.0
13853,57689,GO:0050804,LRRC4C,modulation of chemical synaptic transmission,1.0
13854,57689,GO:0050839,LRRC4C,cell adhesion molecule binding,1.0
13855,57689,GO:0098632,LRRC4C,cell-cell adhesion mediator activity,1.0
13856,57689,GO:0098978,LRRC4C,glutamatergic synapse,1.0
13857,57689,GO:0099560,LRRC4C,synaptic membrane adhesion,1.0
13875,4130,GO:0000226,MAP1A,microtubule cytoskeleton organization,1.0
13876,4130,GO:0000226,MAP1A,microtubule cytoskeleton organization,1.0
13877,4130,GO:0003779,MAP1A,actin binding,1.0
13878,4130,GO:0003779,MAP1A,actin binding,1.0
13879,4130,GO:0005198,MAP1A,structural molecule activity,1.0
13880,4130,GO:0005515,MAP1A,protein binding,1.0
13881,4130,GO:0005737,MAP1A,cytoplasm,1.0
13882,4130,GO:0005829,MAP1A,cytosol,1.0
13883,4130,GO:0005874,MAP1A,microtubule,1.0
13884,4130,GO:0005875,MAP1A,microtubule associated complex,1.0
13885,4130,GO:0007409,MAP1A,axonogenesis,1.0
13886,4130,GO:0007613,MAP1A,memory,1.0
13887,4130,GO:0008017,MAP1A,microtubule binding,1.0
13888,4130,GO:0008017,MAP1A,microtubule binding,1.0
13889,4130,GO:0008017,MAP1A,microtubule binding,1.0
13890,4130,GO:0008093,MAP1A,cytoskeletal anchor activity,1.0
13891,4130,GO:0008306,MAP1A,associative learning,1.0
13892,4130,GO:0015631,MAP1A,tubulin binding,1.0
13893,4130,GO:0016358,MAP1A,dendrite development,1.0
13894,4130,GO:0030424,MAP1A,axon,1.0
13895,4130,GO:0030425,MAP1A,dendrite,1.0
13896,4130,GO:0030425,MAP1A,dendrite,1.0
13897,4130,GO:0031114,MAP1A,regulation of microtubule depolymerization,1.0
13898,4130,GO:0032435,MAP1A,negative regulation of proteasomal ubiquitin-dependent protein catabolic process,1.0
13899,4130,GO:0043005,MAP1A,neuron projection,1.0
13900,4130,GO:0043025,MAP1A,neuronal cell body,1.0
13901,4130,GO:0043025,MAP1A,neuronal cell body,1.0
13902,4130,GO:0043194,MAP1A,axon initial segment,1.0
13903,4130,GO:0043198,MAP1A,dendritic shaft,1.0
13904,4130,GO:0044307,MAP1A,dendritic branch,1.0
13905,4130,GO:0045202,MAP1A,synapse,1.0
13906,4130,GO:0048156,MAP1A,tau protein binding,1.0
13907,4130,GO:0048167,MAP1A,regulation of synaptic plasticity,1.0
13908,4130,GO:0050882,MAP1A,voluntary musculoskeletal movement,1.0
13909,4130,GO:0070050,MAP1A,neuron cellular homeostasis,1.0
13910,4130,GO:0099641,MAP1A,anterograde axonal protein transport,1.0
13911,4130,GO:0099642,MAP1A,retrograde axonal protein transport,1.0
13912,4130,GO:0150001,MAP1A,primary dendrite,1.0
13913,4130,GO:1901588,MAP1A,dendritic microtubule,1.0
13914,4130,GO:1902817,MAP1A,negative regulation of protein localization to microtubule,1.0
13915,4130,GO:1903829,MAP1A,positive regulation of cellular protein localization,1.0
13916,4130,GO:1904115,MAP1A,axon cytoplasm,1.0
13917,4130,GO:1990535,MAP1A,neuron projection maintenance,1.0
13918,4130,GO:2000010,MAP1A,positive regulation of protein localization to cell surface,1.0
13927,9969,GO:0003712,MED13,transcription coregulator activity,1.0
13928,9969,GO:0003712,MED13,transcription coregulator activity,1.0
13929,9969,GO:0003713,MED13,transcription coactivator activity,1.0
13930,9969,GO:0005634,MED13,nucleus,1.0
13931,9969,GO:0005654,MED13,nucleoplasm,1.0
13932,9969,GO:0005654,MED13,nucleoplasm,1.0
13933,9969,GO:0006357,MED13,regulation of transcription by RNA polymerase II,1.0
13934,9969,GO:0006367,MED13,transcription initiation from RNA polymerase II promoter,1.0
13935,9969,GO:0016020,MED13,membrane,1.0
13936,9969,GO:0016592,MED13,mediator complex,1.0
13937,9969,GO:0016592,MED13,mediator complex,1.0
13938,9969,GO:0030374,MED13,nuclear receptor coactivator activity,1.0
13939,9969,GO:0042632,MED13,cholesterol homeostasis,1.0
13940,9969,GO:0042809,MED13,vitamin D receptor binding,1.0
13941,9969,GO:0043433,MED13,negative regulation of DNA-binding transcription factor activity,1.0
13942,9969,GO:0045893,MED13,"positive regulation of transcription, DNA-templated",1.0
13943,9969,GO:0045944,MED13,positive regulation of transcription by RNA polymerase II,1.0
13944,9969,GO:0046966,MED13,thyroid hormone receptor binding,1.0
13945,9969,GO:0060261,MED13,positive regulation of transcription initiation from RNA polymerase II promoter,1.0
13946,9969,GO:0070328,MED13,triglyceride homeostasis,1.0
13947,23389,GO:0003712,MED13L,transcription coregulator activity,1.0
13948,23389,GO:0006357,MED13L,regulation of transcription by RNA polymerase II,1.0
13949,23389,GO:0016592,MED13L,mediator complex,1.0
14108,4212,GO:0000122,MEIS2,negative regulation of transcription by RNA polymerase II,1.0
14109,4212,GO:0000785,MEIS2,chromatin,1.0
14110,4212,GO:0000785,MEIS2,chromatin,1.0
14111,4212,GO:0000978,MEIS2,RNA polymerase II cis-regulatory region sequence-specific DNA binding,1.0
14112,4212,GO:0000978,MEIS2,RNA polymerase II cis-regulatory region sequence-specific DNA binding,1.0
14113,4212,GO:0000981,MEIS2,"DNA-binding transcription factor activity, RNA polymerase II-specific",1.0
14114,4212,GO:0000981,MEIS2,"DNA-binding transcription factor activity, RNA polymerase II-specific",1.0
14115,4212,GO:0001228,MEIS2,"DNA-binding transcription activator activity, RNA polymerase II-specific",1.0
14116,4212,GO:0001228,MEIS2,"DNA-binding transcription activator activity, RNA polymerase II-specific",1.0
14117,4212,GO:0001228,MEIS2,"DNA-binding transcription activator activity, RNA polymerase II-specific",1.0
14118,4212,GO:0001654,MEIS2,eye development,1.0
14119,4212,GO:0003677,MEIS2,DNA binding,1.0
14120,4212,GO:0005515,MEIS2,protein binding,1.0
14121,4212,GO:0006357,MEIS2,regulation of transcription by RNA polymerase II,1.0
14122,4212,GO:0007420,MEIS2,brain development,1.0
14123,4212,GO:0008134,MEIS2,transcription factor binding,1.0
14124,4212,GO:0008284,MEIS2,positive regulation of cell population proliferation,1.0
14125,4212,GO:0008542,MEIS2,visual learning,1.0
14126,4212,GO:0009612,MEIS2,response to mechanical stimulus,1.0
14127,4212,GO:0009880,MEIS2,embryonic pattern specification,1.0
14128,4212,GO:0009887,MEIS2,animal organ morphogenesis,1.0
14129,4212,GO:0031016,MEIS2,pancreas development,1.0
14130,4212,GO:0045638,MEIS2,negative regulation of myeloid cell differentiation,1.0
14131,4212,GO:0045931,MEIS2,positive regulation of mitotic cell cycle,1.0
14132,4212,GO:0045944,MEIS2,positive regulation of transcription by RNA polymerase II,1.0
14133,4212,GO:0045944,MEIS2,positive regulation of transcription by RNA polymerase II,1.0
14134,4212,GO:0048471,MEIS2,perinuclear region of cytoplasm,1.0
14135,4212,GO:0070848,MEIS2,response to growth factor,1.0
14136,4212,GO:0110024,MEIS2,positive regulation of cardiac muscle myoblast proliferation,1.0
14137,4212,GO:1990837,MEIS2,sequence-specific double-stranded DNA binding,1.0
14790,23040,GO:0000122,MYT1L,negative regulation of transcription by RNA polymerase II,1.0
14791,23040,GO:0000785,MYT1L,chromatin,1.0
14792,23040,GO:0000978,MYT1L,RNA polymerase II cis-regulatory region sequence-specific DNA binding,1.0
14793,23040,GO:0000981,MYT1L,"DNA-binding transcription factor activity, RNA polymerase II-specific",1.0
14794,23040,GO:0000981,MYT1L,"DNA-binding transcription factor activity, RNA polymerase II-specific",1.0
14795,23040,GO:0001227,MYT1L,"DNA-binding transcription repressor activity, RNA polymerase II-specific",1.0
14796,23040,GO:0005634,MYT1L,nucleus,1.0
14797,23040,GO:0005634,MYT1L,nucleus,1.0
14798,23040,GO:0006357,MYT1L,regulation of transcription by RNA polymerase II,1.0
14799,23040,GO:0006357,MYT1L,regulation of transcription by RNA polymerase II,1.0
14800,23040,GO:0007399,MYT1L,nervous system development,1.0
14801,23040,GO:0008270,MYT1L,zinc ion binding,1.0
14802,23040,GO:0030182,MYT1L,neuron differentiation,1.0
14803,23040,GO:0048663,MYT1L,neuron fate commitment,1.0
14804,23040,GO:0048665,MYT1L,neuron fate specification,1.0
14805,23040,GO:0048666,MYT1L,neuron development,1.0
14806,80155,GO:0001525,NAA15,angiogenesis,1.0
14807,80155,GO:0003723,NAA15,RNA binding,1.0
14808,80155,GO:0004596,NAA15,peptide alpha-N-acetyltransferase activity,1.0
14809,80155,GO:0005515,NAA15,protein binding,1.0
14810,80155,GO:0005634,NAA15,nucleus,1.0
14811,80155,GO:0005667,NAA15,transcription regulator complex,1.0
14812,80155,GO:0005737,NAA15,cytoplasm,1.0
14813,80155,GO:0005737,NAA15,cytoplasm,1.0
14814,80155,GO:0005829,NAA15,cytosol,1.0
14815,80155,GO:0006474,NAA15,N-terminal protein amino acid acetylation,1.0
14816,80155,GO:0016020,NAA15,membrane,1.0
14817,80155,GO:0016407,NAA15,acetyltransferase activity,1.0
14818,80155,GO:0017196,NAA15,N-terminal peptidyl-methionine acetylation,1.0
14819,80155,GO:0030154,NAA15,cell differentiation,1.0
14820,80155,GO:0031415,NAA15,NatA complex,1.0
14821,80155,GO:0031415,NAA15,NatA complex,1.0
14822,80155,GO:0043022,NAA15,ribosome binding,1.0
14823,80155,GO:0043022,NAA15,ribosome binding,1.0
14824,80155,GO:0043066,NAA15,negative regulation of apoptotic process,1.0
14825,80155,GO:0045893,NAA15,"positive regulation of transcription, DNA-templated",1.0
14826,80155,GO:0050821,NAA15,protein stabilization,1.0
14827,283078,GO:0000785,MKX,chromatin,1.0
14828,283078,GO:0000978,MKX,RNA polymerase II cis-regulatory region sequence-specific DNA binding,1.0
14829,283078,GO:0000981,MKX,"DNA-binding transcription factor activity, RNA polymerase II-specific",1.0
14830,283078,GO:0000981,MKX,"DNA-binding transcription factor activity, RNA polymerase II-specific",1.0
14831,283078,GO:0005634,MKX,nucleus,1.0
14832,283078,GO:0006357,MKX,regulation of transcription by RNA polymerase II,1.0
14833,283078,GO:0007517,MKX,muscle organ development,1.0
14834,283078,GO:0007517,MKX,muscle organ development,1.0
14835,283078,GO:0048468,MKX,cell development,1.0
14976,112939,GO:0000122,NACC1,negative regulation of transcription by RNA polymerase II,1.0
14977,112939,GO:0000785,NACC1,chromatin,1.0
14978,112939,GO:0000978,NACC1,RNA polymerase II cis-regulatory region sequence-specific DNA binding,1.0
14979,112939,GO:0000978,NACC1,RNA polymerase II cis-regulatory region sequence-specific DNA binding,1.0
14980,112939,GO:0000981,NACC1,"DNA-binding transcription factor activity, RNA polymerase II-specific",1.0
14981,112939,GO:0001227,NACC1,"DNA-binding transcription repressor activity, RNA polymerase II-specific",1.0
14982,112939,GO:0005515,NACC1,protein binding,1.0
14983,112939,GO:0005634,NACC1,nucleus,1.0
14984,112939,GO:0005654,NACC1,nucleoplasm,1.0
14985,112939,GO:0005737,NACC1,cytoplasm,1.0
14986,112939,GO:0006357,NACC1,regulation of transcription by RNA polymerase II,1.0
14987,112939,GO:0008284,NACC1,positive regulation of cell population proliferation,1.0
14988,112939,GO:0030054,NACC1,cell junction,1.0
14989,112939,GO:0042826,NACC1,histone deacetylase binding,1.0
14990,112939,GO:0043231,NACC1,intracellular membrane-bounded organelle,1.0
14991,112939,GO:0045892,NACC1,"negative regulation of transcription, DNA-templated",1.0
14999,26960,GO:0005634,NBEA,nucleus,1.0
15000,26960,GO:0005802,NBEA,trans-Golgi network,1.0
15001,26960,GO:0005829,NBEA,cytosol,1.0
15002,26960,GO:0005829,NBEA,cytosol,1.0
15003,26960,GO:0005886,NBEA,plasma membrane,1.0
15004,26960,GO:0008104,NBEA,protein localization,1.0
15005,26960,GO:0012505,NBEA,endomembrane system,1.0
15006,26960,GO:0016020,NBEA,membrane,1.0
15007,26960,GO:0019901,NBEA,protein kinase binding,1.0
15008,10787,GO:0000902,NCKAP1,cell morphogenesis,1.0
15009,10787,GO:0001726,NCKAP1,ruffle,1.0
15010,10787,GO:0005515,NCKAP1,protein binding,1.0
15011,10787,GO:0005829,NCKAP1,cytosol,1.0
15012,10787,GO:0005925,NCKAP1,focal adhesion,1.0
15013,10787,GO:0006915,NCKAP1,apoptotic process,1.0
15014,10787,GO:0007417,NCKAP1,central nervous system development,1.0
15015,10787,GO:0010592,NCKAP1,positive regulation of lamellipodium assembly,1.0
15016,10787,GO:0010592,NCKAP1,positive regulation of lamellipodium assembly,1.0
15017,10787,GO:0016021,NCKAP1,integral component of membrane,1.0
15018,10787,GO:0016032,NCKAP1,viral process,1.0
15019,10787,GO:0016477,NCKAP1,cell migration,1.0
15020,10787,GO:0016601,NCKAP1,Rac protein signal transduction,1.0
15021,10787,GO:0030027,NCKAP1,lamellipodium,1.0
15022,10787,GO:0030031,NCKAP1,cell projection assembly,1.0
15023,10787,GO:0030838,NCKAP1,positive regulation of actin filament polymerization,1.0
15024,10787,GO:0030866,NCKAP1,cortical actin cytoskeleton organization,1.0
15025,10787,GO:0031209,NCKAP1,SCAR complex,1.0
15026,10787,GO:0031209,NCKAP1,SCAR complex,1.0
15027,10787,GO:0031258,NCKAP1,lamellipodium membrane,1.0
15028,10787,GO:0031267,NCKAP1,small GTPase binding,1.0
15029,10787,GO:0031267,NCKAP1,small GTPase binding,1.0
15030,10787,GO:0031941,NCKAP1,filamentous actin,1.0
15031,10787,GO:0038096,NCKAP1,Fc-gamma receptor signaling pathway involved in phagocytosis,1.0
15032,10787,GO:0048010,NCKAP1,vascular endothelial growth factor receptor signaling pathway,1.0
15033,10787,GO:0048812,NCKAP1,neuron projection morphogenesis,1.0
15034,10787,GO:0070062,NCKAP1,extracellular exosome,1.0
15035,10787,GO:2000601,NCKAP1,positive regulation of Arp2/3 complex-mediated actin nucleation,1.0
15103,4763,GO:0000165,NF1,MAPK cascade,1.0
15104,4763,GO:0000165,NF1,MAPK cascade,1.0
15105,4763,GO:0001649,NF1,osteoblast differentiation,1.0
15106,4763,GO:0001656,NF1,metanephros development,1.0
15107,4763,GO:0001666,NF1,response to hypoxia,1.0
15108,4763,GO:0001889,NF1,liver development,1.0
15109,4763,GO:0001937,NF1,negative regulation of endothelial cell proliferation,1.0
15110,4763,GO:0001938,NF1,positive regulation of endothelial cell proliferation,1.0
15111,4763,GO:0001952,NF1,regulation of cell-matrix adhesion,1.0
15112,4763,GO:0001953,NF1,negative regulation of cell-matrix adhesion,1.0
15113,4763,GO:0005096,NF1,GTPase activator activity,1.0
15114,4763,GO:0005515,NF1,protein binding,1.0
15115,4763,GO:0005634,NF1,nucleus,1.0
15116,4763,GO:0005730,NF1,nucleolus,1.0
15117,4763,GO:0005737,NF1,cytoplasm,1.0
15118,4763,GO:0005829,NF1,cytosol,1.0
15119,4763,GO:0006469,NF1,negative regulation of protein kinase activity,1.0
15120,4763,GO:0007154,NF1,cell communication,1.0
15121,4763,GO:0007265,NF1,Ras protein signal transduction,1.0
15122,4763,GO:0007406,NF1,negative regulation of neuroblast proliferation,1.0
15123,4763,GO:0007420,NF1,brain development,1.0
15124,4763,GO:0007422,NF1,peripheral nervous system development,1.0
15125,4763,GO:0007507,NF1,heart development,1.0
15126,4763,GO:0007519,NF1,skeletal muscle tissue development,1.0
15127,4763,GO:0008429,NF1,phosphatidylethanolamine binding,1.0
15128,4763,GO:0008542,NF1,visual learning,1.0
15129,4763,GO:0008625,NF1,extrinsic apoptotic signaling pathway via death domain receptors,1.0
15130,4763,GO:0010468,NF1,regulation of gene expression,1.0
15131,4763,GO:0014044,NF1,Schwann cell development,1.0
15132,4763,GO:0014065,NF1,phosphatidylinositol 3-kinase signaling,1.0
15133,4763,GO:0016020,NF1,membrane,1.0
15134,4763,GO:0016525,NF1,negative regulation of angiogenesis,1.0
15135,4763,GO:0021510,NF1,spinal cord development,1.0
15136,4763,GO:0021764,NF1,amygdala development,1.0
15137,4763,GO:0021897,NF1,forebrain astrocyte development,1.0
15138,4763,GO:0021915,NF1,neural tube development,1.0
15139,4763,GO:0021987,NF1,cerebral cortex development,1.0
15140,4763,GO:0022011,NF1,myelination in peripheral nervous system,1.0
15141,4763,GO:0030036,NF1,actin cytoskeleton organization,1.0
15142,4763,GO:0030198,NF1,extracellular matrix organization,1.0
15143,4763,GO:0030199,NF1,collagen fibril organization,1.0
15144,4763,GO:0030325,NF1,adrenal gland development,1.0
15145,4763,GO:0030336,NF1,negative regulation of cell migration,1.0
15146,4763,GO:0030424,NF1,axon,1.0
15147,4763,GO:0030425,NF1,dendrite,1.0
15148,4763,GO:0031210,NF1,phosphatidylcholine binding,1.0
15149,4763,GO:0032228,NF1,"regulation of synaptic transmission, GABAergic",1.0
15150,4763,GO:0034605,NF1,cellular response to heat,1.0
15151,4763,GO:0035021,NF1,negative regulation of Rac protein signal transduction,1.0
15152,4763,GO:0042060,NF1,wound healing,1.0
15153,4763,GO:0042308,NF1,negative regulation of protein import into nucleus,1.0
15154,4763,GO:0043065,NF1,positive regulation of apoptotic process,1.0
15155,4763,GO:0043087,NF1,regulation of GTPase activity,1.0
15156,4763,GO:0043407,NF1,negative regulation of MAP kinase activity,1.0
15157,4763,GO:0043409,NF1,negative regulation of MAPK cascade,1.0
15158,4763,GO:0043409,NF1,negative regulation of MAPK cascade,1.0
15159,4763,GO:0043473,NF1,pigmentation,1.0
15160,4763,GO:0043525,NF1,positive regulation of neuron apoptotic process,1.0
15161,4763,GO:0043535,NF1,regulation of blood vessel endothelial cell migration,1.0
15162,4763,GO:0043547,NF1,positive regulation of GTPase activity,1.0
15163,4763,GO:0043547,NF1,positive regulation of GTPase activity,1.0
15164,4763,GO:0043547,NF1,positive regulation of GTPase activity,1.0
15165,4763,GO:0045124,NF1,regulation of bone resorption,1.0
15166,4763,GO:0045671,NF1,negative regulation of osteoclast differentiation,1.0
15167,4763,GO:0045685,NF1,regulation of glial cell differentiation,1.0
15168,4763,GO:0045762,NF1,positive regulation of adenylate cyclase activity,1.0
15169,4763,GO:0045765,NF1,regulation of angiogenesis,1.0
15170,4763,GO:0046929,NF1,negative regulation of neurotransmitter secretion,1.0
15171,4763,GO:0048147,NF1,negative regulation of fibroblast proliferation,1.0
15172,4763,GO:0048169,NF1,regulation of long-term neuronal synaptic plasticity,1.0
15173,4763,GO:0048485,NF1,sympathetic nervous system development,1.0
15174,4763,GO:0048593,NF1,camera-type eye morphogenesis,1.0
15175,4763,GO:0048712,NF1,negative regulation of astrocyte differentiation,1.0
15176,4763,GO:0048715,NF1,negative regulation of oligodendrocyte differentiation,1.0
15177,4763,GO:0048745,NF1,smooth muscle tissue development,1.0
15178,4763,GO:0048820,NF1,hair follicle maturation,1.0
15179,4763,GO:0048844,NF1,artery morphogenesis,1.0
15180,4763,GO:0048853,NF1,forebrain morphogenesis,1.0
15181,4763,GO:0050890,NF1,cognition,1.0
15182,4763,GO:0061534,NF1,"gamma-aminobutyric acid secretion, neurotransmission",1.0
15183,4763,GO:0061535,NF1,"glutamate secretion, neurotransmission",1.0
15184,4763,GO:0098597,NF1,observational learning,1.0
15185,4763,GO:0098793,NF1,presynapse,1.0
15186,4763,GO:1900271,NF1,regulation of long-term synaptic potentiation,1.0
15187,4763,GO:2001241,NF1,positive regulation of extrinsic apoptotic signaling pathway in absence of ligand,1.0
15295,25836,GO:0000122,NIPBL,negative regulation of transcription by RNA polymerase II,1.0
15296,25836,GO:0000785,NIPBL,chromatin,1.0
15297,25836,GO:0001656,NIPBL,metanephros development,1.0
15298,25836,GO:0003007,NIPBL,heart morphogenesis,1.0
15299,25836,GO:0003007,NIPBL,heart morphogenesis,1.0
15300,25836,GO:0003151,NIPBL,outflow tract morphogenesis,1.0
15301,25836,GO:0003682,NIPBL,chromatin binding,1.0
15302,25836,GO:0005515,NIPBL,protein binding,1.0
15303,25836,GO:0005634,NIPBL,nucleus,1.0
15304,25836,GO:0005654,NIPBL,nucleoplasm,1.0
15305,25836,GO:0005654,NIPBL,nucleoplasm,1.0
15306,25836,GO:0005829,NIPBL,cytosol,1.0
15307,25836,GO:0006974,NIPBL,cellular response to DNA damage stimulus,1.0
15308,25836,GO:0007064,NIPBL,mitotic sister chromatid cohesion,1.0
15309,25836,GO:0007076,NIPBL,mitotic chromosome condensation,1.0
15310,25836,GO:0007420,NIPBL,brain development,1.0
15311,25836,GO:0007420,NIPBL,brain development,1.0
15312,25836,GO:0007605,NIPBL,sensory perception of sound,1.0
15313,25836,GO:0008022,NIPBL,protein C-terminus binding,1.0
15314,25836,GO:0019827,NIPBL,stem cell population maintenance,1.0
15315,25836,GO:0031065,NIPBL,positive regulation of histone deacetylation,1.0
15316,25836,GO:0032039,NIPBL,integrator complex,1.0
15317,25836,GO:0032116,NIPBL,SMC loading complex,1.0
15318,25836,GO:0034087,NIPBL,establishment of mitotic sister chromatid cohesion,1.0
15319,25836,GO:0034088,NIPBL,maintenance of mitotic sister chromatid cohesion,1.0
15320,25836,GO:0034613,NIPBL,cellular protein localization,1.0
15321,25836,GO:0035115,NIPBL,embryonic forelimb morphogenesis,1.0
15322,25836,GO:0035136,NIPBL,forelimb morphogenesis,1.0
15323,25836,GO:0035261,NIPBL,external genitalia morphogenesis,1.0
15324,25836,GO:0036033,NIPBL,mediator complex binding,1.0
15325,25836,GO:0040018,NIPBL,positive regulation of multicellular organism growth,1.0
15326,25836,GO:0042471,NIPBL,ear morphogenesis,1.0
15327,25836,GO:0042634,NIPBL,regulation of hair cycle,1.0
15328,25836,GO:0042826,NIPBL,histone deacetylase binding,1.0
15329,25836,GO:0043231,NIPBL,intracellular membrane-bounded organelle,1.0
15330,25836,GO:0045444,NIPBL,fat cell differentiation,1.0
15331,25836,GO:0045778,NIPBL,positive regulation of ossification,1.0
15332,25836,GO:0045892,NIPBL,"negative regulation of transcription, DNA-templated",1.0
15333,25836,GO:0045995,NIPBL,regulation of embryonic development,1.0
15334,25836,GO:0047485,NIPBL,protein N-terminus binding,1.0
15335,25836,GO:0048557,NIPBL,embryonic digestive tract morphogenesis,1.0
15336,25836,GO:0048565,NIPBL,digestive tract development,1.0
15337,25836,GO:0048589,NIPBL,developmental growth,1.0
15338,25836,GO:0048592,NIPBL,eye morphogenesis,1.0
15339,25836,GO:0048638,NIPBL,regulation of developmental growth,1.0
15340,25836,GO:0048703,NIPBL,embryonic viscerocranium morphogenesis,1.0
15341,25836,GO:0050890,NIPBL,cognition,1.0
15342,25836,GO:0060325,NIPBL,face morphogenesis,1.0
15343,25836,GO:0061010,NIPBL,gall bladder development,1.0
15344,25836,GO:0061038,NIPBL,uterus morphogenesis,1.0
15345,25836,GO:0070062,NIPBL,extracellular exosome,1.0
15346,25836,GO:0070087,NIPBL,chromo shadow domain binding,1.0
15347,25836,GO:0070550,NIPBL,rDNA condensation,1.0
15348,25836,GO:0071169,NIPBL,establishment of protein localization to chromatin,1.0
15349,25836,GO:0071481,NIPBL,cellular response to X-ray,1.0
15350,25836,GO:0071733,NIPBL,transcriptional activation by promoter-enhancer looping,1.0
15351,25836,GO:0071921,NIPBL,cohesin loading,1.0
15352,25836,GO:0090694,NIPBL,Scc2-Scc4 cohesin loading complex,1.0
15353,25836,GO:0090694,NIPBL,Scc2-Scc4 cohesin loading complex,1.0
15354,25836,GO:1905406,NIPBL,positive regulation of mitotic cohesin loading,1.0
15355,25836,GO:1990414,NIPBL,replication-born double-strand break repair via sister chromatid exchange,1.0
15356,25836,GO:1990841,NIPBL,promoter-specific chromatin binding,1.0
15357,25836,GO:2001224,NIPBL,positive regulation of neuron migration,1.0
15467,57555,GO:0002087,NLGN2,regulation of respiratory gaseous exchange by nervous system process,1.0
15468,57555,GO:0005886,NLGN2,plasma membrane,1.0
15469,57555,GO:0005887,NLGN2,integral component of plasma membrane,1.0
15470,57555,GO:0007158,NLGN2,neuron cell-cell adhesion,1.0
15471,57555,GO:0007158,NLGN2,neuron cell-cell adhesion,1.0
15472,57555,GO:0007268,NLGN2,chemical synaptic transmission,1.0
15473,57555,GO:0007416,NLGN2,synapse assembly,1.0
15474,57555,GO:0007416,NLGN2,synapse assembly,1.0
15475,57555,GO:0009986,NLGN2,cell surface,1.0
15476,57555,GO:0009986,NLGN2,cell surface,1.0
15477,57555,GO:0016020,NLGN2,membrane,1.0
15478,57555,GO:0019233,NLGN2,sensory perception of pain,1.0
15479,57555,GO:0032024,NLGN2,positive regulation of insulin secretion,1.0
15480,57555,GO:0032230,NLGN2,"positive regulation of synaptic transmission, GABAergic",1.0
15481,57555,GO:0035418,NLGN2,protein localization to synapse,1.0
15482,57555,GO:0035641,NLGN2,locomotory exploration behavior,1.0
15483,57555,GO:0038023,NLGN2,signaling receptor activity,1.0
15484,57555,GO:0042043,NLGN2,neurexin family protein binding,1.0
15485,57555,GO:0042043,NLGN2,neurexin family protein binding,1.0
15486,57555,GO:0042043,NLGN2,neurexin family protein binding,1.0
15487,57555,GO:0042734,NLGN2,presynaptic membrane,1.0
15488,57555,GO:0042802,NLGN2,identical protein binding,1.0
15489,57555,GO:0042995,NLGN2,cell projection,1.0
15490,57555,GO:0045202,NLGN2,synapse,1.0
15491,57555,GO:0045202,NLGN2,synapse,1.0
15492,57555,GO:0045211,NLGN2,postsynaptic membrane,1.0
15493,57555,GO:0045217,NLGN2,cell-cell junction maintenance,1.0
15494,57555,GO:0048488,NLGN2,synaptic vesicle endocytosis,1.0
15495,57555,GO:0050804,NLGN2,modulation of chemical synaptic transmission,1.0
15496,57555,GO:0050804,NLGN2,modulation of chemical synaptic transmission,1.0
15497,57555,GO:0050808,NLGN2,synapse organization,1.0
15498,57555,GO:0050839,NLGN2,cell adhesion molecule binding,1.0
15499,57555,GO:0050885,NLGN2,neuromuscular process controlling balance,1.0
15500,57555,GO:0051965,NLGN2,positive regulation of synapse assembly,1.0
15501,57555,GO:0051968,NLGN2,"positive regulation of synaptic transmission, glutamatergic",1.0
15502,57555,GO:0060077,NLGN2,inhibitory synapse,1.0
15503,57555,GO:0072553,NLGN2,terminal button organization,1.0
15504,57555,GO:0089717,NLGN2,spanning component of membrane,1.0
15505,57555,GO:0097104,NLGN2,postsynaptic membrane assembly,1.0
15506,57555,GO:0097104,NLGN2,postsynaptic membrane assembly,1.0
15507,57555,GO:0097105,NLGN2,presynaptic membrane assembly,1.0
15508,57555,GO:0097105,NLGN2,presynaptic membrane assembly,1.0
15509,57555,GO:0097116,NLGN2,gephyrin clustering involved in postsynaptic density assembly,1.0
15510,57555,GO:0097119,NLGN2,postsynaptic density protein 95 clustering,1.0
15511,57555,GO:0097151,NLGN2,positive regulation of inhibitory postsynaptic potential,1.0
15512,57555,GO:0098609,NLGN2,cell-cell adhesion,1.0
15513,57555,GO:0098690,NLGN2,glycinergic synapse,1.0
15514,57555,GO:0098691,NLGN2,dopaminergic synapse,1.0
15515,57555,GO:0098983,NLGN2,"symmetric, GABA-ergic, inhibitory synapse",1.0
15516,57555,GO:0099054,NLGN2,presynapse assembly,1.0
15517,57555,GO:0099055,NLGN2,integral component of postsynaptic membrane,1.0
15518,57555,GO:0099060,NLGN2,integral component of postsynaptic specialization membrane,1.0
15519,57555,GO:1902474,NLGN2,positive regulation of protein localization to synapse,1.0
15520,57555,GO:1904862,NLGN2,inhibitory synapse assembly,1.0
15521,57555,GO:2000311,NLGN2,regulation of AMPA receptor activity,1.0
15522,57555,GO:2000463,NLGN2,positive regulation of excitatory postsynaptic potential,1.0
15523,57555,GO:2000809,NLGN2,positive regulation of synaptic vesicle clustering,1.0
15524,54413,GO:0002087,NLGN3,regulation of respiratory gaseous exchange by nervous system process,1.0
15525,54413,GO:0005515,NLGN3,protein binding,1.0
15526,54413,GO:0005886,NLGN3,plasma membrane,1.0
15527,54413,GO:0005887,NLGN3,integral component of plasma membrane,1.0
15528,54413,GO:0006898,NLGN3,receptor-mediated endocytosis,1.0
15529,54413,GO:0007158,NLGN3,neuron cell-cell adhesion,1.0
15530,54413,GO:0007158,NLGN3,neuron cell-cell adhesion,1.0
15531,54413,GO:0007268,NLGN3,chemical synaptic transmission,1.0
15532,54413,GO:0007416,NLGN3,synapse assembly,1.0
15533,54413,GO:0007612,NLGN3,learning,1.0
15534,54413,GO:0008542,NLGN3,visual learning,1.0
15535,54413,GO:0009986,NLGN3,cell surface,1.0
15536,54413,GO:0009986,NLGN3,cell surface,1.0
15537,54413,GO:0030139,NLGN3,endocytic vesicle,1.0
15538,54413,GO:0030534,NLGN3,adult behavior,1.0
15539,54413,GO:0035176,NLGN3,social behavior,1.0
15540,54413,GO:0038023,NLGN3,signaling receptor activity,1.0
15541,54413,GO:0038023,NLGN3,signaling receptor activity,1.0
15542,54413,GO:0042043,NLGN3,neurexin family protein binding,1.0
15543,54413,GO:0042043,NLGN3,neurexin family protein binding,1.0
15544,54413,GO:0045202,NLGN3,synapse,1.0
15545,54413,GO:0045202,NLGN3,synapse,1.0
15546,54413,GO:0048488,NLGN3,synaptic vesicle endocytosis,1.0
15547,54413,GO:0048675,NLGN3,axon extension,1.0
15548,54413,GO:0048709,NLGN3,oligodendrocyte differentiation,1.0
15549,54413,GO:0050804,NLGN3,modulation of chemical synaptic transmission,1.0
15550,54413,GO:0050804,NLGN3,modulation of chemical synaptic transmission,1.0
15551,54413,GO:0050808,NLGN3,synapse organization,1.0
15552,54413,GO:0050839,NLGN3,cell adhesion molecule binding,1.0
15553,54413,GO:0051965,NLGN3,positive regulation of synapse assembly,1.0
15554,54413,GO:0051968,NLGN3,"positive regulation of synaptic transmission, glutamatergic",1.0
15555,54413,GO:0060024,NLGN3,rhythmic synaptic transmission,1.0
15556,54413,GO:0060076,NLGN3,excitatory synapse,1.0
15557,54413,GO:0060079,NLGN3,excitatory postsynaptic potential,1.0
15558,54413,GO:0060080,NLGN3,inhibitory postsynaptic potential,1.0
15559,54413,GO:0060291,NLGN3,long-term synaptic potentiation,1.0
15560,54413,GO:0061002,NLGN3,negative regulation of dendritic spine morphogenesis,1.0
15561,54413,GO:0071625,NLGN3,vocalization behavior,1.0
15562,54413,GO:0089717,NLGN3,spanning component of membrane,1.0
15563,54413,GO:0090394,NLGN3,negative regulation of excitatory postsynaptic potential,1.0
15564,54413,GO:0097104,NLGN3,postsynaptic membrane assembly,1.0
15565,54413,GO:0097104,NLGN3,postsynaptic membrane assembly,1.0
15566,54413,GO:0097105,NLGN3,presynaptic membrane assembly,1.0
15567,54413,GO:0097105,NLGN3,presynaptic membrane assembly,1.0
15568,54413,GO:0097110,NLGN3,scaffold protein binding,1.0
15569,54413,GO:0098793,NLGN3,presynapse,1.0
15570,54413,GO:0098983,NLGN3,"symmetric, GABA-ergic, inhibitory synapse",1.0
15571,54413,GO:0098985,NLGN3,"asymmetric, glutamatergic, excitatory synapse",1.0
15572,54413,GO:0099054,NLGN3,presynapse assembly,1.0
15573,54413,GO:0099055,NLGN3,integral component of postsynaptic membrane,1.0
15574,54413,GO:1900271,NLGN3,regulation of long-term synaptic potentiation,1.0
15575,54413,GO:2000310,NLGN3,regulation of NMDA receptor activity,1.0
15576,54413,GO:2000331,NLGN3,regulation of terminal button organization,1.0
15577,54413,GO:2000463,NLGN3,positive regulation of excitatory postsynaptic potential,1.0
15578,54413,GO:2000809,NLGN3,positive regulation of synaptic vesicle clustering,1.0
15579,54413,GO:2000969,NLGN3,positive regulation of AMPA receptor activity,1.0
15741,4306,GO:0000785,NR3C2,chromatin,1.0
15742,4306,GO:0000785,NR3C2,chromatin,1.0
15743,4306,GO:0000978,NR3C2,RNA polymerase II cis-regulatory region sequence-specific DNA binding,1.0
15744,4306,GO:0000981,NR3C2,"DNA-binding transcription factor activity, RNA polymerase II-specific",1.0
15745,4306,GO:0003700,NR3C2,DNA-binding transcription factor activity,1.0
15746,4306,GO:0003707,NR3C2,steroid hormone receptor activity,1.0
15747,4306,GO:0004879,NR3C2,nuclear receptor activity,1.0
15748,4306,GO:0005496,NR3C2,steroid binding,1.0
15749,4306,GO:0005515,NR3C2,protein binding,1.0
15750,4306,GO:0005654,NR3C2,nucleoplasm,1.0
15751,4306,GO:0005654,NR3C2,nucleoplasm,1.0
15752,4306,GO:0005789,NR3C2,endoplasmic reticulum membrane,1.0
15753,4306,GO:0005829,NR3C2,cytosol,1.0
15754,4306,GO:0006357,NR3C2,regulation of transcription by RNA polymerase II,1.0
15755,4306,GO:0006367,NR3C2,transcription initiation from RNA polymerase II promoter,1.0
15756,4306,GO:0007165,NR3C2,signal transduction,1.0
15757,4306,GO:0008270,NR3C2,zinc ion binding,1.0
15758,4306,GO:0030518,NR3C2,intracellular steroid hormone receptor signaling pathway,1.0
15759,4306,GO:0043235,NR3C2,receptor complex,1.0
15760,4306,GO:1901224,NR3C2,positive regulation of NIK/NF-kappaB signaling,1.0
15761,4306,GO:1990837,NR3C2,sequence-specific double-stranded DNA binding,1.0
15762,4929,GO:0000122,NR4A2,negative regulation of transcription by RNA polymerase II,1.0
15763,4929,GO:0000122,NR4A2,negative regulation of transcription by RNA polymerase II,1.0
15764,4929,GO:0000785,NR4A2,chromatin,1.0
15765,4929,GO:0000978,NR4A2,RNA polymerase II cis-regulatory region sequence-specific DNA binding,1.0
15766,4929,GO:0000981,NR4A2,"DNA-binding transcription factor activity, RNA polymerase II-specific",1.0
15767,4929,GO:0000981,NR4A2,"DNA-binding transcription factor activity, RNA polymerase II-specific",1.0
15768,4929,GO:0001228,NR4A2,"DNA-binding transcription activator activity, RNA polymerase II-specific",1.0
15769,4929,GO:0001666,NR4A2,response to hypoxia,1.0
15770,4929,GO:0001764,NR4A2,neuron migration,1.0
15771,4929,GO:0001975,NR4A2,response to amphetamine,1.0
15772,4929,GO:0003677,NR4A2,DNA binding,1.0
15773,4929,GO:0004879,NR4A2,nuclear receptor activity,1.0
15774,4929,GO:0005515,NR4A2,protein binding,1.0
15775,4929,GO:0005634,NR4A2,nucleus,1.0
15776,4929,GO:0005634,NR4A2,nucleus,1.0
15777,4929,GO:0005634,NR4A2,nucleus,1.0
15778,4929,GO:0005654,NR4A2,nucleoplasm,1.0
15779,4929,GO:0005667,NR4A2,transcription regulator complex,1.0
15780,4929,GO:0005737,NR4A2,cytoplasm,1.0
15781,4929,GO:0006351,NR4A2,"transcription, DNA-templated",1.0
15782,4929,GO:0006357,NR4A2,regulation of transcription by RNA polymerase II,1.0
15783,4929,GO:0006367,NR4A2,transcription initiation from RNA polymerase II promoter,1.0
15784,4929,GO:0007165,NR4A2,signal transduction,1.0
15785,4929,GO:0008013,NR4A2,beta-catenin binding,1.0
15786,4929,GO:0008270,NR4A2,zinc ion binding,1.0
15787,4929,GO:0008344,NR4A2,adult locomotory behavior,1.0
15788,4929,GO:0009791,NR4A2,post-embryonic development,1.0
15789,4929,GO:0016607,NR4A2,nuclear speck,1.0
15790,4929,GO:0021952,NR4A2,central nervous system projection neuron axonogenesis,1.0
15791,4929,GO:0021953,NR4A2,central nervous system neuron differentiation,1.0
15792,4929,GO:0021986,NR4A2,habenula development,1.0
15793,4929,GO:0030522,NR4A2,intracellular receptor signaling pathway,1.0
15794,4929,GO:0031668,NR4A2,cellular response to extracellular stimulus,1.0
15795,4929,GO:0032991,NR4A2,protein-containing complex,1.0
15796,4929,GO:0034599,NR4A2,cellular response to oxidative stress,1.0
15797,4929,GO:0035259,NR4A2,glucocorticoid receptor binding,1.0
15798,4929,GO:0042053,NR4A2,regulation of dopamine metabolic process,1.0
15799,4929,GO:0042416,NR4A2,dopamine biosynthetic process,1.0
15800,4929,GO:0042551,NR4A2,neuron maturation,1.0
15801,4929,GO:0043085,NR4A2,positive regulation of catalytic activity,1.0
15802,4929,GO:0043524,NR4A2,negative regulation of neuron apoptotic process,1.0
15803,4929,GO:0043576,NR4A2,regulation of respiratory gaseous exchange,1.0
15804,4929,GO:0045444,NR4A2,fat cell differentiation,1.0
15805,4929,GO:0045944,NR4A2,positive regulation of transcription by RNA polymerase II,1.0
15806,4929,GO:0045944,NR4A2,positive regulation of transcription by RNA polymerase II,1.0
15807,4929,GO:0046965,NR4A2,retinoid X receptor binding,1.0
15808,4929,GO:0046982,NR4A2,protein heterodimerization activity,1.0
15809,4929,GO:0051866,NR4A2,general adaptation syndrome,1.0
15810,4929,GO:0060070,NR4A2,canonical Wnt signaling pathway,1.0
15811,4929,GO:0071376,NR4A2,cellular response to corticotropin-releasing hormone stimulus,1.0
15812,4929,GO:0071376,NR4A2,cellular response to corticotropin-releasing hormone stimulus,1.0
15813,4929,GO:0071542,NR4A2,dopaminergic neuron differentiation,1.0
15814,4929,GO:0071542,NR4A2,dopaminergic neuron differentiation,1.0
15815,4929,GO:1904948,NR4A2,midbrain dopaminergic neuron differentiation,1.0
15816,4929,GO:1990837,NR4A2,sequence-specific double-stranded DNA binding,1.0
15817,4929,GO:2001234,NR4A2,negative regulation of apoptotic signaling pathway,1.0
15884,9378,GO:0005246,NRXN1,calcium channel regulator activity,1.0
15885,9378,GO:0005509,NRXN1,calcium ion binding,1.0
15886,9378,GO:0005515,NRXN1,protein binding,1.0
15887,9378,GO:0005730,NRXN1,nucleolus,1.0
15888,9378,GO:0005783,NRXN1,endoplasmic reticulum,1.0
15889,9378,GO:0005886,NRXN1,plasma membrane,1.0
15890,9378,GO:0005886,NRXN1,plasma membrane,1.0
15891,9378,GO:0005886,NRXN1,plasma membrane,1.0
15892,9378,GO:0005886,NRXN1,plasma membrane,1.0
15893,9378,GO:0005887,NRXN1,integral component of plasma membrane,1.0
15894,9378,GO:0007158,NRXN1,neuron cell-cell adhesion,1.0
15895,9378,GO:0007268,NRXN1,chemical synaptic transmission,1.0
15896,9378,GO:0007269,NRXN1,neurotransmitter secretion,1.0
15897,9378,GO:0007411,NRXN1,axon guidance,1.0
15898,9378,GO:0007416,NRXN1,synapse assembly,1.0
15899,9378,GO:0007612,NRXN1,learning,1.0
15900,9378,GO:0009986,NRXN1,cell surface,1.0
15901,9378,GO:0030534,NRXN1,adult behavior,1.0
15902,9378,GO:0031965,NRXN1,nuclear membrane,1.0
15903,9378,GO:0031982,NRXN1,vesicle,1.0
15904,9378,GO:0032991,NRXN1,protein-containing complex,1.0
15905,9378,GO:0033130,NRXN1,acetylcholine receptor binding,1.0
15906,9378,GO:0035176,NRXN1,social behavior,1.0
15907,9378,GO:0038023,NRXN1,signaling receptor activity,1.0
15908,9378,GO:0042297,NRXN1,vocal learning,1.0
15909,9378,GO:0042734,NRXN1,presynaptic membrane,1.0
15910,9378,GO:0042995,NRXN1,cell projection,1.0
15911,9378,GO:0043025,NRXN1,neuronal cell body,1.0
15912,9378,GO:0050839,NRXN1,cell adhesion molecule binding,1.0
15913,9378,GO:0050885,NRXN1,neuromuscular process controlling balance,1.0
15914,9378,GO:0050885,NRXN1,neuromuscular process controlling balance,1.0
15915,9378,GO:0051965,NRXN1,positive regulation of synapse assembly,1.0
15916,9378,GO:0051968,NRXN1,"positive regulation of synaptic transmission, glutamatergic",1.0
15917,9378,GO:0060134,NRXN1,prepulse inhibition,1.0
15918,9378,GO:0071625,NRXN1,vocalization behavior,1.0
15919,9378,GO:0090129,NRXN1,positive regulation of synapse maturation,1.0
15920,9378,GO:0097104,NRXN1,postsynaptic membrane assembly,1.0
15921,9378,GO:0097109,NRXN1,neuroligin family protein binding,1.0
15922,9378,GO:0097116,NRXN1,gephyrin clustering involved in postsynaptic density assembly,1.0
15923,9378,GO:0097118,NRXN1,neuroligin clustering involved in postsynaptic membrane assembly,1.0
15924,9378,GO:0097119,NRXN1,postsynaptic density protein 95 clustering,1.0
15925,9378,GO:0098978,NRXN1,glutamatergic synapse,1.0
15926,9378,GO:0099059,NRXN1,integral component of presynaptic active zone membrane,1.0
15927,9378,GO:0099151,NRXN1,regulation of postsynaptic density assembly,1.0
15928,9378,GO:0099560,NRXN1,synaptic membrane adhesion,1.0
15929,9378,GO:1905606,NRXN1,regulation of presynapse assembly,1.0
15930,9378,GO:2000463,NRXN1,positive regulation of excitatory postsynaptic potential,1.0
15931,9378,GO:2000821,NRXN1,regulation of grooming behavior,1.0
15946,8648,GO:0000435,NCOA1,positive regulation of transcription from RNA polymerase II promoter by galactose,1.0
15947,8648,GO:0000785,NCOA1,chromatin,1.0
15948,8648,GO:0000785,NCOA1,chromatin,1.0
15949,8648,GO:0000977,NCOA1,RNA polymerase II transcription regulatory region sequence-specific DNA binding,1.0
15950,8648,GO:0002155,NCOA1,regulation of thyroid hormone mediated signaling pathway,1.0
15951,8648,GO:0003682,NCOA1,chromatin binding,1.0
15952,8648,GO:0003713,NCOA1,transcription coactivator activity,1.0
15953,8648,GO:0003713,NCOA1,transcription coactivator activity,1.0
15954,8648,GO:0004402,NCOA1,histone acetyltransferase activity,1.0
15955,8648,GO:0005515,NCOA1,protein binding,1.0
15956,8648,GO:0005634,NCOA1,nucleus,1.0
15957,8648,GO:0005654,NCOA1,nucleoplasm,1.0
15958,8648,GO:0005654,NCOA1,nucleoplasm,1.0
15959,8648,GO:0005829,NCOA1,cytosol,1.0
15960,8648,GO:0005886,NCOA1,plasma membrane,1.0
15961,8648,GO:0007595,NCOA1,lactation,1.0
15962,8648,GO:0008584,NCOA1,male gonad development,1.0
15963,8648,GO:0015721,NCOA1,bile acid and bile salt transport,1.0
15964,8648,GO:0016922,NCOA1,nuclear receptor binding,1.0
15965,8648,GO:0016922,NCOA1,nuclear receptor binding,1.0
15966,8648,GO:0017162,NCOA1,aryl hydrocarbon receptor binding,1.0
15967,8648,GO:0019216,NCOA1,regulation of lipid metabolic process,1.0
15968,8648,GO:0019899,NCOA1,enzyme binding,1.0
15969,8648,GO:0021549,NCOA1,cerebellum development,1.0
15970,8648,GO:0021766,NCOA1,hippocampus development,1.0
15971,8648,GO:0021854,NCOA1,hypothalamus development,1.0
15972,8648,GO:0021987,NCOA1,cerebral cortex development,1.0
15973,8648,GO:0030331,NCOA1,estrogen receptor binding,1.0
15974,8648,GO:0030374,NCOA1,nuclear receptor coactivator activity,1.0
15975,8648,GO:0030374,NCOA1,nuclear receptor coactivator activity,1.0
15976,8648,GO:0032355,NCOA1,response to estradiol,1.0
15977,8648,GO:0032526,NCOA1,response to retinoic acid,1.0
15978,8648,GO:0032570,NCOA1,response to progesterone,1.0
15979,8648,GO:0032870,NCOA1,cellular response to hormone stimulus,1.0
15980,8648,GO:0032991,NCOA1,protein-containing complex,1.0
15981,8648,GO:0033142,NCOA1,progesterone receptor binding,1.0
15982,8648,GO:0035257,NCOA1,nuclear hormone receptor binding,1.0
15983,8648,GO:0043005,NCOA1,neuron projection,1.0
15984,8648,GO:0043065,NCOA1,positive regulation of apoptotic process,1.0
15985,8648,GO:0043967,NCOA1,histone H4 acetylation,1.0
15986,8648,GO:0044849,NCOA1,estrous cycle,1.0
15987,8648,GO:0044877,NCOA1,protein-containing complex binding,1.0
15988,8648,GO:0045666,NCOA1,positive regulation of neuron differentiation,1.0
15989,8648,GO:0045893,NCOA1,"positive regulation of transcription, DNA-templated",1.0
15990,8648,GO:0045925,NCOA1,positive regulation of female receptivity,1.0
15991,8648,GO:0045944,NCOA1,positive regulation of transcription by RNA polymerase II,1.0
15992,8648,GO:0045944,NCOA1,positive regulation of transcription by RNA polymerase II,1.0
15993,8648,GO:0045944,NCOA1,positive regulation of transcription by RNA polymerase II,1.0
15994,8648,GO:0046965,NCOA1,retinoid X receptor binding,1.0
15995,8648,GO:0046983,NCOA1,protein dimerization activity,1.0
15996,8648,GO:0047485,NCOA1,protein N-terminus binding,1.0
15997,8648,GO:0060179,NCOA1,male mating behavior,1.0
15998,8648,GO:0060713,NCOA1,labyrinthine layer morphogenesis,1.0
15999,8648,GO:1904017,NCOA1,cellular response to Thyroglobulin triiodothyronine,1.0
16000,8648,GO:2001038,NCOA1,regulation of cellular response to drug,1.0
16059,9379,GO:0004888,NRXN2,transmembrane signaling receptor activity,1.0
16060,9379,GO:0005246,NRXN2,calcium channel regulator activity,1.0
16061,9379,GO:0005886,NRXN2,plasma membrane,1.0
16062,9379,GO:0007158,NRXN2,neuron cell-cell adhesion,1.0
16063,9379,GO:0007165,NRXN2,signal transduction,1.0
16064,9379,GO:0007268,NRXN2,chemical synaptic transmission,1.0
16065,9379,GO:0007269,NRXN2,neurotransmitter secretion,1.0
16066,9379,GO:0007416,NRXN2,synapse assembly,1.0
16067,9379,GO:0016021,NRXN2,integral component of membrane,1.0
16068,9379,GO:0030534,NRXN2,adult behavior,1.0
16069,9379,GO:0035176,NRXN2,social behavior,1.0
16070,9379,GO:0042297,NRXN2,vocal learning,1.0
16071,9379,GO:0046872,NRXN2,metal ion binding,1.0
16072,9379,GO:0050839,NRXN2,cell adhesion molecule binding,1.0
16073,9379,GO:0071625,NRXN2,vocalization behavior,1.0
16074,9379,GO:0097104,NRXN2,postsynaptic membrane assembly,1.0
16075,9379,GO:0097109,NRXN2,neuroligin family protein binding,1.0
16076,9379,GO:0097116,NRXN2,gephyrin clustering involved in postsynaptic density assembly,1.0
16077,9379,GO:0097118,NRXN2,neuroligin clustering involved in postsynaptic membrane assembly,1.0
16078,9379,GO:0097119,NRXN2,postsynaptic density protein 95 clustering,1.0
16079,9379,GO:0098793,NRXN2,presynapse,1.0
16080,9369,GO:0005886,NRXN3,plasma membrane,1.0
16081,9369,GO:0005887,NRXN3,integral component of plasma membrane,1.0
16082,9369,GO:0007158,NRXN3,neuron cell-cell adhesion,1.0
16083,9369,GO:0007411,NRXN3,axon guidance,1.0
16084,9369,GO:0007612,NRXN3,learning,1.0
16085,9369,GO:0030534,NRXN3,adult behavior,1.0
16086,9369,GO:0035176,NRXN3,social behavior,1.0
16087,9369,GO:0038023,NRXN3,signaling receptor activity,1.0
16088,9369,GO:0046872,NRXN3,metal ion binding,1.0
16089,9369,GO:0050839,NRXN3,cell adhesion molecule binding,1.0
16090,9369,GO:0071625,NRXN3,vocalization behavior,1.0
16091,9369,GO:0097109,NRXN3,neuroligin family protein binding,1.0
16092,64324,GO:0000122,NSD1,negative regulation of transcription by RNA polymerase II,1.0
16093,64324,GO:0000414,NSD1,regulation of histone H3-K36 methylation,1.0
16094,64324,GO:0000785,NSD1,chromatin,1.0
16095,64324,GO:0000978,NSD1,RNA polymerase II cis-regulatory region sequence-specific DNA binding,1.0
16096,64324,GO:0003682,NSD1,chromatin binding,1.0
16097,64324,GO:0003712,NSD1,transcription coregulator activity,1.0
16098,64324,GO:0003714,NSD1,transcription corepressor activity,1.0
16099,64324,GO:0005515,NSD1,protein binding,1.0
16100,64324,GO:0005634,NSD1,nucleus,1.0
16101,64324,GO:0005654,NSD1,nucleoplasm,1.0
16102,64324,GO:0006355,NSD1,"regulation of transcription, DNA-templated",1.0
16103,64324,GO:0008270,NSD1,zinc ion binding,1.0
16104,64324,GO:0010452,NSD1,histone H3-K36 methylation,1.0
16105,64324,GO:0016571,NSD1,histone methylation,1.0
16106,64324,GO:0030331,NSD1,estrogen receptor binding,1.0
16107,64324,GO:0033135,NSD1,regulation of peptidyl-serine phosphorylation,1.0
16108,64324,GO:0034770,NSD1,histone H4-K20 methylation,1.0
16109,64324,GO:0042799,NSD1,histone methyltransferase activity (H4-K20 specific),1.0
16110,64324,GO:0042974,NSD1,retinoic acid receptor binding,1.0
16111,64324,GO:0045893,NSD1,"positive regulation of transcription, DNA-templated",1.0
16112,64324,GO:0046965,NSD1,retinoid X receptor binding,1.0
16113,64324,GO:0046966,NSD1,thyroid hormone receptor binding,1.0
16114,64324,GO:0046975,NSD1,histone methyltransferase activity (H3-K36 specific),1.0
16115,64324,GO:0046975,NSD1,histone methyltransferase activity (H3-K36 specific),1.0
16116,64324,GO:0046975,NSD1,histone methyltransferase activity (H3-K36 specific),1.0
16117,64324,GO:0050681,NSD1,androgen receptor binding,1.0
16118,64324,GO:1903025,NSD1,regulation of RNA polymerase II regulatory region sequence-specific DNA binding,1.0
16643,9631,GO:0000972,NUP155,transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery,1.0
16644,9631,GO:0005515,NUP155,protein binding,1.0
16645,9631,GO:0005635,NUP155,nuclear envelope,1.0
16646,9631,GO:0005635,NUP155,nuclear envelope,1.0
16647,9631,GO:0006110,NUP155,regulation of glycolytic process,1.0
16648,9631,GO:0006405,NUP155,RNA export from nucleus,1.0
16649,9631,GO:0006406,NUP155,mRNA export from nucleus,1.0
16650,9631,GO:0006409,NUP155,tRNA export from nucleus,1.0
16651,9631,GO:0006606,NUP155,protein import into nucleus,1.0
16652,9631,GO:0006998,NUP155,nuclear envelope organization,1.0
16653,9631,GO:0016020,NUP155,membrane,1.0
16654,9631,GO:0016032,NUP155,viral process,1.0
16655,9631,GO:0016925,NUP155,protein sumoylation,1.0
16656,9631,GO:0017056,NUP155,structural constituent of nuclear pore,1.0
16657,9631,GO:0019083,NUP155,viral transcription,1.0
16658,9631,GO:0031965,NUP155,nuclear membrane,1.0
16659,9631,GO:0036228,NUP155,protein localization to nuclear inner membrane,1.0
16660,9631,GO:0043657,NUP155,host cell,1.0
16661,9631,GO:0044611,NUP155,nuclear pore inner ring,1.0
16662,9631,GO:0060964,NUP155,regulation of gene silencing by miRNA,1.0
16663,9631,GO:0075733,NUP155,intracellular transport of virus,1.0
16664,9631,GO:0086014,NUP155,atrial cardiac muscle cell action potential,1.0
16665,9631,GO:1900034,NUP155,regulation of cellular response to heat,1.0
16823,55690,GO:0005515,PACS1,protein binding,1.0
16824,55690,GO:0005794,PACS1,Golgi apparatus,1.0
16825,55690,GO:0005829,PACS1,cytosol,1.0
16826,55690,GO:0030137,PACS1,COPI-coated vesicle,1.0
16827,55690,GO:0034067,PACS1,protein localization to Golgi apparatus,1.0
16828,55690,GO:0044325,PACS1,ion channel binding,1.0
16829,55690,GO:0044325,PACS1,ion channel binding,1.0
16830,55690,GO:0050690,PACS1,regulation of defense response to virus by virus,1.0
16831,55690,GO:0072659,PACS1,protein localization to plasma membrane,1.0
16832,55690,GO:0072659,PACS1,protein localization to plasma membrane,1.0
17057,5079,GO:0000122,PAX5,negative regulation of transcription by RNA polymerase II,1.0
17058,5079,GO:0000785,PAX5,chromatin,1.0
17059,5079,GO:0000785,PAX5,chromatin,1.0
17060,5079,GO:0000978,PAX5,RNA polymerase II cis-regulatory region sequence-specific DNA binding,1.0
17061,5079,GO:0000981,PAX5,"DNA-binding transcription factor activity, RNA polymerase II-specific",1.0
17062,5079,GO:0000981,PAX5,"DNA-binding transcription factor activity, RNA polymerase II-specific",1.0
17063,5079,GO:0001228,PAX5,"DNA-binding transcription activator activity, RNA polymerase II-specific",1.0
17064,5079,GO:0001650,PAX5,fibrillar center,1.0
17065,5079,GO:0005515,PAX5,protein binding,1.0
17066,5079,GO:0005654,PAX5,nucleoplasm,1.0
17067,5079,GO:0005654,PAX5,nucleoplasm,1.0
17068,5079,GO:0005829,PAX5,cytosol,1.0
17069,5079,GO:0006357,PAX5,regulation of transcription by RNA polymerase II,1.0
17070,5079,GO:0006366,PAX5,transcription by RNA polymerase II,1.0
17071,5079,GO:0006959,PAX5,humoral immune response,1.0
17072,5079,GO:0007275,PAX5,multicellular organism development,1.0
17073,5079,GO:0007283,PAX5,spermatogenesis,1.0
17074,5079,GO:0007568,PAX5,aging,1.0
17075,5079,GO:0009887,PAX5,animal organ morphogenesis,1.0
17076,5079,GO:0021670,PAX5,lateral ventricle development,1.0
17077,5079,GO:0021987,PAX5,cerebral cortex development,1.0
17078,5079,GO:0030534,PAX5,adult behavior,1.0
17079,5079,GO:0035914,PAX5,skeletal muscle cell differentiation,1.0
17080,5079,GO:0043231,PAX5,intracellular membrane-bounded organelle,1.0
17081,5079,GO:0045944,PAX5,positive regulation of transcription by RNA polymerase II,1.0
17082,5079,GO:0048701,PAX5,embryonic cranial skeleton morphogenesis,1.0
17083,5079,GO:0048856,PAX5,anatomical structure development,1.0
17084,5079,GO:0050855,PAX5,regulation of B cell receptor signaling pathway,1.0
17085,5079,GO:0051573,PAX5,negative regulation of histone H3-K9 methylation,1.0
17258,57526,GO:0005509,PCDH19,calcium ion binding,1.0
17259,57526,GO:0005887,PCDH19,integral component of plasma membrane,1.0
17260,57526,GO:0007155,PCDH19,cell adhesion,1.0
17261,57526,GO:0007156,PCDH19,homophilic cell adhesion via plasma membrane adhesion molecules,1.0
17262,57526,GO:0007420,PCDH19,brain development,1.0
17534,5253,GO:0000776,PHF2,kinetochore,1.0
17535,5253,GO:0000777,PHF2,condensed chromosome kinetochore,1.0
17536,5253,GO:0000785,PHF2,chromatin,1.0
17537,5253,GO:0001889,PHF2,liver development,1.0
17538,5253,GO:0003712,PHF2,transcription coregulator activity,1.0
17539,5253,GO:0003713,PHF2,transcription coactivator activity,1.0
17540,5253,GO:0005506,PHF2,iron ion binding,1.0
17541,5253,GO:0005515,PHF2,protein binding,1.0
17542,5253,GO:0005634,PHF2,nucleus,1.0
17543,5253,GO:0005654,PHF2,nucleoplasm,1.0
17544,5253,GO:0005654,PHF2,nucleoplasm,1.0
17545,5253,GO:0005730,PHF2,nucleolus,1.0
17546,5253,GO:0006357,PHF2,regulation of transcription by RNA polymerase II,1.0
17547,5253,GO:0006482,PHF2,protein demethylation,1.0
17548,5253,GO:0006482,PHF2,protein demethylation,1.0
17549,5253,GO:0008270,PHF2,zinc ion binding,1.0
17550,5253,GO:0032452,PHF2,histone demethylase activity,1.0
17551,5253,GO:0032454,PHF2,histone demethylase activity (H3-K9 specific),1.0
17552,5253,GO:0033169,PHF2,histone H3-K9 demethylation,1.0
17553,5253,GO:0035064,PHF2,methylated histone binding,1.0
17554,5253,GO:0051213,PHF2,dioxygenase activity,1.0
17555,5253,GO:0055114,PHF2,oxidation-reduction process,1.0
17556,5253,GO:0061188,PHF2,negative regulation of ribosomal DNA heterochromatin assembly,1.0
17557,51317,GO:0000118,PHF21A,histone deacetylase complex,1.0
17558,51317,GO:0000118,PHF21A,histone deacetylase complex,1.0
17559,51317,GO:0000122,PHF21A,negative regulation of transcription by RNA polymerase II,1.0
17560,51317,GO:0003677,PHF21A,DNA binding,1.0
17561,51317,GO:0003682,PHF21A,chromatin binding,1.0
17562,51317,GO:0005515,PHF21A,protein binding,1.0
17563,51317,GO:0005654,PHF21A,nucleoplasm,1.0
17564,51317,GO:0006325,PHF21A,chromatin organization,1.0
17565,51317,GO:0007596,PHF21A,blood coagulation,1.0
17566,51317,GO:0046872,PHF21A,metal ion binding,1.0
17567,51317,GO:1990391,PHF21A,DNA repair complex,1.0
17568,23469,GO:0003674,PHF3,molecular_function,1.0
17569,23469,GO:0005575,PHF3,cellular_component,1.0
17570,23469,GO:0006351,PHF3,"transcription, DNA-templated",1.0
17571,23469,GO:0007275,PHF3,multicellular organism development,1.0
17572,23469,GO:0046872,PHF3,metal ion binding,1.0
17607,55023,GO:0001932,PHIP,regulation of protein phosphorylation,1.0
17608,55023,GO:0005158,PHIP,insulin receptor binding,1.0
17609,55023,GO:0005515,PHIP,protein binding,1.0
17610,55023,GO:0005634,PHIP,nucleus,1.0
17611,55023,GO:0005634,PHIP,nucleus,1.0
17612,55023,GO:0006357,PHIP,regulation of transcription by RNA polymerase II,1.0
17613,55023,GO:0007010,PHIP,cytoskeleton organization,1.0
17614,55023,GO:0007010,PHIP,cytoskeleton organization,1.0
17615,55023,GO:0008284,PHIP,positive regulation of cell population proliferation,1.0
17616,55023,GO:0008286,PHIP,insulin receptor signaling pathway,1.0
17617,55023,GO:0008360,PHIP,regulation of cell shape,1.0
17618,55023,GO:0022604,PHIP,regulation of cell morphogenesis,1.0
17619,55023,GO:0043066,PHIP,negative regulation of apoptotic process,1.0
17620,55023,GO:0043568,PHIP,positive regulation of insulin-like growth factor receptor signaling pathway,1.0
17621,55023,GO:0045840,PHIP,positive regulation of mitotic nuclear division,1.0
17622,55023,GO:0045893,PHIP,"positive regulation of transcription, DNA-templated",1.0
17623,55023,GO:0045944,PHIP,positive regulation of transcription by RNA polymerase II,1.0
17624,55023,GO:0070577,PHIP,lysine-acetylated histone binding,1.0
17625,55023,GO:2001237,PHIP,negative regulation of extrinsic apoptotic signaling pathway,1.0
17629,57649,GO:0000122,PHF12,negative regulation of transcription by RNA polymerase II,1.0
17630,57649,GO:0000122,PHF12,negative regulation of transcription by RNA polymerase II,1.0
17631,57649,GO:0001222,PHF12,transcription corepressor binding,1.0
17632,57649,GO:0003712,PHF12,transcription coregulator activity,1.0
17633,57649,GO:0003714,PHF12,transcription corepressor activity,1.0
17634,57649,GO:0005515,PHF12,protein binding,1.0
17635,57649,GO:0005634,PHF12,nucleus,1.0
17636,57649,GO:0005634,PHF12,nucleus,1.0
17637,57649,GO:0005654,PHF12,nucleoplasm,1.0
17638,57649,GO:0006355,PHF12,"regulation of transcription, DNA-templated",1.0
17639,57649,GO:0016580,PHF12,Sin3 complex,1.0
17640,57649,GO:0017053,PHF12,transcription repressor complex,1.0
17641,57649,GO:0035091,PHF12,phosphatidylinositol binding,1.0
17642,57649,GO:0045892,PHF12,"negative regulation of transcription, DNA-templated",1.0
17643,57649,GO:0046872,PHF12,metal ion binding,1.0
17644,57649,GO:0070822,PHF12,Sin3-type complex,1.0
17949,23126,GO:0000785,POGZ,chromatin,1.0
17950,23126,GO:0003677,POGZ,DNA binding,1.0
17951,23126,GO:0005515,POGZ,protein binding,1.0
17952,23126,GO:0005634,POGZ,nucleus,1.0
17953,23126,GO:0005654,POGZ,nucleoplasm,1.0
17954,23126,GO:0005737,POGZ,cytoplasm,1.0
17955,23126,GO:0005829,POGZ,cytosol,1.0
17956,23126,GO:0007064,POGZ,mitotic sister chromatid cohesion,1.0
17957,23126,GO:0010468,POGZ,regulation of gene expression,1.0
17958,23126,GO:0045944,POGZ,positive regulation of transcription by RNA polymerase II,1.0
17959,23126,GO:0046872,POGZ,metal ion binding,1.0
17960,23126,GO:0051301,POGZ,cell division,1.0
17961,23126,GO:0051382,POGZ,kinetochore assembly,1.0
17975,55624,GO:0000139,POMGNT1,Golgi membrane,1.0
17976,55624,GO:0005515,POMGNT1,protein binding,1.0
17977,55624,GO:0006493,POMGNT1,protein O-linked glycosylation,1.0
17978,55624,GO:0006493,POMGNT1,protein O-linked glycosylation,1.0
17979,55624,GO:0006493,POMGNT1,protein O-linked glycosylation,1.0
17980,55624,GO:0008375,POMGNT1,acetylglucosaminyltransferase activity,1.0
17981,55624,GO:0008375,POMGNT1,acetylglucosaminyltransferase activity,1.0
17982,55624,GO:0016021,POMGNT1,integral component of membrane,1.0
17983,55624,GO:0016266,POMGNT1,O-glycan processing,1.0
17984,55624,GO:0016266,POMGNT1,O-glycan processing,1.0
17985,55624,GO:0030145,POMGNT1,manganese ion binding,1.0
17986,55624,GO:0030173,POMGNT1,integral component of Golgi membrane,1.0
17987,55624,GO:0030173,POMGNT1,integral component of Golgi membrane,1.0
17988,55624,GO:0047223,POMGNT1,"beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity",1.0
17989,55624,GO:0047223,POMGNT1,"beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity",1.0
17990,55624,GO:0047223,POMGNT1,"beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity",1.0
18188,5528,GO:0000159,PPP2R5D,protein phosphatase type 2A complex,1.0
18189,5528,GO:0004721,PPP2R5D,phosphoprotein phosphatase activity,1.0
18190,5528,GO:0005515,PPP2R5D,protein binding,1.0
18191,5528,GO:0005634,PPP2R5D,nucleus,1.0
18192,5528,GO:0005654,PPP2R5D,nucleoplasm,1.0
18193,5528,GO:0005829,PPP2R5D,cytosol,1.0
18194,5528,GO:0005829,PPP2R5D,cytosol,1.0
18195,5528,GO:0006470,PPP2R5D,protein dephosphorylation,1.0
18196,5528,GO:0006470,PPP2R5D,protein dephosphorylation,1.0
18197,5528,GO:0007165,PPP2R5D,signal transduction,1.0
18198,5528,GO:0007399,PPP2R5D,nervous system development,1.0
18199,5528,GO:0010801,PPP2R5D,negative regulation of peptidyl-threonine phosphorylation,1.0
18200,5528,GO:0019888,PPP2R5D,protein phosphatase regulator activity,1.0
18201,5528,GO:0031952,PPP2R5D,regulation of protein autophosphorylation,1.0
18202,5528,GO:0035307,PPP2R5D,positive regulation of protein dephosphorylation,1.0
18203,5528,GO:0043666,PPP2R5D,regulation of phosphoprotein phosphatase activity,1.0
18204,5528,GO:0072542,PPP2R5D,protein phosphatase activator activity,1.0
18817,57479,GO:0005634,PRR12,nucleus,1.0
18818,57479,GO:0014069,PRR12,postsynaptic density,1.0
18819,57479,GO:0043005,PRR12,neuron projection,1.0
18830,5718,GO:0000165,PSMD12,MAPK cascade,1.0
18831,5718,GO:0000209,PSMD12,protein polyubiquitination,1.0
18832,5718,GO:0000502,PSMD12,proteasome complex,1.0
18833,5718,GO:0002223,PSMD12,stimulatory C-type lectin receptor signaling pathway,1.0
18834,5718,GO:0002479,PSMD12,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent",1.0
18835,5718,GO:0005515,PSMD12,protein binding,1.0
18836,5718,GO:0005576,PSMD12,extracellular region,1.0
18837,5718,GO:0005654,PSMD12,nucleoplasm,1.0
18838,5718,GO:0005737,PSMD12,cytoplasm,1.0
18839,5718,GO:0005829,PSMD12,cytosol,1.0
18840,5718,GO:0005838,PSMD12,proteasome regulatory particle,1.0
18841,5718,GO:0006521,PSMD12,regulation of cellular amino acid metabolic process,1.0
18842,5718,GO:0008541,PSMD12,"proteasome regulatory particle, lid subcomplex",1.0
18843,5718,GO:0010972,PSMD12,negative regulation of G2/M transition of mitotic cell cycle,1.0
18844,5718,GO:0016020,PSMD12,membrane,1.0
18845,5718,GO:0016579,PSMD12,protein deubiquitination,1.0
18846,5718,GO:0022624,PSMD12,proteasome accessory complex,1.0
18847,5718,GO:0031145,PSMD12,anaphase-promoting complex-dependent catabolic process,1.0
18848,5718,GO:0031146,PSMD12,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,1.0
18849,5718,GO:0031595,PSMD12,nuclear proteasome complex,1.0
18850,5718,GO:0033209,PSMD12,tumor necrosis factor-mediated signaling pathway,1.0
18851,5718,GO:0034774,PSMD12,secretory granule lumen,1.0
18852,5718,GO:0038061,PSMD12,NIK/NF-kappaB signaling,1.0
18853,5718,GO:0038095,PSMD12,Fc-epsilon receptor signaling pathway,1.0
18854,5718,GO:0043161,PSMD12,proteasome-mediated ubiquitin-dependent protein catabolic process,1.0
18855,5718,GO:0043161,PSMD12,proteasome-mediated ubiquitin-dependent protein catabolic process,1.0
18856,5718,GO:0043312,PSMD12,neutrophil degranulation,1.0
18857,5718,GO:0043488,PSMD12,regulation of mRNA stability,1.0
18858,5718,GO:0043687,PSMD12,post-translational protein modification,1.0
18859,5718,GO:0050852,PSMD12,T cell receptor signaling pathway,1.0
18860,5718,GO:0055085,PSMD12,transmembrane transport,1.0
18861,5718,GO:0060071,PSMD12,"Wnt signaling pathway, planar cell polarity pathway",1.0
18862,5718,GO:0061418,PSMD12,regulation of transcription from RNA polymerase II promoter in response to hypoxia,1.0
18863,5718,GO:0070062,PSMD12,extracellular exosome,1.0
18864,5718,GO:0070498,PSMD12,interleukin-1-mediated signaling pathway,1.0
18865,5718,GO:0090090,PSMD12,negative regulation of canonical Wnt signaling pathway,1.0
18866,5718,GO:0090263,PSMD12,positive regulation of canonical Wnt signaling pathway,1.0
18867,5718,GO:1901990,PSMD12,regulation of mitotic cell cycle phase transition,1.0
18868,5718,GO:1902036,PSMD12,regulation of hematopoietic stem cell differentiation,1.0
18869,5718,GO:1904813,PSMD12,ficolin-1-rich granule lumen,1.0
18884,139411,GO:0003674,PTCHD1,molecular_function,1.0
18885,139411,GO:0005886,PTCHD1,plasma membrane,1.0
18886,139411,GO:0005886,PTCHD1,plasma membrane,1.0
18887,139411,GO:0007224,PTCHD1,smoothened signaling pathway,1.0
18888,139411,GO:0007268,PTCHD1,chemical synaptic transmission,1.0
18889,139411,GO:0007614,PTCHD1,short-term memory,1.0
18890,139411,GO:0007616,PTCHD1,long-term memory,1.0
18891,139411,GO:0016020,PTCHD1,membrane,1.0
18892,139411,GO:0016021,PTCHD1,integral component of membrane,1.0
18893,139411,GO:0021794,PTCHD1,thalamus development,1.0
18894,139411,GO:0035176,PTCHD1,social behavior,1.0
18895,139411,GO:0045202,PTCHD1,synapse,1.0
18896,139411,GO:0050890,PTCHD1,cognition,1.0
18897,139411,GO:0050890,PTCHD1,cognition,1.0
18898,139411,GO:0098976,PTCHD1,excitatory chemical synaptic transmission,1.0
18899,139411,GO:0098977,PTCHD1,inhibitory chemical synaptic transmission,1.0
18900,5728,GO:0001525,PTEN,angiogenesis,1.0
18901,5728,GO:0001933,PTEN,negative regulation of protein phosphorylation,1.0
18902,5728,GO:0001933,PTEN,negative regulation of protein phosphorylation,1.0
18903,5728,GO:0002902,PTEN,regulation of B cell apoptotic process,1.0
18904,5728,GO:0004438,PTEN,phosphatidylinositol-3-phosphatase activity,1.0
18905,5728,GO:0004721,PTEN,phosphoprotein phosphatase activity,1.0
18906,5728,GO:0004722,PTEN,protein serine/threonine phosphatase activity,1.0
18907,5728,GO:0004725,PTEN,protein tyrosine phosphatase activity,1.0
18908,5728,GO:0004725,PTEN,protein tyrosine phosphatase activity,1.0
18909,5728,GO:0005161,PTEN,platelet-derived growth factor receptor binding,1.0
18910,5728,GO:0005515,PTEN,protein binding,1.0
18911,5728,GO:0005576,PTEN,extracellular region,1.0
18912,5728,GO:0005634,PTEN,nucleus,1.0
18913,5728,GO:0005634,PTEN,nucleus,1.0
18914,5728,GO:0005654,PTEN,nucleoplasm,1.0
18915,5728,GO:0005654,PTEN,nucleoplasm,1.0
18916,5728,GO:0005737,PTEN,cytoplasm,1.0
18917,5728,GO:0005737,PTEN,cytoplasm,1.0
18918,5728,GO:0005739,PTEN,mitochondrion,1.0
18919,5728,GO:0005829,PTEN,cytosol,1.0
18920,5728,GO:0005829,PTEN,cytosol,1.0
18921,5728,GO:0005829,PTEN,cytosol,1.0
18922,5728,GO:0005886,PTEN,plasma membrane,1.0
18923,5728,GO:0005886,PTEN,plasma membrane,1.0
18924,5728,GO:0006367,PTEN,transcription initiation from RNA polymerase II promoter,1.0
18925,5728,GO:0006470,PTEN,protein dephosphorylation,1.0
18926,5728,GO:0006470,PTEN,protein dephosphorylation,1.0
18927,5728,GO:0006470,PTEN,protein dephosphorylation,1.0
18928,5728,GO:0006661,PTEN,phosphatidylinositol biosynthetic process,1.0
18929,5728,GO:0006915,PTEN,apoptotic process,1.0
18930,5728,GO:0007270,PTEN,neuron-neuron synaptic transmission,1.0
18931,5728,GO:0007416,PTEN,synapse assembly,1.0
18932,5728,GO:0007417,PTEN,central nervous system development,1.0
18933,5728,GO:0007507,PTEN,heart development,1.0
18934,5728,GO:0007568,PTEN,aging,1.0
18935,5728,GO:0007584,PTEN,response to nutrient,1.0
18936,5728,GO:0007611,PTEN,learning or memory,1.0
18937,5728,GO:0007613,PTEN,memory,1.0
18938,5728,GO:0007626,PTEN,locomotory behavior,1.0
18939,5728,GO:0008138,PTEN,protein tyrosine/serine/threonine phosphatase activity,1.0
18940,5728,GO:0008284,PTEN,positive regulation of cell population proliferation,1.0
18941,5728,GO:0008285,PTEN,negative regulation of cell population proliferation,1.0
18942,5728,GO:0008285,PTEN,negative regulation of cell population proliferation,1.0
18943,5728,GO:0008285,PTEN,negative regulation of cell population proliferation,1.0
18944,5728,GO:0008289,PTEN,lipid binding,1.0
18945,5728,GO:0009749,PTEN,response to glucose,1.0
18946,5728,GO:0009898,PTEN,cytoplasmic side of plasma membrane,1.0
18947,5728,GO:0010043,PTEN,response to zinc ion,1.0
18948,5728,GO:0010628,PTEN,positive regulation of gene expression,1.0
18949,5728,GO:0010666,PTEN,positive regulation of cardiac muscle cell apoptotic process,1.0
18950,5728,GO:0010719,PTEN,negative regulation of epithelial to mesenchymal transition,1.0
18951,5728,GO:0010975,PTEN,regulation of neuron projection development,1.0
18952,5728,GO:0010977,PTEN,negative regulation of neuron projection development,1.0
18953,5728,GO:0010997,PTEN,anaphase-promoting complex binding,1.0
18954,5728,GO:0014065,PTEN,phosphatidylinositol 3-kinase signaling,1.0
18955,5728,GO:0014067,PTEN,negative regulation of phosphatidylinositol 3-kinase signaling,1.0
18956,5728,GO:0014067,PTEN,negative regulation of phosphatidylinositol 3-kinase signaling,1.0
18957,5728,GO:0014823,PTEN,response to activity,1.0
18958,5728,GO:0016311,PTEN,dephosphorylation,1.0
18959,5728,GO:0016314,PTEN,"phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity",1.0
18960,5728,GO:0016314,PTEN,"phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity",1.0
18961,5728,GO:0016314,PTEN,"phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity",1.0
18962,5728,GO:0016324,PTEN,apical plasma membrane,1.0
18963,5728,GO:0016477,PTEN,cell migration,1.0
18964,5728,GO:0016579,PTEN,protein deubiquitination,1.0
18965,5728,GO:0016605,PTEN,PML body,1.0
18966,5728,GO:0019899,PTEN,enzyme binding,1.0
18967,5728,GO:0021542,PTEN,dentate gyrus development,1.0
18968,5728,GO:0021955,PTEN,central nervous system neuron axonogenesis,1.0
18969,5728,GO:0030165,PTEN,PDZ domain binding,1.0
18970,5728,GO:0030336,PTEN,negative regulation of cell migration,1.0
18971,5728,GO:0030534,PTEN,adult behavior,1.0
18972,5728,GO:0031642,PTEN,negative regulation of myelination,1.0
18973,5728,GO:0031647,PTEN,regulation of protein stability,1.0
18974,5728,GO:0032228,PTEN,"regulation of synaptic transmission, GABAergic",1.0
18975,5728,GO:0032286,PTEN,central nervous system myelin maintenance,1.0
18976,5728,GO:0032355,PTEN,response to estradiol,1.0
18977,5728,GO:0032535,PTEN,regulation of cellular component size,1.0
18978,5728,GO:0032869,PTEN,cellular response to insulin stimulus,1.0
18979,5728,GO:0033032,PTEN,regulation of myeloid cell apoptotic process,1.0
18980,5728,GO:0033137,PTEN,negative regulation of peptidyl-serine phosphorylation,1.0
18981,5728,GO:0033198,PTEN,response to ATP,1.0
18982,5728,GO:0033555,PTEN,multicellular organismal response to stress,1.0
18983,5728,GO:0035176,PTEN,social behavior,1.0
18984,5728,GO:0035255,PTEN,ionotropic glutamate receptor binding,1.0
18985,5728,GO:0035335,PTEN,peptidyl-tyrosine dephosphorylation,1.0
18986,5728,GO:0035749,PTEN,myelin sheath adaxonal region,1.0
18987,5728,GO:0042493,PTEN,response to drug,1.0
18988,5728,GO:0042711,PTEN,maternal behavior,1.0
18989,5728,GO:0042802,PTEN,identical protein binding,1.0
18990,5728,GO:0042995,PTEN,cell projection,1.0
18991,5728,GO:0042995,PTEN,cell projection,1.0
18992,5728,GO:0043005,PTEN,neuron projection,1.0
18993,5728,GO:0043066,PTEN,negative regulation of apoptotic process,1.0
18994,5728,GO:0043197,PTEN,dendritic spine,1.0
18995,5728,GO:0043220,PTEN,Schmidt-Lanterman incisure,1.0
18996,5728,GO:0043491,PTEN,protein kinase B signaling,1.0
18997,5728,GO:0043542,PTEN,endothelial cell migration,1.0
18998,5728,GO:0043647,PTEN,inositol phosphate metabolic process,1.0
18999,5728,GO:0044320,PTEN,cellular response to leptin stimulus,1.0
19000,5728,GO:0045211,PTEN,postsynaptic membrane,1.0
19001,5728,GO:0045475,PTEN,locomotor rhythm,1.0
19002,5728,GO:0045666,PTEN,positive regulation of neuron differentiation,1.0
19003,5728,GO:0045736,PTEN,negative regulation of cyclin-dependent protein serine/threonine kinase activity,1.0
19004,5728,GO:0045792,PTEN,negative regulation of cell size,1.0
19005,5728,GO:0046621,PTEN,negative regulation of organ growth,1.0
19006,5728,GO:0046685,PTEN,response to arsenic-containing substance,1.0
19007,5728,GO:0046855,PTEN,inositol phosphate dephosphorylation,1.0
19008,5728,GO:0046856,PTEN,phosphatidylinositol dephosphorylation,1.0
19009,5728,GO:0046856,PTEN,phosphatidylinositol dephosphorylation,1.0
19010,5728,GO:0046856,PTEN,phosphatidylinositol dephosphorylation,1.0
19011,5728,GO:0048008,PTEN,platelet-derived growth factor receptor signaling pathway,1.0
19012,5728,GO:0048681,PTEN,negative regulation of axon regeneration,1.0
19013,5728,GO:0048738,PTEN,cardiac muscle tissue development,1.0
19014,5728,GO:0048853,PTEN,forebrain morphogenesis,1.0
19015,5728,GO:0048854,PTEN,brain morphogenesis,1.0
19016,5728,GO:0048870,PTEN,cell motility,1.0
19017,5728,GO:0050680,PTEN,negative regulation of epithelial cell proliferation,1.0
19018,5728,GO:0050765,PTEN,negative regulation of phagocytosis,1.0
19019,5728,GO:0050771,PTEN,negative regulation of axonogenesis,1.0
19020,5728,GO:0050821,PTEN,protein stabilization,1.0
19021,5728,GO:0051091,PTEN,positive regulation of DNA-binding transcription factor activity,1.0
19022,5728,GO:0051548,PTEN,negative regulation of keratinocyte migration,1.0
19023,5728,GO:0051717,PTEN,"inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity",1.0
19024,5728,GO:0051800,PTEN,"phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity",1.0
19025,5728,GO:0051800,PTEN,"phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity",1.0
19026,5728,GO:0051895,PTEN,negative regulation of focal adhesion assembly,1.0
19027,5728,GO:0051896,PTEN,regulation of protein kinase B signaling,1.0
19028,5728,GO:0051898,PTEN,negative regulation of protein kinase B signaling,1.0
19029,5728,GO:0051898,PTEN,negative regulation of protein kinase B signaling,1.0
19030,5728,GO:0060024,PTEN,rhythmic synaptic transmission,1.0
19031,5728,GO:0060044,PTEN,negative regulation of cardiac muscle cell proliferation,1.0
19032,5728,GO:0060070,PTEN,canonical Wnt signaling pathway,1.0
19033,5728,GO:0060074,PTEN,synapse maturation,1.0
19034,5728,GO:0060134,PTEN,prepulse inhibition,1.0
19035,5728,GO:0060179,PTEN,male mating behavior,1.0
19036,5728,GO:0060291,PTEN,long-term synaptic potentiation,1.0
19037,5728,GO:0060292,PTEN,long-term synaptic depression,1.0
19038,5728,GO:0060736,PTEN,prostate gland growth,1.0
19039,5728,GO:0060997,PTEN,dendritic spine morphogenesis,1.0
19040,5728,GO:0061002,PTEN,negative regulation of dendritic spine morphogenesis,1.0
19041,5728,GO:0070373,PTEN,negative regulation of ERK1 and ERK2 cascade,1.0
19042,5728,GO:0070374,PTEN,positive regulation of ERK1 and ERK2 cascade,1.0
19043,5728,GO:0071257,PTEN,cellular response to electrical stimulus,1.0
19044,5728,GO:0071361,PTEN,cellular response to ethanol,1.0
19045,5728,GO:0071456,PTEN,cellular response to hypoxia,1.0
19046,5728,GO:0090071,PTEN,negative regulation of ribosome biogenesis,1.0
19047,5728,GO:0090344,PTEN,negative regulation of cell aging,1.0
19048,5728,GO:0090394,PTEN,negative regulation of excitatory postsynaptic potential,1.0
19049,5728,GO:0097105,PTEN,presynaptic membrane assembly,1.0
19050,5728,GO:0097107,PTEN,postsynaptic density assembly,1.0
19051,5728,GO:0106306,PTEN,protein serine phosphatase activity,1.0
19052,5728,GO:0106307,PTEN,protein threonine phosphatase activity,1.0
19053,5728,GO:1901017,PTEN,negative regulation of potassium ion transmembrane transporter activity,1.0
19054,5728,GO:1902807,PTEN,negative regulation of cell cycle G1/S phase transition,1.0
19055,5728,GO:1903690,PTEN,"negative regulation of wound healing, spreading of epidermal cells",1.0
19056,5728,GO:1903984,PTEN,positive regulation of TRAIL-activated apoptotic signaling pathway,1.0
19057,5728,GO:1904668,PTEN,positive regulation of ubiquitin protein ligase activity,1.0
19058,5728,GO:1904706,PTEN,negative regulation of vascular associated smooth muscle cell proliferation,1.0
19059,5728,GO:1990090,PTEN,cellular response to nerve growth factor stimulus,1.0
19060,5728,GO:1990314,PTEN,cellular response to insulin-like growth factor stimulus,1.0
19061,5728,GO:1990381,PTEN,ubiquitin-specific protease binding,1.0
19062,5728,GO:1990782,PTEN,protein tyrosine kinase binding,1.0
19063,5728,GO:2000060,PTEN,positive regulation of ubiquitin-dependent protein catabolic process,1.0
19064,5728,GO:2000134,PTEN,negative regulation of G1/S transition of mitotic cell cycle,1.0
19065,5728,GO:2000272,PTEN,negative regulation of signaling receptor activity,1.0
19066,5728,GO:2000463,PTEN,positive regulation of excitatory postsynaptic potential,1.0
19067,5728,GO:2000808,PTEN,negative regulation of synaptic vesicle clustering,1.0
19310,84687,GO:0000164,PPP1R9B,protein phosphatase type 1 complex,1.0
19311,84687,GO:0001560,PPP1R9B,regulation of cell growth by extracellular stimulus,1.0
19312,84687,GO:0001932,PPP1R9B,regulation of protein phosphorylation,1.0
19313,84687,GO:0001975,PPP1R9B,response to amphetamine,1.0
19314,84687,GO:0003006,PPP1R9B,developmental process involved in reproduction,1.0
19315,84687,GO:0004672,PPP1R9B,protein kinase activity,1.0
19316,84687,GO:0004864,PPP1R9B,protein phosphatase inhibitor activity,1.0
19317,84687,GO:0005515,PPP1R9B,protein binding,1.0
19318,84687,GO:0005654,PPP1R9B,nucleoplasm,1.0
19319,84687,GO:0005737,PPP1R9B,cytoplasm,1.0
19320,84687,GO:0005737,PPP1R9B,cytoplasm,1.0
19321,84687,GO:0005886,PPP1R9B,plasma membrane,1.0
19322,84687,GO:0005912,PPP1R9B,adherens junction,1.0
19323,84687,GO:0006468,PPP1R9B,protein phosphorylation,1.0
19324,84687,GO:0007015,PPP1R9B,actin filament organization,1.0
19325,84687,GO:0007050,PPP1R9B,cell cycle arrest,1.0
19326,84687,GO:0007096,PPP1R9B,regulation of exit from mitosis,1.0
19327,84687,GO:0007568,PPP1R9B,aging,1.0
19328,84687,GO:0007612,PPP1R9B,learning,1.0
19329,84687,GO:0008022,PPP1R9B,protein C-terminus binding,1.0
19330,84687,GO:0008157,PPP1R9B,protein phosphatase 1 binding,1.0
19331,84687,GO:0008380,PPP1R9B,RNA splicing,1.0
19332,84687,GO:0014069,PPP1R9B,postsynaptic density,1.0
19333,84687,GO:0015629,PPP1R9B,actin cytoskeleton,1.0
19334,84687,GO:0016358,PPP1R9B,dendrite development,1.0
19335,84687,GO:0016477,PPP1R9B,cell migration,1.0
19336,84687,GO:0019722,PPP1R9B,calcium-mediated signaling,1.0
19337,84687,GO:0019900,PPP1R9B,kinase binding,1.0
19338,84687,GO:0021766,PPP1R9B,hippocampus development,1.0
19339,84687,GO:0021987,PPP1R9B,cerebral cortex development,1.0
19340,84687,GO:0030027,PPP1R9B,lamellipodium,1.0
19341,84687,GO:0030042,PPP1R9B,actin filament depolymerization,1.0
19342,84687,GO:0030175,PPP1R9B,filopodium,1.0
19343,84687,GO:0030308,PPP1R9B,negative regulation of cell growth,1.0
19344,84687,GO:0030425,PPP1R9B,dendrite,1.0
19345,84687,GO:0030426,PPP1R9B,growth cone,1.0
19346,84687,GO:0030864,PPP1R9B,cortical actin cytoskeleton,1.0
19347,84687,GO:0031175,PPP1R9B,neuron projection development,1.0
19348,84687,GO:0031749,PPP1R9B,D2 dopamine receptor binding,1.0
19349,84687,GO:0032515,PPP1R9B,negative regulation of phosphoprotein phosphatase activity,1.0
19350,84687,GO:0032587,PPP1R9B,ruffle membrane,1.0
19351,84687,GO:0034695,PPP1R9B,response to prostaglandin E,1.0
19352,84687,GO:0035094,PPP1R9B,response to nicotine,1.0
19353,84687,GO:0035690,PPP1R9B,cellular response to drug,1.0
19354,84687,GO:0035902,PPP1R9B,response to immobilization stress,1.0
19355,84687,GO:0042127,PPP1R9B,regulation of cell population proliferation,1.0
19356,84687,GO:0043025,PPP1R9B,neuronal cell body,1.0
19357,84687,GO:0044325,PPP1R9B,ion channel binding,1.0
19358,84687,GO:0044326,PPP1R9B,dendritic spine neck,1.0
19359,84687,GO:0044327,PPP1R9B,dendritic spine head,1.0
19360,84687,GO:0046847,PPP1R9B,filopodium assembly,1.0
19361,84687,GO:0048545,PPP1R9B,response to steroid hormone,1.0
19362,84687,GO:0050804,PPP1R9B,modulation of chemical synaptic transmission,1.0
19363,84687,GO:0051015,PPP1R9B,actin filament binding,1.0
19364,84687,GO:0060179,PPP1R9B,male mating behavior,1.0
19365,84687,GO:0061458,PPP1R9B,reproductive system development,1.0
19366,84687,GO:0071315,PPP1R9B,cellular response to morphine,1.0
19367,84687,GO:0071364,PPP1R9B,cellular response to epidermal growth factor stimulus,1.0
19368,84687,GO:0071392,PPP1R9B,cellular response to estradiol stimulus,1.0
19369,84687,GO:0097338,PPP1R9B,response to clozapine,1.0
19370,84687,GO:1901653,PPP1R9B,cellular response to peptide,1.0
19371,84687,GO:1903078,PPP1R9B,positive regulation of protein localization to plasma membrane,1.0
19372,84687,GO:1903119,PPP1R9B,protein localization to actin cytoskeleton,1.0
19373,84687,GO:1904372,PPP1R9B,positive regulation of protein localization to actin cortical patch,1.0
19374,84687,GO:1904373,PPP1R9B,response to kainic acid,1.0
19375,84687,GO:1904386,PPP1R9B,response to L-phenylalanine derivative,1.0
19376,84687,GO:1990778,PPP1R9B,protein localization to cell periphery,1.0
19377,84687,GO:1990780,PPP1R9B,cytoplasmic side of dendritic spine plasma membrane,1.0
19378,84687,GO:2000474,PPP1R9B,regulation of opioid receptor signaling pathway,1.0
19379,5536,GO:0000165,PPP5C,MAPK cascade,1.0
19380,5536,GO:0000278,PPP5C,mitotic cell cycle,1.0
19381,5536,GO:0001933,PPP5C,negative regulation of protein phosphorylation,1.0
19382,5536,GO:0001965,PPP5C,G-protein alpha-subunit binding,1.0
19383,5536,GO:0003723,PPP5C,RNA binding,1.0
19384,5536,GO:0004721,PPP5C,phosphoprotein phosphatase activity,1.0
19385,5536,GO:0004721,PPP5C,phosphoprotein phosphatase activity,1.0
19386,5536,GO:0004722,PPP5C,protein serine/threonine phosphatase activity,1.0
19387,5536,GO:0004722,PPP5C,protein serine/threonine phosphatase activity,1.0
19388,5536,GO:0004722,PPP5C,protein serine/threonine phosphatase activity,1.0
19389,5536,GO:0004722,PPP5C,protein serine/threonine phosphatase activity,1.0
19390,5536,GO:0005515,PPP5C,protein binding,1.0
19391,5536,GO:0005524,PPP5C,ATP binding,1.0
19392,5536,GO:0005634,PPP5C,nucleus,1.0
19393,5536,GO:0005654,PPP5C,nucleoplasm,1.0
19394,5536,GO:0005829,PPP5C,cytosol,1.0
19395,5536,GO:0005829,PPP5C,cytosol,1.0
19396,5536,GO:0005829,PPP5C,cytosol,1.0
19397,5536,GO:0005886,PPP5C,plasma membrane,1.0
19398,5536,GO:0006281,PPP5C,DNA repair,1.0
19399,5536,GO:0006351,PPP5C,"transcription, DNA-templated",1.0
19400,5536,GO:0006470,PPP5C,protein dephosphorylation,1.0
19401,5536,GO:0008017,PPP5C,microtubule binding,1.0
19402,5536,GO:0008289,PPP5C,lipid binding,1.0
19403,5536,GO:0010288,PPP5C,response to lead ion,1.0
19404,5536,GO:0016576,PPP5C,histone dephosphorylation,1.0
19405,5536,GO:0016791,PPP5C,phosphatase activity,1.0
19406,5536,GO:0032991,PPP5C,protein-containing complex,1.0
19407,5536,GO:0035970,PPP5C,peptidyl-threonine dephosphorylation,1.0
19408,5536,GO:0042802,PPP5C,identical protein binding,1.0
19409,5536,GO:0043123,PPP5C,positive regulation of I-kappaB kinase/NF-kappaB signaling,1.0
19410,5536,GO:0043204,PPP5C,perikaryon,1.0
19411,5536,GO:0043231,PPP5C,intracellular membrane-bounded organelle,1.0
19412,5536,GO:0043278,PPP5C,response to morphine,1.0
19413,5536,GO:0043531,PPP5C,ADP binding,1.0
19414,5536,GO:0044877,PPP5C,protein-containing complex binding,1.0
19415,5536,GO:0046872,PPP5C,metal ion binding,1.0
19416,5536,GO:0048156,PPP5C,tau protein binding,1.0
19417,5536,GO:0051879,PPP5C,Hsp90 protein binding,1.0
19418,5536,GO:0070262,PPP5C,peptidyl-serine dephosphorylation,1.0
19419,5536,GO:0070262,PPP5C,peptidyl-serine dephosphorylation,1.0
19420,5536,GO:0070301,PPP5C,cellular response to hydrogen peroxide,1.0
19421,5536,GO:0071276,PPP5C,cellular response to cadmium ion,1.0
19422,5536,GO:0101031,PPP5C,chaperone complex,1.0
19423,5536,GO:0106306,PPP5C,protein serine phosphatase activity,1.0
19424,5536,GO:0106307,PPP5C,protein threonine phosphatase activity,1.0
19425,5536,GO:1901215,PPP5C,negative regulation of neuron death,1.0
19426,5536,GO:1904550,PPP5C,response to arachidonic acid,1.0
19427,5536,GO:1990635,PPP5C,proximal dendrite,1.0
19428,5536,GO:2000324,PPP5C,positive regulation of glucocorticoid receptor signaling pathway,1.0
19519,5754,GO:0001822,PTK7,kidney development,1.0
19520,5754,GO:0003281,PTK7,ventricular septum development,1.0
19521,5754,GO:0004672,PTK7,protein kinase activity,1.0
19522,5754,GO:0005515,PTK7,protein binding,1.0
19523,5754,GO:0005524,PTK7,ATP binding,1.0
19524,5754,GO:0005886,PTK7,plasma membrane,1.0
19525,5754,GO:0005887,PTK7,integral component of plasma membrane,1.0
19526,5754,GO:0005911,PTK7,cell-cell junction,1.0
19527,5754,GO:0005911,PTK7,cell-cell junction,1.0
19528,5754,GO:0005925,PTK7,focal adhesion,1.0
19529,5754,GO:0006468,PTK7,protein phosphorylation,1.0
19530,5754,GO:0007155,PTK7,cell adhesion,1.0
19531,5754,GO:0007155,PTK7,cell adhesion,1.0
19532,5754,GO:0007165,PTK7,signal transduction,1.0
19533,5754,GO:0010976,PTK7,positive regulation of neuron projection development,1.0
19534,5754,GO:0016477,PTK7,cell migration,1.0
19535,5754,GO:0031532,PTK7,actin cytoskeleton reorganization,1.0
19536,5754,GO:0042060,PTK7,wound healing,1.0
19537,5754,GO:0045198,PTK7,establishment of epithelial cell apical/basal polarity,1.0
19538,5754,GO:0050839,PTK7,cell adhesion molecule binding,1.0
19539,5754,GO:0060026,PTK7,convergent extension,1.0
19540,5754,GO:0060484,PTK7,lung-associated mesenchyme development,1.0
19541,5754,GO:0060828,PTK7,regulation of canonical Wnt signaling pathway,1.0
19542,5754,GO:0060976,PTK7,coronary vasculature development,1.0
19543,5754,GO:0071300,PTK7,cellular response to retinoic acid,1.0
19544,5754,GO:0090103,PTK7,cochlea morphogenesis,1.0
19545,5754,GO:0090179,PTK7,planar cell polarity pathway involved in neural tube closure,1.0
19546,5754,GO:0090263,PTK7,positive regulation of canonical Wnt signaling pathway,1.0
19547,5754,GO:1904929,PTK7,"coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway",1.0
19548,5781,GO:0000077,PTPN11,DNA damage checkpoint,1.0
19549,5781,GO:0000187,PTPN11,activation of MAPK activity,1.0
19550,5781,GO:0001784,PTPN11,phosphotyrosine residue binding,1.0
19551,5781,GO:0001784,PTPN11,phosphotyrosine residue binding,1.0
19552,5781,GO:0004721,PTPN11,phosphoprotein phosphatase activity,1.0
19553,5781,GO:0004725,PTPN11,protein tyrosine phosphatase activity,1.0
19554,5781,GO:0004725,PTPN11,protein tyrosine phosphatase activity,1.0
19555,5781,GO:0004725,PTPN11,protein tyrosine phosphatase activity,1.0
19556,5781,GO:0004725,PTPN11,protein tyrosine phosphatase activity,1.0
19557,5781,GO:0004726,PTPN11,non-membrane spanning protein tyrosine phosphatase activity,1.0
19558,5781,GO:0004726,PTPN11,non-membrane spanning protein tyrosine phosphatase activity,1.0
19559,5781,GO:0004726,PTPN11,non-membrane spanning protein tyrosine phosphatase activity,1.0
19560,5781,GO:0005158,PTPN11,insulin receptor binding,1.0
19561,5781,GO:0005515,PTPN11,protein binding,1.0
19562,5781,GO:0005634,PTPN11,nucleus,1.0
19563,5781,GO:0005654,PTPN11,nucleoplasm,1.0
19564,5781,GO:0005737,PTPN11,cytoplasm,1.0
19565,5781,GO:0005739,PTPN11,mitochondrion,1.0
19566,5781,GO:0005829,PTPN11,cytosol,1.0
19567,5781,GO:0006641,PTPN11,triglyceride metabolic process,1.0
19568,5781,GO:0007173,PTPN11,epidermal growth factor receptor signaling pathway,1.0
19569,5781,GO:0007229,PTPN11,integrin-mediated signaling pathway,1.0
19570,5781,GO:0007411,PTPN11,axon guidance,1.0
19571,5781,GO:0007420,PTPN11,brain development,1.0
19572,5781,GO:0007507,PTPN11,heart development,1.0
19573,5781,GO:0008543,PTPN11,fibroblast growth factor receptor signaling pathway,1.0
19574,5781,GO:0008543,PTPN11,fibroblast growth factor receptor signaling pathway,1.0
19575,5781,GO:0009755,PTPN11,hormone-mediated signaling pathway,1.0
19576,5781,GO:0019221,PTPN11,cytokine-mediated signaling pathway,1.0
19577,5781,GO:0019901,PTPN11,protein kinase binding,1.0
19578,5781,GO:0019904,PTPN11,protein domain specific binding,1.0
19579,5781,GO:0021697,PTPN11,cerebellar cortex formation,1.0
19580,5781,GO:0030159,PTPN11,signaling receptor complex adaptor activity,1.0
19581,5781,GO:0030168,PTPN11,platelet activation,1.0
19582,5781,GO:0030220,PTPN11,platelet formation,1.0
19583,5781,GO:0030971,PTPN11,receptor tyrosine kinase binding,1.0
19584,5781,GO:0031295,PTPN11,T cell costimulation,1.0
19585,5781,GO:0031748,PTPN11,D1 dopamine receptor binding,1.0
19586,5781,GO:0032331,PTPN11,negative regulation of chondrocyte differentiation,1.0
19587,5781,GO:0032528,PTPN11,microvillus organization,1.0
19588,5781,GO:0032728,PTPN11,positive regulation of interferon-beta production,1.0
19589,5781,GO:0032755,PTPN11,positive regulation of interleukin-6 production,1.0
19590,5781,GO:0032760,PTPN11,positive regulation of tumor necrosis factor production,1.0
19591,5781,GO:0032991,PTPN11,protein-containing complex,1.0
19592,5781,GO:0033277,PTPN11,abortive mitotic cell cycle,1.0
19593,5781,GO:0033628,PTPN11,regulation of cell adhesion mediated by integrin,1.0
19594,5781,GO:0033629,PTPN11,negative regulation of cell adhesion mediated by integrin,1.0
19595,5781,GO:0035264,PTPN11,multicellular organism growth,1.0
19596,5781,GO:0035265,PTPN11,organ growth,1.0
19597,5781,GO:0035335,PTPN11,peptidyl-tyrosine dephosphorylation,1.0
19598,5781,GO:0035335,PTPN11,peptidyl-tyrosine dephosphorylation,1.0
19599,5781,GO:0035855,PTPN11,megakaryocyte development,1.0
19600,5781,GO:0036302,PTPN11,atrioventricular canal development,1.0
19601,5781,GO:0038127,PTPN11,ERBB signaling pathway,1.0
19602,5781,GO:0042445,PTPN11,hormone metabolic process,1.0
19603,5781,GO:0042593,PTPN11,glucose homeostasis,1.0
19604,5781,GO:0043254,PTPN11,regulation of protein-containing complex assembly,1.0
19605,5781,GO:0043274,PTPN11,phospholipase binding,1.0
19606,5781,GO:0043560,PTPN11,insulin receptor substrate binding,1.0
19607,5781,GO:0045296,PTPN11,cadherin binding,1.0
19608,5781,GO:0045778,PTPN11,positive regulation of ossification,1.0
19609,5781,GO:0045931,PTPN11,positive regulation of mitotic cell cycle,1.0
19610,5781,GO:0046326,PTPN11,positive regulation of glucose import,1.0
19611,5781,GO:0046628,PTPN11,positive regulation of insulin receptor signaling pathway,1.0
19612,5781,GO:0046676,PTPN11,negative regulation of insulin secretion,1.0
19613,5781,GO:0046825,PTPN11,regulation of protein export from nucleus,1.0
19614,5781,GO:0046887,PTPN11,positive regulation of hormone secretion,1.0
19615,5781,GO:0048008,PTPN11,platelet-derived growth factor receptor signaling pathway,1.0
19616,5781,GO:0048011,PTPN11,neurotrophin TRK receptor signaling pathway,1.0
19617,5781,GO:0048013,PTPN11,ephrin receptor signaling pathway,1.0
19618,5781,GO:0048609,PTPN11,multicellular organismal reproductive process,1.0
19619,5781,GO:0048806,PTPN11,genitalia development,1.0
19620,5781,GO:0048839,PTPN11,inner ear development,1.0
19621,5781,GO:0048873,PTPN11,homeostasis of number of cells within a tissue,1.0
19622,5781,GO:0050731,PTPN11,positive regulation of peptidyl-tyrosine phosphorylation,1.0
19623,5781,GO:0050839,PTPN11,cell adhesion molecule binding,1.0
19624,5781,GO:0050900,PTPN11,leukocyte migration,1.0
19625,5781,GO:0051428,PTPN11,peptide hormone receptor binding,1.0
19626,5781,GO:0051463,PTPN11,negative regulation of cortisol secretion,1.0
19627,5781,GO:0051897,PTPN11,positive regulation of protein kinase B signaling,1.0
19628,5781,GO:0060020,PTPN11,Bergmann glial cell differentiation,1.0
19629,5781,GO:0060125,PTPN11,negative regulation of growth hormone secretion,1.0
19630,5781,GO:0060325,PTPN11,face morphogenesis,1.0
19631,5781,GO:0060338,PTPN11,regulation of type I interferon-mediated signaling pathway,1.0
19632,5781,GO:0061582,PTPN11,intestinal epithelial cell migration,1.0
19633,5781,GO:0070102,PTPN11,interleukin-6-mediated signaling pathway,1.0
19634,5781,GO:0070374,PTPN11,positive regulation of ERK1 and ERK2 cascade,1.0
19635,5781,GO:0071260,PTPN11,cellular response to mechanical stimulus,1.0
19636,5781,GO:0071345,PTPN11,cellular response to cytokine stimulus,1.0
19637,5781,GO:0071364,PTPN11,cellular response to epidermal growth factor stimulus,1.0
19638,5781,GO:1990782,PTPN11,protein tyrosine kinase binding,1.0
20040,10743,GO:0001501,RAI1,skeletal system development,1.0
20041,10743,GO:0005515,RAI1,protein binding,1.0
20042,10743,GO:0005634,RAI1,nucleus,1.0
20043,10743,GO:0005654,RAI1,nucleoplasm,1.0
20044,10743,GO:0005737,RAI1,cytoplasm,1.0
20045,10743,GO:0006357,RAI1,regulation of transcription by RNA polymerase II,1.0
20046,10743,GO:0032922,RAI1,circadian regulation of gene expression,1.0
20047,10743,GO:0032922,RAI1,circadian regulation of gene expression,1.0
20048,10743,GO:0040015,RAI1,negative regulation of multicellular organism growth,1.0
20049,10743,GO:0045893,RAI1,"positive regulation of transcription, DNA-templated",1.0
20050,10743,GO:0046872,RAI1,metal ion binding,1.0
20167,5649,GO:0000904,RELN,cell morphogenesis involved in differentiation,1.0
20168,5649,GO:0001764,RELN,neuron migration,1.0
20169,5649,GO:0001764,RELN,neuron migration,1.0
20170,5649,GO:0005576,RELN,extracellular region,1.0
20171,5649,GO:0005615,RELN,extracellular space,1.0
20172,5649,GO:0005615,RELN,extracellular space,1.0
20173,5649,GO:0005737,RELN,cytoplasm,1.0
20174,5649,GO:0005886,RELN,plasma membrane,1.0
20175,5649,GO:0006508,RELN,proteolysis,1.0
20176,5649,GO:0007155,RELN,cell adhesion,1.0
20177,5649,GO:0007411,RELN,axon guidance,1.0
20178,5649,GO:0007411,RELN,axon guidance,1.0
20179,5649,GO:0007417,RELN,central nervous system development,1.0
20180,5649,GO:0007417,RELN,central nervous system development,1.0
20181,5649,GO:0007420,RELN,brain development,1.0
20182,5649,GO:0007616,RELN,long-term memory,1.0
20183,5649,GO:0007626,RELN,locomotory behavior,1.0
20184,5649,GO:0008236,RELN,serine-type peptidase activity,1.0
20185,5649,GO:0008306,RELN,associative learning,1.0
20186,5649,GO:0010001,RELN,glial cell differentiation,1.0
20187,5649,GO:0010976,RELN,positive regulation of neuron projection development,1.0
20188,5649,GO:0014068,RELN,positive regulation of phosphatidylinositol 3-kinase signaling,1.0
20189,5649,GO:0016358,RELN,dendrite development,1.0
20190,5649,GO:0018108,RELN,peptidyl-tyrosine phosphorylation,1.0
20191,5649,GO:0021511,RELN,spinal cord patterning,1.0
20192,5649,GO:0021517,RELN,ventral spinal cord development,1.0
20193,5649,GO:0021766,RELN,hippocampus development,1.0
20194,5649,GO:0021800,RELN,cerebral cortex tangential migration,1.0
20195,5649,GO:0021819,RELN,layer formation in cerebral cortex,1.0
20196,5649,GO:0030425,RELN,dendrite,1.0
20197,5649,GO:0031012,RELN,extracellular matrix,1.0
20198,5649,GO:0032008,RELN,positive regulation of TOR signaling,1.0
20199,5649,GO:0032793,RELN,positive regulation of CREB transcription factor activity,1.0
20200,5649,GO:0038026,RELN,reelin-mediated signaling pathway,1.0
20201,5649,GO:0043005,RELN,neuron projection,1.0
20202,5649,GO:0045860,RELN,positive regulation of protein kinase activity,1.0
20203,5649,GO:0046872,RELN,metal ion binding,1.0
20204,5649,GO:0048265,RELN,response to pain,1.0
20205,5649,GO:0050731,RELN,positive regulation of peptidyl-tyrosine phosphorylation,1.0
20206,5649,GO:0050795,RELN,regulation of behavior,1.0
20207,5649,GO:0050804,RELN,modulation of chemical synaptic transmission,1.0
20208,5649,GO:0051057,RELN,positive regulation of small GTPase mediated signal transduction,1.0
20209,5649,GO:0051968,RELN,"positive regulation of synaptic transmission, glutamatergic",1.0
20210,5649,GO:0060291,RELN,long-term synaptic potentiation,1.0
20211,5649,GO:0061003,RELN,positive regulation of dendritic spine morphogenesis,1.0
20212,5649,GO:0061098,RELN,positive regulation of protein tyrosine kinase activity,1.0
20213,5649,GO:0070325,RELN,lipoprotein particle receptor binding,1.0
20214,5649,GO:0070325,RELN,lipoprotein particle receptor binding,1.0
20215,5649,GO:0070326,RELN,very-low-density lipoprotein particle receptor binding,1.0
20216,5649,GO:0090129,RELN,positive regulation of synapse maturation,1.0
20217,5649,GO:0097114,RELN,NMDA glutamate receptor clustering,1.0
20218,5649,GO:0097119,RELN,postsynaptic density protein 95 clustering,1.0
20219,5649,GO:0097120,RELN,receptor localization to synapse,1.0
20220,5649,GO:0097477,RELN,lateral motor column neuron migration,1.0
20221,5649,GO:1900273,RELN,positive regulation of long-term synaptic potentiation,1.0
20222,5649,GO:1902078,RELN,positive regulation of lateral motor column neuron migration,1.0
20223,5649,GO:2000310,RELN,regulation of NMDA receptor activity,1.0
20224,5649,GO:2000463,RELN,positive regulation of excitatory postsynaptic potential,1.0
20225,5649,GO:2000969,RELN,positive regulation of AMPA receptor activity,1.0
20226,473,GO:0000118,RERE,histone deacetylase complex,1.0
20227,473,GO:0001085,RERE,RNA polymerase II transcription factor binding,1.0
20228,473,GO:0003682,RERE,chromatin binding,1.0
20229,473,GO:0003713,RERE,transcription coactivator activity,1.0
20230,473,GO:0003714,RERE,transcription corepressor activity,1.0
20231,473,GO:0005515,RERE,protein binding,1.0
20232,473,GO:0005634,RERE,nucleus,1.0
20233,473,GO:0005634,RERE,nucleus,1.0
20234,473,GO:0006338,RERE,chromatin remodeling,1.0
20235,473,GO:0006355,RERE,"regulation of transcription, DNA-templated",1.0
20236,473,GO:0008270,RERE,zinc ion binding,1.0
20237,473,GO:0021691,RERE,cerebellar Purkinje cell layer maturation,1.0
20238,473,GO:0021930,RERE,cerebellar granule cell precursor proliferation,1.0
20239,473,GO:0021942,RERE,radial glia guided migration of Purkinje cell,1.0
20240,473,GO:0043565,RERE,sequence-specific DNA binding,1.0
20241,473,GO:0048755,RERE,branching morphogenesis of a nerve,1.0
20242,473,GO:0048813,RERE,dendrite morphogenesis,1.0
20243,473,GO:1903507,RERE,negative regulation of nucleic acid-templated transcription,1.0
20244,473,GO:1903508,RERE,positive regulation of nucleic acid-templated transcription,1.0
20245,5991,GO:0000785,RFX3,chromatin,1.0
20246,5991,GO:0000785,RFX3,chromatin,1.0
20247,5991,GO:0000785,RFX3,chromatin,1.0
20248,5991,GO:0000976,RFX3,transcription regulatory region sequence-specific DNA binding,1.0
20249,5991,GO:0000978,RFX3,RNA polymerase II cis-regulatory region sequence-specific DNA binding,1.0
20250,5991,GO:0000981,RFX3,"DNA-binding transcription factor activity, RNA polymerase II-specific",1.0
20251,5991,GO:0000981,RFX3,"DNA-binding transcription factor activity, RNA polymerase II-specific",1.0
20252,5991,GO:0003677,RFX3,DNA binding,1.0
20253,5991,GO:0005515,RFX3,protein binding,1.0
20254,5991,GO:0005576,RFX3,extracellular region,1.0
20255,5991,GO:0005634,RFX3,nucleus,1.0
20256,5991,GO:0005667,RFX3,transcription regulator complex,1.0
20257,5991,GO:0006351,RFX3,"transcription, DNA-templated",1.0
20258,5991,GO:0006355,RFX3,"regulation of transcription, DNA-templated",1.0
20259,5991,GO:0006357,RFX3,regulation of transcription by RNA polymerase II,1.0
20260,5991,GO:0031018,RFX3,endocrine pancreas development,1.0
20261,5991,GO:0045892,RFX3,"negative regulation of transcription, DNA-templated",1.0
20262,5991,GO:0045893,RFX3,"positive regulation of transcription, DNA-templated",1.0
20263,5991,GO:0045944,RFX3,positive regulation of transcription by RNA polymerase II,1.0
20264,5991,GO:0048469,RFX3,cell maturation,1.0
20265,5991,GO:0050796,RFX3,regulation of insulin secretion,1.0
20266,5991,GO:0060271,RFX3,cilium assembly,1.0
20267,5991,GO:0060285,RFX3,cilium-dependent cell motility,1.0
20268,5991,GO:0060287,RFX3,epithelial cilium movement involved in determination of left/right asymmetry,1.0
20269,5991,GO:0072560,RFX3,type B pancreatic cell maturation,1.0
20270,5991,GO:1990837,RFX3,sequence-specific double-stranded DNA binding,1.0
20271,5991,GO:2000078,RFX3,positive regulation of type B pancreatic cell development,1.0
20310,22999,GO:0003723,RIMS1,RNA binding,1.0
20311,22999,GO:0005515,RIMS1,protein binding,1.0
20312,22999,GO:0005829,RIMS1,cytosol,1.0
20313,22999,GO:0005886,RIMS1,plasma membrane,1.0
20314,22999,GO:0006886,RIMS1,intracellular protein transport,1.0
20315,22999,GO:0007269,RIMS1,neurotransmitter secretion,1.0
20316,22999,GO:0007601,RIMS1,visual perception,1.0
20317,22999,GO:0010628,RIMS1,positive regulation of gene expression,1.0
20318,22999,GO:0014047,RIMS1,glutamate secretion,1.0
20319,22999,GO:0016079,RIMS1,synaptic vesicle exocytosis,1.0
20320,22999,GO:0017156,RIMS1,calcium-ion regulated exocytosis,1.0
20321,22999,GO:0030695,RIMS1,GTPase regulator activity,1.0
20322,22999,GO:0031267,RIMS1,small GTPase binding,1.0
20323,22999,GO:0031267,RIMS1,small GTPase binding,1.0
20324,22999,GO:0042391,RIMS1,regulation of membrane potential,1.0
20325,22999,GO:0042734,RIMS1,presynaptic membrane,1.0
20326,22999,GO:0042734,RIMS1,presynaptic membrane,1.0
20327,22999,GO:0042734,RIMS1,presynaptic membrane,1.0
20328,22999,GO:0042995,RIMS1,cell projection,1.0
20329,22999,GO:0044325,RIMS1,ion channel binding,1.0
20330,22999,GO:0045055,RIMS1,regulated exocytosis,1.0
20331,22999,GO:0046872,RIMS1,metal ion binding,1.0
20332,22999,GO:0046903,RIMS1,secretion,1.0
20333,22999,GO:0046928,RIMS1,regulation of neurotransmitter secretion,1.0
20334,22999,GO:0048167,RIMS1,regulation of synaptic plasticity,1.0
20335,22999,GO:0048786,RIMS1,presynaptic active zone,1.0
20336,22999,GO:0048788,RIMS1,cytoskeleton of presynaptic active zone,1.0
20337,22999,GO:0048791,RIMS1,calcium ion-regulated exocytosis of neurotransmitter,1.0
20338,22999,GO:0050790,RIMS1,regulation of catalytic activity,1.0
20339,22999,GO:0050806,RIMS1,positive regulation of synaptic transmission,1.0
20340,22999,GO:0050896,RIMS1,response to stimulus,1.0
20341,22999,GO:0060478,RIMS1,acrosomal vesicle exocytosis,1.0
20342,22999,GO:0061025,RIMS1,membrane fusion,1.0
20343,22999,GO:0065003,RIMS1,protein-containing complex assembly,1.0
20344,22999,GO:0097151,RIMS1,positive regulation of inhibitory postsynaptic potential,1.0
20345,22999,GO:1903861,RIMS1,positive regulation of dendrite extension,1.0
20346,22999,GO:2000300,RIMS1,regulation of synaptic vesicle exocytosis,1.0
20347,22999,GO:2000463,RIMS1,positive regulation of excitatory postsynaptic potential,1.0
20521,6096,GO:0000785,RORB,chromatin,1.0
20522,6096,GO:0000978,RORB,RNA polymerase II cis-regulatory region sequence-specific DNA binding,1.0
20523,6096,GO:0000978,RORB,RNA polymerase II cis-regulatory region sequence-specific DNA binding,1.0
20524,6096,GO:0000981,RORB,"DNA-binding transcription factor activity, RNA polymerase II-specific",1.0
20525,6096,GO:0000981,RORB,"DNA-binding transcription factor activity, RNA polymerase II-specific",1.0
20526,6096,GO:0001228,RORB,"DNA-binding transcription activator activity, RNA polymerase II-specific",1.0
20527,6096,GO:0003700,RORB,DNA-binding transcription factor activity,1.0
20528,6096,GO:0004879,RORB,nuclear receptor activity,1.0
20529,6096,GO:0004879,RORB,nuclear receptor activity,1.0
20530,6096,GO:0005515,RORB,protein binding,1.0
20531,6096,GO:0005634,RORB,nucleus,1.0
20532,6096,GO:0005634,RORB,nucleus,1.0
20533,6096,GO:0005654,RORB,nucleoplasm,1.0
20534,6096,GO:0005654,RORB,nucleoplasm,1.0
20535,6096,GO:0006355,RORB,"regulation of transcription, DNA-templated",1.0
20536,6096,GO:0006357,RORB,regulation of transcription by RNA polymerase II,1.0
20537,6096,GO:0006367,RORB,transcription initiation from RNA polymerase II promoter,1.0
20538,6096,GO:0007186,RORB,G protein-coupled receptor signaling pathway,1.0
20539,6096,GO:0007601,RORB,visual perception,1.0
20540,6096,GO:0008134,RORB,transcription factor binding,1.0
20541,6096,GO:0008270,RORB,zinc ion binding,1.0
20542,6096,GO:0008502,RORB,melatonin receptor activity,1.0
20543,6096,GO:0030522,RORB,intracellular receptor signaling pathway,1.0
20544,6096,GO:0035881,RORB,amacrine cell differentiation,1.0
20545,6096,GO:0042462,RORB,eye photoreceptor cell development,1.0
20546,6096,GO:0042752,RORB,regulation of circadian rhythm,1.0
20547,6096,GO:0045668,RORB,negative regulation of osteoblast differentiation,1.0
20548,6096,GO:0045892,RORB,"negative regulation of transcription, DNA-templated",1.0
20549,6096,GO:0045893,RORB,"positive regulation of transcription, DNA-templated",1.0
20550,6096,GO:0045944,RORB,positive regulation of transcription by RNA polymerase II,1.0
20551,6096,GO:0046548,RORB,retinal rod cell development,1.0
20552,6096,GO:0046549,RORB,retinal cone cell development,1.0
20553,6096,GO:0048511,RORB,rhythmic process,1.0
20554,6096,GO:0060041,RORB,retina development in camera-type eye,1.0
20555,6096,GO:0071300,RORB,cellular response to retinoic acid,1.0
20556,6096,GO:1990837,RORB,sequence-specific double-stranded DNA binding,1.0
20755,6304,GO:0000122,SATB1,negative regulation of transcription by RNA polymerase II,1.0
20756,6304,GO:0000122,SATB1,negative regulation of transcription by RNA polymerase II,1.0
20757,6304,GO:0000785,SATB1,chromatin,1.0
20758,6304,GO:0000785,SATB1,chromatin,1.0
20759,6304,GO:0000792,SATB1,heterochromatin,1.0
20760,6304,GO:0000977,SATB1,RNA polymerase II transcription regulatory region sequence-specific DNA binding,1.0
20761,6304,GO:0000978,SATB1,RNA polymerase II cis-regulatory region sequence-specific DNA binding,1.0
20762,6304,GO:0000981,SATB1,"DNA-binding transcription factor activity, RNA polymerase II-specific",1.0
20763,6304,GO:0000981,SATB1,"DNA-binding transcription factor activity, RNA polymerase II-specific",1.0
20764,6304,GO:0001227,SATB1,"DNA-binding transcription repressor activity, RNA polymerase II-specific",1.0
20765,6304,GO:0003682,SATB1,chromatin binding,1.0
20766,6304,GO:0003690,SATB1,double-stranded DNA binding,1.0
20767,6304,GO:0005515,SATB1,protein binding,1.0
20768,6304,GO:0005634,SATB1,nucleus,1.0
20769,6304,GO:0005654,SATB1,nucleoplasm,1.0
20770,6304,GO:0005654,SATB1,nucleoplasm,1.0
20771,6304,GO:0006325,SATB1,chromatin organization,1.0
20772,6304,GO:0006338,SATB1,chromatin remodeling,1.0
20773,6304,GO:0006357,SATB1,regulation of transcription by RNA polymerase II,1.0
20774,6304,GO:0008544,SATB1,epidermis development,1.0
20775,6304,GO:0016032,SATB1,viral process,1.0
20776,6304,GO:0016363,SATB1,nuclear matrix,1.0
20777,6304,GO:0016571,SATB1,histone methylation,1.0
20778,6304,GO:0016604,SATB1,nuclear body,1.0
20779,6304,GO:0016605,SATB1,PML body,1.0
20780,6304,GO:0043367,SATB1,"CD4-positive, alpha-beta T cell differentiation",1.0
20781,6304,GO:0043374,SATB1,"CD8-positive, alpha-beta T cell differentiation",1.0
20782,6304,GO:0043565,SATB1,sequence-specific DNA binding,1.0
20783,6304,GO:0050798,SATB1,activated T cell proliferation,1.0
20784,6304,GO:0060004,SATB1,reflex,1.0
20819,6323,GO:0001518,SCN1A,voltage-gated sodium channel complex,1.0
20820,6323,GO:0005244,SCN1A,voltage-gated ion channel activity,1.0
20821,6323,GO:0005248,SCN1A,voltage-gated sodium channel activity,1.0
20822,6323,GO:0005248,SCN1A,voltage-gated sodium channel activity,1.0
20823,6323,GO:0005248,SCN1A,voltage-gated sodium channel activity,1.0
20824,6323,GO:0005654,SCN1A,nucleoplasm,1.0
20825,6323,GO:0005886,SCN1A,plasma membrane,1.0
20826,6323,GO:0006814,SCN1A,sodium ion transport,1.0
20827,6323,GO:0006814,SCN1A,sodium ion transport,1.0
20828,6323,GO:0016604,SCN1A,nuclear body,1.0
20829,6323,GO:0019228,SCN1A,neuronal action potential,1.0
20830,6323,GO:0030018,SCN1A,Z disc,1.0
20831,6323,GO:0030424,SCN1A,axon,1.0
20832,6323,GO:0034765,SCN1A,regulation of ion transmembrane transport,1.0
20833,6323,GO:0035725,SCN1A,sodium ion transmembrane transport,1.0
20834,6323,GO:0050966,SCN1A,detection of mechanical stimulus involved in sensory perception of pain,1.0
20835,6323,GO:0086002,SCN1A,cardiac muscle cell action potential involved in contraction,1.0
20836,6323,GO:0086010,SCN1A,membrane depolarization during action potential,1.0
20837,6326,GO:0001518,SCN2A,voltage-gated sodium channel complex,1.0
20838,6326,GO:0005244,SCN2A,voltage-gated ion channel activity,1.0
20839,6326,GO:0005248,SCN2A,voltage-gated sodium channel activity,1.0
20840,6326,GO:0005248,SCN2A,voltage-gated sodium channel activity,1.0
20841,6326,GO:0005248,SCN2A,voltage-gated sodium channel activity,1.0
20842,6326,GO:0005515,SCN2A,protein binding,1.0
20843,6326,GO:0005886,SCN2A,plasma membrane,1.0
20844,6326,GO:0005887,SCN2A,integral component of plasma membrane,1.0
20845,6326,GO:0006814,SCN2A,sodium ion transport,1.0
20846,6326,GO:0007399,SCN2A,nervous system development,1.0
20847,6326,GO:0007613,SCN2A,memory,1.0
20848,6326,GO:0008627,SCN2A,intrinsic apoptotic signaling pathway in response to osmotic stress,1.0
20849,6326,GO:0014704,SCN2A,intercalated disc,1.0
20850,6326,GO:0016020,SCN2A,membrane,1.0
20851,6326,GO:0019228,SCN2A,neuronal action potential,1.0
20852,6326,GO:0030315,SCN2A,T-tubule,1.0
20853,6326,GO:0030424,SCN2A,axon,1.0
20854,6326,GO:0030424,SCN2A,axon,1.0
20855,6326,GO:0031226,SCN2A,intrinsic component of plasma membrane,1.0
20856,6326,GO:0033268,SCN2A,node of Ranvier,1.0
20857,6326,GO:0033270,SCN2A,paranode region of axon,1.0
20858,6326,GO:0034706,SCN2A,sodium channel complex,1.0
20859,6326,GO:0034765,SCN2A,regulation of ion transmembrane transport,1.0
20860,6326,GO:0035725,SCN2A,sodium ion transmembrane transport,1.0
20861,6326,GO:0035725,SCN2A,sodium ion transmembrane transport,1.0
20862,6326,GO:0042552,SCN2A,myelination,1.0
20863,6326,GO:0051402,SCN2A,neuron apoptotic process,1.0
20864,6326,GO:0071456,SCN2A,cellular response to hypoxia,1.0
20865,6326,GO:0086010,SCN2A,membrane depolarization during action potential,1.0
20974,6334,GO:0001518,SCN8A,voltage-gated sodium channel complex,1.0
20975,6334,GO:0001518,SCN8A,voltage-gated sodium channel complex,1.0
20976,6334,GO:0005244,SCN8A,voltage-gated ion channel activity,1.0
20977,6334,GO:0005248,SCN8A,voltage-gated sodium channel activity,1.0
20978,6334,GO:0005248,SCN8A,voltage-gated sodium channel activity,1.0
20979,6334,GO:0005248,SCN8A,voltage-gated sodium channel activity,1.0
20980,6334,GO:0005248,SCN8A,voltage-gated sodium channel activity,1.0
20981,6334,GO:0005515,SCN8A,protein binding,1.0
20982,6334,GO:0005524,SCN8A,ATP binding,1.0
20983,6334,GO:0005886,SCN8A,plasma membrane,1.0
20984,6334,GO:0006814,SCN8A,sodium ion transport,1.0
20985,6334,GO:0007399,SCN8A,nervous system development,1.0
20986,6334,GO:0007422,SCN8A,peripheral nervous system development,1.0
20987,6334,GO:0016021,SCN8A,integral component of membrane,1.0
20988,6334,GO:0019228,SCN8A,neuronal action potential,1.0
20989,6334,GO:0030018,SCN8A,Z disc,1.0
20990,6334,GO:0030054,SCN8A,cell junction,1.0
20991,6334,GO:0030424,SCN8A,axon,1.0
20992,6334,GO:0030424,SCN8A,axon,1.0
20993,6334,GO:0031410,SCN8A,cytoplasmic vesicle,1.0
20994,6334,GO:0033268,SCN8A,node of Ranvier,1.0
20995,6334,GO:0034765,SCN8A,regulation of ion transmembrane transport,1.0
20996,6334,GO:0035725,SCN8A,sodium ion transmembrane transport,1.0
20997,6334,GO:0042552,SCN8A,myelination,1.0
20998,6334,GO:0043194,SCN8A,axon initial segment,1.0
20999,6334,GO:0086010,SCN8A,membrane depolarization during action potential,1.0
21183,26040,GO:0003677,SETBP1,DNA binding,1.0
21184,26040,GO:0005515,SETBP1,protein binding,1.0
21185,26040,GO:0005654,SETBP1,nucleoplasm,1.0
21186,26040,GO:0005829,SETBP1,cytosol,1.0
21187,26040,GO:0016604,SETBP1,nuclear body,1.0
21201,29072,GO:0001525,SETD2,angiogenesis,1.0
21202,29072,GO:0001763,SETD2,morphogenesis of a branching structure,1.0
21203,29072,GO:0001843,SETD2,neural tube closure,1.0
21204,29072,GO:0005515,SETD2,protein binding,1.0
21205,29072,GO:0005634,SETD2,nucleus,1.0
21206,29072,GO:0005654,SETD2,nucleoplasm,1.0
21207,29072,GO:0005694,SETD2,chromosome,1.0
21208,29072,GO:0006298,SETD2,mismatch repair,1.0
21209,29072,GO:0006355,SETD2,"regulation of transcription, DNA-templated",1.0
21210,29072,GO:0006368,SETD2,transcription elongation from RNA polymerase II promoter,1.0
21211,29072,GO:0010569,SETD2,regulation of double-strand break repair via homologous recombination,1.0
21212,29072,GO:0010793,SETD2,regulation of mRNA export from nucleus,1.0
21213,29072,GO:0016032,SETD2,viral process,1.0
21214,29072,GO:0016279,SETD2,protein-lysine N-methyltransferase activity,1.0
21215,29072,GO:0018023,SETD2,peptidyl-lysine trimethylation,1.0
21216,29072,GO:0018024,SETD2,histone-lysine N-methyltransferase activity,1.0
21217,29072,GO:0018024,SETD2,histone-lysine N-methyltransferase activity,1.0
21218,29072,GO:0018024,SETD2,histone-lysine N-methyltransferase activity,1.0
21219,29072,GO:0018026,SETD2,peptidyl-lysine monomethylation,1.0
21220,29072,GO:0030900,SETD2,forebrain development,1.0
21221,29072,GO:0032465,SETD2,regulation of cytokinesis,1.0
21222,29072,GO:0032727,SETD2,positive regulation of interferon-alpha production,1.0
21223,29072,GO:0034340,SETD2,response to type I interferon,1.0
21224,29072,GO:0034728,SETD2,nucleosome organization,1.0
21225,29072,GO:0035441,SETD2,cell migration involved in vasculogenesis,1.0
21226,29072,GO:0035987,SETD2,endodermal cell differentiation,1.0
21227,29072,GO:0043014,SETD2,alpha-tubulin binding,1.0
21228,29072,GO:0046872,SETD2,metal ion binding,1.0
21229,29072,GO:0046975,SETD2,histone methyltransferase activity (H3-K36 specific),1.0
21230,29072,GO:0048332,SETD2,mesoderm morphogenesis,1.0
21231,29072,GO:0048701,SETD2,embryonic cranial skeleton morphogenesis,1.0
21232,29072,GO:0048863,SETD2,stem cell differentiation,1.0
21233,29072,GO:0048864,SETD2,stem cell development,1.0
21234,29072,GO:0051607,SETD2,defense response to virus,1.0
21235,29072,GO:0060039,SETD2,pericardium development,1.0
21236,29072,GO:0060669,SETD2,embryonic placenta morphogenesis,1.0
21237,29072,GO:0060977,SETD2,coronary vasculature morphogenesis,1.0
21238,29072,GO:0097198,SETD2,histone H3-K36 trimethylation,1.0
21239,29072,GO:0097198,SETD2,histone H3-K36 trimethylation,1.0
21240,29072,GO:0097676,SETD2,histone H3-K36 dimethylation,1.0
21241,29072,GO:1902850,SETD2,microtubule cytoskeleton organization involved in mitosis,1.0
21242,29072,GO:1905634,SETD2,regulation of protein localization to chromatin,1.0
21243,55209,GO:0000791,SETD5,euchromatin,1.0
21244,55209,GO:0005634,SETD5,nucleus,1.0
21245,55209,GO:0005654,SETD5,nucleoplasm,1.0
21246,55209,GO:0016569,SETD5,covalent chromatin modification,1.0
21247,55209,GO:0016593,SETD5,Cdc73/Paf1 complex,1.0
21248,55209,GO:0032784,SETD5,"regulation of DNA-templated transcription, elongation",1.0
21249,55209,GO:0035065,SETD5,regulation of histone acetylation,1.0
21250,55209,GO:0046974,SETD5,histone methyltransferase activity (H3-K9 specific),1.0
21251,55209,GO:0046975,SETD5,histone methyltransferase activity (H3-K36 specific),1.0
21252,55209,GO:0050890,SETD5,cognition,1.0
21253,55209,GO:0051567,SETD5,histone H3-K9 methylation,1.0
21254,55209,GO:0051963,SETD5,regulation of synapse assembly,1.0
21255,55209,GO:0097198,SETD5,histone H3-K36 trimethylation,1.0
21256,55209,GO:1902275,SETD5,regulation of chromatin organization,1.0
21426,22941,GO:0001750,SHANK2,photoreceptor outer segment,1.0
21427,22941,GO:0001917,SHANK2,photoreceptor inner segment,1.0
21428,22941,GO:0005515,SHANK2,protein binding,1.0
21429,22941,GO:0005575,SHANK2,cellular_component,1.0
21430,22941,GO:0005829,SHANK2,cytosol,1.0
21431,22941,GO:0005883,SHANK2,neurofilament,1.0
21432,22941,GO:0005886,SHANK2,plasma membrane,1.0
21433,22941,GO:0007416,SHANK2,synapse assembly,1.0
21434,22941,GO:0007610,SHANK2,behavior,1.0
21435,22941,GO:0007612,SHANK2,learning,1.0
21436,22941,GO:0008284,SHANK2,positive regulation of cell population proliferation,1.0
21437,22941,GO:0008328,SHANK2,ionotropic glutamate receptor complex,1.0
21438,22941,GO:0008328,SHANK2,ionotropic glutamate receptor complex,1.0
21439,22941,GO:0014069,SHANK2,postsynaptic density,1.0
21440,22941,GO:0014069,SHANK2,postsynaptic density,1.0
21441,22941,GO:0016324,SHANK2,apical plasma membrane,1.0
21442,22941,GO:0017124,SHANK2,SH3 domain binding,1.0
21443,22941,GO:0030160,SHANK2,synaptic receptor adaptor activity,1.0
21444,22941,GO:0030160,SHANK2,synaptic receptor adaptor activity,1.0
21445,22941,GO:0030426,SHANK2,growth cone,1.0
21446,22941,GO:0030534,SHANK2,adult behavior,1.0
21447,22941,GO:0031526,SHANK2,brush border membrane,1.0
21448,22941,GO:0035176,SHANK2,social behavior,1.0
21449,22941,GO:0035255,SHANK2,ionotropic glutamate receptor binding,1.0
21450,22941,GO:0035255,SHANK2,ionotropic glutamate receptor binding,1.0
21451,22941,GO:0035331,SHANK2,negative regulation of hippo signaling,1.0
21452,22941,GO:0043005,SHANK2,neuron projection,1.0
21453,22941,GO:0043025,SHANK2,neuronal cell body,1.0
21454,22941,GO:0043197,SHANK2,dendritic spine,1.0
21455,22941,GO:0043197,SHANK2,dendritic spine,1.0
21456,22941,GO:0045211,SHANK2,postsynaptic membrane,1.0
21457,22941,GO:0045211,SHANK2,postsynaptic membrane,1.0
21458,22941,GO:0048854,SHANK2,brain morphogenesis,1.0
21459,22941,GO:0051124,SHANK2,synaptic growth at neuromuscular junction,1.0
21460,22941,GO:0051968,SHANK2,"positive regulation of synaptic transmission, glutamatergic",1.0
21461,22941,GO:0060170,SHANK2,ciliary membrane,1.0
21462,22941,GO:0060291,SHANK2,long-term synaptic potentiation,1.0
21463,22941,GO:0060291,SHANK2,long-term synaptic potentiation,1.0
21464,22941,GO:0060292,SHANK2,long-term synaptic depression,1.0
21465,22941,GO:0060997,SHANK2,dendritic spine morphogenesis,1.0
21466,22941,GO:0060999,SHANK2,positive regulation of dendritic spine development,1.0
21467,22941,GO:0071625,SHANK2,vocalization behavior,1.0
21468,22941,GO:0097107,SHANK2,postsynaptic density assembly,1.0
21469,22941,GO:2000311,SHANK2,regulation of AMPA receptor activity,1.0
21470,22941,GO:2000463,SHANK2,positive regulation of excitatory postsynaptic potential,1.0
21471,85358,GO:0000165,SHANK3,MAPK cascade,1.0
21472,85358,GO:0003779,SHANK3,actin binding,1.0
21473,85358,GO:0005515,SHANK3,protein binding,1.0
21474,85358,GO:0005829,SHANK3,cytosol,1.0
21475,85358,GO:0007411,SHANK3,axon guidance,1.0
21476,85358,GO:0007416,SHANK3,synapse assembly,1.0
21477,85358,GO:0007610,SHANK3,behavior,1.0
21478,85358,GO:0007612,SHANK3,learning,1.0
21479,85358,GO:0007612,SHANK3,learning,1.0
21480,85358,GO:0007613,SHANK3,memory,1.0
21481,85358,GO:0008022,SHANK3,protein C-terminus binding,1.0
21482,85358,GO:0008270,SHANK3,zinc ion binding,1.0
21483,85358,GO:0008328,SHANK3,ionotropic glutamate receptor complex,1.0
21484,85358,GO:0014069,SHANK3,postsynaptic density,1.0
21485,85358,GO:0014069,SHANK3,postsynaptic density,1.0
21486,85358,GO:0017124,SHANK3,SH3 domain binding,1.0
21487,85358,GO:0021773,SHANK3,striatal medium spiny neuron differentiation,1.0
21488,85358,GO:0030160,SHANK3,synaptic receptor adaptor activity,1.0
21489,85358,GO:0030160,SHANK3,synaptic receptor adaptor activity,1.0
21490,85358,GO:0030534,SHANK3,adult behavior,1.0
21491,85358,GO:0031234,SHANK3,extrinsic component of cytoplasmic side of plasma membrane,1.0
21492,85358,GO:0032232,SHANK3,negative regulation of actin filament bundle assembly,1.0
21493,85358,GO:0035176,SHANK3,social behavior,1.0
21494,85358,GO:0035176,SHANK3,social behavior,1.0
21495,85358,GO:0035255,SHANK3,ionotropic glutamate receptor binding,1.0
21496,85358,GO:0035255,SHANK3,ionotropic glutamate receptor binding,1.0
21497,85358,GO:0042297,SHANK3,vocal learning,1.0
21498,85358,GO:0043005,SHANK3,neuron projection,1.0
21499,85358,GO:0043197,SHANK3,dendritic spine,1.0
21500,85358,GO:0043621,SHANK3,protein self-association,1.0
21501,85358,GO:0044309,SHANK3,neuron spine,1.0
21502,85358,GO:0045211,SHANK3,postsynaptic membrane,1.0
21503,85358,GO:0045794,SHANK3,negative regulation of cell volume,1.0
21504,85358,GO:0048170,SHANK3,positive regulation of long-term neuronal synaptic plasticity,1.0
21505,85358,GO:0048854,SHANK3,brain morphogenesis,1.0
21506,85358,GO:0048854,SHANK3,brain morphogenesis,1.0
21507,85358,GO:0051124,SHANK3,synaptic growth at neuromuscular junction,1.0
21508,85358,GO:0051835,SHANK3,positive regulation of synapse structural plasticity,1.0
21509,85358,GO:0051968,SHANK3,"positive regulation of synaptic transmission, glutamatergic",1.0
21510,85358,GO:0051968,SHANK3,"positive regulation of synaptic transmission, glutamatergic",1.0
21511,85358,GO:0060170,SHANK3,ciliary membrane,1.0
21512,85358,GO:0060291,SHANK3,long-term synaptic potentiation,1.0
21513,85358,GO:0060997,SHANK3,dendritic spine morphogenesis,1.0
21514,85358,GO:0060997,SHANK3,dendritic spine morphogenesis,1.0
21515,85358,GO:0060999,SHANK3,positive regulation of dendritic spine development,1.0
21516,85358,GO:0060999,SHANK3,positive regulation of dendritic spine development,1.0
21517,85358,GO:0061001,SHANK3,regulation of dendritic spine morphogenesis,1.0
21518,85358,GO:0071625,SHANK3,vocalization behavior,1.0
21519,85358,GO:0071625,SHANK3,vocalization behavior,1.0
21520,85358,GO:0097107,SHANK3,postsynaptic density assembly,1.0
21521,85358,GO:0097107,SHANK3,postsynaptic density assembly,1.0
21522,85358,GO:0097110,SHANK3,scaffold protein binding,1.0
21523,85358,GO:0097113,SHANK3,AMPA glutamate receptor clustering,1.0
21524,85358,GO:0097114,SHANK3,NMDA glutamate receptor clustering,1.0
21525,85358,GO:0097117,SHANK3,guanylate kinase-associated protein clustering,1.0
21526,85358,GO:1900271,SHANK3,regulation of long-term synaptic potentiation,1.0
21527,85358,GO:1900273,SHANK3,positive regulation of long-term synaptic potentiation,1.0
21528,85358,GO:1900451,SHANK3,positive regulation of glutamate receptor signaling pathway,1.0
21529,85358,GO:1900452,SHANK3,regulation of long-term synaptic depression,1.0
21530,85358,GO:2000311,SHANK3,regulation of AMPA receptor activity,1.0
21531,85358,GO:2000463,SHANK3,positive regulation of excitatory postsynaptic potential,1.0
21532,85358,GO:2000463,SHANK3,positive regulation of excitatory postsynaptic potential,1.0
21533,85358,GO:2000969,SHANK3,positive regulation of AMPA receptor activity,1.0
21607,25942,GO:0000118,SIN3A,histone deacetylase complex,1.0
21608,25942,GO:0000122,SIN3A,negative regulation of transcription by RNA polymerase II,1.0
21609,25942,GO:0000122,SIN3A,negative regulation of transcription by RNA polymerase II,1.0
21610,25942,GO:0000776,SIN3A,kinetochore,1.0
21611,25942,GO:0000785,SIN3A,chromatin,1.0
21612,25942,GO:0001102,SIN3A,RNA polymerase II activating transcription factor binding,1.0
21613,25942,GO:0001103,SIN3A,RNA polymerase II repressing transcription factor binding,1.0
21614,25942,GO:0001701,SIN3A,in utero embryonic development,1.0
21615,25942,GO:0002218,SIN3A,activation of innate immune response,1.0
21616,25942,GO:0002230,SIN3A,positive regulation of defense response to virus by host,1.0
21617,25942,GO:0002244,SIN3A,hematopoietic progenitor cell differentiation,1.0
21618,25942,GO:0003677,SIN3A,DNA binding,1.0
21619,25942,GO:0003682,SIN3A,chromatin binding,1.0
21620,25942,GO:0003714,SIN3A,transcription corepressor activity,1.0
21621,25942,GO:0004407,SIN3A,histone deacetylase activity,1.0
21622,25942,GO:0005515,SIN3A,protein binding,1.0
21623,25942,GO:0005634,SIN3A,nucleus,1.0
21624,25942,GO:0005634,SIN3A,nucleus,1.0
21625,25942,GO:0005654,SIN3A,nucleoplasm,1.0
21626,25942,GO:0005654,SIN3A,nucleoplasm,1.0
21627,25942,GO:0005730,SIN3A,nucleolus,1.0
21628,25942,GO:0006260,SIN3A,DNA replication,1.0
21629,25942,GO:0006476,SIN3A,protein deacetylation,1.0
21630,25942,GO:0010971,SIN3A,positive regulation of G2/M transition of mitotic cell cycle,1.0
21631,25942,GO:0016575,SIN3A,histone deacetylation,1.0
21632,25942,GO:0016580,SIN3A,Sin3 complex,1.0
21633,25942,GO:0016580,SIN3A,Sin3 complex,1.0
21634,25942,GO:0016580,SIN3A,Sin3 complex,1.0
21635,25942,GO:0017053,SIN3A,transcription repressor complex,1.0
21636,25942,GO:0019216,SIN3A,regulation of lipid metabolic process,1.0
21637,25942,GO:0021895,SIN3A,cerebral cortex neuron differentiation,1.0
21638,25942,GO:0030516,SIN3A,regulation of axon extension,1.0
21639,25942,GO:0031937,SIN3A,positive regulation of chromatin silencing,1.0
21640,25942,GO:0034613,SIN3A,cellular protein localization,1.0
21641,25942,GO:0042754,SIN3A,negative regulation of circadian rhythm,1.0
21642,25942,GO:0043066,SIN3A,negative regulation of apoptotic process,1.0
21643,25942,GO:0045652,SIN3A,regulation of megakaryocyte differentiation,1.0
21644,25942,GO:0045666,SIN3A,positive regulation of neuron differentiation,1.0
21645,25942,GO:0045892,SIN3A,"negative regulation of transcription, DNA-templated",1.0
21646,25942,GO:0045944,SIN3A,positive regulation of transcription by RNA polymerase II,1.0
21647,25942,GO:0048511,SIN3A,rhythmic process,1.0
21648,25942,GO:0051595,SIN3A,response to methylglyoxal,1.0
21649,25942,GO:0071333,SIN3A,cellular response to glucose stimulus,1.0
21650,25942,GO:0140416,SIN3A,transcription regulator inhibitor activity,1.0
21651,25942,GO:1900181,SIN3A,negative regulation of protein localization to nucleus,1.0
21652,25942,GO:1901675,SIN3A,negative regulation of histone H3-K27 acetylation,1.0
21653,25942,GO:2000678,SIN3A,negative regulation of transcription regulatory region DNA binding,1.0
22016,6529,GO:0005332,SLC6A1,gamma-aminobutyric acid:sodium symporter activity,1.0
22017,6529,GO:0005332,SLC6A1,gamma-aminobutyric acid:sodium symporter activity,1.0
22018,6529,GO:0005515,SLC6A1,protein binding,1.0
22019,6529,GO:0005886,SLC6A1,plasma membrane,1.0
22020,6529,GO:0005886,SLC6A1,plasma membrane,1.0
22021,6529,GO:0005886,SLC6A1,plasma membrane,1.0
22022,6529,GO:0007268,SLC6A1,chemical synaptic transmission,1.0
22023,6529,GO:0007613,SLC6A1,memory,1.0
22024,6529,GO:0008306,SLC6A1,associative learning,1.0
22025,6529,GO:0009636,SLC6A1,response to toxic substance,1.0
22026,6529,GO:0009744,SLC6A1,response to sucrose,1.0
22027,6529,GO:0009986,SLC6A1,cell surface,1.0
22028,6529,GO:0010035,SLC6A1,response to inorganic substance,1.0
22029,6529,GO:0010288,SLC6A1,response to lead ion,1.0
22030,6529,GO:0014054,SLC6A1,positive regulation of gamma-aminobutyric acid secretion,1.0
22031,6529,GO:0014074,SLC6A1,response to purine-containing compound,1.0
22032,6529,GO:0015185,SLC6A1,gamma-aminobutyric acid transmembrane transporter activity,1.0
22033,6529,GO:0015378,SLC6A1,sodium:chloride symporter activity,1.0
22034,6529,GO:0016020,SLC6A1,membrane,1.0
22035,6529,GO:0016021,SLC6A1,integral component of membrane,1.0
22036,6529,GO:0030424,SLC6A1,axon,1.0
22037,6529,GO:0030424,SLC6A1,axon,1.0
22038,6529,GO:0032229,SLC6A1,"negative regulation of synaptic transmission, GABAergic",1.0
22039,6529,GO:0032355,SLC6A1,response to estradiol,1.0
22040,6529,GO:0035725,SLC6A1,sodium ion transmembrane transport,1.0
22041,6529,GO:0042165,SLC6A1,neurotransmitter binding,1.0
22042,6529,GO:0042220,SLC6A1,response to cocaine,1.0
22043,6529,GO:0042802,SLC6A1,identical protein binding,1.0
22044,6529,GO:0043005,SLC6A1,neuron projection,1.0
22045,6529,GO:0043025,SLC6A1,neuronal cell body,1.0
22046,6529,GO:0046872,SLC6A1,metal ion binding,1.0
22047,6529,GO:0050808,SLC6A1,synapse organization,1.0
22048,6529,GO:0051592,SLC6A1,response to calcium ion,1.0
22049,6529,GO:0051939,SLC6A1,gamma-aminobutyric acid import,1.0
22050,6529,GO:0051939,SLC6A1,gamma-aminobutyric acid import,1.0
22051,6529,GO:0098658,SLC6A1,inorganic anion import across plasma membrane,1.0
22052,6529,GO:0098719,SLC6A1,sodium ion import across plasma membrane,1.0
22053,6529,GO:0098810,SLC6A1,neurotransmitter reuptake,1.0
22054,6529,GO:0098982,SLC6A1,GABA-ergic synapse,1.0
22055,6529,GO:0099055,SLC6A1,integral component of postsynaptic membrane,1.0
22056,6529,GO:0099056,SLC6A1,integral component of presynaptic membrane,1.0
22057,6529,GO:0150104,SLC6A1,transport across blood-brain barrier,1.0
22058,6529,GO:1902476,SLC6A1,chloride transmembrane transport,1.0
22059,6497,GO:0000122,SKI,negative regulation of transcription by RNA polymerase II,1.0
22060,6497,GO:0000122,SKI,negative regulation of transcription by RNA polymerase II,1.0
22061,6497,GO:0000122,SKI,negative regulation of transcription by RNA polymerase II,1.0
22062,6497,GO:0000122,SKI,negative regulation of transcription by RNA polymerase II,1.0
22063,6497,GO:0000978,SKI,RNA polymerase II cis-regulatory region sequence-specific DNA binding,1.0
22064,6497,GO:0000981,SKI,"DNA-binding transcription factor activity, RNA polymerase II-specific",1.0
22065,6497,GO:0001227,SKI,"DNA-binding transcription repressor activity, RNA polymerase II-specific",1.0
22066,6497,GO:0001843,SKI,neural tube closure,1.0
22067,6497,GO:0002089,SKI,lens morphogenesis in camera-type eye,1.0
22068,6497,GO:0005515,SKI,protein binding,1.0
22069,6497,GO:0005634,SKI,nucleus,1.0
22070,6497,GO:0005634,SKI,nucleus,1.0
22071,6497,GO:0005654,SKI,nucleoplasm,1.0
22072,6497,GO:0005654,SKI,nucleoplasm,1.0
22073,6497,GO:0005667,SKI,transcription regulator complex,1.0
22074,6497,GO:0005667,SKI,transcription regulator complex,1.0
22075,6497,GO:0005737,SKI,cytoplasm,1.0
22076,6497,GO:0005813,SKI,centrosome,1.0
22077,6497,GO:0006351,SKI,"transcription, DNA-templated",1.0
22078,6497,GO:0007179,SKI,transforming growth factor beta receptor signaling pathway,1.0
22079,6497,GO:0008270,SKI,zinc ion binding,1.0
22080,6497,GO:0008285,SKI,negative regulation of cell population proliferation,1.0
22081,6497,GO:0009948,SKI,anterior/posterior axis specification,1.0
22082,6497,GO:0010626,SKI,negative regulation of Schwann cell proliferation,1.0
22083,6497,GO:0014902,SKI,myotube differentiation,1.0
22084,6497,GO:0016604,SKI,nuclear body,1.0
22085,6497,GO:0016605,SKI,PML body,1.0
22086,6497,GO:0017053,SKI,transcription repressor complex,1.0
22087,6497,GO:0019901,SKI,protein kinase binding,1.0
22088,6497,GO:0019904,SKI,protein domain specific binding,1.0
22089,6497,GO:0021772,SKI,olfactory bulb development,1.0
22090,6497,GO:0022011,SKI,myelination in peripheral nervous system,1.0
22091,6497,GO:0030177,SKI,positive regulation of Wnt signaling pathway,1.0
22092,6497,GO:0030326,SKI,embryonic limb morphogenesis,1.0
22093,6497,GO:0030509,SKI,BMP signaling pathway,1.0
22094,6497,GO:0030512,SKI,negative regulation of transforming growth factor beta receptor signaling pathway,1.0
22095,6497,GO:0030512,SKI,negative regulation of transforming growth factor beta receptor signaling pathway,1.0
22096,6497,GO:0030512,SKI,negative regulation of transforming growth factor beta receptor signaling pathway,1.0
22097,6497,GO:0030512,SKI,negative regulation of transforming growth factor beta receptor signaling pathway,1.0
22098,6497,GO:0030514,SKI,negative regulation of BMP signaling pathway,1.0
22099,6497,GO:0030514,SKI,negative regulation of BMP signaling pathway,1.0
22100,6497,GO:0030514,SKI,negative regulation of BMP signaling pathway,1.0
22101,6497,GO:0031064,SKI,negative regulation of histone deacetylation,1.0
22102,6497,GO:0031625,SKI,ubiquitin protein ligase binding,1.0
22103,6497,GO:0032926,SKI,negative regulation of activin receptor signaling pathway,1.0
22104,6497,GO:0032991,SKI,protein-containing complex,1.0
22105,6497,GO:0035019,SKI,somatic stem cell population maintenance,1.0
22106,6497,GO:0042802,SKI,identical protein binding,1.0
22107,6497,GO:0043010,SKI,camera-type eye development,1.0
22108,6497,GO:0043388,SKI,positive regulation of DNA binding,1.0
22109,6497,GO:0043585,SKI,nose morphogenesis,1.0
22110,6497,GO:0045668,SKI,negative regulation of osteoblast differentiation,1.0
22111,6497,GO:0045944,SKI,positive regulation of transcription by RNA polymerase II,1.0
22112,6497,GO:0046332,SKI,SMAD binding,1.0
22113,6497,GO:0046332,SKI,SMAD binding,1.0
22114,6497,GO:0046811,SKI,histone deacetylase inhibitor activity,1.0
22115,6497,GO:0048147,SKI,negative regulation of fibroblast proliferation,1.0
22116,6497,GO:0048593,SKI,camera-type eye morphogenesis,1.0
22117,6497,GO:0048741,SKI,skeletal muscle fiber development,1.0
22118,6497,GO:0048870,SKI,cell motility,1.0
22119,6497,GO:0060021,SKI,roof of mouth development,1.0
22120,6497,GO:0060041,SKI,retina development in camera-type eye,1.0
22121,6497,GO:0060325,SKI,face morphogenesis,1.0
22122,6497,GO:0060349,SKI,bone morphogenesis,1.0
22123,6497,GO:0060395,SKI,SMAD protein signal transduction,1.0
22124,6497,GO:0070491,SKI,repressing transcription factor binding,1.0
22332,10479,GO:0005739,SLC9A6,mitochondrion,1.0
22333,10479,GO:0005770,SLC9A6,late endosome,1.0
22334,10479,GO:0005789,SLC9A6,endoplasmic reticulum membrane,1.0
22335,10479,GO:0005886,SLC9A6,plasma membrane,1.0
22336,10479,GO:0005886,SLC9A6,plasma membrane,1.0
22337,10479,GO:0006811,SLC9A6,ion transport,1.0
22338,10479,GO:0015385,SLC9A6,sodium:proton antiporter activity,1.0
22339,10479,GO:0015386,SLC9A6,potassium:proton antiporter activity,1.0
22340,10479,GO:0016021,SLC9A6,integral component of membrane,1.0
22341,10479,GO:0030425,SLC9A6,dendrite,1.0
22342,10479,GO:0031547,SLC9A6,brain-derived neurotrophic factor receptor signaling pathway,1.0
22343,10479,GO:0031901,SLC9A6,early endosome membrane,1.0
22344,10479,GO:0031901,SLC9A6,early endosome membrane,1.0
22345,10479,GO:0043231,SLC9A6,intracellular membrane-bounded organelle,1.0
22346,10479,GO:0043679,SLC9A6,axon terminus,1.0
22347,10479,GO:0044308,SLC9A6,axonal spine,1.0
22348,10479,GO:0048675,SLC9A6,axon extension,1.0
22349,10479,GO:0048812,SLC9A6,neuron projection morphogenesis,1.0
22350,10479,GO:0050808,SLC9A6,synapse organization,1.0
22351,10479,GO:0051386,SLC9A6,regulation of neurotrophin TRK receptor signaling pathway,1.0
22352,10479,GO:0051453,SLC9A6,regulation of intracellular pH,1.0
22353,10479,GO:0051453,SLC9A6,regulation of intracellular pH,1.0
22354,10479,GO:0055037,SLC9A6,recycling endosome,1.0
22355,10479,GO:0055038,SLC9A6,recycling endosome membrane,1.0
22356,10479,GO:0060996,SLC9A6,dendritic spine development,1.0
22357,10479,GO:0071805,SLC9A6,potassium ion transmembrane transport,1.0
22358,10479,GO:0097484,SLC9A6,dendrite extension,1.0
22359,10479,GO:0098656,SLC9A6,anion transmembrane transport,1.0
22360,10479,GO:0098719,SLC9A6,sodium ion import across plasma membrane,1.0
22361,10479,GO:1902600,SLC9A6,proton transmembrane transport,1.0
22625,6601,GO:0000785,SMARCC2,chromatin,1.0
22626,6601,GO:0003713,SMARCC2,transcription coactivator activity,1.0
22627,6601,GO:0005515,SMARCC2,protein binding,1.0
22628,6601,GO:0005654,SMARCC2,nucleoplasm,1.0
22629,6601,GO:0005654,SMARCC2,nucleoplasm,1.0
22630,6601,GO:0006337,SMARCC2,nucleosome disassembly,1.0
22631,6601,GO:0006338,SMARCC2,chromatin remodeling,1.0
22632,6601,GO:0006357,SMARCC2,regulation of transcription by RNA polymerase II,1.0
22633,6601,GO:0007399,SMARCC2,nervous system development,1.0
22634,6601,GO:0016514,SMARCC2,SWI/SNF complex,1.0
22635,6601,GO:0016514,SMARCC2,SWI/SNF complex,1.0
22636,6601,GO:0031492,SMARCC2,nucleosomal DNA binding,1.0
22637,6601,GO:0032991,SMARCC2,protein-containing complex,1.0
22638,6601,GO:0042393,SMARCC2,histone binding,1.0
22639,6601,GO:0043044,SMARCC2,ATP-dependent chromatin remodeling,1.0
22640,6601,GO:0043044,SMARCC2,ATP-dependent chromatin remodeling,1.0
22641,6601,GO:0045892,SMARCC2,"negative regulation of transcription, DNA-templated",1.0
22642,6601,GO:0045893,SMARCC2,"positive regulation of transcription, DNA-templated",1.0
22643,6601,GO:0045893,SMARCC2,"positive regulation of transcription, DNA-templated",1.0
22644,6601,GO:0071564,SMARCC2,npBAF complex,1.0
22645,6601,GO:0071564,SMARCC2,npBAF complex,1.0
22646,6601,GO:0071565,SMARCC2,nBAF complex,1.0
22647,6601,GO:0071565,SMARCC2,nBAF complex,1.0
22928,6651,GO:0000226,SON,microtubule cytoskeleton organization,1.0
22929,6651,GO:0000281,SON,mitotic cytokinesis,1.0
22930,6651,GO:0003677,SON,DNA binding,1.0
22931,6651,GO:0003723,SON,RNA binding,1.0
22932,6651,GO:0003723,SON,RNA binding,1.0
22933,6651,GO:0003723,SON,RNA binding,1.0
22934,6651,GO:0005515,SON,protein binding,1.0
22935,6651,GO:0006397,SON,mRNA processing,1.0
22936,6651,GO:0008380,SON,RNA splicing,1.0
22937,6651,GO:0016607,SON,nuclear speck,1.0
22938,6651,GO:0043066,SON,negative regulation of apoptotic process,1.0
22939,6651,GO:0043484,SON,regulation of RNA splicing,1.0
22940,6651,GO:0048024,SON,"regulation of mRNA splicing, via spliceosome",1.0
22941,6651,GO:0048024,SON,"regulation of mRNA splicing, via spliceosome",1.0
22942,6651,GO:0050733,SON,RS domain binding,1.0
22943,6651,GO:0051726,SON,regulation of cell cycle,1.0
22944,6660,GO:0000785,SOX5,chromatin,1.0
22945,6660,GO:0000976,SOX5,transcription regulatory region sequence-specific DNA binding,1.0
22946,6660,GO:0000978,SOX5,RNA polymerase II cis-regulatory region sequence-specific DNA binding,1.0
22947,6660,GO:0000981,SOX5,"DNA-binding transcription factor activity, RNA polymerase II-specific",1.0
22948,6660,GO:0000981,SOX5,"DNA-binding transcription factor activity, RNA polymerase II-specific",1.0
22949,6660,GO:0000987,SOX5,cis-regulatory region sequence-specific DNA binding,1.0
22950,6660,GO:0001502,SOX5,cartilage condensation,1.0
22951,6660,GO:0002062,SOX5,chondrocyte differentiation,1.0
22952,6660,GO:0003700,SOX5,DNA-binding transcription factor activity,1.0
22953,6660,GO:0005515,SOX5,protein binding,1.0
22954,6660,GO:0005634,SOX5,nucleus,1.0
22955,6660,GO:0006357,SOX5,regulation of transcription by RNA polymerase II,1.0
22956,6660,GO:0006366,SOX5,transcription by RNA polymerase II,1.0
22957,6660,GO:0032332,SOX5,positive regulation of chondrocyte differentiation,1.0
22958,6660,GO:0032332,SOX5,positive regulation of chondrocyte differentiation,1.0
22959,6660,GO:0045165,SOX5,cell fate commitment,1.0
22960,6660,GO:0051216,SOX5,cartilage development,1.0
22961,6660,GO:0055059,SOX5,asymmetric neuroblast division,1.0
22962,6660,GO:0061036,SOX5,positive regulation of cartilage development,1.0
22963,6660,GO:0071560,SOX5,cellular response to transforming growth factor beta stimulus,1.0
22964,6660,GO:2000741,SOX5,positive regulation of mesenchymal stem cell differentiation,1.0
22978,6683,GO:0000281,SPAST,mitotic cytokinesis,1.0
22979,6683,GO:0001578,SPAST,microtubule bundle formation,1.0
22980,6683,GO:0005515,SPAST,protein binding,1.0
22981,6683,GO:0005524,SPAST,ATP binding,1.0
22982,6683,GO:0005634,SPAST,nucleus,1.0
22983,6683,GO:0005634,SPAST,nucleus,1.0
22984,6683,GO:0005654,SPAST,nucleoplasm,1.0
22985,6683,GO:0005737,SPAST,cytoplasm,1.0
22986,6683,GO:0005768,SPAST,endosome,1.0
22987,6683,GO:0005783,SPAST,endoplasmic reticulum,1.0
22988,6683,GO:0005789,SPAST,endoplasmic reticulum membrane,1.0
22989,6683,GO:0005811,SPAST,lipid droplet,1.0
22990,6683,GO:0005813,SPAST,centrosome,1.0
22991,6683,GO:0005819,SPAST,spindle,1.0
22992,6683,GO:0005829,SPAST,cytosol,1.0
22993,6683,GO:0005874,SPAST,microtubule,1.0
22994,6683,GO:0006888,SPAST,endoplasmic reticulum to Golgi vesicle-mediated transport,1.0
22995,6683,GO:0007409,SPAST,axonogenesis,1.0
22996,6683,GO:0008017,SPAST,microtubule binding,1.0
22997,6683,GO:0008089,SPAST,anterograde axonal transport,1.0
22998,6683,GO:0008152,SPAST,metabolic process,1.0
22999,6683,GO:0008568,SPAST,microtubule-severing ATPase activity,1.0
23000,6683,GO:0008568,SPAST,microtubule-severing ATPase activity,1.0
23001,6683,GO:0010458,SPAST,exit from mitosis,1.0
23002,6683,GO:0015630,SPAST,microtubule cytoskeleton,1.0
23003,6683,GO:0016021,SPAST,integral component of membrane,1.0
23004,6683,GO:0016853,SPAST,isomerase activity,1.0
23005,6683,GO:0016887,SPAST,ATPase activity,1.0
23006,6683,GO:0019896,SPAST,axonal transport of mitochondrion,1.0
23007,6683,GO:0030496,SPAST,midbody,1.0
23008,6683,GO:0030496,SPAST,midbody,1.0
23009,6683,GO:0030496,SPAST,midbody,1.0
23010,6683,GO:0031117,SPAST,positive regulation of microtubule depolymerization,1.0
23011,6683,GO:0031122,SPAST,cytoplasmic microtubule organization,1.0
23012,6683,GO:0031410,SPAST,cytoplasmic vesicle,1.0
23013,6683,GO:0031468,SPAST,nuclear envelope reassembly,1.0
23014,6683,GO:0031965,SPAST,nuclear membrane,1.0
23015,6683,GO:0032467,SPAST,positive regulation of cytokinesis,1.0
23016,6683,GO:0032506,SPAST,cytokinetic process,1.0
23017,6683,GO:0034214,SPAST,protein hexamerization,1.0
23018,6683,GO:0043014,SPAST,alpha-tubulin binding,1.0
23019,6683,GO:0044877,SPAST,protein-containing complex binding,1.0
23020,6683,GO:0048471,SPAST,perinuclear region of cytoplasm,1.0
23021,6683,GO:0048487,SPAST,beta-tubulin binding,1.0
23022,6683,GO:0048487,SPAST,beta-tubulin binding,1.0
23023,6683,GO:0051013,SPAST,microtubule severing,1.0
23024,6683,GO:0051013,SPAST,microtubule severing,1.0
23025,6683,GO:0051013,SPAST,microtubule severing,1.0
23026,6683,GO:0051228,SPAST,mitotic spindle disassembly,1.0
23027,6683,GO:0051260,SPAST,protein homooligomerization,1.0
23028,6683,GO:0061640,SPAST,cytoskeleton-dependent cytokinesis,1.0
23029,6683,GO:0070062,SPAST,extracellular exosome,1.0
23030,6683,GO:0090148,SPAST,membrane fission,1.0
23031,6683,GO:1904115,SPAST,axon cytoplasm,1.0
23059,10847,GO:0000812,SRCAP,Swr1 complex,1.0
23060,10847,GO:0003677,SRCAP,DNA binding,1.0
23061,10847,GO:0003713,SRCAP,transcription coactivator activity,1.0
23062,10847,GO:0004386,SRCAP,helicase activity,1.0
23063,10847,GO:0004402,SRCAP,histone acetyltransferase activity,1.0
23064,10847,GO:0005515,SRCAP,protein binding,1.0
23065,10847,GO:0005524,SRCAP,ATP binding,1.0
23066,10847,GO:0005634,SRCAP,nucleus,1.0
23067,10847,GO:0005654,SRCAP,nucleoplasm,1.0
23068,10847,GO:0005794,SRCAP,Golgi apparatus,1.0
23069,10847,GO:0006357,SRCAP,regulation of transcription by RNA polymerase II,1.0
23070,10847,GO:0016032,SRCAP,viral process,1.0
23071,10847,GO:0016458,SRCAP,gene silencing,1.0
23072,10847,GO:0016573,SRCAP,histone acetylation,1.0
23073,10847,GO:0016604,SRCAP,nuclear body,1.0
23074,10847,GO:0016887,SRCAP,ATPase activity,1.0
23075,10847,GO:0032991,SRCAP,protein-containing complex,1.0
23076,10847,GO:0042393,SRCAP,histone binding,1.0
23077,10847,GO:0043044,SRCAP,ATP-dependent chromatin remodeling,1.0
23078,10847,GO:0043486,SRCAP,histone exchange,1.0
23079,10847,GO:0048471,SRCAP,perinuclear region of cytoplasm,1.0
23080,10847,GO:1903508,SRCAP,positive regulation of nucleic acid-templated transcription,1.0
23223,6812,GO:0000149,STXBP1,SNARE binding,1.0
23224,6812,GO:0002576,STXBP1,platelet degranulation,1.0
23225,6812,GO:0003006,STXBP1,developmental process involved in reproduction,1.0
23226,6812,GO:0003723,STXBP1,RNA binding,1.0
23227,6812,GO:0005515,STXBP1,protein binding,1.0
23228,6812,GO:0005654,STXBP1,nucleoplasm,1.0
23229,6812,GO:0005737,STXBP1,cytoplasm,1.0
23230,6812,GO:0005739,STXBP1,mitochondrion,1.0
23231,6812,GO:0005829,STXBP1,cytosol,1.0
23232,6812,GO:0005829,STXBP1,cytosol,1.0
23233,6812,GO:0005856,STXBP1,cytoskeleton,1.0
23234,6812,GO:0005886,STXBP1,plasma membrane,1.0
23235,6812,GO:0005886,STXBP1,plasma membrane,1.0
23236,6812,GO:0005886,STXBP1,plasma membrane,1.0
23237,6812,GO:0006886,STXBP1,intracellular protein transport,1.0
23238,6812,GO:0006904,STXBP1,vesicle docking involved in exocytosis,1.0
23239,6812,GO:0006904,STXBP1,vesicle docking involved in exocytosis,1.0
23240,6812,GO:0007269,STXBP1,neurotransmitter secretion,1.0
23241,6812,GO:0007269,STXBP1,neurotransmitter secretion,1.0
23242,6812,GO:0007274,STXBP1,neuromuscular synaptic transmission,1.0
23243,6812,GO:0007412,STXBP1,axon target recognition,1.0
23244,6812,GO:0010807,STXBP1,regulation of synaptic vesicle priming,1.0
23245,6812,GO:0014047,STXBP1,glutamate secretion,1.0
23246,6812,GO:0016082,STXBP1,synaptic vesicle priming,1.0
23247,6812,GO:0016188,STXBP1,synaptic vesicle maturation,1.0
23248,6812,GO:0016192,STXBP1,vesicle-mediated transport,1.0
23249,6812,GO:0017075,STXBP1,syntaxin-1 binding,1.0
23250,6812,GO:0017075,STXBP1,syntaxin-1 binding,1.0
23251,6812,GO:0017075,STXBP1,syntaxin-1 binding,1.0
23252,6812,GO:0019901,STXBP1,protein kinase binding,1.0
23253,6812,GO:0019904,STXBP1,protein domain specific binding,1.0
23254,6812,GO:0019905,STXBP1,syntaxin binding,1.0
23255,6812,GO:0019905,STXBP1,syntaxin binding,1.0
23256,6812,GO:0030141,STXBP1,secretory granule,1.0
23257,6812,GO:0030424,STXBP1,axon,1.0
23258,6812,GO:0031091,STXBP1,platelet alpha granule,1.0
23259,6812,GO:0031333,STXBP1,negative regulation of protein-containing complex assembly,1.0
23260,6812,GO:0031630,STXBP1,regulation of synaptic vesicle fusion to presynaptic active zone membrane,1.0
23261,6812,GO:0032229,STXBP1,"negative regulation of synaptic transmission, GABAergic",1.0
23262,6812,GO:0032355,STXBP1,response to estradiol,1.0
23263,6812,GO:0032991,STXBP1,protein-containing complex,1.0
23264,6812,GO:0035493,STXBP1,SNARE complex assembly,1.0
23265,6812,GO:0035542,STXBP1,regulation of SNARE complex assembly,1.0
23266,6812,GO:0042802,STXBP1,identical protein binding,1.0
23267,6812,GO:0043274,STXBP1,phospholipase binding,1.0
23268,6812,GO:0043306,STXBP1,positive regulation of mast cell degranulation,1.0
23269,6812,GO:0043524,STXBP1,negative regulation of neuron apoptotic process,1.0
23270,6812,GO:0045335,STXBP1,phagocytic vesicle,1.0
23271,6812,GO:0045956,STXBP1,positive regulation of calcium ion-dependent exocytosis,1.0
23272,6812,GO:0047485,STXBP1,protein N-terminus binding,1.0
23273,6812,GO:0048471,STXBP1,perinuclear region of cytoplasm,1.0
23274,6812,GO:0048787,STXBP1,presynaptic active zone membrane,1.0
23275,6812,GO:0050821,STXBP1,protein stabilization,1.0
23276,6812,GO:0060292,STXBP1,long-term synaptic depression,1.0
23277,6812,GO:0070062,STXBP1,extracellular exosome,1.0
23278,6812,GO:0070527,STXBP1,platelet aggregation,1.0
23279,6812,GO:0071346,STXBP1,cellular response to interferon-gamma,1.0
23280,6812,GO:0072659,STXBP1,protein localization to plasma membrane,1.0
23281,6812,GO:0098794,STXBP1,postsynapse,1.0
23282,6812,GO:0098978,STXBP1,glutamatergic synapse,1.0
23283,6812,GO:0099525,STXBP1,presynaptic dense core vesicle exocytosis,1.0
23284,6812,GO:0106022,STXBP1,positive regulation of vesicle docking,1.0
23285,6812,GO:1903296,STXBP1,"positive regulation of glutamate secretion, neurotransmission",1.0
23286,6812,GO:2000367,STXBP1,regulation of acrosomal vesicle exocytosis,1.0
23485,8831,GO:0000165,SYNGAP1,MAPK cascade,1.0
23486,8831,GO:0005096,SYNGAP1,GTPase activator activity,1.0
23487,8831,GO:0005515,SYNGAP1,protein binding,1.0
23488,8831,GO:0005829,SYNGAP1,cytosol,1.0
23489,8831,GO:0005886,SYNGAP1,plasma membrane,1.0
23490,8831,GO:0007265,SYNGAP1,Ras protein signal transduction,1.0
23491,8831,GO:0007389,SYNGAP1,pattern specification process,1.0
23492,8831,GO:0008542,SYNGAP1,visual learning,1.0
23493,8831,GO:0014069,SYNGAP1,postsynaptic density,1.0
23494,8831,GO:0016358,SYNGAP1,dendrite development,1.0
23495,8831,GO:0017124,SYNGAP1,SH3 domain binding,1.0
23496,8831,GO:0043113,SYNGAP1,receptor clustering,1.0
23497,8831,GO:0043198,SYNGAP1,dendritic shaft,1.0
23498,8831,GO:0043408,SYNGAP1,regulation of MAPK cascade,1.0
23499,8831,GO:0043524,SYNGAP1,negative regulation of neuron apoptotic process,1.0
23500,8831,GO:0043547,SYNGAP1,positive regulation of GTPase activity,1.0
23501,8831,GO:0046580,SYNGAP1,negative regulation of Ras protein signal transduction,1.0
23502,8831,GO:0048167,SYNGAP1,regulation of synaptic plasticity,1.0
23503,8831,GO:0048169,SYNGAP1,regulation of long-term neuronal synaptic plasticity,1.0
23504,8831,GO:0050771,SYNGAP1,negative regulation of axonogenesis,1.0
23505,8831,GO:0050803,SYNGAP1,regulation of synapse structure or activity,1.0
23506,6734,GO:0003723,SRPRA,RNA binding,1.0
23507,6734,GO:0003924,SRPRA,GTPase activity,1.0
23508,6734,GO:0005047,SRPRA,signal recognition particle binding,1.0
23509,6734,GO:0005525,SRPRA,GTP binding,1.0
23510,6734,GO:0005785,SRPRA,signal recognition particle receptor complex,1.0
23511,6734,GO:0005789,SRPRA,endoplasmic reticulum membrane,1.0
23512,6734,GO:0005789,SRPRA,endoplasmic reticulum membrane,1.0
23513,6734,GO:0006605,SRPRA,protein targeting,1.0
23514,6734,GO:0006613,SRPRA,cotranslational protein targeting to membrane,1.0
23515,6734,GO:0006614,SRPRA,SRP-dependent cotranslational protein targeting to membrane,1.0
23516,6734,GO:0016020,SRPRA,membrane,1.0
23517,6734,GO:0016020,SRPRA,membrane,1.0
23518,6734,GO:0036498,SRPRA,IRE1-mediated unfolded protein response,1.0
23519,6734,GO:0045047,SRPRA,protein targeting to ER,1.0
23520,6734,GO:0070062,SRPRA,extracellular exosome,1.0
23753,26115,GO:0001701,TANC2,in utero embryonic development,1.0
23754,26115,GO:0030424,TANC2,axon,1.0
23755,26115,GO:0043197,TANC2,dendritic spine,1.0
23756,26115,GO:0060998,TANC2,regulation of dendritic spine development,1.0
23757,26115,GO:0061001,TANC2,regulation of dendritic spine morphogenesis,1.0
23758,26115,GO:0099519,TANC2,dense core granule cytoskeletal transport,1.0
23759,57551,GO:0000165,TAOK1,MAPK cascade,1.0
23760,57551,GO:0000187,TAOK1,activation of MAPK activity,1.0
23761,57551,GO:0000226,TAOK1,microtubule cytoskeleton organization,1.0
23762,57551,GO:0004672,TAOK1,protein kinase activity,1.0
23763,57551,GO:0004672,TAOK1,protein kinase activity,1.0
23764,57551,GO:0004674,TAOK1,protein serine/threonine kinase activity,1.0
23765,57551,GO:0004674,TAOK1,protein serine/threonine kinase activity,1.0
23766,57551,GO:0004674,TAOK1,protein serine/threonine kinase activity,1.0
23767,57551,GO:0005515,TAOK1,protein binding,1.0
23768,57551,GO:0005524,TAOK1,ATP binding,1.0
23769,57551,GO:0005737,TAOK1,cytoplasm,1.0
23770,57551,GO:0005829,TAOK1,cytosol,1.0
23771,57551,GO:0006281,TAOK1,DNA repair,1.0
23772,57551,GO:0006468,TAOK1,protein phosphorylation,1.0
23773,57551,GO:0006974,TAOK1,cellular response to DNA damage stimulus,1.0
23774,57551,GO:0007026,TAOK1,negative regulation of microtubule depolymerization,1.0
23775,57551,GO:0007095,TAOK1,mitotic G2 DNA damage checkpoint,1.0
23776,57551,GO:0007257,TAOK1,activation of JUN kinase activity,1.0
23777,57551,GO:0015630,TAOK1,microtubule cytoskeleton,1.0
23778,57551,GO:0016301,TAOK1,kinase activity,1.0
23779,57551,GO:0016301,TAOK1,kinase activity,1.0
23780,57551,GO:0016310,TAOK1,phosphorylation,1.0
23781,57551,GO:0016740,TAOK1,transferase activity,1.0
23782,57551,GO:0023014,TAOK1,signal transduction by protein phosphorylation,1.0
23783,57551,GO:0031098,TAOK1,stress-activated protein kinase signaling cascade,1.0
23784,57551,GO:0032147,TAOK1,activation of protein kinase activity,1.0
23785,57551,GO:0032874,TAOK1,positive regulation of stress-activated MAPK cascade,1.0
23786,57551,GO:0032956,TAOK1,regulation of actin cytoskeleton organization,1.0
23787,57551,GO:0043014,TAOK1,alpha-tubulin binding,1.0
23788,57551,GO:0043539,TAOK1,protein serine/threonine kinase activator activity,1.0
23789,57551,GO:0046330,TAOK1,positive regulation of JNK cascade,1.0
23790,57551,GO:0046777,TAOK1,protein autophosphorylation,1.0
23791,57551,GO:0048156,TAOK1,tau protein binding,1.0
23792,57551,GO:0048471,TAOK1,perinuclear region of cytoplasm,1.0
23793,57551,GO:0048487,TAOK1,beta-tubulin binding,1.0
23794,57551,GO:0048812,TAOK1,neuron projection morphogenesis,1.0
23795,57551,GO:0050321,TAOK1,tau-protein kinase activity,1.0
23796,57551,GO:0051493,TAOK1,regulation of cytoskeleton organization,1.0
23797,57551,GO:0070050,TAOK1,neuron cellular homeostasis,1.0
23798,57551,GO:0070062,TAOK1,extracellular exosome,1.0
23799,57551,GO:0070507,TAOK1,regulation of microtubule cytoskeleton organization,1.0
23800,57551,GO:0097194,TAOK1,execution phase of apoptosis,1.0
23801,57551,GO:0097194,TAOK1,execution phase of apoptosis,1.0
23802,57551,GO:0106310,TAOK1,protein serine kinase activity,1.0
23803,57551,GO:0106311,TAOK1,protein threonine kinase activity,1.0
23804,57551,GO:1901985,TAOK1,positive regulation of protein acetylation,1.0
23902,93627,GO:0004672,TBCK,protein kinase activity,1.0
23903,93627,GO:0005096,TBCK,GTPase activator activity,1.0
23904,93627,GO:0005524,TBCK,ATP binding,1.0
23905,93627,GO:0005737,TBCK,cytoplasm,1.0
23906,93627,GO:0006468,TBCK,protein phosphorylation,1.0
23907,93627,GO:0006886,TBCK,intracellular protein transport,1.0
23908,93627,GO:0008283,TBCK,cell population proliferation,1.0
23909,93627,GO:0030036,TBCK,actin cytoskeleton organization,1.0
23910,93627,GO:0030496,TBCK,midbody,1.0
23911,93627,GO:0031267,TBCK,small GTPase binding,1.0
23912,93627,GO:0032006,TBCK,regulation of TOR signaling,1.0
23913,93627,GO:0072686,TBCK,mitotic spindle,1.0
23914,93627,GO:0090630,TBCK,activation of GTPase activity,1.0
23915,79718,GO:0000118,TBL1XR1,histone deacetylase complex,1.0
23916,79718,GO:0000118,TBL1XR1,histone deacetylase complex,1.0
23917,79718,GO:0000122,TBL1XR1,negative regulation of transcription by RNA polymerase II,1.0
23918,79718,GO:0000976,TBL1XR1,transcription regulatory region sequence-specific DNA binding,1.0
23919,79718,GO:0000976,TBL1XR1,transcription regulatory region sequence-specific DNA binding,1.0
23920,79718,GO:0001835,TBL1XR1,blastocyst hatching,1.0
23921,79718,GO:0002021,TBL1XR1,response to dietary excess,1.0
23922,79718,GO:0003714,TBL1XR1,transcription corepressor activity,1.0
23923,79718,GO:0003714,TBL1XR1,transcription corepressor activity,1.0
23924,79718,GO:0003714,TBL1XR1,transcription corepressor activity,1.0
23925,79718,GO:0005515,TBL1XR1,protein binding,1.0
23926,79718,GO:0005634,TBL1XR1,nucleus,1.0
23927,79718,GO:0005654,TBL1XR1,nucleoplasm,1.0
23928,79718,GO:0006357,TBL1XR1,regulation of transcription by RNA polymerase II,1.0
23929,79718,GO:0008013,TBL1XR1,beta-catenin binding,1.0
23930,79718,GO:0016042,TBL1XR1,lipid catabolic process,1.0
23931,79718,GO:0016575,TBL1XR1,histone deacetylation,1.0
23932,79718,GO:0017053,TBL1XR1,transcription repressor complex,1.0
23933,79718,GO:0019216,TBL1XR1,regulation of lipid metabolic process,1.0
23934,79718,GO:0035264,TBL1XR1,multicellular organism growth,1.0
23935,79718,GO:0042393,TBL1XR1,histone binding,1.0
23936,79718,GO:0043161,TBL1XR1,proteasome-mediated ubiquitin-dependent protein catabolic process,1.0
23937,79718,GO:0045893,TBL1XR1,"positive regulation of transcription, DNA-templated",1.0
23938,79718,GO:0045944,TBL1XR1,positive regulation of transcription by RNA polymerase II,1.0
23939,79718,GO:0047485,TBL1XR1,protein N-terminus binding,1.0
23940,79718,GO:0050872,TBL1XR1,white fat cell differentiation,1.0
23941,79718,GO:0060613,TBL1XR1,fat pad development,1.0
23942,79718,GO:0072686,TBL1XR1,mitotic spindle,1.0
23943,79718,GO:0090207,TBL1XR1,regulation of triglyceride metabolic process,1.0
23944,79718,GO:0090263,TBL1XR1,positive regulation of canonical Wnt signaling pathway,1.0
23945,10716,GO:0000785,TBR1,chromatin,1.0
23946,10716,GO:0000978,TBR1,RNA polymerase II cis-regulatory region sequence-specific DNA binding,1.0
23947,10716,GO:0000978,TBR1,RNA polymerase II cis-regulatory region sequence-specific DNA binding,1.0
23948,10716,GO:0000981,TBR1,"DNA-binding transcription factor activity, RNA polymerase II-specific",1.0
23949,10716,GO:0001661,TBR1,conditioned taste aversion,1.0
23950,10716,GO:0001708,TBR1,cell fate specification,1.0
23951,10716,GO:0001947,TBR1,heart looping,1.0
23952,10716,GO:0003700,TBR1,DNA-binding transcription factor activity,1.0
23953,10716,GO:0005515,TBR1,protein binding,1.0
23954,10716,GO:0005634,TBR1,nucleus,1.0
23955,10716,GO:0006357,TBR1,regulation of transcription by RNA polymerase II,1.0
23956,10716,GO:0007420,TBR1,brain development,1.0
23957,10716,GO:0010092,TBR1,specification of animal organ identity,1.0
23958,10716,GO:0010975,TBR1,regulation of neuron projection development,1.0
23959,10716,GO:0019901,TBR1,protein kinase binding,1.0
23960,10716,GO:0021764,TBR1,amygdala development,1.0
23961,10716,GO:0021902,TBR1,commitment of neuronal cell to specific neuron type in forebrain,1.0
23962,10716,GO:0021987,TBR1,cerebral cortex development,1.0
23963,10716,GO:0030902,TBR1,hindbrain development,1.0
23964,10716,GO:0042802,TBR1,identical protein binding,1.0
23965,10716,GO:0045892,TBR1,"negative regulation of transcription, DNA-templated",1.0
23966,10716,GO:1902667,TBR1,regulation of axon guidance,1.0
24314,6942,GO:0003723,TCF20,RNA binding,1.0
24315,6942,GO:0005515,TCF20,protein binding,1.0
24316,6942,GO:0005634,TCF20,nucleus,1.0
24317,6942,GO:0005634,TCF20,nucleus,1.0
24318,6942,GO:0005654,TCF20,nucleoplasm,1.0
24319,6942,GO:0006357,TCF20,regulation of transcription by RNA polymerase II,1.0
24320,6942,GO:0016604,TCF20,nuclear body,1.0
24321,6942,GO:0045944,TCF20,positive regulation of transcription by RNA polymerase II,1.0
24322,6942,GO:0046872,TCF20,metal ion binding,1.0
24323,6925,GO:0000785,TCF4,chromatin,1.0
24324,6925,GO:0000785,TCF4,chromatin,1.0
24325,6925,GO:0000785,TCF4,chromatin,1.0
24326,6925,GO:0000978,TCF4,RNA polymerase II cis-regulatory region sequence-specific DNA binding,1.0
24327,6925,GO:0000978,TCF4,RNA polymerase II cis-regulatory region sequence-specific DNA binding,1.0
24328,6925,GO:0000978,TCF4,RNA polymerase II cis-regulatory region sequence-specific DNA binding,1.0
24329,6925,GO:0000981,TCF4,"DNA-binding transcription factor activity, RNA polymerase II-specific",1.0
24330,6925,GO:0000981,TCF4,"DNA-binding transcription factor activity, RNA polymerase II-specific",1.0
24331,6925,GO:0000981,TCF4,"DNA-binding transcription factor activity, RNA polymerase II-specific",1.0
24332,6925,GO:0001093,TCF4,TFIIB-class transcription factor binding,1.0
24333,6925,GO:0001228,TCF4,"DNA-binding transcription activator activity, RNA polymerase II-specific",1.0
24334,6925,GO:0003677,TCF4,DNA binding,1.0
24335,6925,GO:0003700,TCF4,DNA-binding transcription factor activity,1.0
24336,6925,GO:0005515,TCF4,protein binding,1.0
24337,6925,GO:0005634,TCF4,nucleus,1.0
24338,6925,GO:0005667,TCF4,transcription regulator complex,1.0
24339,6925,GO:0005667,TCF4,transcription regulator complex,1.0
24340,6925,GO:0006357,TCF4,regulation of transcription by RNA polymerase II,1.0
24341,6925,GO:0008013,TCF4,beta-catenin binding,1.0
24342,6925,GO:0008022,TCF4,protein C-terminus binding,1.0
24343,6925,GO:0042802,TCF4,identical protein binding,1.0
24344,6925,GO:0045666,TCF4,positive regulation of neuron differentiation,1.0
24345,6925,GO:0045893,TCF4,"positive regulation of transcription, DNA-templated",1.0
24346,6925,GO:0045944,TCF4,positive regulation of transcription by RNA polymerase II,1.0
24347,6925,GO:0046982,TCF4,protein heterodimerization activity,1.0
24348,6925,GO:0065004,TCF4,protein-DNA complex assembly,1.0
24349,6925,GO:0070369,TCF4,beta-catenin-TCF7L2 complex,1.0
24350,6925,GO:0070888,TCF4,E-box binding,1.0
24351,6925,GO:1990837,TCF4,sequence-specific double-stranded DNA binding,1.0
24352,6925,GO:1990907,TCF4,beta-catenin-TCF complex,1.0
24353,6934,GO:0000122,TCF7L2,negative regulation of transcription by RNA polymerase II,1.0
24354,6934,GO:0000785,TCF7L2,chromatin,1.0
24355,6934,GO:0000785,TCF7L2,chromatin,1.0
24356,6934,GO:0000976,TCF7L2,transcription regulatory region sequence-specific DNA binding,1.0
24357,6934,GO:0000978,TCF7L2,RNA polymerase II cis-regulatory region sequence-specific DNA binding,1.0
24358,6934,GO:0000978,TCF7L2,RNA polymerase II cis-regulatory region sequence-specific DNA binding,1.0
24359,6934,GO:0000981,TCF7L2,"DNA-binding transcription factor activity, RNA polymerase II-specific",1.0
24360,6934,GO:0001103,TCF7L2,RNA polymerase II repressing transcription factor binding,1.0
24361,6934,GO:0001568,TCF7L2,blood vessel development,1.0
24362,6934,GO:0003700,TCF7L2,DNA-binding transcription factor activity,1.0
24363,6934,GO:0005515,TCF7L2,protein binding,1.0
24364,6934,GO:0005634,TCF7L2,nucleus,1.0
24365,6934,GO:0005654,TCF7L2,nucleoplasm,1.0
24366,6934,GO:0005654,TCF7L2,nucleoplasm,1.0
24367,6934,GO:0006357,TCF7L2,regulation of transcription by RNA polymerase II,1.0
24368,6934,GO:0006357,TCF7L2,regulation of transcription by RNA polymerase II,1.0
24369,6934,GO:0007050,TCF7L2,cell cycle arrest,1.0
24370,6934,GO:0007223,TCF7L2,"Wnt signaling pathway, calcium modulating pathway",1.0
24371,6934,GO:0008013,TCF7L2,beta-catenin binding,1.0
24372,6934,GO:0008013,TCF7L2,beta-catenin binding,1.0
24373,6934,GO:0008134,TCF7L2,transcription factor binding,1.0
24374,6934,GO:0009749,TCF7L2,response to glucose,1.0
24375,6934,GO:0010909,TCF7L2,positive regulation of heparan sulfate proteoglycan biosynthetic process,1.0
24376,6934,GO:0016605,TCF7L2,PML body,1.0
24377,6934,GO:0019901,TCF7L2,protein kinase binding,1.0
24378,6934,GO:0031016,TCF7L2,pancreas development,1.0
24379,6934,GO:0032024,TCF7L2,positive regulation of insulin secretion,1.0
24380,6934,GO:0032092,TCF7L2,positive regulation of protein binding,1.0
24381,6934,GO:0032350,TCF7L2,regulation of hormone metabolic process,1.0
24382,6934,GO:0032993,TCF7L2,protein-DNA complex,1.0
24383,6934,GO:0035257,TCF7L2,nuclear hormone receptor binding,1.0
24384,6934,GO:0042593,TCF7L2,glucose homeostasis,1.0
24385,6934,GO:0043433,TCF7L2,negative regulation of DNA-binding transcription factor activity,1.0
24386,6934,GO:0043565,TCF7L2,sequence-specific DNA binding,1.0
24387,6934,GO:0043565,TCF7L2,sequence-specific DNA binding,1.0
24388,6934,GO:0043570,TCF7L2,maintenance of DNA repeat elements,1.0
24389,6934,GO:0044334,TCF7L2,canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition,1.0
24390,6934,GO:0045295,TCF7L2,gamma-catenin binding,1.0
24391,6934,GO:0045444,TCF7L2,fat cell differentiation,1.0
24392,6934,GO:0045892,TCF7L2,"negative regulation of transcription, DNA-templated",1.0
24393,6934,GO:0045892,TCF7L2,"negative regulation of transcription, DNA-templated",1.0
24394,6934,GO:0045944,TCF7L2,positive regulation of transcription by RNA polymerase II,1.0
24395,6934,GO:0046827,TCF7L2,positive regulation of protein export from nucleus,1.0
24396,6934,GO:0048625,TCF7L2,myoblast fate commitment,1.0
24397,6934,GO:0048660,TCF7L2,regulation of smooth muscle cell proliferation,1.0
24398,6934,GO:0050679,TCF7L2,positive regulation of epithelial cell proliferation,1.0
24399,6934,GO:0051897,TCF7L2,positive regulation of protein kinase B signaling,1.0
24400,6934,GO:0060070,TCF7L2,canonical Wnt signaling pathway,1.0
24401,6934,GO:0060070,TCF7L2,canonical Wnt signaling pathway,1.0
24402,6934,GO:0070016,TCF7L2,armadillo repeat domain binding,1.0
24403,6934,GO:0070369,TCF7L2,beta-catenin-TCF7L2 complex,1.0
24404,6934,GO:0071664,TCF7L2,catenin-TCF7L2 complex,1.0
24405,6934,GO:0090090,TCF7L2,negative regulation of canonical Wnt signaling pathway,1.0
24406,6934,GO:1904837,TCF7L2,beta-catenin-TCF complex assembly,1.0
24407,6934,GO:1990907,TCF7L2,beta-catenin-TCF complex,1.0
24408,6934,GO:2000675,TCF7L2,negative regulation of type B pancreatic cell apoptotic process,1.0
24409,6934,GO:2001237,TCF7L2,negative regulation of extrinsic apoptotic signaling pathway,1.0
24668,11011,GO:0001672,TLK2,regulation of chromatin assembly or disassembly,1.0
24669,11011,GO:0001672,TLK2,regulation of chromatin assembly or disassembly,1.0
24670,11011,GO:0004674,TLK2,protein serine/threonine kinase activity,1.0
24671,11011,GO:0004674,TLK2,protein serine/threonine kinase activity,1.0
24672,11011,GO:0005515,TLK2,protein binding,1.0
24673,11011,GO:0005524,TLK2,ATP binding,1.0
24674,11011,GO:0005634,TLK2,nucleus,1.0
24675,11011,GO:0005634,TLK2,nucleus,1.0
24676,11011,GO:0005882,TLK2,intermediate filament,1.0
24677,11011,GO:0006325,TLK2,chromatin organization,1.0
24678,11011,GO:0006468,TLK2,protein phosphorylation,1.0
24679,11011,GO:0006974,TLK2,cellular response to DNA damage stimulus,1.0
24680,11011,GO:0007049,TLK2,cell cycle,1.0
24681,11011,GO:0007059,TLK2,chromosome segregation,1.0
24682,11011,GO:0007059,TLK2,chromosome segregation,1.0
24683,11011,GO:0010507,TLK2,negative regulation of autophagy,1.0
24684,11011,GO:0018105,TLK2,peptidyl-serine phosphorylation,1.0
24685,11011,GO:0018105,TLK2,peptidyl-serine phosphorylation,1.0
24686,11011,GO:0032435,TLK2,negative regulation of proteasomal ubiquitin-dependent protein catabolic process,1.0
24687,11011,GO:0035556,TLK2,intracellular signal transduction,1.0
24688,11011,GO:0035556,TLK2,intracellular signal transduction,1.0
24689,11011,GO:0042802,TLK2,identical protein binding,1.0
24690,11011,GO:0048471,TLK2,perinuclear region of cytoplasm,1.0
24691,11011,GO:0071480,TLK2,cellular response to gamma radiation,1.0
24692,11011,GO:0106310,TLK2,protein serine kinase activity,1.0
24693,11011,GO:0106311,TLK2,protein threonine kinase activity,1.0
24743,84231,GO:0000027,TRAF7,ribosomal large subunit assembly,1.0
24744,84231,GO:0000151,TRAF7,ubiquitin ligase complex,1.0
24745,84231,GO:0000185,TRAF7,activation of MAPKKK activity,1.0
24746,84231,GO:0004842,TRAF7,ubiquitin-protein transferase activity,1.0
24747,84231,GO:0005515,TRAF7,protein binding,1.0
24748,84231,GO:0005730,TRAF7,nucleolus,1.0
24749,84231,GO:0005886,TRAF7,plasma membrane,1.0
24750,84231,GO:0006915,TRAF7,apoptotic process,1.0
24751,84231,GO:0007219,TRAF7,Notch signaling pathway,1.0
24752,84231,GO:0008270,TRAF7,zinc ion binding,1.0
24753,84231,GO:0016567,TRAF7,protein ubiquitination,1.0
24754,84231,GO:0016567,TRAF7,protein ubiquitination,1.0
24755,84231,GO:0031410,TRAF7,cytoplasmic vesicle,1.0
24756,84231,GO:0043231,TRAF7,intracellular membrane-bounded organelle,1.0
24757,84231,GO:0043410,TRAF7,positive regulation of MAPK cascade,1.0
24758,84231,GO:0070372,TRAF7,regulation of ERK1 and ERK2 cascade,1.0
24759,84231,GO:2001235,TRAF7,positive regulation of apoptotic signaling pathway,1.0
24781,7204,GO:0004674,TRIO,protein serine/threonine kinase activity,1.0
24782,7204,GO:0005085,TRIO,guanyl-nucleotide exchange factor activity,1.0
24783,7204,GO:0005515,TRIO,protein binding,1.0
24784,7204,GO:0005524,TRIO,ATP binding,1.0
24785,7204,GO:0005829,TRIO,cytosol,1.0
24786,7204,GO:0006468,TRIO,protein phosphorylation,1.0
24787,7204,GO:0007185,TRIO,transmembrane receptor protein tyrosine phosphatase signaling pathway,1.0
24788,7204,GO:0007186,TRIO,G protein-coupled receptor signaling pathway,1.0
24789,7204,GO:0007411,TRIO,axon guidance,1.0
24790,7204,GO:0007417,TRIO,central nervous system development,1.0
24791,7204,GO:0042995,TRIO,cell projection,1.0
24792,7204,GO:0043065,TRIO,positive regulation of apoptotic process,1.0
24793,7204,GO:0045599,TRIO,negative regulation of fat cell differentiation,1.0
24794,7204,GO:0048812,TRIO,neuron projection morphogenesis,1.0
24795,7204,GO:0051056,TRIO,regulation of small GTPase mediated signal transduction,1.0
24796,7204,GO:0106310,TRIO,protein serine kinase activity,1.0
24797,7204,GO:0106311,TRIO,protein threonine kinase activity,1.0
24798,9320,GO:0000209,TRIP12,protein polyubiquitination,1.0
24799,9320,GO:0000209,TRIP12,protein polyubiquitination,1.0
24800,9320,GO:0005515,TRIP12,protein binding,1.0
24801,9320,GO:0005634,TRIP12,nucleus,1.0
24802,9320,GO:0005654,TRIP12,nucleoplasm,1.0
24803,9320,GO:0005829,TRIP12,cytosol,1.0
24804,9320,GO:0006281,TRIP12,DNA repair,1.0
24805,9320,GO:0006511,TRIP12,ubiquitin-dependent protein catabolic process,1.0
24806,9320,GO:0006511,TRIP12,ubiquitin-dependent protein catabolic process,1.0
24807,9320,GO:0006511,TRIP12,ubiquitin-dependent protein catabolic process,1.0
24808,9320,GO:0006974,TRIP12,cellular response to DNA damage stimulus,1.0
24809,9320,GO:0006974,TRIP12,cellular response to DNA damage stimulus,1.0
24810,9320,GO:0016607,TRIP12,nuclear speck,1.0
24811,9320,GO:0016607,TRIP12,nuclear speck,1.0
24812,9320,GO:0045995,TRIP12,regulation of embryonic development,1.0
24813,9320,GO:0046966,TRIP12,thyroid hormone receptor binding,1.0
24814,9320,GO:0061630,TRIP12,ubiquitin protein ligase activity,1.0
24815,9320,GO:0061630,TRIP12,ubiquitin protein ligase activity,1.0
24816,9320,GO:1901315,TRIP12,negative regulation of histone H2A K63-linked ubiquitination,1.0
24817,9320,GO:1901315,TRIP12,negative regulation of histone H2A K63-linked ubiquitination,1.0
24818,9320,GO:2000779,TRIP12,regulation of double-strand break repair,1.0
24819,9320,GO:2000780,TRIP12,negative regulation of double-strand break repair,1.0
24895,7248,GO:0001822,TSC1,kidney development,1.0
24896,7248,GO:0001843,TSC1,neural tube closure,1.0
24897,7248,GO:0001952,TSC1,regulation of cell-matrix adhesion,1.0
24898,7248,GO:0002250,TSC1,adaptive immune response,1.0
24899,7248,GO:0005515,TSC1,protein binding,1.0
24900,7248,GO:0005634,TSC1,nucleus,1.0
24901,7248,GO:0005737,TSC1,cytoplasm,1.0
24902,7248,GO:0005811,TSC1,lipid droplet,1.0
24903,7248,GO:0005829,TSC1,cytosol,1.0
24904,7248,GO:0005829,TSC1,cytosol,1.0
24905,7248,GO:0005884,TSC1,actin filament,1.0
24906,7248,GO:0005886,TSC1,plasma membrane,1.0
24907,7248,GO:0005938,TSC1,cell cortex,1.0
24908,7248,GO:0006407,TSC1,rRNA export from nucleus,1.0
24909,7248,GO:0006417,TSC1,regulation of translation,1.0
24910,7248,GO:0006813,TSC1,potassium ion transport,1.0
24911,7248,GO:0007160,TSC1,cell-matrix adhesion,1.0
24912,7248,GO:0008285,TSC1,negative regulation of cell population proliferation,1.0
24913,7248,GO:0008344,TSC1,adult locomotory behavior,1.0
24914,7248,GO:0014069,TSC1,postsynaptic density,1.0
24915,7248,GO:0016020,TSC1,membrane,1.0
24916,7248,GO:0016242,TSC1,negative regulation of macroautophagy,1.0
24917,7248,GO:0017148,TSC1,negative regulation of translation,1.0
24918,7248,GO:0021766,TSC1,hippocampus development,1.0
24919,7248,GO:0021987,TSC1,cerebral cortex development,1.0
24920,7248,GO:0030027,TSC1,lamellipodium,1.0
24921,7248,GO:0030030,TSC1,cell projection organization,1.0
24922,7248,GO:0030544,TSC1,Hsp70 protein binding,1.0
24923,7248,GO:0032007,TSC1,negative regulation of TOR signaling,1.0
24924,7248,GO:0032007,TSC1,negative regulation of TOR signaling,1.0
24925,7248,GO:0032007,TSC1,negative regulation of TOR signaling,1.0
24926,7248,GO:0032780,TSC1,negative regulation of ATPase activity,1.0
24927,7248,GO:0032868,TSC1,response to insulin,1.0
24928,7248,GO:0032991,TSC1,protein-containing complex,1.0
24929,7248,GO:0033596,TSC1,TSC1-TSC2 complex,1.0
24930,7248,GO:0033596,TSC1,TSC1-TSC2 complex,1.0
24931,7248,GO:0042030,TSC1,ATPase inhibitor activity,1.0
24932,7248,GO:0042552,TSC1,myelination,1.0
24933,7248,GO:0043379,TSC1,memory T cell differentiation,1.0
24934,7248,GO:0043666,TSC1,regulation of phosphoprotein phosphatase activity,1.0
24935,7248,GO:0045792,TSC1,negative regulation of cell size,1.0
24936,7248,GO:0045859,TSC1,regulation of protein kinase activity,1.0
24937,7248,GO:0046323,TSC1,glucose import,1.0
24938,7248,GO:0046627,TSC1,negative regulation of insulin receptor signaling pathway,1.0
24939,7248,GO:0047485,TSC1,protein N-terminus binding,1.0
24940,7248,GO:0048471,TSC1,perinuclear region of cytoplasm,1.0
24941,7248,GO:0050808,TSC1,synapse organization,1.0
24942,7248,GO:0050821,TSC1,protein stabilization,1.0
24943,7248,GO:0050821,TSC1,protein stabilization,1.0
24944,7248,GO:0051087,TSC1,chaperone binding,1.0
24945,7248,GO:0051492,TSC1,regulation of stress fiber assembly,1.0
24946,7248,GO:0051726,TSC1,regulation of cell cycle,1.0
24947,7248,GO:0051879,TSC1,Hsp90 protein binding,1.0
24948,7248,GO:0051894,TSC1,positive regulation of focal adhesion assembly,1.0
24949,7248,GO:0055007,TSC1,cardiac muscle cell differentiation,1.0
24950,7248,GO:0090630,TSC1,activation of GTPase activity,1.0
24951,7248,GO:0090650,TSC1,cellular response to oxygen-glucose deprivation,1.0
24952,7248,GO:0101031,TSC1,chaperone complex,1.0
24953,7248,GO:1901214,TSC1,regulation of neuron death,1.0
24954,7249,GO:0001843,TSC2,neural tube closure,1.0
24955,7249,GO:0005096,TSC2,GTPase activator activity,1.0
24956,7249,GO:0005096,TSC2,GTPase activator activity,1.0
24957,7249,GO:0005515,TSC2,protein binding,1.0
24958,7249,GO:0005634,TSC2,nucleus,1.0
24959,7249,GO:0005634,TSC2,nucleus,1.0
24960,7249,GO:0005737,TSC2,cytoplasm,1.0
24961,7249,GO:0005737,TSC2,cytoplasm,1.0
24962,7249,GO:0005737,TSC2,cytoplasm,1.0
24963,7249,GO:0005764,TSC2,lysosome,1.0
24964,7249,GO:0005794,TSC2,Golgi apparatus,1.0
24965,7249,GO:0005794,TSC2,Golgi apparatus,1.0
24966,7249,GO:0005829,TSC2,cytosol,1.0
24967,7249,GO:0005829,TSC2,cytosol,1.0
24968,7249,GO:0006469,TSC2,negative regulation of protein kinase activity,1.0
24969,7249,GO:0006606,TSC2,protein import into nucleus,1.0
24970,7249,GO:0006897,TSC2,endocytosis,1.0
24971,7249,GO:0007507,TSC2,heart development,1.0
24972,7249,GO:0008104,TSC2,protein localization,1.0
24973,7249,GO:0008285,TSC2,negative regulation of cell population proliferation,1.0
24974,7249,GO:0014067,TSC2,negative regulation of phosphatidylinositol 3-kinase signaling,1.0
24975,7249,GO:0014069,TSC2,postsynaptic density,1.0
24976,7249,GO:0014069,TSC2,postsynaptic density,1.0
24977,7249,GO:0016020,TSC2,membrane,1.0
24978,7249,GO:0016032,TSC2,viral process,1.0
24979,7249,GO:0016192,TSC2,vesicle-mediated transport,1.0
24980,7249,GO:0016239,TSC2,positive regulation of macroautophagy,1.0
24981,7249,GO:0019902,TSC2,phosphatase binding,1.0
24982,7249,GO:0030100,TSC2,regulation of endocytosis,1.0
24983,7249,GO:0030178,TSC2,negative regulation of Wnt signaling pathway,1.0
24984,7249,GO:0031267,TSC2,small GTPase binding,1.0
24985,7249,GO:0032007,TSC2,negative regulation of TOR signaling,1.0
24986,7249,GO:0032007,TSC2,negative regulation of TOR signaling,1.0
24987,7249,GO:0033596,TSC2,TSC1-TSC2 complex,1.0
24988,7249,GO:0033596,TSC2,TSC1-TSC2 complex,1.0
24989,7249,GO:0042803,TSC2,protein homodimerization activity,1.0
24990,7249,GO:0043276,TSC2,anoikis,1.0
24991,7249,GO:0043491,TSC2,protein kinase B signaling,1.0
24992,7249,GO:0043547,TSC2,positive regulation of GTPase activity,1.0
24993,7249,GO:0046626,TSC2,regulation of insulin receptor signaling pathway,1.0
24994,7249,GO:0046627,TSC2,negative regulation of insulin receptor signaling pathway,1.0
24995,7249,GO:0048009,TSC2,insulin-like growth factor receptor signaling pathway,1.0
24996,7249,GO:0048471,TSC2,perinuclear region of cytoplasm,1.0
24997,7249,GO:0050918,TSC2,positive chemotaxis,1.0
24998,7249,GO:0051056,TSC2,regulation of small GTPase mediated signal transduction,1.0
24999,7249,GO:0051726,TSC2,regulation of cell cycle,1.0
25000,7249,GO:0051879,TSC2,Hsp90 protein binding,1.0
25001,7249,GO:0051898,TSC2,negative regulation of protein kinase B signaling,1.0
25002,7249,GO:0051898,TSC2,negative regulation of protein kinase B signaling,1.0
25003,7249,GO:1901525,TSC2,negative regulation of mitophagy,1.0
25004,7010,GO:0000165,TEK,MAPK cascade,1.0
25005,7010,GO:0001525,TEK,angiogenesis,1.0
25006,7010,GO:0001525,TEK,angiogenesis,1.0
25007,7010,GO:0001666,TEK,response to hypoxia,1.0
25008,7010,GO:0001725,TEK,stress fiber,1.0
25009,7010,GO:0001934,TEK,positive regulation of protein phosphorylation,1.0
25010,7010,GO:0001934,TEK,positive regulation of protein phosphorylation,1.0
25011,7010,GO:0001935,TEK,endothelial cell proliferation,1.0
25012,7010,GO:0001935,TEK,endothelial cell proliferation,1.0
25013,7010,GO:0001938,TEK,positive regulation of endothelial cell proliferation,1.0
25014,7010,GO:0001958,TEK,endochondral ossification,1.0
25015,7010,GO:0002040,TEK,sprouting angiogenesis,1.0
25016,7010,GO:0004672,TEK,protein kinase activity,1.0
25017,7010,GO:0004713,TEK,protein tyrosine kinase activity,1.0
25018,7010,GO:0004713,TEK,protein tyrosine kinase activity,1.0
25019,7010,GO:0004714,TEK,transmembrane receptor protein tyrosine kinase activity,1.0
25020,7010,GO:0005515,TEK,protein binding,1.0
25021,7010,GO:0005524,TEK,ATP binding,1.0
25022,7010,GO:0005576,TEK,extracellular region,1.0
25023,7010,GO:0005737,TEK,cytoplasm,1.0
25024,7010,GO:0005884,TEK,actin filament,1.0
25025,7010,GO:0005886,TEK,plasma membrane,1.0
25026,7010,GO:0005886,TEK,plasma membrane,1.0
25027,7010,GO:0005887,TEK,integral component of plasma membrane,1.0
25028,7010,GO:0005887,TEK,integral component of plasma membrane,1.0
25029,7010,GO:0005902,TEK,microvillus,1.0
25030,7010,GO:0005911,TEK,cell-cell junction,1.0
25031,7010,GO:0005925,TEK,focal adhesion,1.0
25032,7010,GO:0007165,TEK,signal transduction,1.0
25033,7010,GO:0007169,TEK,transmembrane receptor protein tyrosine kinase signaling pathway,1.0
25034,7010,GO:0007169,TEK,transmembrane receptor protein tyrosine kinase signaling pathway,1.0
25035,7010,GO:0007267,TEK,cell-cell signaling,1.0
25036,7010,GO:0007275,TEK,multicellular organism development,1.0
25037,7010,GO:0007507,TEK,heart development,1.0
25038,7010,GO:0009925,TEK,basal plasma membrane,1.0
25039,7010,GO:0009986,TEK,cell surface,1.0
25040,7010,GO:0010595,TEK,positive regulation of endothelial cell migration,1.0
25041,7010,GO:0010595,TEK,positive regulation of endothelial cell migration,1.0
25042,7010,GO:0010595,TEK,positive regulation of endothelial cell migration,1.0
25043,7010,GO:0014068,TEK,positive regulation of phosphatidylinositol 3-kinase signaling,1.0
25044,7010,GO:0014068,TEK,positive regulation of phosphatidylinositol 3-kinase signaling,1.0
25045,7010,GO:0016323,TEK,basolateral plasma membrane,1.0
25046,7010,GO:0016324,TEK,apical plasma membrane,1.0
25047,7010,GO:0016525,TEK,negative regulation of angiogenesis,1.0
25048,7010,GO:0018108,TEK,peptidyl-tyrosine phosphorylation,1.0
25049,7010,GO:0019838,TEK,growth factor binding,1.0
25050,7010,GO:0032878,TEK,regulation of establishment or maintenance of cell polarity,1.0
25051,7010,GO:0033674,TEK,positive regulation of kinase activity,1.0
25052,7010,GO:0034446,TEK,substrate adhesion-dependent cell spreading,1.0
25053,7010,GO:0034451,TEK,centriolar satellite,1.0
25054,7010,GO:0038023,TEK,signaling receptor activity,1.0
25055,7010,GO:0042802,TEK,identical protein binding,1.0
25056,7010,GO:0043066,TEK,negative regulation of apoptotic process,1.0
25057,7010,GO:0043114,TEK,regulation of vascular permeability,1.0
25058,7010,GO:0043235,TEK,receptor complex,1.0
25059,7010,GO:0043410,TEK,positive regulation of MAPK cascade,1.0
25060,7010,GO:0043434,TEK,response to peptide hormone,1.0
25061,7010,GO:0043552,TEK,positive regulation of phosphatidylinositol 3-kinase activity,1.0
25062,7010,GO:0043627,TEK,response to estrogen,1.0
25063,7010,GO:0045121,TEK,membrane raft,1.0
25064,7010,GO:0045766,TEK,positive regulation of angiogenesis,1.0
25065,7010,GO:0045766,TEK,positive regulation of angiogenesis,1.0
25066,7010,GO:0045766,TEK,positive regulation of angiogenesis,1.0
25067,7010,GO:0046777,TEK,protein autophosphorylation,1.0
25068,7010,GO:0048014,TEK,Tie signaling pathway,1.0
25069,7010,GO:0050728,TEK,negative regulation of inflammatory response,1.0
25070,7010,GO:0050900,TEK,leukocyte migration,1.0
25071,7010,GO:0051591,TEK,response to cAMP,1.0
25072,7010,GO:0051894,TEK,positive regulation of focal adhesion assembly,1.0
25073,7010,GO:0051897,TEK,positive regulation of protein kinase B signaling,1.0
25074,7010,GO:0051897,TEK,positive regulation of protein kinase B signaling,1.0
25075,7010,GO:0051897,TEK,positive regulation of protein kinase B signaling,1.0
25076,7010,GO:0060216,TEK,definitive hemopoiesis,1.0
25077,7010,GO:0060347,TEK,heart trabecula formation,1.0
25078,7010,GO:0070374,TEK,positive regulation of ERK1 and ERK2 cascade,1.0
25079,7010,GO:0070374,TEK,positive regulation of ERK1 and ERK2 cascade,1.0
25080,7010,GO:0072012,TEK,glomerulus vasculature development,1.0
25081,7010,GO:1902533,TEK,positive regulation of intracellular signal transduction,1.0
25082,7010,GO:2000251,TEK,positive regulation of actin cytoskeleton reorganization,1.0
25083,7010,GO:2000351,TEK,regulation of endothelial cell apoptotic process,1.0
25084,7010,GO:2000352,TEK,negative regulation of endothelial cell apoptotic process,1.0
25121,9777,GO:0001666,TM9SF4,response to hypoxia,1.0
25122,9777,GO:0005515,TM9SF4,protein binding,1.0
25123,9777,GO:0005769,TM9SF4,early endosome,1.0
25124,9777,GO:0005794,TM9SF4,Golgi apparatus,1.0
25125,9777,GO:0006909,TM9SF4,phagocytosis,1.0
25126,9777,GO:0007155,TM9SF4,cell adhesion,1.0
25127,9777,GO:0016020,TM9SF4,membrane,1.0
25128,9777,GO:0016021,TM9SF4,integral component of membrane,1.0
25129,9777,GO:0051453,TM9SF4,regulation of intracellular pH,1.0
25130,9777,GO:0070072,TM9SF4,vacuolar proton-transporting V-type ATPase complex assembly,1.0
25131,9777,GO:0070863,TM9SF4,positive regulation of protein exit from endoplasmic reticulum,1.0
25132,9777,GO:0072657,TM9SF4,protein localization to membrane,1.0
25133,9777,GO:2000010,TM9SF4,positive regulation of protein localization to cell surface,1.0
25151,373,GO:0000139,TRIM23,Golgi membrane,1.0
25152,373,GO:0003924,TRIM23,GTPase activity,1.0
25153,373,GO:0004842,TRIM23,ubiquitin-protein transferase activity,1.0
25154,373,GO:0005515,TRIM23,protein binding,1.0
25155,373,GO:0005525,TRIM23,GTP binding,1.0
25156,373,GO:0005525,TRIM23,GTP binding,1.0
25157,373,GO:0005634,TRIM23,nucleus,1.0
25158,373,GO:0005737,TRIM23,cytoplasm,1.0
25159,373,GO:0005765,TRIM23,lysosomal membrane,1.0
25160,373,GO:0005765,TRIM23,lysosomal membrane,1.0
25161,373,GO:0005886,TRIM23,plasma membrane,1.0
25162,373,GO:0006886,TRIM23,intracellular protein transport,1.0
25163,373,GO:0008047,TRIM23,enzyme activator activity,1.0
25164,373,GO:0008270,TRIM23,zinc ion binding,1.0
25165,373,GO:0016032,TRIM23,viral process,1.0
25166,373,GO:0016192,TRIM23,vesicle-mediated transport,1.0
25167,373,GO:0016567,TRIM23,protein ubiquitination,1.0
25168,373,GO:0016567,TRIM23,protein ubiquitination,1.0
25169,373,GO:0019003,TRIM23,GDP binding,1.0
25170,373,GO:0042802,TRIM23,identical protein binding,1.0
25171,373,GO:0043085,TRIM23,positive regulation of catalytic activity,1.0
25172,373,GO:0045087,TRIM23,innate immune response,1.0
25227,57616,GO:0000785,TSHZ3,chromatin,1.0
25228,57616,GO:0000981,TSHZ3,"DNA-binding transcription factor activity, RNA polymerase II-specific",1.0
25229,57616,GO:0000981,TSHZ3,"DNA-binding transcription factor activity, RNA polymerase II-specific",1.0
25230,57616,GO:0002087,TSHZ3,regulation of respiratory gaseous exchange by nervous system process,1.0
25231,57616,GO:0003677,TSHZ3,DNA binding,1.0
25232,57616,GO:0003677,TSHZ3,DNA binding,1.0
25233,57616,GO:0003682,TSHZ3,chromatin binding,1.0
25234,57616,GO:0005515,TSHZ3,protein binding,1.0
25235,57616,GO:0005634,TSHZ3,nucleus,1.0
25236,57616,GO:0005634,TSHZ3,nucleus,1.0
25237,57616,GO:0005654,TSHZ3,nucleoplasm,1.0
25238,57616,GO:0005886,TSHZ3,plasma membrane,1.0
25239,57616,GO:0006357,TSHZ3,regulation of transcription by RNA polymerase II,1.0
25240,57616,GO:0007275,TSHZ3,multicellular organism development,1.0
25241,57616,GO:0030426,TSHZ3,growth cone,1.0
25242,57616,GO:0045892,TSHZ3,"negative regulation of transcription, DNA-templated",1.0
25243,57616,GO:0046872,TSHZ3,metal ion binding,1.0
25244,57616,GO:0051968,TSHZ3,"positive regulation of synaptic transmission, glutamatergic",1.0
25245,57616,GO:0060291,TSHZ3,long-term synaptic potentiation,1.0
25382,7337,GO:0000502,UBE3A,proteasome complex,1.0
25383,7337,GO:0001541,UBE3A,ovarian follicle development,1.0
25384,7337,GO:0003713,UBE3A,transcription coactivator activity,1.0
25385,7337,GO:0004842,UBE3A,ubiquitin-protein transferase activity,1.0
25386,7337,GO:0005515,UBE3A,protein binding,1.0
25387,7337,GO:0005634,UBE3A,nucleus,1.0
25388,7337,GO:0005829,UBE3A,cytosol,1.0
25389,7337,GO:0006508,UBE3A,proteolysis,1.0
25390,7337,GO:0006511,UBE3A,ubiquitin-dependent protein catabolic process,1.0
25391,7337,GO:0007420,UBE3A,brain development,1.0
25392,7337,GO:0014068,UBE3A,positive regulation of phosphatidylinositol 3-kinase signaling,1.0
25393,7337,GO:0016032,UBE3A,viral process,1.0
25394,7337,GO:0030521,UBE3A,androgen receptor signaling pathway,1.0
25395,7337,GO:0031398,UBE3A,positive regulation of protein ubiquitination,1.0
25396,7337,GO:0032570,UBE3A,response to progesterone,1.0
25397,7337,GO:0035037,UBE3A,sperm entry,1.0
25398,7337,GO:0042220,UBE3A,response to cocaine,1.0
25399,7337,GO:0042542,UBE3A,response to hydrogen peroxide,1.0
25400,7337,GO:0042752,UBE3A,regulation of circadian rhythm,1.0
25401,7337,GO:0045944,UBE3A,positive regulation of transcription by RNA polymerase II,1.0
25402,7337,GO:0046872,UBE3A,metal ion binding,1.0
25403,7337,GO:0048511,UBE3A,rhythmic process,1.0
25404,7337,GO:0050847,UBE3A,progesterone receptor signaling pathway,1.0
25405,7337,GO:0051865,UBE3A,protein autoubiquitination,1.0
25406,7337,GO:0060736,UBE3A,prostate gland growth,1.0
25407,7337,GO:0061002,UBE3A,negative regulation of dendritic spine morphogenesis,1.0
25408,7337,GO:0061630,UBE3A,ubiquitin protein ligase activity,1.0
25409,7337,GO:0070936,UBE3A,protein K48-linked ubiquitination,1.0
25410,7337,GO:1905528,UBE3A,positive regulation of Golgi lumen acidification,1.0
25411,7337,GO:1990416,UBE3A,cellular response to brain-derived neurotrophic factor stimulus,1.0
25412,7337,GO:2000058,UBE3A,regulation of ubiquitin-dependent protein catabolic process,1.0
25542,65109,GO:0000184,UPF3B,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay",1.0
25543,65109,GO:0000184,UPF3B,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay",1.0
25544,65109,GO:0000184,UPF3B,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay",1.0
25545,65109,GO:0000184,UPF3B,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay",1.0
25546,65109,GO:0000184,UPF3B,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay",1.0
25547,65109,GO:0000398,UPF3B,"mRNA splicing, via spliceosome",1.0
25548,65109,GO:0003723,UPF3B,RNA binding,1.0
25549,65109,GO:0003729,UPF3B,mRNA binding,1.0
25550,65109,GO:0003729,UPF3B,mRNA binding,1.0
25551,65109,GO:0005515,UPF3B,protein binding,1.0
25552,65109,GO:0005634,UPF3B,nucleus,1.0
25553,65109,GO:0005654,UPF3B,nucleoplasm,1.0
25554,65109,GO:0005654,UPF3B,nucleoplasm,1.0
25555,65109,GO:0005730,UPF3B,nucleolus,1.0
25556,65109,GO:0005730,UPF3B,nucleolus,1.0
25557,65109,GO:0005737,UPF3B,cytoplasm,1.0
25558,65109,GO:0005737,UPF3B,cytoplasm,1.0
25559,65109,GO:0005829,UPF3B,cytosol,1.0
25560,65109,GO:0005829,UPF3B,cytosol,1.0
25561,65109,GO:0006405,UPF3B,RNA export from nucleus,1.0
25562,65109,GO:0006406,UPF3B,mRNA export from nucleus,1.0
25563,65109,GO:0017056,UPF3B,structural constituent of nuclear pore,1.0
25564,65109,GO:0031124,UPF3B,mRNA 3'-end processing,1.0
25565,65109,GO:0034451,UPF3B,centriolar satellite,1.0
25566,65109,GO:0035145,UPF3B,exon-exon junction complex,1.0
25567,65109,GO:0045727,UPF3B,positive regulation of translation,1.0
25568,65109,GO:0045727,UPF3B,positive regulation of translation,1.0
25882,157680,GO:0015031,VPS13B,protein transport,1.0
25894,51322,GO:0000993,WAC,RNA polymerase II complex binding,1.0
25895,51322,GO:0003682,WAC,chromatin binding,1.0
25896,51322,GO:0005515,WAC,protein binding,1.0
25897,51322,GO:0005634,WAC,nucleus,1.0
25898,51322,GO:0005654,WAC,nucleoplasm,1.0
25899,51322,GO:0005654,WAC,nucleoplasm,1.0
25900,51322,GO:0005681,WAC,spliceosomal complex,1.0
25901,51322,GO:0006974,WAC,cellular response to DNA damage stimulus,1.0
25902,51322,GO:0010390,WAC,histone monoubiquitination,1.0
25903,51322,GO:0016239,WAC,positive regulation of macroautophagy,1.0
25904,51322,GO:0016567,WAC,protein ubiquitination,1.0
25905,51322,GO:0016607,WAC,nuclear speck,1.0
25906,51322,GO:0032435,WAC,negative regulation of proteasomal ubiquitin-dependent protein catabolic process,1.0
25907,51322,GO:0044783,WAC,G1 DNA damage checkpoint,1.0
25908,51322,GO:0045893,WAC,"positive regulation of transcription, DNA-templated",1.0
25909,51322,GO:0071894,WAC,histone H2B conserved C-terminal lysine ubiquitination,1.0
25940,23001,GO:0003831,WDFY3,"beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity",1.0
25941,23001,GO:0005515,WDFY3,protein binding,1.0
25942,23001,GO:0005545,WDFY3,1-phosphatidylinositol binding,1.0
25943,23001,GO:0005635,WDFY3,nuclear envelope,1.0
25944,23001,GO:0005654,WDFY3,nucleoplasm,1.0
25945,23001,GO:0005730,WDFY3,nucleolus,1.0
25946,23001,GO:0005737,WDFY3,cytoplasm,1.0
25947,23001,GO:0005776,WDFY3,autophagosome,1.0
25948,23001,GO:0005776,WDFY3,autophagosome,1.0
25949,23001,GO:0005829,WDFY3,cytosol,1.0
25950,23001,GO:0005886,WDFY3,plasma membrane,1.0
25951,23001,GO:0007275,WDFY3,multicellular organism development,1.0
25952,23001,GO:0016234,WDFY3,inclusion body,1.0
25953,23001,GO:0016605,WDFY3,PML body,1.0
25954,23001,GO:0019898,WDFY3,extrinsic component of membrane,1.0
25955,23001,GO:0030424,WDFY3,axon,1.0
25956,23001,GO:0031965,WDFY3,nuclear membrane,1.0
25957,23001,GO:0034274,WDFY3,Atg12-Atg5-Atg16 complex,1.0
25958,23001,GO:0035973,WDFY3,aggrephagy,1.0
25959,23001,GO:0043204,WDFY3,perikaryon,1.0
25960,23001,GO:0046872,WDFY3,metal ion binding,1.0
25961,23001,GO:0097635,WDFY3,extrinsic component of autophagosome membrane,1.0
26108,7716,GO:0000977,VEZF1,RNA polymerase II transcription regulatory region sequence-specific DNA binding,1.0
26109,7716,GO:0000977,VEZF1,RNA polymerase II transcription regulatory region sequence-specific DNA binding,1.0
26110,7716,GO:0000981,VEZF1,"DNA-binding transcription factor activity, RNA polymerase II-specific",1.0
26111,7716,GO:0001228,VEZF1,"DNA-binding transcription activator activity, RNA polymerase II-specific",1.0
26112,7716,GO:0001525,VEZF1,angiogenesis,1.0
26113,7716,GO:0001885,VEZF1,endothelial cell development,1.0
26114,7716,GO:0005515,VEZF1,protein binding,1.0
26115,7716,GO:0005634,VEZF1,nucleus,1.0
26116,7716,GO:0005654,VEZF1,nucleoplasm,1.0
26117,7716,GO:0006357,VEZF1,regulation of transcription by RNA polymerase II,1.0
26118,7716,GO:0006968,VEZF1,cellular defense response,1.0
26119,7716,GO:0045603,VEZF1,positive regulation of endothelial cell differentiation,1.0
26120,7716,GO:0045944,VEZF1,positive regulation of transcription by RNA polymerase II,1.0
26121,7716,GO:0046872,VEZF1,metal ion binding,1.0
26482,197131,GO:0000151,UBR1,ubiquitin ligase complex,1.0
26483,197131,GO:0000502,UBR1,proteasome complex,1.0
26484,197131,GO:0005515,UBR1,protein binding,1.0
26485,197131,GO:0005737,UBR1,cytoplasm,1.0
26486,197131,GO:0005829,UBR1,cytosol,1.0
26487,197131,GO:0008270,UBR1,zinc ion binding,1.0
26488,197131,GO:0016567,UBR1,protein ubiquitination,1.0
26489,197131,GO:0016567,UBR1,protein ubiquitination,1.0
26490,197131,GO:0032007,UBR1,negative regulation of TOR signaling,1.0
26491,197131,GO:0061630,UBR1,ubiquitin protein ligase activity,1.0
26492,197131,GO:0070728,UBR1,leucine binding,1.0
26493,197131,GO:0071233,UBR1,cellular response to leucine,1.0
26494,197131,GO:0071596,UBR1,ubiquitin-dependent protein catabolic process via the N-end rule pathway,1.0
26678,26137,GO:0000122,ZBTB20,negative regulation of transcription by RNA polymerase II,1.0
26679,26137,GO:0000976,ZBTB20,transcription regulatory region sequence-specific DNA binding,1.0
26680,26137,GO:0000978,ZBTB20,RNA polymerase II cis-regulatory region sequence-specific DNA binding,1.0
26681,26137,GO:0001227,ZBTB20,"DNA-binding transcription repressor activity, RNA polymerase II-specific",1.0
26682,26137,GO:0005634,ZBTB20,nucleus,1.0
26683,26137,GO:0005654,ZBTB20,nucleoplasm,1.0
26684,26137,GO:0005654,ZBTB20,nucleoplasm,1.0
26685,26137,GO:0005737,ZBTB20,cytoplasm,1.0
26686,26137,GO:0006357,ZBTB20,regulation of transcription by RNA polymerase II,1.0
26687,26137,GO:0016604,ZBTB20,nuclear body,1.0
26688,26137,GO:0045821,ZBTB20,positive regulation of glycolytic process,1.0
26689,26137,GO:0046872,ZBTB20,metal ion binding,1.0
26690,26137,GO:0046889,ZBTB20,positive regulation of lipid biosynthetic process,1.0
26691,26137,GO:0055088,ZBTB20,lipid homeostasis,1.0
26692,26137,GO:0071333,ZBTB20,cellular response to glucose stimulus,1.0
26693,26137,GO:1990837,ZBTB20,sequence-specific double-stranded DNA binding,1.0
26752,23036,GO:0000981,ZNF292,"DNA-binding transcription factor activity, RNA polymerase II-specific",1.0
26753,23036,GO:0003677,ZNF292,DNA binding,1.0
26754,23036,GO:0005634,ZNF292,nucleus,1.0
26755,23036,GO:0006357,ZNF292,regulation of transcription by RNA polymerase II,1.0
26756,23036,GO:0045944,ZNF292,positive regulation of transcription by RNA polymerase II,1.0
26757,23036,GO:0046872,ZNF292,metal ion binding,1.0
26786,23613,GO:0003714,ZMYND8,transcription corepressor activity,1.0
26787,23613,GO:0003714,ZMYND8,transcription corepressor activity,1.0
26788,23613,GO:0005515,ZMYND8,protein binding,1.0
26789,23613,GO:0005634,ZMYND8,nucleus,1.0
26790,23613,GO:0005634,ZMYND8,nucleus,1.0
26791,23613,GO:0005654,ZMYND8,nucleoplasm,1.0
26792,23613,GO:0005737,ZMYND8,cytoplasm,1.0
26793,23613,GO:0005794,ZMYND8,Golgi apparatus,1.0
26794,23613,GO:0006355,ZMYND8,"regulation of transcription, DNA-templated",1.0
26795,23613,GO:0008270,ZMYND8,zinc ion binding,1.0
26796,23613,GO:0019904,ZMYND8,protein domain specific binding,1.0
26797,23613,GO:0030336,ZMYND8,negative regulation of cell migration,1.0
26798,23613,GO:0035064,ZMYND8,methylated histone binding,1.0
26799,23613,GO:0043197,ZMYND8,dendritic spine,1.0
26800,23613,GO:0043198,ZMYND8,dendritic shaft,1.0
26801,23613,GO:0047485,ZMYND8,protein N-terminus binding,1.0
26802,23613,GO:0051491,ZMYND8,positive regulation of filopodium assembly,1.0
26803,23613,GO:0060999,ZMYND8,positive regulation of dendritic spine development,1.0
26804,23613,GO:0070491,ZMYND8,repressing transcription factor binding,1.0
26805,23613,GO:0070577,ZMYND8,lysine-acetylated histone binding,1.0
26806,23613,GO:0098815,ZMYND8,modulation of excitatory postsynaptic potential,1.0
26807,23613,GO:1902897,ZMYND8,regulation of postsynaptic density protein 95 clustering,1.0
26808,23613,GO:1902952,ZMYND8,positive regulation of dendritic spine maintenance,1.0
26809,23613,GO:1903507,ZMYND8,negative regulation of nucleic acid-templated transcription,1.0
26816,58499,GO:0003677,ZNF462,DNA binding,1.0
26817,58499,GO:0005515,ZNF462,protein binding,1.0
26818,58499,GO:0005634,ZNF462,nucleus,1.0
26819,58499,GO:0006325,ZNF462,chromatin organization,1.0
26820,58499,GO:0010468,ZNF462,regulation of gene expression,1.0
26821,58499,GO:0043392,ZNF462,negative regulation of DNA binding,1.0
26822,58499,GO:0045944,ZNF462,positive regulation of transcription by RNA polymerase II,1.0
26823,58499,GO:0046872,ZNF462,metal ion binding,1.0
